<SEC-DOCUMENT>0001933414-26-000084.txt : 20260506
<SEC-HEADER>0001933414-26-000084.hdr.sgml : 20260506
<ACCEPTANCE-DATETIME>20260506171541
ACCESSION NUMBER:		0001933414-26-000084
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		55
CONFORMED PERIOD OF REPORT:	20260331
FILED AS OF DATE:		20260506
DATE AS OF CHANGE:		20260506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mineralys Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001933414
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41614
		FILM NUMBER:		26949704

	BUSINESS ADDRESS:	
		STREET 1:		150 N. RADNOR CHESTER RD.
		STREET 2:		SUITE F200
		CITY:			RADNOR
		STATE:			PA
		ZIP:			19087
		BUSINESS PHONE:		(888) 378-6240

	MAIL ADDRESS:	
		STREET 1:		150 N. RADNOR CHESTER RD.
		STREET 2:		SUITE F200
		CITY:			RADNOR
		STATE:			PA
		ZIP:			19087
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mlys-20260331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d6f31-ff89-7928-a1ca-06ccbd9e4802,g:1233a744-2d7f-4bba-93f2-58a8edc900ae,d:57b16674741942018798123fe81d3bc9-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:mlys="http://www.mineralystx.com/20260331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mlys-20260331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-27">0001933414</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2026</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-29">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-30">False</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-31">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-78" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-312">446</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mlys-20260331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>mlys:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-14</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mlys:TanabeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mlys:TanabeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mlys:TanabeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mlys:TanabeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mlys:TanabeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:EquityIncentivePlan2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mlys:PreFundedWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:EquityIncentivePlan2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-11-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PriorATMAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-21</xbrli:startDate><xbrli:endDate>2025-11-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PriorATMAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-11-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2023IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2023IncentiveAwardPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2023IncentiveAwardPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2025IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2025IncentiveAwardPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2025IncentiveAwardPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2020EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2020EquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2020EquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2023EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2023EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">mlys:CatalysPacificFundLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001933414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">mlys:CatalysPacificFundLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-175 f-176" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"/></ix:resources></ix:header></div><div id="i57b16674741942018798123fe81d3bc9_235"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-indent:36pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:35.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.160%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.348%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March&#160;31, 2026</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.348%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#168;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ______ to ______</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-41614</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:35.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.160%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">MINERALYS THERAPEUTICS, INC.</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">84-1966887</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">150 N. Radnor Chester Road</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-10">Suite F200</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Radnor</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-12">PA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">19087</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Address, including zip code, of principal executive offices)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">888</ix:nonNumeric>-<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">378-6240</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report): NA</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common stock, $0.0001 par value per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">MLYS</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-19">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-20">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.040%"><tr><td style="width:1.0%"/><td style="width:36.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.933%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.731%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Large accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-21">Non-accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-22">x</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-23">x</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-24">o</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-25">x</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;27, 2026, there were <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-26">82,498,101</ix:nonFraction> shares of the registrant&#8217;s common stock outstanding.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div></div></div><div id="i57b16674741942018798123fe81d3bc9_238"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.067%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_241">Part I - Financial Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_241">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_103">Item 1. Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_103">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_52">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_13">13</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_244">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_244">24</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_247">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_247">25</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_250">Part II - Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_250">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_253">Item 1. Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_253">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_256">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_256">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_259">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_259">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_262">Item 3. Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_262">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_265">Item 4. Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_265">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_184">Item 5. Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_184">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_220">Item 6. Exhibits</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_220">27</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_271">Signatures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i57b16674741942018798123fe81d3bc9_241"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Part I - Financial Information</span></div><div id="i57b16674741942018798123fe81d3bc9_103"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements </span></div><div id="i57b16674741942018798123fe81d3bc9_106"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(unaudited)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-32">112,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-33">172,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">533,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">483,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">6,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">4,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">652,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-39">661,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-40">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-41">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="f-42">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="f-43">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-44">652,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-45">661,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-46">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-47">2,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-48">13,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-49">13,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">14,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">15,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 4)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-52"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-53"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-54"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-55">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-56"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-57">500,000,000</ix:nonFraction></ix:nonFraction> shares authorized as of March&#160;31, 2026 and December&#160;31, 2025; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-58"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-59">82,454,950</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-60"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-61">81,536,557</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-62">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-63">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-64">1,134,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-65">1,103,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-66">496,508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-67">457,169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-68">638,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-69">646,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-70">652,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-71">661,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed financial statements.</span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i57b16674741942018798123fe81d3bc9_109"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-72">24,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-73">37,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-74">20,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-75">6,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-76">45,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-77">44,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-78">45,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-79">44,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-80">5,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-81">2,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-82">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-83">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-84">6,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-85">2,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-86">39,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-87">42,211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-88"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-89">0.47</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-90"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-91">0.79</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-92"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-93">82,834,752</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-94"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-95">53,163,551</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed financial statements.</span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i57b16674741942018798123fe81d3bc9_112"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.888%"><tr><td style="width:1.0%"/><td style="width:48.288%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.584%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Additional <br/>Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-96">49,821,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-97">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-98">493,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-99">302,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-100">191,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock in public offering, net of offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-101">12,509</ix:nonFraction></span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-102">14,907,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-103">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-104">188,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-105">188,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock from stock option exercises</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-106">146,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-107">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-108">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-109">3,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-110">3,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-111">42,211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-112">42,211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-113">64,876,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-114">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-115">686,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-116">344,729</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-117">341,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.888%"><tr><td style="width:1.0%"/><td style="width:48.288%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.577%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.584%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Additional <br/>Paid-In Capital</span></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-118">81,536,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-119">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-120">1,103,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-121">457,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-122">646,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock pursuant to ATM Agreement, net of issuance costs and shelf offering costs of $<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-123">82</ix:nonFraction></span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-124">568,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-125">20,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-126">20,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock from stock option exercises</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-127">350,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-128">4,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-129">4,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-130">6,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-131">6,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-132">39,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-133">39,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-134">82,454,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-135">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-136">1,134,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-137">496,508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-138">638,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed financial statements.</span></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i57b16674741942018798123fe81d3bc9_115"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-139">39,339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-140">42,211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-141">6,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-142">3,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discount on held-to-maturity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-143">4,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="f-144">1,046</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="f-145">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="f-146">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="3" id="f-147">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="3" id="f-148">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid, other current assets, and other assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-149">1,948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-150">4,396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="f-151">402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-152">1,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-153">39,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-154">45,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-155">347,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-156">127,876</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-157">302,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-158">35,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-159">44,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-160">92,876</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock pursuant to ATM Agreement, net of ATM issuance costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-161">20,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-162">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock option exercises</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-163">4,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-164">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payment of shelf offering costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-165">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-166">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock in public offering, net of offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-167">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-168">189,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-169">24,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-170">189,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-171">60,142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-172">50,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - beginning</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-173">172,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-174">114,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - ending</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-175">112,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-176">165,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Disclosure of Non-Cash Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Public offering and shelf offering costs included in accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="mlys:OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" scale="3" id="f-177">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="mlys:OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" scale="3" id="f-178">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><ix:footnote id="fn-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cash and cash equivalents as of March&#160;31, 2026 exclude investments of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DebtSecuritiesCurrent" scale="6" id="f-179">533.3</ix:nonFraction>&#160;million. Cash, cash equivalents, and investments amounted to $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InvestmentsAndCash" scale="6" id="f-180">646.1</ix:nonFraction>&#160;million as of March&#160;31, 2026.</span></ix:footnote></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i57b16674741942018798123fe81d3bc9_118"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i57b16674741942018798123fe81d3bc9_121"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 1. <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-181" continuedAt="f-181-1" escape="true">Nature of Business</ix:nonNumeric></span></div><ix:continuation id="f-181-1" continuedAt="f-181-2"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mineralys Therapeutics, Inc. (the Company) is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company&#8217;s product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. The Company has completed two pivotal clinical trials of lorundrostat for hypertension, one Phase 2 clinical trial in hypertensive participants with chronic kidney disease, and one Phase 2 clinical trial in hypertensive participants with obstructive sleep apnea. The Company submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in December&#160;2025 for lorundrostat for the treatment of hypertension in combination with other antihypertensive drugs. The FDA accepted the NDA submission and provided the Company with a Prescription Drug User Fee Act target date of December&#160;22, 2026 for lorundrostat. The Company was incorporated as a Delaware corporation in May 2019, and it is headquartered in Radnor, Pennsylvania. The Company&#8217;s operations to date have been limited to business planning, raising capital, in-licensing, conducting preclinical and clinical trials, and performing research and development and other activities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception, the Company has not generated any revenue from product sales or other sources and has incurred significant operating losses and negative cash flows from operations. The Company&#8217;s primary uses of cash to date have been to fund research and development activities, business planning, establishing and maintaining the Company&#8217;s intellectual property portfolio, hiring personnel, raising capital, and providing general and administrative support for these operations. As of March&#160;31, 2026, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-182">496.5</ix:nonFraction>&#160;million and cash, cash equivalents, and investments of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InvestmentsAndCash" scale="6" id="f-183">646.1</ix:nonFraction> million. For the three months ended March&#160;31, 2026, the Company had a net loss of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="f-184">39.3</ix:nonFraction>&#160;million and net cash used in operating activities of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-185">39.5</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-181-2">Since inception, the Company has funded its operations by raising aggregate gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-8" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="9" id="f-186">1.1</ix:nonFraction> billion from the sale of the Company&#8217;s common stock, convertible preferred stock, pre-funded warrants, and convertible notes. The Company has a limited operating history, and the sales and income potential of its business is unproven. The Company expects to continue to incur substantial losses for the foreseeable future as a result of the Company&#8217;s research and development and other activities. Additional funding will be required to continue with the Company&#8217;s planned research and development and commercial launch activities. The Company expects to finance its operations through equity offerings, debt financings, and other capital sources, including potential strategic collaborations, licensing, and other similar arrangements. The Company believes that its cash, cash equivalents, and investments as of March&#160;31, 2026 will be sufficient to allow the Company to fund operations for at least twelve months from the issuance date of these condensed financial statements.</ix:continuation> </span></div><div id="i57b16674741942018798123fe81d3bc9_127"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="f-187" continuedAt="f-187-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-188" continuedAt="f-188-1" escape="true"><ix:continuation id="f-187-1" continuedAt="f-187-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and applicable rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules and regulations, certain footnotes or other financial information normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the Company&#8217;s financial information. These unaudited condensed financial statements should be read in </span></div></ix:continuation></ix:nonNumeric><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-187-2" continuedAt="f-187-3"><ix:continuation id="f-188-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">conjunction with the audited financial statements and related notes in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2025.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable guidance is meant to refer to authoritative U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) of the Financial Accounting Standards Board (FASB).</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-189" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-190">one</ix:nonFraction> operating segment for the purposes of assessing performance, making operating decisions, and allocating Company resources. The Company&#8217;s chief operating decision maker (CODM) is its chief executive officer, who considers net loss to evaluate overall expenses associated with conducting research and development activities, which includes evaluating the progress of ongoing clinical trials and the planning and execution of current and future research and development and other activities. Further, the CODM reviews and utilizes functional expenses (research and development and general and administrative) as reported in the statements of operations to manage the Company&#8217;s operations. Other segment items included in net loss are interest income, net and other income (expense). These measures of performance, significant expenses, and other items are each reflected in the condensed statements of operations. The accounting policies of the segment are the same as those described below. The measure of segment assets is reported on the condensed balance sheets as total assets. All assets are held in the United States.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-191" continuedAt="f-191-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-191-1">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Estimates have been used in the following areas, among others: research and development accruals and income taxes.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-192" continuedAt="f-192-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-192-1">All highly liquid investments that have maturities of 90 days or less at the date of purchase are classified as cash equivalents.</ix:continuation> The Company&#8217;s cash and cash equivalents balances as of March&#160;31, 2026 and December&#160;31, 2025 include cash balances and amounts held primarily in interest-bearing money market accounts and U.S. Treasury bills. As of March&#160;31, 2026 and December&#160;31, 2025, the Company did <ix:nonFraction unitRef="usd" contextRef="c-3" decimals="INF" name="us-gaap:RestrictedCash" format="ixt:fixed-zero" scale="0" id="f-193"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:RestrictedCash" format="ixt:fixed-zero" scale="0" id="f-194">no</ix:nonFraction></ix:nonFraction>t have any restricted cash balances. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-195" continuedAt="f-195-1" escape="true">The following table provides a reconciliation of cash and cash equivalents as reported in the condensed statements of cash flows to the condensed balance sheets (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-195-1"><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"/><td style="width:69.183%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.424%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.426%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="f-196">1,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="f-197">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-198">111,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-199">171,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-200">112,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-201">172,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-202" continuedAt="f-202-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-202-1">The Company has no significant off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts, or other hedging arrangements. Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash balances in several accounts with three financial institutions that, from time to time, are in excess of federally insured limits.</ix:continuation> </span></div></ix:continuation><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-187-3" continuedAt="f-187-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-203" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to disclose information on all assets and liabilities reported at fair value that enables an assessment of the inputs used in determining the reported fair values. ASC Topic 820, Fair Value Measurement, establishes a hierarchy of inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the observable inputs be used when available. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy applies only to the valuation inputs used in determining the reported fair value and is not a measure of the investment credit quality. The three levels of the fair value hierarchy are described below: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; quoted prices in active markets for identical assets and liabilities</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; other significant observable inputs (including quoted prices for similar assets and liabilities, interest rates, credit risk, etc.)</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; significant unobservable inputs (including the Company&#8217;s own assumptions in determining the fair value of assets and liabilities)</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For certain financial instruments, including cash and cash equivalents, prepaid expenses, accounts payable, and certain accrued liabilities, the recorded amount approximates estimated fair value due to their relatively short maturity period. Refer to Note 3. &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">for additional details of the Company&#8217;s financial instruments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentPolicyTextBlock" id="f-204" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally invests its excess cash in money market funds and investment-grade short- and long-term fixed-income debt securities, such as U.S. Treasury bills. Such investments are included in cash and cash equivalents and investments in the condensed balance sheets. The Company determines the appropriate classification of securities at the time of purchase and re-evaluates such designation as of each balance sheet date. Securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are carried at amortized cost, adjusted for the accretion of discounts using the interest method.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company invested in marketable securities during the three months ended March&#160;31, 2026 and 2025, and no impairment charges were recorded. For held-to-maturity investments, the Company periodically reviews each individual security position that has an unrealized loss, or impairment, to determine if that impairment is other-than-temporary. If the Company believes an impairment of a security position is other than temporary, based on available quantitative and qualitative information as of the report date, the loss will be recognized within total other income, net in the Company&#8217;s condensed statements of operations, and a new cost basis in the investment will be established.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredChargesPolicyTextBlock" id="f-205" continuedAt="f-205-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Offering Costs</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-205-1">The Company capitalizes certain legal, professional, accounting, and other third-party fees that are directly associated with in-process equity issuances as deferred offering costs until such equity issuances are consummated. After consummation of the equity issuance, these costs are recorded as a reduction in the capitalized amount associated with the equity issuance. Should the equity issuance be abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the condensed statements of operations.</ix:continuation> Deferred offering costs as of each of March&#160;31, 2026 and December&#160;31, 2025 were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredOfferingCosts" scale="6" id="f-206"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredOfferingCosts" scale="6" id="f-207">0.2</ix:nonFraction></ix:nonFraction>&#160;million. Such costs are classified in other assets on the condensed balance sheets.</span></div></ix:continuation><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-187-4" continuedAt="f-187-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-208" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its stock-based compensation awards in accordance with ASC Topic 718, Compensation &#8211; Stock Compensation (ASC 718). ASC 718 requires share-based payment arrangements to be recognized in the condensed statements of operations based on their grant date fair values. The Company&#8217;s stock-based awards are subject only to service-based vesting conditions. The Company measures restricted common stock awards using the difference, if any, between the purchase price per share of the award and the fair value of the Company&#8217;s common stock at the date of the grant or modification. Restricted stock unit awards are measured at the grant date fair value based on the closing price of the Company&#8217;s common stock on the date of the grant. The Company estimates the fair value of its stock option awards using the Black-Scholes option pricing model, which requires the input of assumptions, including (i)&#160;the expected stock price volatility, (ii)&#160;the calculation of the expected term of the award, (iii)&#160;the risk-free interest rate, and (iv)&#160;expected dividends. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Volatility</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Due to the Company&#8217;s limited operating history and a lack of company-specific historical and implied volatility data, the Company has based its estimate of expected volatility on the historical volatility of a group of similar publicly-traded companies. The Company believes that the companies in the group were most representative of the Company and had characteristics similar to its own, including stage of product development, a focus on the life sciences industry, and other economic and industry characteristics. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company uses the simplified method to calculate the expected term, as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term for options granted, and utilizes the contractual term for options granted. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividends </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; To date, the Company has not issued any dividends and does not expect to issue dividends over the life of the options and therefore has estimated the dividend yield to be zero.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the Company&#8217;s initial public offering of its common stock in February 2023, the Company determines the fair market value of its common stock using the closing price of its common stock as reported on the Nasdaq Global Select Market.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense related to time-based awards, including restricted stock units, is recognized on a straight-line basis by recognizing the grant date fair value over the requisite service period, which is generally the vesting term. Management evaluates its award grants and modifications and will adjust the fair value if any are determined to be spring-loaded. The Company accounts for forfeitures as they occur.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-209" continuedAt="f-209-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Loss Per Share </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-209-1">The Company&#8217;s basic net loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share attributable to common stockholders is computed by giving effect to all potential common stock equivalents outstanding for the period, determined using the treasury stock method. For purposes of this calculation, unvested restricted stock awards, restricted stock units, and stock options to purchase common stock are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive. The weighted-average number of common shares used in the basic and diluted net loss per share attributable to common stockholders calculations includes the weighted-average pre-funded warrants outstanding during the period, as they are exercisable at any time for nominal cash consideration.</ix:continuation> <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-210" continuedAt="f-210-1" escape="true">The following table sets forth the </ix:nonNumeric></span></div></ix:continuation><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-187-5"><ix:continuation id="f-210-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">potential common shares excluded from the calculation of net loss per share attributable to common stockholders because their inclusion would be anti-dilutive: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-211">7,420,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-212">6,778,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-37" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-213">702,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-214">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-215">64,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-216">309,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-217">8,188,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-218">7,087,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-219" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard-setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#160;(ASU 2024-03), and in January 2025, the FASB issued ASU 2025-01, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require the Company to disclose additional information about specific expense categories in the notes to the financial statements on an annual and interim basis.&#160;ASU 2024-03 is effective for the Company's fiscal year 2027 and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of ASU 2024-03 on its disclosures. While the Company expects that additional disaggregated disclosures will be required upon adoption, the guidance will not affect the recognition or measurement of expenses.</span></div></ix:nonNumeric></ix:continuation><div id="i57b16674741942018798123fe81d3bc9_130"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-220" continuedAt="f-220-1" escape="true">Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="f-220-1" continuedAt="f-220-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-221" escape="true"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents financial instruments measured at fair value on a recurring basis based on the fair value hierarchy as of March&#160;31, 2026 and December&#160;31, 2025 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-222">111,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-223">161,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers within the fair value hierarchy during the periods presented.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used by the Company in estimating the fair values of each class of financial instrument disclosed herein:</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Money Market Funds &#8212; The carrying amounts of money market funds reported as cash and cash equivalents in the condensed balance sheets approximate their fair values due to their short-term nature. The fair values of money market funds are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury Bills &#8212; As of March&#160;31, 2026 and December&#160;31, 2025, the Company had short-term U.S. Treasury bills. Fair values of these securities are determined by Level 2 inputs utilizing quoted prices </span></div></ix:continuation><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-220-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(unadjusted) in active markets for similar assets. <ix:nonNumeric contextRef="c-1" name="us-gaap:HeldToMaturitySecuritiesTextBlock" id="f-224" continuedAt="f-224-1" escape="true">The following table presents information about the Company&#8217;s investments in held-to-maturity U.S. Treasury bills as of each reported date (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-224-1"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Original Maturities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">between 3 and 12 months</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-225">533,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityFairValueCurrent" format="ixt:num-dot-decimal" scale="3" id="f-226">533,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Original Maturities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">less than 3 months</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-227">9,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityFairValueCurrent" format="ixt:num-dot-decimal" scale="3" id="f-228">9,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">between 3 and 12 months</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-229">483,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityFairValueCurrent" format="ixt:num-dot-decimal" scale="3" id="f-230">483,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-231">493,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesFairValue" format="ixt:num-dot-decimal" scale="3" id="f-232">493,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div id="i57b16674741942018798123fe81d3bc9_133"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-233" continuedAt="f-233-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-233-1" continuedAt="f-233-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tanabe License Agreement </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company entered into an exclusive license agreement (the Tanabe License) with Tanabe Pharma Corporation (Tanabe) (formerly Mitsubishi Tanabe Pharma Corporation), pursuant to which Tanabe granted the Company an exclusive, worldwide, royalty-bearing, sublicensable license under Tanabe&#8217;s patent and other intellectual property rights to exploit products incorporating lorundrostat (formerly MT-4129) (Lorundrostat Product) for the prevention, treatment, diagnosis, detection, monitoring, or predisposition testing with respect to indications, diseases, and conditions in humans. Pursuant to the Tanabe License, the Company paid Tanabe a $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="mlys:CollaborativeArrangementRightsAndObligationsUpfrontFee" scale="6" id="f-234">1.0</ix:nonFraction>&#160;million upfront fee and development milestone payments of $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="mlys:CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments" scale="6" id="f-235">9.0</ix:nonFraction>&#160;million in the aggregate. The Company has remaining obligations to pay Tanabe commercial milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="mlys:CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" scale="6" id="f-236">155.0</ix:nonFraction>&#160;million in the aggregate upon first commercial sale and upon meeting certain annual sales targets, as well as additional commercial milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="mlys:CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments" scale="6" id="f-237">10.0</ix:nonFraction>&#160;million for a second indication. Additionally, the Company is obligated to pay Tanabe tiered royalties at percentages ranging from the mid-single digits to ten percent (<ix:nonFraction unitRef="number" contextRef="c-47" decimals="2" name="mlys:CollaborativeArrangementRightsAndObligationsRoyaltyPercentage" scale="-2" id="f-238">10</ix:nonFraction>%) of aggregate net sales of each Lorundrostat Product on a Lorundrostat Product-by-Lorundrostat Product and country-by-country basis, until the later of (i) the expiration of the last-to-expire valid Tanabe patent claim covering a Lorundrostat Product, (ii) <ix:nonNumeric contextRef="c-46" name="mlys:CollaborativeArrangementRightsAndObligationsExpirationPeriod" format="ixt-sec:durwordsen" id="f-239">ten years</ix:nonNumeric> from the first commercial sale of a Lorundrostat Product, or (iii) the expiration of regulatory exclusivity in such country. Such royalties are subject to reduction under specified conditions, including lack of patent coverage and generic competition.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="usd" contextRef="c-48" decimals="INF" name="mlys:CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" format="ixt:fixed-zero" scale="0" id="f-240"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="INF" name="mlys:CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" format="ixt:fixed-zero" scale="0" id="f-241">no</ix:nonFraction></ix:nonFraction> remaining development milestone obligations under the Tanabe License and did not incur any development or commercial expenses pursuant to the Tanabe License during the three months ended March&#160;31, 2026 and 2025.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated to use commercially reasonable efforts to conduct and complete the development activities and to file for regulatory approval for at least one Lorundrostat Product in a major market country and consider in good faith developing at least one Lorundrostat Product in a non-major market country. If the Company elects to sublicense its rights under the Tanabe License to a third party with respect to exploitation of lorundrostat or any Lorundrostat Product in certain countries in Asia, the Company has agreed to negotiate such a sublicense first, for a specified period of time, with Tanabe, if Tanabe notifies the Company that it would like to obtain such a sublicense. The Company also agreed not to commercialize any competing product prior to <ix:nonNumeric contextRef="c-46" name="mlys:CollaborativeArrangementRightsAndObligationsNonCompetePeriod" format="ixt-sec:durwordsen" id="f-242">three years</ix:nonNumeric> following the first commercial sale of the first Lorundrostat Product in any country without Tanabe&#8217;s prior consent.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unless terminated earlier, the Tanabe License will continue until the expiration of all of the Company&#8217;s royalty obligations to Tanabe. The Company may terminate the Tanabe License for any or no reason upon <ix:nonNumeric contextRef="c-50" name="mlys:CollaborativeArrangementRightsAndObligationsTerminationPeriod" format="ixt-sec:durday" id="f-243">90</ix:nonNumeric> or <ix:nonNumeric contextRef="c-47" name="mlys:CollaborativeArrangementRightsAndObligationsTerminationPeriod" format="ixt-sec:durday" id="f-244">180</ix:nonNumeric> days&#8217; prior written notice to Tanabe, depending on whether the Lorundrostat Product has received </span></div></ix:continuation><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-233-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">regulatory approval. Tanabe may terminate the Tanabe License if the Company or its affiliates or sublicensees initiate a challenge to the patent rights licensed to the Company by Tanabe. In addition, either party may terminate the Tanabe License in the event of an uncured material breach by or bankruptcy of the other party, subject to certain notice and cure periods, or upon the other party&#8217;s bankruptcy or insolvency.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company was not subject to any material legal proceedings during the three months ended March&#160;31, 2026 and 2025, and no material legal proceedings are currently pending or threatened.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Agreements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners, and other parties with respect to certain matters including, but not limited to, losses arising from breach of such agreements or intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with officers of the Company and members of its board of directors that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as officers or directors. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not aware of any claims under indemnification arrangements, and it has not accrued any material liabilities related to such obligations in its condensed financial statements as of March&#160;31, 2026 and December&#160;31, 2025.</span></div></ix:continuation><div id="i57b16674741942018798123fe81d3bc9_136"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="f-245" continuedAt="f-245-1" escape="true">Accrued Liabilities</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-246" escape="true"><ix:continuation id="f-245-1"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="mlys:AccruedResearchAndDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-247">4,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="mlys:AccruedResearchAndDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-248">3,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-249">2,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-250">5,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-251">6,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-252">4,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-253">13,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-254">13,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i57b16674741942018798123fe81d3bc9_139"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-255" continuedAt="f-255-1" escape="true">Capital Stock</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="mlys:ScheduleOfCommonStockAuthorizedTableTextBlock" id="f-256" escape="true"><ix:continuation id="f-255-1" continuedAt="f-255-2"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, the Company had reserved authorized shares of common stock for future issuance as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-257">7,420,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under the 2023 Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-52" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-258">2,866,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under the ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-259">2,067,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-54" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-260">702,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-funded warrants issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-261">549,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under the 2025 Inducement Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-262">539,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-263">14,147,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-255-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">At-the-Market Equity Offering Sales Agreements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;10, 2025, the Company entered into an ATM Equity Offering Sales Agreement (the ATM Agreement) with BofA Securities, Inc., Evercore Group L.L.C., and Goldman Sachs &amp; Co. LLC, pursuant to which the Company may sell shares of its common stock having an aggregate offering price of up to $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="mlys:SaleOfStockConsiderationReceivableOnTransaction" scale="6" id="f-264">300.0</ix:nonFraction>&#160;million from time to time. During the three months ended March&#160;31, 2026, the Company sold pursuant to the ATM Agreement an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-23" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-265">568,320</ix:nonFraction> shares of common stock at a weighted-average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-23" decimals="2" name="mlys:SaleOfStockPricePerShareWeightedAveragePrice" scale="0" id="f-266">35.66</ix:nonFraction> per share for aggregate net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="mlys:ProceedsFromIssuanceOfCommonStockNet" scale="6" id="f-267">20.2</ix:nonFraction>&#160;million after deducting commissions and offering expenses. There were no sales of common stock pursuant to the ATM Agreement during the three months ended March&#160;31, 2025. From inception of the ATM Agreement and through March&#160;31, 2026, the Company sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-58" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-268">2,720,508</ix:nonFraction> shares of common stock at a weighted-average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-59" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-269">41.45</ix:nonFraction> per share for aggregate net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-5" name="mlys:ProceedsFromIssuanceOfCommonStockNet" scale="6" id="f-270">112.4</ix:nonFraction>&#160;million after deducting commissions and offering expenses. As of March&#160;31, 2026, approximately $<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-5" name="mlys:MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale" scale="6" id="f-271">187.2</ix:nonFraction>&#160;million of shares remained available for sale pursuant to the ATM Agreement. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;21, 2024, the Company entered into an ATM Equity Offering Sales Agreement (the Prior ATM Agreement) with BofA Securities, Inc. and Evercore Group L.L.C. Effective November&#160;9, 2025, the Prior ATM Agreement was terminated in connection with the execution of the ATM Agreement. There were no sales of common stock pursuant to the Prior ATM Agreement during each of the three months ended March&#160;31, 2026 and March&#160;31, 2025. From inception of the Prior ATM Agreement and through its termination effective November&#160;9, 2025, the Company sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-60" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-272">1,914,040</ix:nonFraction> shares of common stock at a weighted-average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-61" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-273">14.32</ix:nonFraction> per share for aggregate net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-274">27.3</ix:nonFraction>&#160;million after deducting commissions and offering expenses.</span></div></ix:continuation><div id="i57b16674741942018798123fe81d3bc9_148"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-275" continuedAt="f-275-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-275-1" continuedAt="f-275-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Incentive Award Plan</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants equity awards under the 2023 Incentive Award Plan (the 2023 Plan). During the three months ended March 31, 2026, the Company began granting restricted stock units under the 2023 Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Employment Inducement Incentive Award Plan</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains the 2025 Employment Inducement Incentive Award Plan (the 2025 Inducement Plan), under which non&#8209;qualified stock options and restricted stock units may be granted in connection with the commencement of employment. During the three months ended March 31, 2026, the Company began granting restricted stock units under the 2025 Inducement Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Equity Incentive Plan (the 2020 Plan) continues to govern the terms of outstanding awards, although no new awards are granted under the plan.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-276" escape="true"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, the Company had the following balances by plan:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Unvested<br/>Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Unvested<br/>Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares Available<br/>for Grant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2023 Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-62" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-277">6,841,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="f-278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-64" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-279">568,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-62" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-280">2,866,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025 Inducement Plan</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-281">325,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-66" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="f-282">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-67" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-283">134,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-284">539,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2020 Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-68" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-285">253,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-69" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-286">64,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-70" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="f-287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-68" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="0" id="f-288">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-289">7,420,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-71" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-290">64,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-54" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-291">702,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-292">3,406,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Mineralys Therapeutics, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-275-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains the 2023 Employee Stock Purchase Plan (the ESPP) under which eligible employees may purchase shares of common stock through payroll deductions. As of March&#160;31, 2026, the Company had <ix:nonFraction unitRef="shares" contextRef="c-72" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-293">2,067,084</ix:nonFraction> shares available for issuance, and <ix:nonFraction unitRef="shares" contextRef="c-73" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-294">57,839</ix:nonFraction> cumulative shares had been issued under the ESPP.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-295" escape="true"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was allocated as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.401%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-296">2,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-297">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-298">4,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-299">2,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-300">6,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-301">3,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i57b16674741942018798123fe81d3bc9_52"></div><div style="margin-bottom:9pt"><span id="i9cd148d418184cc0b86ad4c8aad7d56f_748"></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis and the unaudited interim financial statements included in this Quarterly Report on Form 10-Q (Quarterly Report) should be read in conjunction with the financial statements and notes thereto for the year ended December&#160;31, 2025 and the related Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, both of which are contained in the Annual Report on Form 10-K for the year ended December&#160;31, 2025.</span></div><div id="i57b16674741942018798123fe81d3bc9_13"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). All statements other than statements of historical facts contained in this Quarterly Report, including statements regarding our future results of operations and financial position, business strategy, research and development plans, the anticipated timing, costs, design, and conduct of our ongoing and planned preclinical studies and planned clinical trials for lorundrostat and any future product candidates, the timing and likelihood of regulatory filings and approvals for lorundrostat (including the anticipated timing of any U.S. Food and Drug Administration&#8217;s (FDA) approval of our new drug application (NDA) that was submitted to the FDA for lorundrostat for the treatment of hypertension when used in combination with other antihypertensive drugs in December 2025) and any future product candidates, our ability to commercialize our product candidates, if approved, the potential to develop future product candidates, the potential benefits of strategic collaborations and our intent to enter into any strategic arrangements, the timing and likelihood of success, plans and objectives of management for future operations and future results of anticipated product development efforts, and the sufficiency of our cash, cash equivalents and investments to fund our operations, are forward-looking statements. These statements involve known and unknown risks, uncertainties, and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements, including the timing, volume and nature of feedback or requests from the FDA in connection with our NDA submission, macroeconomic trends and uncertainty with regard to high interest rates, elevated inflation, tariffs and other trade policies, geopolitical conflict, and the potential for a local and/or global economic recession. This Quarterly Report also contains estimates and other statistical data made by independent parties and by us relating to market size and growth and other data about our industry. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. In addition, projections, assumptions, and estimates of our future performance and the future performance of the markets in which we operate are necessarily subject to a high degree of uncertainty and risk. </span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; or &#8220;would,&#8221; or the negative of these terms or other similar expressions. The forward-looking statements in this Quarterly Report are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of risks, uncertainties, and assumptions, including, without limitation, the risk factors described in Part II, Item 1A, &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_256">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Quarterly Report, in Part I, Item 1A, &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001933414/000193341426000056/mlys-20251231.htm#ic3329316665b4be9b86db1f0dd7e6dd9_187">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2025, and under a similar heading in any other periodic or current report we may file with the U.S. Securities and Exchange Commission (the SEC) in the future. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances, or otherwise. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report includes trademarks, trade names, and service marks that are the property of other organizations. Solely for convenience, trademarks and trade names referred to in this Quarterly Report appear without the &#174; and &#8482; symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights, or that the applicable owner will not assert its rights, to these trademarks and trade names.</span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i57b16674741942018798123fe81d3bc9_55"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA), and other diseases driven by dysregulated aldosterone. Our initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have now completed six clinical trials of lorundrostat supporting its efficacy and safety profile while also validating aldosterone as an integral therapeutic target in uncontrolled hypertension (uHTN) and resistant hypertension (rHTN). The clinical program includes two pivotal, registrational trials, the Phase 3 Launch-HTN trial and Phase 2 Advance-HTN trial, which support the robust, durable, and clinically meaningful reductions in systolic blood pressure (BP) by lorundrostat. Lorundrostat was well tolerated in both trials with a favorable safety profile. We submitted our NDA to the FDA in December 2025 for lorundrostat for the treatment of hypertension in combination with other antihypertensive drugs. The FDA accepted the NDA submission and provided us with a Prescription Drug User Fee Act (PDUFA) target date of December 22, 2026 for lorundrostat.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, there are approximately 120&#160;million patients with sustained elevated BP, or hypertension. Approximately 60 million patients are treated and over 30 million do not achieve their BP goal, with approximately 20 million having systolic BP levels greater than 140 mmHg. Patients with hypertension that persists despite taking two or more medications have 1.8 and 2.5 times greater mortality risk due to either cardiovascular disease or stroke, respectively. Dysregulated aldosterone levels are a key factor in uHTN or rHTN in approximately 30% of patients.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The image below summarizes the status of recently completed and ongoing clinical trials. Detailed results of our trials are set forth in Part I, Item 1, &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001933414/000193341426000056/mlys-20251231.htm#ic3329316665b4be9b86db1f0dd7e6dd9_184">Business</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2025. </span></div><div style="margin-bottom:9pt;text-align:center"><img src="mlys-20260331_g1.jpg" alt="Lorundrostat Program.jpg" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:600px" id="i-1"/></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Transform-HTN is an open-label extension trial that is ongoing and enables participants to continue to receive lorundrostat and allows us to gather additional long-term safety and efficacy data. All participants in the pivotal hypertension program, including the Advance-HTN and Launch-HTN trials, as well as the Explore-CKD trial, were given the opportunity to participate in the extension trial. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 9,&#160;2026, we announced topline data from our exploratory Phase 2 Explore-OSA trial that evaluated the effect of lorundrostat in the treatment of overweight and obese participants with moderate-to-severe OSA and hypertension. After four weeks of treatment, lorundrostat 50 mg dosed in the evening did not demonstrate a clinically meaningful difference relative to placebo on the apnea-hypopnea index, the primary endpoint. The trial demonstrated a clinically meaningful reduction in BP at week four, with an 11.1 mmHg (p &lt; </span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">0.0001) and a 1.0 mmHg (p = NS) BP reduction with lorundrostat and placebo, respectively, in the pre-planned parallel arm analysis of the first period. There was a 6.2 mmHg placebo-adjusted reduction (p &lt; 0.0003) in BP in the crossover analysis. Lorundrostat demonstrated a favorable safety profile and was well tolerated, with no serum potassium excursions above 5.5 mmol/L. Analysis is ongoing for other endpoints in the trial and may be reported in future publications or medical meetings. Detailed results of our trials are set forth in Part I, Item 1, &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001933414/000193341426000056/mlys-20251231.htm#ic3329316665b4be9b86db1f0dd7e6dd9_184">Business</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2025. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Financial Overview</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We commenced our operations in May 2019 and have devoted substantially all of our resources to date to organizing and staffing our company, business planning, raising capital, in-licensing our product candidate, lorundrostat, establishing our intellectual property portfolio, conducting research, preclinical studies, and clinical trials, and providing other general and administrative support for our operations. As of March&#160;31, 2026, we had cash, cash equivalents, and investments of $646.1&#160;million. Since inception, we have raised aggregate gross proceeds of approximately $1.1&#160;billion from the sale of common stock, convertible preferred stock, pre-funded warrants, and convertible notes. Our net losses for the three months ended March&#160;31, 2026 and 2025 were $39.3&#160;million and $42.2&#160;million, respectively. As of March&#160;31, 2026 and December&#160;31, 2025, we had an accumulated deficit of $496.5&#160;million and $457.2&#160;million, respectively. Our net losses may fluctuate significantly from quarter to quarter and year to year, depending on the timing of our clinical development activities and other research and development activities. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that certain expenses will increase substantially as we prepare for a potential approval and launch of lorundrostat, including the following:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conducting ongoing regulatory activities, including responding to FDA information requests, supporting a potential advisory committee meeting (not anticipated currently), preparing for potential approval and post-marketing commitments, and commercial launch of lorundrostat;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continuing to expand our pre-commercial organization, including building out medical affairs, market access, health economics and outcomes research, regulatory, quality, manufacturing, and commercial functions;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining, maintaining, protecting, and enforcing our intellectual property;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continuing the Transform-HTN open-label extension trial and conducting any required post-approval studies;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attracting and retaining experienced scientific, regulatory, medical, commercial, and operational talent; and</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating as a public company with expanding SEC compliance, legal, and finance obligations.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have never generated any revenue and do not expect to generate any revenue from product sales unless and until we obtain regulatory approval for lorundrostat, if ever. Accordingly, until such time as we can generate significant revenue from sales of lorundrostat, if ever, we expect to finance our cash needs through equity offerings, debt financings, or other capital sources, including potential collaborations, licenses, and other similar arrangements. However, we may be unable to raise additional funds or enter into such other arrangements when needed on favorable terms or at all. Our failure to raise capital or enter into such other arrangements when needed would have a negative impact on our financial condition and could force us to delay, limit, reduce, or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. For more information, see &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_67">Liquidity and Capital Resources</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tanabe License Agreement</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we entered into an exclusive license agreement (the Tanabe License) with Tanabe Pharma Corporation (Tanabe) (formerly Mitsubishi Tanabe Pharma Corporation), pursuant to which Tanabe granted us an exclusive, worldwide, royalty-bearing, sublicensable license under Tanabe&#8217;s patent and other intellectual property rights to exploit products incorporating lorundrostat (formerly MT-4129) (Lorundrostat Product) for the prevention, treatment, diagnosis, detection, monitoring, or predisposition testing with respect to indications, diseases, and conditions in humans. Pursuant to the Tanabe License, we paid Tanabe a $1.0&#160;million upfront fee and development milestone payments of $9.0&#160;million in the aggregate. We have remaining obligations to pay Tanabe commercial milestone payments of up to $155.0&#160;million in the aggregate upon first commercial sale and upon meeting certain annual sales targets, as well as additional commercial milestone payments of up to $10.0&#160;million for a second indication. Additionally, we are obligated to pay Tanabe tiered royalties at percentages ranging from the mid-single digits to ten percent (10%) of aggregate net sales of each Lorundrostat Product on a Lorundrostat Product-by-Lorundrostat Product and country-by-country basis, until the later of (i) the expiration of the last-to-expire valid Tanabe patent claim covering a Lorundrostat Product, (ii) ten years from the first commercial sale of a Lorundrostat Product, or (iii) the expiration of regulatory exclusivity in such country. Such royalties are subject to reduction under specified conditions, including lack of patent coverage and generic competition. We have no remaining development milestone obligations under the Tanabe License and did not incur any development or commercial expenses pursuant to the Tanabe License during the three months ended March&#160;31, 2026 and 2025.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are obligated to use commercially reasonable efforts to conduct and complete the development activities and to file for regulatory approval for at least one Lorundrostat Product in a major market country and consider in good faith developing at least one Lorundrostat Product in a non-major market country. If we elect to sublicense our rights under the Tanabe License to a third party with respect to exploitation of lorundrostat or any Lorundrostat Product in certain countries in Asia, we have agreed to negotiate such a sublicense first, for a specified period of time, with Tanabe, if Tanabe notifies us that it would like to obtain such a sublicense. We also agreed not to commercialize any competing product prior to three years following the first commercial sale of the first Lorundrostat Product in any country without Tanabe&#8217;s prior consent.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Public Offerings</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;11, 2025, we entered into an underwriting agreement relating to the issuance and sale of 14,907,406 shares of our common stock at a price of $13.50 per share for net proceeds of approximately $188.7&#160;million after deducting an underwriting discount of 6% and offering expenses. The offering was made pursuant to our shelf registration statement on Form S-3 (Registration Statement No. 333-278122) previously filed with and declared effective by the SEC (the Registration Statement), and a prospectus supplement and accompanying prospectus filed with the SEC. We are using the net proceeds from this offering to fund the clinical development of lorundrostat, including research and development, manufacturing, and pre-commercialization activities, as well as for working capital and general corporate purposes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">At-the-Market Equity Offering Sales Agreements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;10, 2025, we entered into an ATM Equity Offering Sales Agreement (the ATM Agreement) with BofA Securities, Inc., Evercore Group L.L.C., and Goldman Sachs &amp; Co. LLC, pursuant to which we may sell shares of our common stock having an aggregate offering price of up to $300.0&#160;million from time to time. During the three months ended March&#160;31, 2026, we sold pursuant to the ATM Agreement an aggregate of 568,320 shares of common stock at a weighted-average price of $35.66 per share for aggregate net proceeds of approximately $20.2&#160;million after deducting commissions and offering expenses. There were no sales of common stock pursuant to the ATM Agreement during the three months ended March&#160;31, 2025. From inception of the ATM Agreement and through March&#160;31, 2026, we sold an aggregate of 2,720,508 shares of common stock at a weighted-average price of $41.45 per share for aggregate net proceeds of approximately $112.4&#160;million after deducting commissions and offering expenses. As of March&#160;31, 2026, approximately $187.2&#160;million of shares remained available for sale pursuant to the ATM Agreement. </span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;21, 2024, we entered into an ATM Equity Offering Sales Agreement (the Prior ATM Agreement) with BofA Securities, Inc. and Evercore Group L.L.C. Effective November&#160;9, 2025, the Prior ATM Agreement was terminated in connection with the execution of the ATM Agreement. There were no sales of common stock pursuant to the Prior ATM Agreement during each of the three months ended March&#160;31, 2026 and March&#160;31, 2025. From inception of the Prior ATM Agreement and through its termination effective November&#160;9, 2025, we sold an aggregate of 1,914,040 shares of common stock at a weighted-average price of $14.32 per share for aggregate net proceeds of approximately $27.3&#160;million after deducting commissions and offering expenses.</span></div><div id="i57b16674741942018798123fe81d3bc9_58"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Key Components of Results of Operations</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of external and internal costs related to the development of lorundrostat. Research and development expenses are recognized as incurred, and payments made prior to the receipt of goods or services to be used in research and development are capitalized until the goods are received or the services are performed.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses include:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compensation costs, including salaries, benefits, and stock-based compensation for our research and development personnel;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">external research and development expenses incurred under agreements with contract research organizations and consultants to conduct and support our clinical trials of lorundrostat; </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs related to clinical supply, manufacturing, and regulatory activities;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs related to advancing our commercial readiness activities in preparation for a potential launch of lorundrostat for patients with hypertension, if approved by the FDA; and</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">allocated overhead.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses have been primarily driven by the timing and phase of our clinical trials, including the initiation and completion of studies, the number of trials in progress, and the size and complexity of each trial. We expect certain research and development expenses related to our clinical trial activities to decline in the upcoming periods as most trials have been completed relative to prior periods. However, we anticipate that certain other expenses will increase substantially as we:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conduct ongoing regulatory activities, including responding to FDA information requests, supporting a potential advisory committee meeting (not anticipated currently), preparing for potential approval and post-marketing commitments, and commercial launch of lorundrostat;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue the Transform-HTN open-label extension trial and conduct any required post-approval studies; and</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract and retain experienced scientific, regulatory, medical, commercial, and operational talent.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We cannot determine with certainty the timing of initiation, the duration, or the completion costs of current or future clinical trials and preclinical studies of lorundrostat or any future product candidates due to the inherently unpredictable nature of clinical and preclinical development. Clinical and preclinical development timelines, the probability of success, and development costs can differ materially from expectations. In addition, we cannot forecast whether lorundrostat or any future product candidates may be subject to future collaborations, when such arrangements will be secured, if at all, and to what degree such arrangements would affect our development plans and capital requirements.</span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our future development costs may vary significantly based on factors such as: </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, type, number, scope, development phase, progress, duration, expansions, results, costs, and timing of clinical trials and preclinical studies of lorundrostat and any future product candidates we may choose to pursue, including any modifications to clinical development plans based on feedback that we may receive from regulatory authorities;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability and strategic decision to develop future product candidates other than lorundrostat, and the timing of such development, if any;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to receive timely regulatory approvals for lorundrostat, any future product candidates, and any additional indications of lorundrostat and any future product candidates, in the jurisdictions in which we or any future partners apply for such approvals;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of manufacturing lorundrostat or any future product candidates for use in our trials, including as a result of inflation, changes in international trade policies and tariffs, any supply chain issues, or component shortages;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any additional jurisdictions in which we may seek approval for lorundrostat and any future product candidates and the timing of seeking approval in such jurisdictions; and</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we establish strategic collaborations or other arrangements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of (i) compensation costs, including salaries, benefits, and stock-based compensation, for executive and administrative personnel; (ii) professional fees for legal, audit, tax, and other consulting or advisory services; (iii) costs associated with building our pre-commercial organization, including medical affairs, market access, and health economics; (iv) fees relating to intellectual property and corporate matters; and (v) allocated overhead.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span id="iff45da982a8b4897af747e7e7404462a_5158"></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect general and administrative expenses to increase as we build out our pre-commercial and commercial capabilities in preparation for the potential approval and launch of lorundrostat; obtain, maintain, protect, and enforce our intellectual property; and attract and retain scientific, regulatory, medical, commercial, and operational talent, and as we incur higher costs associated with being a more mature public company.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income, Net</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest income reported in each period is associated with our investments in money market funds and U.S. treasuries, net of fees, or other related expenses.</span></div><div id="i57b16674741942018798123fe81d3bc9_64"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comparison of the Three Months Ended March&#160;31, 2026 and 2025</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(24,365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37,879)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(20,975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,568)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39,339)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(42,211)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses decreased by $13.5 million for the three months ended March&#160;31, 2026, compared to the three months ended March&#160;31, 2025. The decrease was primarily driven by a $15.5&#160;million reduction in preclinical and clinical costs following the conclusion of the lorundrostat pivotal program in the second quarter of 2025. This decrease was partially offset by $1.1&#160;million of increased clinical supply, manufacturing, and regulatory costs, and $0.8&#160;million of increased personnel-related expenses resulting from headcount growth and increased compensation.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $14.4&#160;million for the three months ended March&#160;31, 2026, compared to the three months ended March&#160;31, 2025. The increase was primarily driven by $7.9&#160;million of higher professional fees, $6.1&#160;million of increased personnel-related expenses resulting from headcount growth and increased compensation, and $0.4&#160;million of other general and administrative expenses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Other Income, Net</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Total other income, net increased by $3.8&#160;million for the three months ended March&#160;31, 2026, compared to the three months ended March&#160;31, 2025. The increase reflects higher interest earned on investments in money market funds and U.S. Treasuries due to higher average cash balances invested during the three months ended March&#160;31, 2026.</span></div><div id="i57b16674741942018798123fe81d3bc9_67"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred net losses and negative cash flows from operations since our inception and we expect to continue to incur significant expenses and operating losses for the foreseeable future. Since inception, we have raised aggregate gross proceeds of approximately $1.1&#160;billion from the sale of common stock, convertible preferred stock, pre-funded warrants, and convertible notes. Our primary uses of cash to date have been to fund our research and development and other activities, including with respect to lorundrostat, business planning, establishing and maintaining our intellectual property portfolio, hiring personnel, raising capital, and providing general and administrative support for these operations.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, we had cash, cash equivalents, and investments of $646.1&#160;million and an accumulated deficit of $496.5&#160;million. During the three months ended March&#160;31, 2026, we sold an aggregate of 568,320 shares of common stock under the ATM Agreement at a weighted-average price of $35.66 per share for aggregate net proceeds of approximately $20.2&#160;million after deducting commissions and offering expenses. As of March&#160;31, 2026, approximately $187.2&#160;million of shares remained available for sale pursuant to the ATM Agreement, subject to the terms and conditions of the ATM Agreement and applicable securities laws.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Funding Requirements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current operating plan, we believe that our cash, cash equivalents, and investments as of March&#160;31, 2026 will be sufficient to allow us to fund our operations for at least twelve months. However, our forecast of the period of time through which our financial resources will be adequate to support our operations is a forward-looking statement that involves risks and uncertainties, and actual results could vary materially. We have based this estimate on assumptions that may prove to be wrong, and we could deplete our capital resources sooner than we expect. Additionally, the process of testing product candidates in clinical trials is costly, and the timing of progress and expenses in these trials is uncertain.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including, but not limited to:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, type, number, scope, development phase, progress, duration, expansions, results, costs, and timing of clinical trials and preclinical studies of lorundrostat and any future product </span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">candidates we may choose to pursue, including any modifications to clinical development plans based on feedback that we may receive from regulatory authorities; </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability and strategic decision to develop future product candidates other than lorundrostat, and the timing of such development, if any;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to receive timely regulatory approvals for lorundrostat, any future product candidates, and additional indications of lorundrostat and any future product candidates, in the jurisdictions in which we or any future partners apply for such approvals;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of manufacturing for lorundrostat, or any future product candidate, including commercial manufacture at sufficient scale, if any product candidate is approved, including as a result of inflation, changes in international trade policies and tariffs, any supply chain issues, or component shortages;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any additional jurisdictions in which we may seek approval for lorundrostat and any future product candidates and timing of seeking approval in such jurisdictions;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs, timing, and outcome of regulatory approval of lorundrostat or any future product candidates;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of obtaining, maintaining, enforcing, and protecting our patents and other intellectual property and proprietary rights; </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our efforts to enhance operational systems and hire additional personnel to satisfy our obligations as a public company, including enhanced internal control over financial reporting; </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs associated with hiring additional personnel and consultants as our business grows, including additional executive officers and clinical development, regulatory, manufacturing, quality, and commercial personnel; </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and amount of the milestone, royalty, or other payments we must make to Tanabe, from whom we have in-licensed lorundrostat, or any future licensors; </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of establishing or securing sales and marketing capabilities if lorundrostat or any future product candidate is approved; </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to achieve sufficient market acceptance, coverage, and adequate reimbursement from third-party payors, and adequate market share and revenue for any approved products; </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patients&#8217; willingness to pay out-of-pocket for any approved products in the absence of coverage and/or adequate reimbursement from third-party payors;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms and timing of establishing and maintaining collaborations, licenses, and other similar arrangements;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with any products or technologies that we may in-license or acquire;</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any delays and cost increases that may result from any pandemic or other healthcare emergency; and</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the other risks and uncertainties described under the heading &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_256">Risk Factor</a></span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_256">s</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_13">Special Note Regarding Forward-Looking Statements</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and elsewhere in this Quarterly Report. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our cash needs through equity offerings, debt financings, or other capital sources, including potential collaborations, </span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">licenses, and other similar arrangements. We do not have any committed external source of funds. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders may be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, or declaring dividends. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and the disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from factors that include, but are not limited to, geopolitical conflict in and around Ukraine, Israel, Iran, Venezuela, and other areas of the world, inflation, changes in international trade policies and tariffs, diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates, and uncertainty about economic stability. If the equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly, and more dilutive. If we raise additional funds through future collaborations, licenses, or other similar arrangements with third parties, we may have to relinquish valuable rights to our future revenue streams, product candidates, research programs, intellectual property or proprietary technology, or grant licenses on terms that may not be favorable to us and/or may reduce the value of our common stock. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed or on terms acceptable to us, we may be required to delay, limit, reduce, or terminate our product development or future commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves, or on less favorable terms than we would otherwise choose.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comparison of the Three Months Ended March&#160;31, 2026 and 2025</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have primarily used our available cash to fund expenditures related to the in-license and development of lorundrostat. The following table sets forth a summary of cash flows for the periods presented (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39,471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(45,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(44,943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(92,876)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">189,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(165,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(60,142)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50,916&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(111,058)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $39.5&#160;million during the three months ended March&#160;31, 2026, compared to $45.5&#160;million during the three months ended March&#160;31, 2025, resulting in a decrease that was primarily attributable to a decrease in cash used to support our operating activities, including, but not limited to, the development of lorundrostat and related clinical trial expenses, personnel and compensation expense, legal and professional fees to support our operations, and general working capital requirements. The $6.0&#160;million decrease in cash used consisted of the net effect of a decrease in net loss, adjusted for non-cash expenses, of approximately $2.2&#160;million and changes in working capital of $3.8&#160;million.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $44.9&#160;million for the three months ended March&#160;31, 2026, compared to $92.9&#160;million for the three months ended March&#160;31, 2025. Net cash used in investing activities </span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">during the three months ended March&#160;31, 2026 and 2025 was primarily driven by the timing and volume of maturities and purchases of marketable securities in each period. During the three months ended March&#160;31, 2026, there was a $267.5&#160;million increase in maturities of previously purchased marketable securities and a $219.6&#160;million increase in purchases of marketable securities, compared to the three months ended March&#160;31, 2025.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $24.3&#160;million during the three months ended March&#160;31, 2026, compared to $189.3 million during the three months ended March&#160;31, 2025. During the three months ended March&#160;31, 2026, we received net proceeds of $20.2&#160;million from the sale of common stock pursuant to the ATM Agreement, net of issuance costs, and during the three months ended March&#160;31, 2025, we received net proceeds of $189.2&#160;million from the sale of common stock in a public offering, net of offering costs. Additionally, during the three months ended March&#160;31, 2026, we received increased proceeds of $3.9&#160;million from stock option exercises as compared to the three months ended March&#160;31, 2025.</span></div><div id="i57b16674741942018798123fe81d3bc9_70"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the Tanabe License, we have milestone payment obligations that are contingent upon the achievement of specified levels of product sales and are required to make certain royalty payments in connection with the sale of products developed under the agreement. We are currently unable to estimate the timing or likelihood of achieving other future milestones or making future product sales. See above and Note 4. &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to our condensed financial statements included elsewhere in this Quarterly Report for additional information regarding the Tanabe License. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We enter into contracts in the normal course of business for contract research services, contract manufacturing services, professional services, and other services and products for operating purposes. These contracts generally provide for termination after a notice period, and, therefore, are cancelable contracts.</span></div><div id="i57b16674741942018798123fe81d3bc9_73"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the condensed financial statements in accordance with accounting principles generally accepted in the United States. The preparation of these condensed financial statements requires us to make estimates, assumptions, and judgments that affect the reported amounts of assets, liabilities, expenses, and related disclosures at the date of the condensed financial statements, and the reported amounts of expenses during the reporting period. On an ongoing basis, management evaluates its critical estimates, including those related to prepaid and accrued research and development expenses. We base our estimates on our historical experience and on assumptions that we believe are reasonable; however, actual results may differ materially from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes during the three months ended March&#160;31, 2026 to our critical accounting estimates as disclosed in our Annual Report on Form 10-K for the year ended December&#160;31, 2025. For information on our significant accounting policies, please refer to Note 2. &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; within our Annual Report on Form 10-K for the year ended December&#160;31, 2025. </span></div><div id="i57b16674741942018798123fe81d3bc9_76"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">JOBS Act and Smaller Reporting Company Status</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As an emerging growth company under the Jumpstart Our Business Startups Act of 2012, as amended (the JOBS Act), we can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to use the extended transition period for complying with new or revised accounting standards, and as a result of this election, our financial statements may not be comparable to those of companies that comply with public company effective dates. We intend to rely on other exemptions provided by the JOBS Act, including, without </span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">limitation, not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act of 2002. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will remain an emerging growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of the consummation of our initial public offering in February 2023, (ii) the last day of the fiscal year in which we have total annual gross revenue of at least $1.235&#160;billion, (iii) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule 12b-2 under the Exchange Act, which would occur if, among other factors, the market value of our common stock held by non-affiliates exceeded $700.0&#160;million as of the last business day of the second fiscal quarter of such year (subject to certain conditions), or (iv) the date on which we have issued more than $1.0&#160;billion in non-convertible debt securities during the prior three-year period.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are also a smaller reporting company as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as our voting and non-voting common stock held by non-affiliates is less than $250.0&#160;million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0&#160;million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700.0&#160;million measured on the last business day of our second fiscal quarter. </span></div><div id="i57b16674741942018798123fe81d3bc9_79"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed all recently issued accounting pronouncements and have determined that, other than as disclosed elsewhere in this Quarterly Report, such standards do not have a material impact on our condensed financial statements or do not otherwise apply to our operations.</span></div><div id="i57b16674741942018798123fe81d3bc9_244"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk related to changes in interest rates of our investment portfolio of cash equivalents and investments. As of March&#160;31, 2026, our cash equivalents and investments consisted of money market funds and U.S. treasury securities. Our primary exposure to market risk is interest income sensitivity, which is affected by changes in the general level of U.S. interest rates. The fair value of our short-term cash equivalents and investments is subject to change as a result of potential changes in market interest rates. Due to the nature of our cash equivalents and investments, we believe an immediate hypothetical 10% change in interest rates would not have had a material effect on our results of operations during the periods presented. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk related to changes in foreign currency exchange rates. We contract with vendors that are located outside the United States and certain invoices are denominated in foreign currencies. We are subject to fluctuations in foreign currency rates in connection with these arrangements. To date, these fluctuations have not been significant, and we have not had a formal hedging program with respect to foreign currency. We believe an immediate hypothetical 10% change in exchange rates would not have had a material effect on our results of operations during the periods presented.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effects of Inflation</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Inflation generally affects us by increasing our cost of labor and research and development contract costs. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, we may experience some effect in the future due to an impact on the costs to conduct clinical trials, labor costs we incur to attract and retain qualified personnel, and other operational costs. Inflationary costs could adversely affect our business, financial condition, and results of operations.</span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i57b16674741942018798123fe81d3bc9_247"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic and current reports that we file with the SEC is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives. In reaching a reasonable level of assurance, management was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, the design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, control may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the design and operation of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act, as of the end of the period covered by this Quarterly Report. Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective and were operating at a reasonable assurance level as of March&#160;31, 2026.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Management has determined that there were no changes in our internal control over financial reporting that occurred during the three months ended March&#160;31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i57b16674741942018798123fe81d3bc9_250"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Part II - Other Information</span></div><div id="i57b16674741942018798123fe81d3bc9_253"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently a party to any material legal proceeding. From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational harm, and other factors.</span></div><div id="i57b16674741942018798123fe81d3bc9_256"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our business, financial condition, and operating results may be affected by a number of factors, whether currently known or unknown, including, but not limited to, those described in Part I, Item 1A, &#8220;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001933414/000193341425000009/mlys-20241231.htm#i1f0bfc0af8ec444d874c2a28a9e1f732_184">Risk Factors</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001933414/000193341426000056/mlys-20251231.htm#ic3329316665b4be9b86db1f0dd7e6dd9_187"> of our Annual Report on Form 10-K for the year ended December 31, 2025</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Any one or more of such factors could directly or indirectly cause our actual results of operations and financial condition to vary materially from past or anticipated future results of operations and financial condition. Any of these factors, in whole or in part, alone or combined with any of the other factors, could materially and adversely affect our business, financial condition, results of operations, and stock price. There have been no material changes to our risk factors since our Annual Report on Form 10-K for the year ended December&#160;31, 2025.</span></div><div id="i57b16674741942018798123fe81d3bc9_259"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i57b16674741942018798123fe81d3bc9_262"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i57b16674741942018798123fe81d3bc9_265"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i57b16674741942018798123fe81d3bc9_184"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2026, an affiliate of the Company, Catalys Pacific Fund, LP, entered into a Rule 10b5-1 trading plan. Catalys Pacific Fund GP, LP is the general partner of Catalys Pacific Fund, LP. Brian Taylor Slingsby, M.D., Ph.D., M.P.H., one of our directors, is the managing director of Catalys Pacific, LLC, the general partner of Catalys Pacific Fund GP, LP, and has voting and investment power over the shares held by Catalys Pacific Fund, LP. <ix:nonNumeric contextRef="c-78" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-302" continuedAt="f-302-1" escape="true">The material terms of this Rule 10b5-1 trading arrangement are described below:</ix:nonNumeric></span></div><ix:continuation id="f-302-1"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.738%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Name and Title</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Action Taken</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Type of Trading Arrangement</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Nature of Trading Arrangement</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Duration of Trading Arrangement</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Number of Securities</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-78" name="ecd:TrdArrIndName" id="f-303"><ix:nonNumeric contextRef="c-78" name="ecd:TrdArrIndTitle" id="f-304">Catalys Pacific Fund, LP</ix:nonNumeric></ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-78" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-305">Adoption</ix:nonNumeric> <ix:nonNumeric contextRef="c-78" name="ecd:TrdArrAdoptionDate" id="f-306">January&#160;9, 2026</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trading plan intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sale of the Company&#8217;s common stock pursuant to the terms of the plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2026 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">to </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-78" name="ecd:TrdArrExpirationDate" id="f-307">March&#160;31, 2027</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="0" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-308">2,000,000</ix:nonFraction></span></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth above, during the three months ended March 31, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-309">adopted</ix:nonNumeric> or <ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-310"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-311">terminated</ix:nonNumeric></ix:nonNumeric> any contract, instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in the SEC&#8217;s rules).</span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div id="i57b16674741942018798123fe81d3bc9_217"></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div id="i57b16674741942018798123fe81d3bc9_220"></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.569%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Number</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Incorporated by Reference</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Filed Herewith</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit Description</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Number</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1933414/000162828023003502/exhibit31-8xk.htm">Amended and Restated Certificate of Incorporation</a></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2/14/23</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1933414/000162828023003502/exhibit32-8xk.htm">Amended and Restated Bylaws</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2/14/23</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1#</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mlys2026q110qex101.htm">Non-Employee Director Compensation Policy</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mlys2026q110qex311.htm">Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mlys2026q110qex312.htm">Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mlys2026q110qex321.htm">Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mlys2026q110qex322.htm">Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">#       Indicates management contract or compensatory plan.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;This certification is deemed not filed for the purpose of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.</span></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i57b16674741942018798123fe81d3bc9_271"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i57b16674741942018798123fe81d3bc9_238">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:58.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">MINERALYS THERAPEUTICS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jon Congleton</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Jon Congleton</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Adam Levy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adam Levy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Secretary</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer; Principal Accounting Officer)</span></td></tr></table></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>mlys2026q110qex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i09dc0d399ebf4a2899014b57177b8835_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">MINERALYS THERAPEUTICS, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">AS AMENDED AND RESTATED EFFECTIVE FEBRUARY 19, 2026</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Non-employee members of the board of directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) of Mineralys Therapeutics, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (as amended, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Program</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Director</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company and subject to any limits on non-employee director compensation set forth in the Equity Plan (as defined below).  This Program shall remain in effect until it is revised or rescinded by further action of the Board.  This Program may be amended, modified or terminated by the Board at any time in its sole discretion.  The terms and conditions of this Program shall supersede any prior cash and&#47;or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors, except for equity compensation previously granted to a Non-Employee Director.  This amended and restated Program shall become effective on February 19, 2026 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  </font></div><div style="margin-bottom:12pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CASH COMPENSATION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The schedule of annual retainers (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Annual Retainers</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) for the Non-Employee Directors is as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#bfbfbf;border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:12pt;padding-left:20.77pt;padding-right:20.77pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Position</font></div></td><td colspan="3" style="background-color:#bfbfbf;border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:12pt;padding-left:4.77pt;padding-right:4.77pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Amount</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.77pt;padding-right:38.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Base Board Retainer</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:19.38pt;padding-right:19.38pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">$40,000</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.77pt;padding-right:38.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Chair of the Board or Lead Independent Director</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">$32,500</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.77pt;padding-right:38.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Chair of Audit Committee</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">$20,000</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.77pt;padding-right:38.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Chair of Compensation Committee</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">$15,000</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.77pt;padding-right:38.77pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Chair of Nominating and Corporate Governance Committee</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">$10,000</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.77pt;padding-right:38.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Member of Audit Committee (non-Chair)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">$10,000</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.77pt;padding-right:38.77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Member of Compensation Committee (non-Chair)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">$7,500</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.77pt;padding-right:38.77pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Member of Nominating and Corporate Governance Committee (non-Chair)</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">$5,000</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">For the avoidance of doubt, the Annual Retainers in the table above are additive and a Non-Employee Director shall be eligible to earn an Annual Retainer for each position in which he or she serves.  The Annual Retainers shall be earned on a quarterly basis based on a calendar quarter and shall be paid in cash by the Company in arrears not later than the fifteenth day following the end of each calendar quarter.  In the event a Non-Employee Director does not serve as a Non-Employee Director, or in the applicable position, for an entire calendar quarter, the Annual Retainer paid to such Non-Employee Director shall be prorated for the portion of such calendar quarter actually served as a Non-Employee Director, or in such position, as applicable.  The Board may adopt a program that allows Non-Employee Directors to defer Annual Retainers.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">EQUITY COMPENSATION </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Each Non-Employee Director shall be granted the equity awards described below, which equity awards shall be granted under and subject to the terms and provisions of the Company&#8217;s 2023 Incentive Award Plan or any other applicable Company equity incentive plan then-maintained by the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Equity Plan</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and shall be subject to an equity award agreement in substantially the form previously approved by the Board for use under the Equity Plan.  All applicable terms of the Equity Plan apply to this Program as if fully set forth herein, and all grants of equity awards hereby are subject in all respects to the terms of the Equity Plan and the applicable equity award agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Initial Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Non-Employee Director who is initially elected or appointed to the Board following the Effective Date shall be automatically granted stock options and restricted stock units with respect to such number of shares of the Company&#8217;s common stock as is determined by the Board, which awards shall be granted under the Equity Plan on the date of such initial election or appointment.  The awards described in this Section shall be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Initial Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.&#8221;  &#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  A Non-Employee Director who is serving on the Board as of February 19, 2026 or February 15 of each calendar year commencing with calendar year 2027, shall be automatically granted the following awards under the Equity Plan on such date&#58; (1) stock options to purchase 8,300 shares of the Company&#8217;s common stock and (2) 6,200 restricted stock units.  The awards described in this Section shall be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Annual Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.&#8221;  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a Non-Employee Director shall have served as a Non-Employee Director for at least (6) months as of the date of grant of any Annual Award, unless otherwise determined by the Board&#59; in which case, the Board may determine to grant such Non-Employee Director an Annual Award or a Prorated Annual Award (as defined below).  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Prorated Annual Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the product determined by multiplying (i) the Annual Award, by (ii) a fraction, the numerator of which is equal to (x) 365 minus (y) the number of days that elapsed from the date of grant of the Annual Award preceding the Non-Employee Director&#8217;s date of initial election or appointment to the date of such initial election or appointment, and the denominator of which is 365.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Terms of Awards Granted to Non-Employee Directors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Initial Award that is a stock option shall vest and become exercisable in substantially equal monthly installments over the three (3) years beginning on the date of the Non-Employee Director&#8217;s election or appointment to the Board, subject to the Non-Employee Director continuing in service on the Board through each such vesting date.  Each Initial Award that is restricted stock units shall vest in substantially equal annual installments over the three (3) years beginning on the date of the Non-Employee Director&#8217;s election or appointment to the Board, subject to the Non-Employee Director continuing in service on the Board through each such vesting date. Each Annual Award that is a stock option shall vest and &#47;or become exercisable in substantially equal monthly installments over the twelve (12) months following the date of grant of such Annual Award, subject to the Non-Employee Director continuing in service on the Board through such vesting date.  Each Annual Award that is a restricted stock unit shall vest and on the earlier of (a) the first anniversary of the date of grant or (b) the date of the next occurring annual meeting of the Company&#8217;s stockholders following the date of grant of such Annual Award, subject to the Non-Employee Director continuing in service on the Board through such vesting date.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">  Unless the Board otherwise determines or as otherwise provided in this Clause (2), any portion of an Initial Award or Annual Award which is unvested at the time of a Non-Employee Director&#8217;s termination of service on the Board as a Non-Employee Director shall be immediately forfeited upon such termination of service and shall not thereafter become vested.  All of a Non-Employee Director&#8217;s Initial Awards and Annual Awards shall vest in full upon a Non-Employee Director&#8217;s Termination of Service by reason of death or Disability and immediately prior to the occurrence of a Change in Control (as defined in the Equity Plan), to the extent outstanding at such time.  Additionally, all of a Non-Employee Director&#8217;s Annual Awards granted after the Effective Date shall vest in full upon a Non-Employee Director&#8217;s Termination of Service due to the Company&#8217;s failure to nominate the Non-Employee Director for re-election at the annual meeting of the Company&#8217;s stockholders following the applicable grant date, or the failure of the Company&#8217;s stockholders to approve the Non-Employee Director for re-election at such annual meeting.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Reimbursements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company&#8217;s applicable expense reimbursement policies and procedures as in effect from time to time.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>mlys2026q110qex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i5da881e72a3f4b5390b635caf1109296_1"></div><div style="min-height:72pt;width:100%"><div style="padding-right:-4.5pt;text-align:right;text-indent:18pt"><font><br></font></div><div style="padding-right:-4.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 31.1</font></div><div style="padding-right:-22.5pt;text-align:right"><font><br></font></div><div style="padding-right:-22.5pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">RULE 13a-14(a) AND RULE 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">I, Jon Congleton, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:1.5pt">I have reviewed this Quarterly Report on 10-Q of Mineralys Therapeutics, Inc., a Delaware corporation&#59;</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May&#160;6, 2026</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jon Congleton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Jon Congleton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-22.5pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>mlys2026q110qex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i723b7d1f6a794ac3972b5b7fa01a674c_1"></div><div style="min-height:72pt;width:100%"><div style="padding-right:-22.5pt;text-align:right"><font><br></font></div><div style="padding-right:-4.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 31.2</font></div><div style="padding-right:-22.5pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">RULE 13a-14(a) AND RULE 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">I, Adam Levy, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:1.5pt">I have reviewed this Quarterly Report on 10-Q of Mineralys Therapeutics, Inc., a Delaware corporation&#59;</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:9pt;padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:24.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.306%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May&#160;6, 2026</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Adam Levy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adam Levy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</font></td></tr></table></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-22.5pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>mlys2026q110qex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="ifbf039a7d59642468835595ee075a222_1"></div><div style="min-height:81pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 32.1</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">In connection with the Quarterly Report of Mineralys Therapeutics, Inc., a Delaware corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ending March&#160;31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350 as, adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(1) The Report complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.067%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May&#160;6, 2026</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jon Congleton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Jon Congleton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">&#160;</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>mlys2026q110qex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="ie00bb78aed924b8b861b27aa26dee7e1_1"></div><div style="min-height:81pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 32.2</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">In connection with the Quarterly Report of Mineralys Therapeutics, Inc., a Delaware corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ending March&#160;31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350 as, adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(1) The Report complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.067%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May&#160;6, 2026</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Adam Levy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adam Levy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:161%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:81pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>mlys-20260331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d6f31-ff89-7928-a1ca-06ccbd9e4802,g:1233a744-2d7f-4bba-93f2-58a8edc900ae-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mlys="http://www.mineralystx.com/20260331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.mineralystx.com/20260331">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mlys-20260331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mlys-20260331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mlys-20260331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mlys-20260331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.mineralystx.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedBalanceSheets" roleURI="http://www.mineralystx.com/role/CondensedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedBalanceSheetsParenthetical" roleURI="http://www.mineralystx.com/role/CondensedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofOperations" roleURI="http://www.mineralystx.com/role/CondensedStatementsofOperations">
        <link:definition>9952153 - Statement - Condensed Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofStockholdersEquity" roleURI="http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity">
        <link:definition>9952154 - Statement - Condensed Statements of Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofStockholdersEquityParenthetical" roleURI="http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical">
        <link:definition>9952155 - Statement - Condensed Statements of Stockholders&#8217; Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofCashFlows" roleURI="http://www.mineralystx.com/role/CondensedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Condensed Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofCashFlowsParenthetical" roleURI="http://www.mineralystx.com/role/CondensedStatementsofCashFlowsParenthetical">
        <link:definition>9952157 - Statement - Condensed Statements of Cash Flows (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusiness" roleURI="http://www.mineralystx.com/role/NatureofBusiness">
        <link:definition>9952158 - Disclosure - Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952159 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstruments">
        <link:definition>9952160 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.mineralystx.com/role/CommitmentsandContingencies">
        <link:definition>9952161 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilities" roleURI="http://www.mineralystx.com/role/AccruedLiabilities">
        <link:definition>9952162 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStock" roleURI="http://www.mineralystx.com/role/CapitalStock">
        <link:definition>9952163 - Disclosure - Capital Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.mineralystx.com/role/StockBasedCompensation">
        <link:definition>9952164 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsTables" roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsTables">
        <link:definition>9955513 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://www.mineralystx.com/role/AccruedLiabilitiesTables">
        <link:definition>9955514 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockTables" roleURI="http://www.mineralystx.com/role/CapitalStockTables">
        <link:definition>9955515 - Disclosure - Capital Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.mineralystx.com/role/StockBasedCompensationTables">
        <link:definition>9955516 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessDetails" roleURI="http://www.mineralystx.com/role/NatureofBusinessDetails">
        <link:definition>9955517 - Disclosure - Nature of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSegmentInformationDetails" roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails">
        <link:definition>9955518 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails">
        <link:definition>9955519 - Disclosure - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails" roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails">
        <link:definition>9955520 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDeferredOfferingCostsDetails" roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesDeferredOfferingCostsDetails">
        <link:definition>9955521 - Disclosure - Summary of Significant Accounting Policies - Deferred Offering Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails" roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails">
        <link:definition>9955522 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potential Common Shares Excluded From Calculation of Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails" roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails">
        <link:definition>9955523 - Disclosure - Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value Hierarchy (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails" roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails">
        <link:definition>9955524 - Disclosure - Fair Value of Financial Instruments - Schedule of Held-to-Maturity U.S. Treasury Bills (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.mineralystx.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955525 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://www.mineralystx.com/role/AccruedLiabilitiesDetails">
        <link:definition>9955526 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockScheduleofAuthorizedSharesofCommonStockDetails" roleURI="http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails">
        <link:definition>9955527 - Disclosure - Capital Stock - Schedule of Authorized Shares of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockNarrativeDetails" roleURI="http://www.mineralystx.com/role/CapitalStockNarrativeDetails">
        <link:definition>9955528 - Disclosure - Capital Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofOptionsbyPlanDetails" roleURI="http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails">
        <link:definition>9955529 - Disclosure - Stock-Based Compensation - Schedule of Options by Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9955530 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails" roleURI="http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails">
        <link:definition>9955531 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Reported in Statement of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mlys_PublicOfferingMember" abstract="true" name="PublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_AtTheMarketMember" abstract="true" name="AtTheMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" abstract="false" name="OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mlys_ScheduleOfCommonStockAuthorizedTableTextBlock" abstract="false" name="ScheduleOfCommonStockAuthorizedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mlys_TanabeMember" abstract="true" name="TanabeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee" abstract="false" name="CollaborativeArrangementRightsAndObligationsUpfrontFee" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments" abstract="false" name="CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" abstract="false" name="CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments" abstract="false" name="CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage" abstract="false" name="CollaborativeArrangementRightsAndObligationsRoyaltyPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod" abstract="false" name="CollaborativeArrangementRightsAndObligationsExpirationPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod" abstract="false" name="CollaborativeArrangementRightsAndObligationsNonCompetePeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod" abstract="false" name="CollaborativeArrangementRightsAndObligationsTerminationPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mlys_AccruedResearchAndDevelopmentCostsCurrent" abstract="false" name="AccruedResearchAndDevelopmentCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mlys_EquityIncentivePlan2023Member" abstract="true" name="EquityIncentivePlan2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_EquityIncentivePlan2025Member" abstract="true" name="EquityIncentivePlan2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_PreFundedWarrantMember" abstract="true" name="PreFundedWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_PriorATMAgreementMember" abstract="true" name="PriorATMAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_SaleOfStockConsiderationReceivableOnTransaction" abstract="false" name="SaleOfStockConsiderationReceivableOnTransaction" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mlys_SaleOfStockPricePerShareWeightedAveragePrice" abstract="false" name="SaleOfStockPricePerShareWeightedAveragePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mlys_ProceedsFromIssuanceOfCommonStockNet" abstract="false" name="ProceedsFromIssuanceOfCommonStockNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale" abstract="false" name="MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mlys_A2023IncentiveAwardPlanMember" abstract="true" name="A2023IncentiveAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_A2025IncentiveAwardPlanMember" abstract="true" name="A2025IncentiveAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_A2020EquityIncentivePlanMember" abstract="true" name="A2020EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_A2023EmployeeStockPurchasePlanMember" abstract="true" name="A2023EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mlys_CatalysPacificFundLPMember" abstract="true" name="CatalysPacificFundLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>mlys-20260331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d6f31-ff89-7928-a1ca-06ccbd9e4802,g:1233a744-2d7f-4bba-93f2-58a8edc900ae-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedBalanceSheets" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.mineralystx.com/role/CondensedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d6f32-0050-76de-a9f5-b4f8e3ef64f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d6f32-0050-71dd-ab8b-47630d68ad52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d6f32-0050-76de-a9f5-b4f8e3ef64f2" xlink:to="loc_us-gaap_LiabilitiesCurrent_019d6f32-0050-71dd-ab8b-47630d68ad52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d6f32-0050-7c18-987c-9b6b7d0d47df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d6f32-0050-76de-a9f5-b4f8e3ef64f2" xlink:to="loc_us-gaap_StockholdersEquity_019d6f32-0050-7c18-987c-9b6b7d0d47df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019d6f32-0050-73d7-b940-2d2a0dbb6814" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d6f32-0050-76de-a9f5-b4f8e3ef64f2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019d6f32-0050-73d7-b940-2d2a0dbb6814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d6f32-0050-70f8-bfc8-7abb130ce38b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0050-7971-b86b-bf3d9a051bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d6f32-0050-70f8-bfc8-7abb130ce38b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0050-7971-b86b-bf3d9a051bd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesCurrent_019d6f32-0050-74bf-8895-20903d8a652a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d6f32-0050-70f8-bfc8-7abb130ce38b" xlink:to="loc_us-gaap_DebtSecuritiesCurrent_019d6f32-0050-74bf-8895-20903d8a652a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d6f32-0050-77ff-b637-68d66d9d9596" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d6f32-0050-70f8-bfc8-7abb130ce38b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d6f32-0050-77ff-b637-68d66d9d9596" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d6f32-0050-77eb-ac81-2245c322add1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019d6f32-0050-773f-9374-36a396c64037" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d6f32-0050-77eb-ac81-2245c322add1" xlink:to="loc_us-gaap_CommonStockValue_019d6f32-0050-773f-9374-36a396c64037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d6f32-0050-7b18-a819-160f17f0b1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d6f32-0050-77eb-ac81-2245c322add1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d6f32-0050-7b18-a819-160f17f0b1e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019d6f32-0050-7c28-94e4-b83a63a222e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d6f32-0050-77eb-ac81-2245c322add1" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019d6f32-0050-7c28-94e4-b83a63a222e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019d6f32-0050-7e11-a74a-b602c9514fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019d6f32-0050-7ca9-a517-16b26ba9dd67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d6f32-0050-7e11-a74a-b602c9514fe2" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019d6f32-0050-7ca9-a517-16b26ba9dd67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d6f32-0050-7f57-b1a5-eefb1a620fed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d6f32-0050-7e11-a74a-b602c9514fe2" xlink:to="loc_us-gaap_AssetsCurrent_019d6f32-0050-7f57-b1a5-eefb1a620fed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d6f32-0050-7206-bf88-cfde4a34537a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d6f32-0050-7e11-a74a-b602c9514fe2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019d6f32-0050-7206-bf88-cfde4a34537a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d6f32-0050-7cc4-89be-564fcb581aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019d6f32-0050-7a55-98ee-cd769b82ee50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d6f32-0050-7cc4-89be-564fcb581aa0" xlink:to="loc_us-gaap_AccountsPayableCurrent_019d6f32-0050-7a55-98ee-cd769b82ee50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0050-7fbe-acee-7b0c6c43117e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d6f32-0050-7cc4-89be-564fcb581aa0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0050-7fbe-acee-7b0c6c43117e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedStatementsofOperations" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.mineralystx.com/role/CondensedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6f32-0050-758c-9997-fac3303207e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d6f32-0050-7f93-8a79-0eddeb5721c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d6f32-0050-758c-9997-fac3303207e8" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d6f32-0050-7f93-8a79-0eddeb5721c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019d6f32-0050-73a4-8a86-9ecd21496b97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d6f32-0050-758c-9997-fac3303207e8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019d6f32-0050-73a4-8a86-9ecd21496b97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d6f32-0050-708a-bd0c-6971d409e1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d6f32-0050-7116-9ad9-760cdea59224" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d6f32-0050-708a-bd0c-6971d409e1e7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d6f32-0050-7116-9ad9-760cdea59224" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d6f32-0050-781b-95d2-85de9b95b78c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d6f32-0050-708a-bd0c-6971d409e1e7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d6f32-0050-781b-95d2-85de9b95b78c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019d6f32-0050-772c-9c57-12ee2aa708aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019d6f32-0050-7702-b3aa-6163f4522029" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019d6f32-0050-772c-9c57-12ee2aa708aa" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019d6f32-0050-7702-b3aa-6163f4522029" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d6f32-0050-70d9-8ed6-84dd22362e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019d6f32-0050-772c-9c57-12ee2aa708aa" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019d6f32-0050-70d9-8ed6-84dd22362e5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d6f32-0050-7d40-a333-64f7d1659374" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d6f32-0050-702d-a75a-94e32f9a23a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d6f32-0050-7d40-a333-64f7d1659374" xlink:to="loc_us-gaap_OperatingExpenses_019d6f32-0050-702d-a75a-94e32f9a23a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.mineralystx.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6f32-0051-7402-8eff-6f62f2b4d7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_019d6f32-0051-7bad-aefe-94726d44eaac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6f32-0051-7402-8eff-6f62f2b4d7a1" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_019d6f32-0051-7bad-aefe-94726d44eaac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_019d6f32-0051-735a-92e2-8da7b51ee6de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6f32-0051-7402-8eff-6f62f2b4d7a1" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_019d6f32-0051-735a-92e2-8da7b51ee6de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0051-7c76-a70d-ab2dc23f47eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d6f32-0051-7986-a479-63f3819650b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0051-7c76-a70d-ab2dc23f47eb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d6f32-0051-7986-a479-63f3819650b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019d6f32-0051-7432-beb2-da2940c9ba07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0051-7c76-a70d-ab2dc23f47eb" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019d6f32-0051-7432-beb2-da2940c9ba07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_019d6f32-0051-7933-af69-1993d23e6c46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0051-7c76-a70d-ab2dc23f47eb" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_019d6f32-0051-7933-af69-1993d23e6c46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-71b0-bcfa-cc3cee770956" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6f32-0051-7627-b7bb-22508e1c6b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-71b0-bcfa-cc3cee770956" xlink:to="loc_us-gaap_NetIncomeLoss_019d6f32-0051-7627-b7bb-22508e1c6b4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019d6f32-0051-79db-8f29-8837a30f3b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-71b0-bcfa-cc3cee770956" xlink:to="loc_us-gaap_ShareBasedCompensation_019d6f32-0051-79db-8f29-8837a30f3b5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019d6f32-0051-7588-adf9-9a95f0ce14e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-71b0-bcfa-cc3cee770956" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019d6f32-0051-7588-adf9-9a95f0ce14e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019d6f32-0051-7985-b9b6-c2ec45561915" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-71b0-bcfa-cc3cee770956" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019d6f32-0051-7985-b9b6-c2ec45561915" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_019d6f32-0051-7ee6-8f15-28d944f1cf97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-71b0-bcfa-cc3cee770956" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_019d6f32-0051-7ee6-8f15-28d944f1cf97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d6f32-0051-7f00-a1db-2eb3ced8daee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-71b0-bcfa-cc3cee770956" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d6f32-0051-7f00-a1db-2eb3ced8daee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019d6f32-0051-7f2b-9349-95ac4ba87ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-71b0-bcfa-cc3cee770956" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019d6f32-0051-7f2b-9349-95ac4ba87ab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6f32-0051-7026-8215-6e2217410273" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6f32-0051-7eed-96c5-e8dda602b50f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6f32-0051-7026-8215-6e2217410273" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6f32-0051-7eed-96c5-e8dda602b50f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0051-73a5-b03b-c1aaf5309d53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6f32-0051-7026-8215-6e2217410273" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0051-73a5-b03b-c1aaf5309d53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-7be9-8a45-20c17a71875f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6f32-0051-7026-8215-6e2217410273" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-7be9-8a45-20c17a71875f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0051-7622-b175-ac1ac72563cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_019d6f32-0051-76dd-b14d-bcc9de2839b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0051-7622-b175-ac1ac72563cd" xlink:to="loc_us-gaap_Cash_019d6f32-0051-76dd-b14d-bcc9de2839b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_019d6f32-0051-7d9e-9335-68b03dd769ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0051-7622-b175-ac1ac72563cd" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_019d6f32-0051-7d9e-9335-68b03dd769ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"/>
  <link:calculationLink xlink:role="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_019d6f32-0051-7284-bb23-0507f6a490b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent_019d6f32-0051-7636-aa39-f0a874244cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_019d6f32-0051-7284-bb23-0507f6a490b4" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent_019d6f32-0051-7636-aa39-f0a874244cf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_019d6f32-0051-7b66-9b1c-004e20de4397" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent_019d6f32-0051-7377-aa84-8f9e5c60208a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue_019d6f32-0051-7b66-9b1c-004e20de4397" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent_019d6f32-0051-7377-aa84-8f9e5c60208a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.mineralystx.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0051-7366-83f1-edee69db3f22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AccruedResearchAndDevelopmentCostsCurrent_019d6f32-0051-7e77-ad78-0c97c52a9381" xlink:href="mlys-20260331.xsd#mlys_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0051-7366-83f1-edee69db3f22" xlink:to="loc_mlys_AccruedResearchAndDevelopmentCostsCurrent_019d6f32-0051-7e77-ad78-0c97c52a9381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_019d6f32-0051-731b-a4d4-33e13a5278ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0051-7366-83f1-edee69db3f22" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_019d6f32-0051-731b-a4d4-33e13a5278ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019d6f32-0051-763b-8eff-8ba1724b100d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0051-7366-83f1-edee69db3f22" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019d6f32-0051-763b-8eff-8ba1724b100d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>mlys-20260331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d6f31-ff89-7928-a1ca-06ccbd9e4802,g:1233a744-2d7f-4bba-93f2-58a8edc900ae-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019d6f32-0050-7021-81e6-c2e59215b0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019d6f32-0050-747e-81a1-51019f095853" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-7021-81e6-c2e59215b0c7" xlink:to="loc_us-gaap_StatementTable_019d6f32-0050-747e-81a1-51019f095853" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019d6f32-0050-7801-958d-401d6161d572" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-747e-81a1-51019f095853" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019d6f32-0050-7801-958d-401d6161d572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d6f32-0050-7801-958d-401d6161d572_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d6f32-0050-7801-958d-401d6161d572" xlink:to="loc_us-gaap_EquityComponentDomain_019d6f32-0050-7801-958d-401d6161d572_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d6f32-0050-748c-b890-54080ec91dce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d6f32-0050-7801-958d-401d6161d572" xlink:to="loc_us-gaap_EquityComponentDomain_019d6f32-0050-748c-b890-54080ec91dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019d6f32-0050-7cc1-a1d6-43f7a6900348" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019d6f32-0050-748c-b890-54080ec91dce" xlink:to="loc_us-gaap_CommonStockMember_019d6f32-0050-7cc1-a1d6-43f7a6900348" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019d6f32-0050-74b7-9820-5253653cc1db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019d6f32-0050-748c-b890-54080ec91dce" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019d6f32-0050-74b7-9820-5253653cc1db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019d6f32-0050-7e5a-a2e8-2c65bae8812d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019d6f32-0050-748c-b890-54080ec91dce" xlink:to="loc_us-gaap_RetainedEarningsMember_019d6f32-0050-7e5a-a2e8-2c65bae8812d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78fc-8827-e846b60b22a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-747e-81a1-51019f095853" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78fc-8827-e846b60b22a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78fc-8827-e846b60b22a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78fc-8827-e846b60b22a0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78fc-8827-e846b60b22a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-75a3-b38d-aa96f838745c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78fc-8827-e846b60b22a0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-75a3-b38d-aa96f838745c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PublicOfferingMember_019dbee4-62c0-7776-92f3-7fc3acc5e171" xlink:href="mlys-20260331.xsd#mlys_PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-75a3-b38d-aa96f838745c" xlink:to="loc_mlys_PublicOfferingMember_019dbee4-62c0-7776-92f3-7fc3acc5e171" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AtTheMarketMember_019d6f32-0050-7956-a3bc-f2d50cb9d89f" xlink:href="mlys-20260331.xsd#mlys_AtTheMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-75a3-b38d-aa96f838745c" xlink:to="loc_mlys_AtTheMarketMember_019d6f32-0050-7956-a3bc-f2d50cb9d89f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-7021-81e6-c2e59215b0c7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019d6f32-0050-7273-b144-0ef8c8c56d18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019d6f32-0050-7273-b144-0ef8c8c56d18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d6f32-0050-76a0-9c94-9d7e2cbc75f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockholdersEquity_019d6f32-0050-76a0-9c94-9d7e2cbc75f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6f32-0050-7b33-baa4-49528ae78fba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6f32-0050-7b33-baa4-49528ae78fba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6f32-0050-77cd-82ab-9544b511a1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6f32-0050-77cd-82ab-9544b511a1f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d6f32-0050-7c88-9814-40db54cc9fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d6f32-0050-7c88-9814-40db54cc9fdf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019d6f32-0050-765f-acbf-a3b992060798" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019d6f32-0050-765f-acbf-a3b992060798" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019d6f32-0050-7667-8e4f-f6df7495748d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019d6f32-0050-7667-8e4f-f6df7495748d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6f32-0050-74b0-8355-3f6a5aba3800" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_NetIncomeLoss_019d6f32-0050-74b0-8355-3f6a5aba3800" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019d6f32-0050-79fd-a5dc-bbac42afdfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d6f32-0050-7886-b761-cdaa0aa956e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedStatementsofStockholdersEquityParenthetical"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019d6f32-0050-7d81-a7c6-26f17d527b62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019d6f32-0050-7768-82a1-ca65e7063828" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-7d81-a7c6-26f17d527b62" xlink:to="loc_us-gaap_StatementTable_019d6f32-0050-7768-82a1-ca65e7063828" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78b1-99fe-f9e0f06d9d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-7768-82a1-ca65e7063828" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78b1-99fe-f9e0f06d9d5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78b1-99fe-f9e0f06d9d5e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78b1-99fe-f9e0f06d9d5e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78b1-99fe-f9e0f06d9d5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-7a6c-b5c5-e8472a9d8a12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78b1-99fe-f9e0f06d9d5e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-7a6c-b5c5-e8472a9d8a12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PublicOfferingMember_019dbee2-627c-7a98-b36e-f268c5a9a4c2" xlink:href="mlys-20260331.xsd#mlys_PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-7a6c-b5c5-e8472a9d8a12" xlink:to="loc_mlys_PublicOfferingMember_019dbee2-627c-7a98-b36e-f268c5a9a4c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AtTheMarketMember_019d6f32-0050-79b1-816c-e1dd1bf17474" xlink:href="mlys-20260331.xsd#mlys_AtTheMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-7a6c-b5c5-e8472a9d8a12" xlink:to="loc_mlys_AtTheMarketMember_019d6f32-0050-79b1-816c-e1dd1bf17474" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019d6f32-0050-7df7-9522-f70622c4d3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-7d81-a7c6-26f17d527b62" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019d6f32-0050-7df7-9522-f70622c4d3a4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019d6f32-0050-73cc-9935-8bd61644f4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_StatementTable_019d6f32-0050-73cc-9935-8bd61644f4ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-7873-86bf-3b752ec182e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-73cc-9935-8bd61644f4ef" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-7873-86bf-3b752ec182e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-7873-86bf-3b752ec182e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-7873-86bf-3b752ec182e0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-7873-86bf-3b752ec182e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78ba-9485-b7ddfcd3efae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-7873-86bf-3b752ec182e0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78ba-9485-b7ddfcd3efae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AtTheMarketMember_019d6f32-0050-716f-8752-394b9def8c3b" xlink:href="mlys-20260331.xsd#mlys_AtTheMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78ba-9485-b7ddfcd3efae" xlink:to="loc_mlys_AtTheMarketMember_019d6f32-0050-716f-8752-394b9def8c3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PublicOfferingMember_019dbefb-2946-7081-9498-ec6f1378b551" xlink:href="mlys-20260331.xsd#mlys_PublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78ba-9485-b7ddfcd3efae" xlink:to="loc_mlys_PublicOfferingMember_019dbefb-2946-7081-9498-ec6f1378b551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7ad8-9ff6-4b80226c0133" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7ad8-9ff6-4b80226c0133" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6f32-0050-7feb-bcbc-5e8b151092ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7ad8-9ff6-4b80226c0133" xlink:to="loc_us-gaap_NetIncomeLoss_019d6f32-0050-7feb-bcbc-5e8b151092ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7ad8-9ff6-4b80226c0133" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019d6f32-0050-7b7b-ae00-2bb9c42b067b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:to="loc_us-gaap_ShareBasedCompensation_019d6f32-0050-7b7b-ae00-2bb9c42b067b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019d6f32-0050-7f21-adfa-287c30875672" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019d6f32-0050-7f21-adfa-287c30875672" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019d6f32-0051-781e-aa47-7a499a787db9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019d6f32-0051-781e-aa47-7a499a787db9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0051-767f-85dd-6cd9f78a7c88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0051-767f-85dd-6cd9f78a7c88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_019d6f32-0051-7daa-99f5-a2e029b37a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0051-767f-85dd-6cd9f78a7c88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_019d6f32-0051-7daa-99f5-a2e029b37a9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d6f32-0051-7782-bf43-fee31f98d36e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0051-767f-85dd-6cd9f78a7c88" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d6f32-0051-7782-bf43-fee31f98d36e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019d6f32-0051-7fc7-8dd0-c55e779524ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0051-767f-85dd-6cd9f78a7c88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019d6f32-0051-7fc7-8dd0-c55e779524ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-7be3-a2b6-f39a7ef8fe8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7ad8-9ff6-4b80226c0133" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-7be3-a2b6-f39a7ef8fe8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0051-7973-9ced-3fccb5533967" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0051-7973-9ced-3fccb5533967" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_019d6f32-0051-7055-9300-e6304ffdd767" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0051-7973-9ced-3fccb5533967" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_019d6f32-0051-7055-9300-e6304ffdd767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_019d6f32-0051-77f8-827b-fed2a50579b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0051-7973-9ced-3fccb5533967" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_019d6f32-0051-77f8-827b-fed2a50579b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6f32-0051-7c7a-9557-c5578c41b5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0051-7973-9ced-3fccb5533967" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6f32-0051-7c7a-9557-c5578c41b5e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d6f32-0051-7178-9ead-a46a705e53f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d6f32-0051-7178-9ead-a46a705e53f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019d6f32-0051-7bf1-a56f-2c0a3ec33d67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019d6f32-0051-7bf1-a56f-2c0a3ec33d67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_019d6f32-0051-7c65-9bd7-210fb805aad5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_019d6f32-0051-7c65-9bd7-210fb805aad5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0051-7336-bbd2-3525d4cfe9d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0051-7336-bbd2-3525d4cfe9d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6f32-0051-7b97-9288-2ed8a01f4f36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6f32-0051-7b97-9288-2ed8a01f4f36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d6f32-0051-7b35-b5b5-9dfa99e18905" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d6f32-0051-7b35-b5b5-9dfa99e18905" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d6f32-0051-7114-9586-d14042e950e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_019d6f32-0051-719c-af97-d8a0265b067c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_019d6f32-0051-719c-af97-d8a0265b067c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_019d6f32-0051-712c-8797-495c8c77c720" xlink:href="mlys-20260331.xsd#mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_019d6f32-0051-719c-af97-d8a0265b067c" xlink:to="loc_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_019d6f32-0051-712c-8797-495c8c77c720" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7bd5-a013-fdf8931c317a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-74a1-9b98-bf2e17d6d68a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7bd5-a013-fdf8931c317a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-74a1-9b98-bf2e17d6d68a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d6f32-0051-76f9-9e25-406a4deaf987" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-74a1-9b98-bf2e17d6d68a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d6f32-0051-76f9-9e25-406a4deaf987" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-76f9-9e25-406a4deaf987_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d6f32-0051-76f9-9e25-406a4deaf987" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-76f9-9e25-406a4deaf987_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-70b8-8141-64fb408fd0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d6f32-0051-76f9-9e25-406a4deaf987" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-70b8-8141-64fb408fd0e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d6f32-0051-7815-b974-207fd94d14d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-70b8-8141-64fb408fd0e1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d6f32-0051-7815-b974-207fd94d14d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf13-0ab4-79fe-9616-2c72be65caff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-70b8-8141-64fb408fd0e1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf13-0ab4-79fe-9616-2c72be65caff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_019d6f32-0051-799a-befb-03e6939afff6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-70b8-8141-64fb408fd0e1" xlink:to="loc_us-gaap_RestrictedStockMember_019d6f32-0051-799a-befb-03e6939afff6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019d6f32-0051-7400-9254-4af74d68d7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7bd5-a013-fdf8931c317a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019d6f32-0051-7400-9254-4af74d68d7f6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7b58-90cc-3cc4de18851e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7edd-8856-fa8aa13b5d39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7b58-90cc-3cc4de18851e" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7edd-8856-fa8aa13b5d39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_019d6f32-0051-7fe9-8f80-bf31b04e7d00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7edd-8856-fa8aa13b5d39" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_019d6f32-0051-7fe9-8f80-bf31b04e7d00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019d6f32-0051-7fe9-8f80-bf31b04e7d00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019d6f32-0051-7fe9-8f80-bf31b04e7d00" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019d6f32-0051-7fe9-8f80-bf31b04e7d00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019d6f32-0051-7b5f-856d-3748ad88ba10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019d6f32-0051-7fe9-8f80-bf31b04e7d00" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019d6f32-0051-7b5f-856d-3748ad88ba10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_019d6f32-0051-7e21-a93d-75b67af4071f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019d6f32-0051-7b5f-856d-3748ad88ba10" xlink:to="loc_us-gaap_MoneyMarketFundsMember_019d6f32-0051-7e21-a93d-75b67af4071f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019d6f32-0051-7786-a623-b0b21160c078" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7edd-8856-fa8aa13b5d39" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019d6f32-0051-7786-a623-b0b21160c078" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019d6f32-0051-7786-a623-b0b21160c078_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019d6f32-0051-7786-a623-b0b21160c078" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019d6f32-0051-7786-a623-b0b21160c078_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019d6f32-0051-7623-8415-7f5eb1e02df7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019d6f32-0051-7786-a623-b0b21160c078" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019d6f32-0051-7623-8415-7f5eb1e02df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019d6f32-0051-7c95-b76d-a43f89140514" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019d6f32-0051-7623-8415-7f5eb1e02df7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019d6f32-0051-7c95-b76d-a43f89140514" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019d6f32-0051-71b6-9fae-505861dc20ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7b58-90cc-3cc4de18851e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019d6f32-0051-71b6-9fae-505861dc20ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7266-8abf-bc2bd533cce7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7608-bec3-f295c5f6737b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7266-8abf-bc2bd533cce7" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7608-bec3-f295c5f6737b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_019d6f32-0051-72ea-96e8-cea7842c0e87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7608-bec3-f295c5f6737b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_019d6f32-0051-72ea-96e8-cea7842c0e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_019d6f32-0051-72ea-96e8-cea7842c0e87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_019d6f32-0051-72ea-96e8-cea7842c0e87" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_019d6f32-0051-72ea-96e8-cea7842c0e87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_019d6f32-0051-7081-bdc4-505896dd6002" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_019d6f32-0051-72ea-96e8-cea7842c0e87" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_019d6f32-0051-7081-bdc4-505896dd6002" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_019d6f32-0051-7372-92d7-1452acc8bcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_019d6f32-0051-7081-bdc4-505896dd6002" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_019d6f32-0051-7372-92d7-1452acc8bcc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_019d6f32-0051-7443-9384-10486f682b60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_019d6f32-0051-7081-bdc4-505896dd6002" xlink:to="loc_us-gaap_InvestmentsMember_019d6f32-0051-7443-9384-10486f682b60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract_019d6f32-0051-75fb-8e94-4c6b27b874dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7266-8abf-bc2bd533cce7" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract_019d6f32-0051-75fb-8e94-4c6b27b874dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent_019d6f32-0051-7fad-92fe-bc3363dcb86c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract_019d6f32-0051-75fb-8e94-4c6b27b874dd" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent_019d6f32-0051-7fad-92fe-bc3363dcb86c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_019d6f32-0051-7030-8d94-d79f86d00b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract_019d6f32-0051-75fb-8e94-4c6b27b874dd" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_019d6f32-0051-7030-8d94-d79f86d00b1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract_019d6f32-0051-72dc-a1d3-7bc414c58f93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7266-8abf-bc2bd533cce7" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract_019d6f32-0051-72dc-a1d3-7bc414c58f93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent_019d6f32-0051-7051-8538-2e41b64392c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract_019d6f32-0051-72dc-a1d3-7bc414c58f93" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent_019d6f32-0051-7051-8538-2e41b64392c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_019d6f32-0051-7b6b-8813-77d7804ec442" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract_019d6f32-0051-72dc-a1d3-7bc414c58f93" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_019d6f32-0051-7b6b-8813-77d7804ec442" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019d6f32-0051-7512-a4ec-af46713bfbda" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:to="loc_srt_CounterpartyNameAxis_019d6f32-0051-7512-a4ec-af46713bfbda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d6f32-0051-7512-a4ec-af46713bfbda_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_019d6f32-0051-7512-a4ec-af46713bfbda" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d6f32-0051-7512-a4ec-af46713bfbda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d6f32-0051-72bb-8067-7745704e201e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_019d6f32-0051-7512-a4ec-af46713bfbda" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d6f32-0051-72bb-8067-7745704e201e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_TanabeMember_019d6f32-0051-7e0a-a153-81fc1bc23629" xlink:href="mlys-20260331.xsd#mlys_TanabeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d6f32-0051-72bb-8067-7745704e201e" xlink:to="loc_mlys_TanabeMember_019d6f32-0051-7e0a-a153-81fc1bc23629" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019d6f32-0051-7b5a-a34e-c5f88b85f461" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019d6f32-0051-7b5a-a34e-c5f88b85f461" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d6f32-0051-7b5a-a34e-c5f88b85f461_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d6f32-0051-7b5a-a34e-c5f88b85f461" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d6f32-0051-7b5a-a34e-c5f88b85f461_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d6f32-0051-73c3-be6c-8e7f15fa6123" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d6f32-0051-7b5a-a34e-c5f88b85f461" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d6f32-0051-73c3-be6c-8e7f15fa6123" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019d6f32-0051-778b-9912-e4bc20996700" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d6f32-0051-73c3-be6c-8e7f15fa6123" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019d6f32-0051-778b-9912-e4bc20996700" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d6f32-0051-7799-b408-45285ad7f4ae" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:to="loc_srt_RangeAxis_019d6f32-0051-7799-b408-45285ad7f4ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d6f32-0051-7799-b408-45285ad7f4ae_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019d6f32-0051-7799-b408-45285ad7f4ae" xlink:to="loc_srt_RangeMember_019d6f32-0051-7799-b408-45285ad7f4ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d6f32-0051-76c7-ac83-34612a701ac1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019d6f32-0051-7799-b408-45285ad7f4ae" xlink:to="loc_srt_RangeMember_019d6f32-0051-76c7-ac83-34612a701ac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d6f32-0051-78f5-ad5a-dede13d4c8ce" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d6f32-0051-76c7-ac83-34612a701ac1" xlink:to="loc_srt_MaximumMember_019d6f32-0051-78f5-ad5a-dede13d4c8ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019d6f32-0051-7797-8108-6d017ba61b0f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d6f32-0051-76c7-ac83-34612a701ac1" xlink:to="loc_srt_MinimumMember_019d6f32-0051-7797-8108-6d017ba61b0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee_019d6f32-0051-7440-a4ff-752febf8455d" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee_019d6f32-0051-7440-a4ff-752febf8455d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments_019d6f32-0051-78c7-abc8-76247d95d744" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments_019d6f32-0051-78c7-abc8-76247d95d744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments_019d6f32-0051-7432-9a38-03bb7fa58732" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments_019d6f32-0051-7432-9a38-03bb7fa58732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments_019d6f32-0051-7584-b420-1b05f6affbd0" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments_019d6f32-0051-7584-b420-1b05f6affbd0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage_019d6f32-0051-7f64-afbc-5bad53703d48" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage_019d6f32-0051-7f64-afbc-5bad53703d48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod_019d6f32-0051-7571-8003-a70382f4511a" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod_019d6f32-0051-7571-8003-a70382f4511a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod_019d6f32-0051-7408-8d67-69489afcf657" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod_019d6f32-0051-7408-8d67-69489afcf657" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod_019d6f32-0051-73e3-b141-bd3bf10bbe64" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod_019d6f32-0051-73e3-b141-bd3bf10bbe64" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#CapitalStockScheduleofAuthorizedSharesofCommonStockDetails"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7e4f-998e-53283406cb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7e4f-998e-53283406cb5e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d6f32-0051-7e8a-a75a-330932d00691" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:to="loc_us-gaap_AwardTypeAxis_019d6f32-0051-7e8a-a75a-330932d00691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7e8a-a75a-330932d00691_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019d6f32-0051-7e8a-a75a-330932d00691" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7e8a-a75a-330932d00691_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7295-b150-da4ab6f6ca1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019d6f32-0051-7e8a-a75a-330932d00691" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7295-b150-da4ab6f6ca1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d6f32-0051-74d4-af3c-2a4db776338c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7295-b150-da4ab6f6ca1d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d6f32-0051-74d4-af3c-2a4db776338c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019d6f32-0051-7b22-b091-8fcb8488433a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7295-b150-da4ab6f6ca1d" xlink:to="loc_us-gaap_EmployeeStockMember_019d6f32-0051-7b22-b091-8fcb8488433a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf34-c885-7411-a379-f86d59c38d00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7295-b150-da4ab6f6ca1d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf34-c885-7411-a379-f86d59c38d00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d6f32-0051-7e0a-be12-534519a61deb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:to="loc_us-gaap_PlanNameAxis_019d6f32-0051-7e0a-be12-534519a61deb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d6f32-0051-7e0a-be12-534519a61deb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019d6f32-0051-7e0a-be12-534519a61deb" xlink:to="loc_us-gaap_PlanNameDomain_019d6f32-0051-7e0a-be12-534519a61deb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d6f32-0051-7296-8363-e195f72d3314" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019d6f32-0051-7e0a-be12-534519a61deb" xlink:to="loc_us-gaap_PlanNameDomain_019d6f32-0051-7296-8363-e195f72d3314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_EquityIncentivePlan2023Member_019d6f32-0051-7228-b2a4-9adad863f613" xlink:href="mlys-20260331.xsd#mlys_EquityIncentivePlan2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d6f32-0051-7296-8363-e195f72d3314" xlink:to="loc_mlys_EquityIncentivePlan2023Member_019d6f32-0051-7228-b2a4-9adad863f613" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_EquityIncentivePlan2025Member_019d6f32-0051-74a2-9f01-a00ae66430cb" xlink:href="mlys-20260331.xsd#mlys_EquityIncentivePlan2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d6f32-0051-7296-8363-e195f72d3314" xlink:to="loc_mlys_EquityIncentivePlan2025Member_019d6f32-0051-74a2-9f01-a00ae66430cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019d6f32-0051-7906-abe3-5c7df34f69d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019d6f32-0051-7906-abe3-5c7df34f69d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019d6f32-0051-7906-abe3-5c7df34f69d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019d6f32-0051-7906-abe3-5c7df34f69d9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019d6f32-0051-7906-abe3-5c7df34f69d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019d6f32-0051-70d6-a3cd-0338b108de1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019d6f32-0051-7906-abe3-5c7df34f69d9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019d6f32-0051-70d6-a3cd-0338b108de1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PreFundedWarrantMember_019d6f32-0051-7acf-969d-59268a3f780b" xlink:href="mlys-20260331.xsd#mlys_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019d6f32-0051-70d6-a3cd-0338b108de1b" xlink:to="loc_mlys_PreFundedWarrantMember_019d6f32-0051-7acf-969d-59268a3f780b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019d6f32-0051-7766-9139-71d31cb7d82d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7e4f-998e-53283406cb5e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019d6f32-0051-7766-9139-71d31cb7d82d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#CapitalStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/CapitalStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-7029-862a-ba27aac07661" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-7029-862a-ba27aac07661" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0051-7b46-a982-e094ab297177" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-7029-862a-ba27aac07661" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0051-7b46-a982-e094ab297177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0051-7b46-a982-e094ab297177_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0051-7b46-a982-e094ab297177" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0051-7b46-a982-e094ab297177_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0051-7f51-b967-ecea79a184cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0051-7b46-a982-e094ab297177" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0051-7f51-b967-ecea79a184cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AtTheMarketMember_019d6f32-0051-7d57-a891-ef7dbf411da1" xlink:href="mlys-20260331.xsd#mlys_AtTheMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0051-7f51-b967-ecea79a184cb" xlink:to="loc_mlys_AtTheMarketMember_019d6f32-0051-7d57-a891-ef7dbf411da1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PriorATMAgreementMember_019ddf26-4d99-7983-bb58-19f559288ad5" xlink:href="mlys-20260331.xsd#mlys_PriorATMAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0051-7f51-b967-ecea79a184cb" xlink:to="loc_mlys_PriorATMAgreementMember_019ddf26-4d99-7983-bb58-19f559288ad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d6f32-0051-7349-a4da-c34be8ff6563" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-7029-862a-ba27aac07661" xlink:to="loc_srt_RangeAxis_019d6f32-0051-7349-a4da-c34be8ff6563" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d6f32-0051-7349-a4da-c34be8ff6563_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019d6f32-0051-7349-a4da-c34be8ff6563" xlink:to="loc_srt_RangeMember_019d6f32-0051-7349-a4da-c34be8ff6563_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d6f32-0051-76dd-954b-57019e2fdc53" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019d6f32-0051-7349-a4da-c34be8ff6563" xlink:to="loc_srt_RangeMember_019d6f32-0051-76dd-954b-57019e2fdc53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d6f32-0051-77c4-8e9a-6e1977d204cd" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d6f32-0051-76dd-954b-57019e2fdc53" xlink:to="loc_srt_MaximumMember_019d6f32-0051-77c4-8e9a-6e1977d204cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_SaleOfStockConsiderationReceivableOnTransaction_019d6f32-0051-728b-a6fc-ec85086ab40b" xlink:href="mlys-20260331.xsd#mlys_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_mlys_SaleOfStockConsiderationReceivableOnTransaction_019d6f32-0051-728b-a6fc-ec85086ab40b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d6f32-0051-7cdd-97d8-d6943047497a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d6f32-0051-7cdd-97d8-d6943047497a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_SaleOfStockPricePerShareWeightedAveragePrice_019dbfe5-31cc-7b17-82a7-f61e6b032384" xlink:href="mlys-20260331.xsd#mlys_SaleOfStockPricePerShareWeightedAveragePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_mlys_SaleOfStockPricePerShareWeightedAveragePrice_019dbfe5-31cc-7b17-82a7-f61e6b032384" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_ProceedsFromIssuanceOfCommonStockNet_019d6f32-0051-7123-b532-547d8d20785a" xlink:href="mlys-20260331.xsd#mlys_ProceedsFromIssuanceOfCommonStockNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_mlys_ProceedsFromIssuanceOfCommonStockNet_019d6f32-0051-7123-b532-547d8d20785a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019dd311-eac0-7228-b4de-02aea799134d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019dd311-eac0-7228-b4de-02aea799134d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale_019d6f32-0051-70c1-888c-e6b9605f4fa5" xlink:href="mlys-20260331.xsd#mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale_019d6f32-0051-70c1-888c-e6b9605f4fa5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d6f32-0051-793c-b323-b4b9bc92dcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d6f32-0051-793c-b323-b4b9bc92dcb0" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#StockBasedCompensationScheduleofOptionsbyPlanDetails"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7b67-964c-e4c82404fd28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-788a-8935-fdb16f15a07b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7b67-964c-e4c82404fd28" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-788a-8935-fdb16f15a07b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d6f32-0051-7016-b757-957fce44c3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-788a-8935-fdb16f15a07b" xlink:to="loc_us-gaap_PlanNameAxis_019d6f32-0051-7016-b757-957fce44c3e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d6f32-0051-7016-b757-957fce44c3e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019d6f32-0051-7016-b757-957fce44c3e8" xlink:to="loc_us-gaap_PlanNameDomain_019d6f32-0051-7016-b757-957fce44c3e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d6f32-0051-7998-8418-1e972e9b322d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019d6f32-0051-7016-b757-957fce44c3e8" xlink:to="loc_us-gaap_PlanNameDomain_019d6f32-0051-7998-8418-1e972e9b322d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2023IncentiveAwardPlanMember_019d6f32-0051-7166-aa00-15896eb452d4" xlink:href="mlys-20260331.xsd#mlys_A2023IncentiveAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d6f32-0051-7998-8418-1e972e9b322d" xlink:to="loc_mlys_A2023IncentiveAwardPlanMember_019d6f32-0051-7166-aa00-15896eb452d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2025IncentiveAwardPlanMember_019d6f32-0051-7c46-b4a4-22e45ceca912" xlink:href="mlys-20260331.xsd#mlys_A2025IncentiveAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d6f32-0051-7998-8418-1e972e9b322d" xlink:to="loc_mlys_A2025IncentiveAwardPlanMember_019d6f32-0051-7c46-b4a4-22e45ceca912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2020EquityIncentivePlanMember_019d6f32-0051-7f8b-a57c-be0de9323542" xlink:href="mlys-20260331.xsd#mlys_A2020EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d6f32-0051-7998-8418-1e972e9b322d" xlink:to="loc_mlys_A2020EquityIncentivePlanMember_019d6f32-0051-7f8b-a57c-be0de9323542" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d6f32-0051-764c-869f-58b46e2933bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-788a-8935-fdb16f15a07b" xlink:to="loc_us-gaap_AwardTypeAxis_019d6f32-0051-764c-869f-58b46e2933bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-764c-869f-58b46e2933bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019d6f32-0051-764c-869f-58b46e2933bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-764c-869f-58b46e2933bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-75a5-b65f-980b6deefb83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019d6f32-0051-764c-869f-58b46e2933bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-75a5-b65f-980b6deefb83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_019d6f32-0051-7c21-9ae3-b91f90fa58bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-75a5-b65f-980b6deefb83" xlink:to="loc_us-gaap_RestrictedStockMember_019d6f32-0051-7c21-9ae3-b91f90fa58bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf45-dbdc-729e-b5d4-4d2034d04f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-75a5-b65f-980b6deefb83" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf45-dbdc-729e-b5d4-4d2034d04f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d6f32-0051-781a-9b5f-5bf5613887e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7b67-964c-e4c82404fd28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d6f32-0051-781a-9b5f-5bf5613887e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_019d6f32-0051-76f3-99d9-512defd60f63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7b67-964c-e4c82404fd28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_019d6f32-0051-76f3-99d9-512defd60f63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d6f32-0051-7dce-b94c-f8ce7d1a72ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7b67-964c-e4c82404fd28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d6f32-0051-7dce-b94c-f8ce7d1a72ab" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dbf4b-b7aa-720a-a17d-a52930695899" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dbf4b-6573-792a-9b3f-8e38e548a020" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dbf4b-b7aa-720a-a17d-a52930695899" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dbf4b-6573-792a-9b3f-8e38e548a020" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019dbf4b-b7aa-791f-9372-59e1799e1037" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dbf4b-6573-792a-9b3f-8e38e548a020" xlink:to="loc_us-gaap_AwardTypeAxis_019dbf4b-b7aa-791f-9372-59e1799e1037" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dbf4b-b7aa-791f-9372-59e1799e1037_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019dbf4b-b7aa-791f-9372-59e1799e1037" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dbf4b-b7aa-791f-9372-59e1799e1037_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dbf4b-b7aa-79ac-ab1b-a0fb19cb21bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019dbf4b-b7aa-791f-9372-59e1799e1037" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dbf4b-b7aa-79ac-ab1b-a0fb19cb21bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019dbf4b-b7aa-796d-a45e-e98590f1d0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dbf4b-b7aa-79ac-ab1b-a0fb19cb21bb" xlink:to="loc_us-gaap_EmployeeStockMember_019dbf4b-b7aa-796d-a45e-e98590f1d0fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019dbf4b-b7aa-7381-871c-e43933b7737a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dbf4b-6573-792a-9b3f-8e38e548a020" xlink:to="loc_us-gaap_PlanNameAxis_019dbf4b-b7aa-7381-871c-e43933b7737a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019dbf4b-b7aa-7381-871c-e43933b7737a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019dbf4b-b7aa-7381-871c-e43933b7737a" xlink:to="loc_us-gaap_PlanNameDomain_019dbf4b-b7aa-7381-871c-e43933b7737a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019dbf4b-b7aa-7aa1-b3f2-2cf3030ac69a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019dbf4b-b7aa-7381-871c-e43933b7737a" xlink:to="loc_us-gaap_PlanNameDomain_019dbf4b-b7aa-7aa1-b3f2-2cf3030ac69a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2023EmployeeStockPurchasePlanMember_019dbf4b-b7aa-707c-9356-16b8dcc554e1" xlink:href="mlys-20260331.xsd#mlys_A2023EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019dbf4b-b7aa-7aa1-b3f2-2cf3030ac69a" xlink:to="loc_mlys_A2023EmployeeStockPurchasePlanMember_019dbf4b-b7aa-707c-9356-16b8dcc554e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019dbf4b-b7aa-7f22-971a-a5e7f9504dca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dbf4b-b7aa-720a-a17d-a52930695899" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019dbf4b-b7aa-7f22-971a-a5e7f9504dca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_019dbf4b-b7aa-7046-871f-ad0836e159f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dbf4b-b7aa-720a-a17d-a52930695899" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_019dbf4b-b7aa-7046-871f-ad0836e159f3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0102-795c-b3bd-749d7c5ea4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0102-7611-bc8d-6f2dd62a0274" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0102-795c-b3bd-749d7c5ea4f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0102-7611-bc8d-6f2dd62a0274" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_019d6f32-0102-7b86-916b-fbf6fcdd514d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0102-7611-bc8d-6f2dd62a0274" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_019d6f32-0102-7b86-916b-fbf6fcdd514d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7b86-916b-fbf6fcdd514d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019d6f32-0102-7b86-916b-fbf6fcdd514d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7b86-916b-fbf6fcdd514d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7252-ab14-e089b673599b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019d6f32-0102-7b86-916b-fbf6fcdd514d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7252-ab14-e089b673599b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019d6f32-0102-7b35-8f27-e41e45c3b1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7252-ab14-e089b673599b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019d6f32-0102-7b35-8f27-e41e45c3b1d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019d6f32-0102-747b-b08c-59a23cc53468" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7252-ab14-e089b673599b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019d6f32-0102-747b-b08c-59a23cc53468" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d6f32-0102-7ee4-9103-407dc96ba901" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0102-795c-b3bd-749d7c5ea4f7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d6f32-0102-7ee4-9103-407dc96ba901" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CatalysPacificFundLPMember_019ddf0e-2d3d-7015-aa68-73314468d735" xlink:href="mlys-20260331.xsd#mlys_CatalysPacificFundLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_mlys_CatalysPacificFundLPMember_019ddf0e-2d3d-7015-aa68-73314468d735" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>mlys-20260331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d6f31-ff89-7928-a1ca-06ccbd9e4802,g:1233a744-2d7f-4bba-93f2-58a8edc900ae-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentQuarterlyReport_019d6f32-0102-7707-a8a7-4cb421c04e30_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_019d6f32-0102-73bc-b2a1-d51e48740125_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019d6f32-0103-7c15-9911-63c22be065e7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offering costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_019d6f32-0102-70a7-ba44-38c2a756c5e3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_019d6f32-019f-7a2e-9fee-cc981b1772be_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_019d6f32-0103-7db2-afd3-bd1f5302f520_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_019d6f32-0102-7877-829d-a00d192b7b9a_terseLabel_en-US" xlink:label="lab_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Public offering and shelf offering costs included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_label_en-US" xlink:label="lab_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offering Costs Incurred During Noncash or Partial Noncash Transaction</link:label>
    <link:label id="lab_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_documentation_en-US" xlink:label="lab_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Offering Costs Incurred During Noncash or Partial Noncash Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="mlys-20260331.xsd#mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="lab_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019d6f32-0103-7802-8c12-98a3cd2b06f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accretion of discount on held-to-maturity securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019d6f32-0102-7ac3-ae4b-9d9089c59864_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_019d6f32-0102-7716-a281-628728ad673f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional &#8232;Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_019d6f32-0103-7a5e-8c1f-6aef91d16419_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019d6f32-0102-71d3-99c9-7001fe1d2697_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_AtTheMarketMember_019d6f32-0103-7602-a9f3-0d443ac428d2_terseLabel_en-US" xlink:label="lab_mlys_AtTheMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At the Market</link:label>
    <link:label id="lab_mlys_AtTheMarketMember_label_en-US" xlink:label="lab_mlys_AtTheMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At the Market [Member]</link:label>
    <link:label id="lab_mlys_AtTheMarketMember_documentation_en-US" xlink:label="lab_mlys_AtTheMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At the Market</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AtTheMarketMember" xlink:href="mlys-20260331.xsd#mlys_AtTheMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_AtTheMarketMember" xlink:to="lab_mlys_AtTheMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_019d6f32-0102-7b7b-bd97-d915ab4e6eb1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0102-7fcb-96cf-b08a628f7664_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019d6f32-0102-77f8-a3a9-347bcadf700e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share attributable to common stockholders - basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0102-7b9c-b493-39de28da9156_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019d6f32-019f-79f6-ac2c-e100123fbd7a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019d6f32-0102-795f-9c58-bc6ca6a52658_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_019d6f32-0102-7ca3-a5cb-04da534b4cbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_019d6f32-0103-7c4b-88ea-137a8aea3f50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Interest Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_019d6f32-0102-7178-b9c4-bfcf26b274a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_019d6f32-0102-72b0-bf8e-c1402329934f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_019d6f32-0103-72af-bf55-530fa9eea087_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant under the ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_019d6f32-0103-77ef-b1cc-d8251f926122_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee_019d6f32-019f-7e92-8cf6-b026ee45b927_terseLabel_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upfront fee</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee_label_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Upfront Fee</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee_documentation_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Upfront Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee" xlink:to="lab_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019d6f32-0102-7f89-8c43-9bc9f7963f8c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019d6f32-0102-72fd-bd58-837e815b9eb3_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock options outstanding</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_019d6f32-0102-74da-b400-8ea09a1e89ec_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_019d6f32-0103-72c7-a987-967a8f0e2e87_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_019d6f32-019f-7693-95ee-6b4994c75d9d_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d6f32-019f-7256-9c26-66255cba8af8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019d6f32-0102-754e-81f0-6daf9f860efd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_019d6f32-0102-7ef2-8338-92df91cdba93_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019d6f32-0102-7b1e-96e8-0690bfffe110_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019d6f32-0102-7709-8a18-d8bdbfccd438_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_019d6f32-0102-7ed0-96a3-06c683fe74f9_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_019d6f32-0102-74b6-bc34-2fe7f0dac43c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6f32-0103-7c7c-ac13-63749c390946_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of offering costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_019d6f32-0102-7d33-8f1a-59302bff1b9f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_019d6f32-0103-73a0-b2ac-cd10f8b4a0fa_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_AccruedResearchAndDevelopmentCostsCurrent_019d6f32-0103-796b-b7e7-4181f8bba51f_terseLabel_en-US" xlink:label="lab_mlys_AccruedResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_mlys_AccruedResearchAndDevelopmentCostsCurrent_label_en-US" xlink:label="lab_mlys_AccruedResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Research And Development Costs, Current</link:label>
    <link:label id="lab_mlys_AccruedResearchAndDevelopmentCostsCurrent_documentation_en-US" xlink:label="lab_mlys_AccruedResearchAndDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Research And Development Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AccruedResearchAndDevelopmentCostsCurrent" xlink:href="mlys-20260331.xsd#mlys_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_AccruedResearchAndDevelopmentCostsCurrent" xlink:to="lab_mlys_AccruedResearchAndDevelopmentCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_019d6f32-0102-773e-9b88-78a2fd12f290_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0102-72f0-bcd0-67f49ed36ff5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_019d6f32-0102-7b2d-ac81-ca045877811f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage_019d6f32-0102-7e51-85ba-c975aa19adab_terseLabel_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalties percentage</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage_label_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Rights And Obligations Royalty Percentage</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage_documentation_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Rights And Obligations Royalty Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage" xlink:to="lab_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d6f32-0102-700a-8088-ddfc61e45a8f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019d6f32-0102-7ff6-828d-2f751c097087_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019d6f32-0102-7232-9d5d-429d3d50e3c1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_019d6f32-0102-7e2d-a4bd-8b74f5302a75_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_019d6f32-0102-7891-97cc-ce26ab50bacc_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_019d6f32-0102-7b8a-9992-b46862078066_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_A2025IncentiveAwardPlanMember_019d6f32-0103-7f6a-bbd3-5b80f9188d59_terseLabel_en-US" xlink:label="lab_mlys_A2025IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025 Inducement Plan</link:label>
    <link:label id="lab_mlys_A2025IncentiveAwardPlanMember_label_en-US" xlink:label="lab_mlys_A2025IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2025 Incentive Award Plan [Member]</link:label>
    <link:label id="lab_mlys_A2025IncentiveAwardPlanMember_documentation_en-US" xlink:label="lab_mlys_A2025IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2025 Incentive Award Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2025IncentiveAwardPlanMember" xlink:href="mlys-20260331.xsd#mlys_A2025IncentiveAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_A2025IncentiveAwardPlanMember" xlink:to="lab_mlys_A2025IncentiveAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_019d6f32-0102-7d1b-84d2-59dbf5a7eb65_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent_019d6f32-0102-77c9-b56d-f45010a1caaf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents and Investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_019d6f32-0102-74e1-b06d-d93ed07101c1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_019d6f32-019f-74a8-839d-0b0a6e0db4c6_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_019d6f32-019f-78ff-b866-a1ac49f06427_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unvested Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0102-7f17-8c0f-8ab64bdd4573_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_019d6f32-0102-7332-b188-7ce40f4fd1ba_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_019d6f32-0103-7766-94ed-e37a988cec35_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_019d6f32-0102-77f5-91a8-05981fe95d0c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.0001 par value; 500,000,000 shares authorized as of March&#160;31, 2026 and December&#160;31, 2025; 82,454,950 and 81,536,557 shares issued and outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_019d6f32-019f-7472-aa9b-8b19e45cbd33_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019d6f32-0102-7d35-bc1d-cc3dfc8834b1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d6f32-0102-7b26-9a7d-883680676b88_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_EquityIncentivePlan2025Member_019d6f32-0102-75fb-b1d2-6bf73df5fd87_terseLabel_en-US" xlink:label="lab_mlys_EquityIncentivePlan2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant under the 2025 Inducement Plan</link:label>
    <link:label id="lab_mlys_EquityIncentivePlan2025Member_label_en-US" xlink:label="lab_mlys_EquityIncentivePlan2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Incentive Plan 2025 [Member]</link:label>
    <link:label id="lab_mlys_EquityIncentivePlan2025Member_documentation_en-US" xlink:label="lab_mlys_EquityIncentivePlan2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Incentive Plan 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_EquityIncentivePlan2025Member" xlink:href="mlys-20260331.xsd#mlys_EquityIncentivePlan2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_EquityIncentivePlan2025Member" xlink:to="lab_mlys_EquityIncentivePlan2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_019d6f32-0102-70db-8431-6d99c854a493_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_019d6f32-0103-7f3a-8aa7-4904cfa54097_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 4)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_019d6f32-0102-7037-9766-f4a6dded9f63_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_019d6f32-0102-7086-af7d-bdd76e888f97_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_PriorATMAgreementMember_019ddf26-4d99-72a3-8c6d-bfb39bf62836_terseLabel_en-US" xlink:label="lab_mlys_PriorATMAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior ATM Agreement</link:label>
    <link:label id="lab_mlys_PriorATMAgreementMember_label_en-US" xlink:label="lab_mlys_PriorATMAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior ATM Agreement [Member]</link:label>
    <link:label id="lab_mlys_PriorATMAgreementMember_documentation_en-US" xlink:label="lab_mlys_PriorATMAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prior ATM Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PriorATMAgreementMember" xlink:href="mlys-20260331.xsd#mlys_PriorATMAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_PriorATMAgreementMember" xlink:to="lab_mlys_PriorATMAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_019d6f32-0102-7ee3-b67b-d7e926b3b1b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of shelf offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract_019d6f32-0102-76f0-8666-128087cc6228_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019d6f32-019f-7f87-89fd-6b3018cb0338_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-Based Compensation Reported in Statement of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_019d6f32-0102-7566-9728-86a8513f399c_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_019d6f32-0102-70d4-8f57-7cf9ee69e79d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_019d6f32-0102-7819-b1b1-95f0b45696ca_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_019d6f32-0102-7a53-ae93-a3c1051e8ac9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019d6f32-0103-78d8-88d8-29b63217407b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019d6f32-0102-727a-9be1-cfd59befdd81_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_019d6f32-0102-7f21-8e73-00b55d6f7d80_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_019d6f32-0102-744a-92f6-a59b8a9d1607_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_019d6f32-0102-74c5-bdfd-62acdf930fb9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019d6f32-0102-7a08-a480-08e2b14e9feb_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019d6f32-019f-73ab-80ab-f0c5299574b5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019d6f32-0102-7b63-a922-3996113389f1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_019d6f32-0103-779f-a038-1226062b0635_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested Restricted Stock (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0102-74b6-86b5-bdace62c9ad4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_019d6f32-0102-7c54-a52f-f61cb72d93fe_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_019d6f32-0103-75d0-aa0d-20d5e0ae2095_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_019d6f32-0102-74c4-ae9b-ce6ebe56641b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock pursuant to ATM Agreement, net of issuance costs and Proceeds from issuance of common stock public offering, net of offering costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019d6f32-0102-797e-9d16-b4dba8060188_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7a4a-b8bf-d7c21fe64304_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_019dbf13-0ab4-7f17-956a-23eb3e4a2bdb_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_019dbf34-f26c-71b3-8b52-5f99fe884e2d_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units outstanding</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_019dbf45-fb95-7b96-8bf0-9e7a725b1cf8_netLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Unvested Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_A2023IncentiveAwardPlanMember_019d6f32-019f-7f9c-b1b0-0845c30bc5a7_verboseLabel_en-US" xlink:label="lab_mlys_A2023IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2023 Plan</link:label>
    <link:label id="lab_mlys_A2023IncentiveAwardPlanMember_label_en-US" xlink:label="lab_mlys_A2023IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2023 Incentive Award Plan [Member]</link:label>
    <link:label id="lab_mlys_A2023IncentiveAwardPlanMember_documentation_en-US" xlink:label="lab_mlys_A2023IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2023 Incentive Award Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2023IncentiveAwardPlanMember" xlink:href="mlys-20260331.xsd#mlys_A2023IncentiveAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_A2023IncentiveAwardPlanMember" xlink:to="lab_mlys_A2023IncentiveAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_019d6f32-0102-7233-aca6-d22817c45d9d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_019d6f32-0102-7a37-8ad0-edbe43a24b58_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019d6f32-019f-7fc5-a5af-4508b99903cb_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_019d6f32-019f-73f1-a7d7-4f93bfe7698e_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_019d6f32-0102-7353-8e9f-9408f22fd113_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesTextBlock_019d6f32-0103-76cd-b9c7-8fd9b33a2416_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Held-to-Maturity U.S. Treasury Bills</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HeldToMaturitySecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0102-7acf-a983-97bb372e36f6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_TanabeMember_019d6f32-0102-7e30-93bf-f51fc815bd74_terseLabel_en-US" xlink:label="lab_mlys_TanabeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tanabe</link:label>
    <link:label id="lab_mlys_TanabeMember_label_en-US" xlink:label="lab_mlys_TanabeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tanabe [Member]</link:label>
    <link:label id="lab_mlys_TanabeMember_documentation_en-US" xlink:label="lab_mlys_TanabeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tanabe</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_TanabeMember" xlink:href="mlys-20260331.xsd#mlys_TanabeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_TanabeMember" xlink:to="lab_mlys_TanabeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d6f32-0102-79e0-bb38-d34020eda7a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale_019d6f32-0102-7b9c-b8eb-106da633cd68_terseLabel_en-US" xlink:label="lab_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares available for sale</link:label>
    <link:label id="lab_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale_label_en-US" xlink:label="lab_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Aggregate Offering Price Of Remaining Common Shares Available For Sale</link:label>
    <link:label id="lab_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale_documentation_en-US" xlink:label="lab_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Aggregate Offering Price Of Remaining Common Shares Available For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale" xlink:href="mlys-20260331.xsd#mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale" xlink:to="lab_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_CatalysPacificFundLPMember_label_en-US" xlink:label="lab_mlys_CatalysPacificFundLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Catalys Pacific Fund, LP [Member]</link:label>
    <link:label id="lab_mlys_CatalysPacificFundLPMember_documentation_en-US" xlink:label="lab_mlys_CatalysPacificFundLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Catalys Pacific Fund, LP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CatalysPacificFundLPMember" xlink:href="mlys-20260331.xsd#mlys_CatalysPacificFundLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_CatalysPacificFundLPMember" xlink:to="lab_mlys_CatalysPacificFundLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019d6f32-0102-7c8a-83b4-30281b94d8aa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019d6f32-0102-7231-a885-353c3af9c770_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019d6f32-0102-7aae-8953-c3c37409e328_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_SaleOfStockPricePerShareWeightedAveragePrice_019dbfe5-31cc-7fda-b40c-eccad37698bf_terseLabel_en-US" xlink:label="lab_mlys_SaleOfStockPricePerShareWeightedAveragePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share (in USD per share)</link:label>
    <link:label id="lab_mlys_SaleOfStockPricePerShareWeightedAveragePrice_label_en-US" xlink:label="lab_mlys_SaleOfStockPricePerShareWeightedAveragePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share, Weighted Average Price</link:label>
    <link:label id="lab_mlys_SaleOfStockPricePerShareWeightedAveragePrice_documentation_en-US" xlink:label="lab_mlys_SaleOfStockPricePerShareWeightedAveragePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share, Weighted Average Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_SaleOfStockPricePerShareWeightedAveragePrice" xlink:href="mlys-20260331.xsd#mlys_SaleOfStockPricePerShareWeightedAveragePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_SaleOfStockPricePerShareWeightedAveragePrice" xlink:to="lab_mlys_SaleOfStockPricePerShareWeightedAveragePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_019d6f32-0102-7eca-a940-11a9a7855ef2_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_019d6f32-019f-7063-862c-99d740a0aa8f_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod_019d6f32-019f-715b-acd8-0654033525bd_terseLabel_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-compete period</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod_label_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Rights And Obligations, Non-compete Period</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod_documentation_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Rights And Obligations, Non-compete Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod" xlink:to="lab_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_019d6f32-0102-7a5c-9c3a-724f4abbf56b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_019d6f32-019f-7143-ae55-75895e8fb7d3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_019d6f32-0102-7a0c-b4c0-203e926afdce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_019d6f32-0102-7a96-b271-74188586484f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_A2023EmployeeStockPurchasePlanMember_019d6f32-0102-78e3-bc5c-1103a39d5be2_terseLabel_en-US" xlink:label="lab_mlys_A2023EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant under the ESPP</link:label>
    <link:label id="lab_mlys_A2023EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_mlys_A2023EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2023 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_mlys_A2023EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_mlys_A2023EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2023 Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2023EmployeeStockPurchasePlanMember" xlink:href="mlys-20260331.xsd#mlys_A2023EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_A2023EmployeeStockPurchasePlanMember" xlink:to="lab_mlys_A2023EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock_019d6f32-019f-743c-8340-85f45117af28_terseLabel_en-US" xlink:label="lab_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Authorized Shares of Common Stock</link:label>
    <link:label id="lab_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock_label_en-US" xlink:label="lab_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Common Stock Authorized [Table Text Block]</link:label>
    <link:label id="lab_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock_documentation_en-US" xlink:label="lab_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Common Stock Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock" xlink:href="mlys-20260331.xsd#mlys_ScheduleOfCommonStockAuthorizedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock" xlink:to="lab_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019d6f32-0102-7209-9725-1bc9cfe68ebe_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock from stock option exercises</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019d6f32-0102-7e56-829b-adbf300c0b9c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share attributable to common stockholders - diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_019d6f32-0102-7f86-b064-7a11b4dcb084_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of equity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_019d6f32-0103-7599-851e-d49a578842e9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated &#8232;Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d6f32-0102-76a6-a1be-76139e8c0568_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019d6f32-0102-7c82-b27e-6d425f85c5fe_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019d6f32-0102-7c9c-b5e7-95b9e8cf6f35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019d6f32-0102-7d5f-97c4-06c36d35559b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d6f32-0102-73b0-8e17-9bb90d0e7062_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents - beginning</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d6f32-0102-748f-aae5-01c7f58f5142_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents - ending</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d6f32-0102-7eeb-b76d-065ff851b4cc_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0102-7fda-8e68-0a3d640089e0_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_019d6f32-019f-75cb-9a5b-07894c90e7df_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_PublicOfferingMember_019d6f32-0102-7815-acf5-e43f68b81303_terseLabel_en-US" xlink:label="lab_mlys_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Public Offering</link:label>
    <link:label id="lab_mlys_PublicOfferingMember_label_en-US" xlink:label="lab_mlys_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Public Offering [Member]</link:label>
    <link:label id="lab_mlys_PublicOfferingMember_documentation_en-US" xlink:label="lab_mlys_PublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PublicOfferingMember" xlink:href="mlys-20260331.xsd#mlys_PublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_PublicOfferingMember" xlink:to="lab_mlys_PublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod_019d6f32-019f-742c-8902-e0e4770528f7_terseLabel_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination period</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod_label_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Rights And Obligations, Termination Period</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod_documentation_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Rights And Obligations, Termination Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod" xlink:to="lab_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_019d6f32-0103-717e-9bde-ea32e2201613_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019d6f32-0102-72d9-995a-171c653cb2ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Potential Common Shares Excluded From Calculation of Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_019d6f32-0102-7f53-bd68-c9b424a53dcf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_019d6f32-0102-7a74-bff8-c17f35058cc9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from stock option exercises</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019d6f32-0102-7cb5-9545-00cf54bdaa78_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0102-763b-a1c5-4f97f2d3080c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_019d6f32-019f-7c80-9893-2fb6c50e2766_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred offering costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0102-7f5b-bec9-6cc95860bb97_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0102-7f6d-93b7-8a500abfde17_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0102-7575-95df-fc4fc4cc492b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_019d6f32-0103-7cab-965e-a6a013b272c1_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0102-72dc-98c0-c13f6edd73e7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0102-768a-9296-8ecb962a7cbf_negatedLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019d6f32-0102-7da2-9a5b-298b9bed8e83_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_019d6f32-0102-706d-9c25-ce37a2aafa67_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019d6f32-0102-72d5-9c6a-3bcfd6c79ca4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019d6f32-0102-7a62-a79c-8c2ac19ec975_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_019d6f32-019f-745b-9844-66852e919794_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_019d6f32-0103-712d-97c4-d5a7bd7a4a37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_019d6f32-0102-75a9-9221-6708be1bab78_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019d6f32-0103-7f06-a4d9-ad8eee958140_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsMember_019d6f32-0102-74ca-9aae-1c386d12cf1c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsMember_label_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsMember" xlink:to="lab_us-gaap_InvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAndCash_019d6f32-019f-7d58-b379-25136c9e994d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsAndCash_label_en-US" xlink:label="lab_us-gaap_InvestmentsAndCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments and Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsAndCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAndCash" xlink:to="lab_us-gaap_InvestmentsAndCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_019d6f32-0102-786a-ab78-211cfc48661d_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_019d6f32-0103-7e00-b27a-864afdd962a0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019d6f32-0102-7511-a87c-f2d05556f586_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019d6f32-0102-7d06-9a76-a69358ba796c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019d6f32-0102-72fa-baa3-8a8f48beabc1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_SaleOfStockConsiderationReceivableOnTransaction_019d6f32-019f-77ea-9e61-ace79c438eb2_terseLabel_en-US" xlink:label="lab_mlys_SaleOfStockConsiderationReceivableOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum aggregate offering price</link:label>
    <link:label id="lab_mlys_SaleOfStockConsiderationReceivableOnTransaction_label_en-US" xlink:label="lab_mlys_SaleOfStockConsiderationReceivableOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Consideration Receivable On Transaction</link:label>
    <link:label id="lab_mlys_SaleOfStockConsiderationReceivableOnTransaction_documentation_en-US" xlink:label="lab_mlys_SaleOfStockConsiderationReceivableOnTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Consideration Receivable On Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_SaleOfStockConsiderationReceivableOnTransaction" xlink:href="mlys-20260331.xsd#mlys_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_SaleOfStockConsiderationReceivableOnTransaction" xlink:to="lab_mlys_SaleOfStockConsiderationReceivableOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_EquityIncentivePlan2023Member_019d6f32-0103-7b8f-8256-b3e35d14ae66_terseLabel_en-US" xlink:label="lab_mlys_EquityIncentivePlan2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant under the 2023 Plan</link:label>
    <link:label id="lab_mlys_EquityIncentivePlan2023Member_label_en-US" xlink:label="lab_mlys_EquityIncentivePlan2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Incentive Plan 2023 [Member]</link:label>
    <link:label id="lab_mlys_EquityIncentivePlan2023Member_documentation_en-US" xlink:label="lab_mlys_EquityIncentivePlan2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Incentive Plan 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_EquityIncentivePlan2023Member" xlink:href="mlys-20260331.xsd#mlys_EquityIncentivePlan2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_EquityIncentivePlan2023Member" xlink:to="lab_mlys_EquityIncentivePlan2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_019d6f32-0102-7de6-b641-7f8cee9cea1e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_019d6f32-019f-7c72-98b7-e6a57954836c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_019d6f32-0102-73db-8d91-f56af3f967bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_019d6f32-0102-71a0-bbf9-21ef0476ce7a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_019d6f32-019f-7754-a2df-e68c1ef5deba_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_019d6f32-0102-751c-931b-84b47fd85c3d_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_PreFundedWarrantMember_019d6f32-0102-70e4-b479-655ed72664ef_terseLabel_en-US" xlink:label="lab_mlys_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-funded warrants issued and outstanding</link:label>
    <link:label id="lab_mlys_PreFundedWarrantMember_label_en-US" xlink:label="lab_mlys_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant [Member]</link:label>
    <link:label id="lab_mlys_PreFundedWarrantMember_documentation_en-US" xlink:label="lab_mlys_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PreFundedWarrantMember" xlink:href="mlys-20260331.xsd#mlys_PreFundedWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_PreFundedWarrantMember" xlink:to="lab_mlys_PreFundedWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6f32-0102-7598-b316-da885a723662_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019dbf48-225d-78cb-8abe-cdafbf0bd3c8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares Available for Grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d6f32-019f-7d46-be68-e2fc86cca6b9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_019d6f32-0103-753f-8fbf-43f2101143c3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_019d6f32-0102-7f38-8200-6917453cd2ed_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract_019d6f32-019f-7fe7-a647-a082ac4205e8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0103-721f-b246-f8646ef4507b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0102-7c10-8b5e-b35c38cdc120_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_019d6f32-019f-73bb-97c7-269412b4444e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019d6f32-0102-7103-9d7f-f4b980b0ed82_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_019d6f32-0102-780f-8d62-678289735753_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation and benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_019d6f32-0102-7afc-ac48-1b0eaa11a3ef_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_019d6f32-0102-7dfb-abef-5d0db00ccbc2_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_019d6f32-0102-7a9c-bea3-c00d748c8aa3_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019d6f32-0102-7134-b101-7c1516fdb835_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d6f32-0103-7d10-9169-e38aac61d0d8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock from stock option exercises (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_019d6f32-019f-78db-9877-c119112ff8a9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019d6f32-0103-78b5-aeb0-9410cac502f9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_019d6f32-0102-7155-bf8e-e924a38d4c7e_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod_019d6f32-0102-7d07-9077-8ff323819459_terseLabel_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod_label_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Rights And Obligations Expiration Period</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod_documentation_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Rights And Obligations Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod" xlink:to="lab_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_019d6f32-0102-784b-90c3-60cb03553210_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Options by Plan</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesCurrent_019d6f32-0102-7acf-9c56-b16685e123bd_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesCurrent_019d6f32-0102-7968-8897-1b8082eac261_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesCurrent" xlink:to="lab_us-gaap_DebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_019d6f32-0102-7d26-a236-974c71a4f6eb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0102-71f9-8c3e-1a522d18cbcc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments_019d6f32-0103-7e9a-a79f-c110dfc2ce16_terseLabel_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development milestone payments</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments_label_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Developmental Maximum Aggregate Milestone Payments</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments_documentation_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Developmental Maximum Aggregate Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments" xlink:to="lab_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_019d6f32-019f-79e0-924f-7e400720c8f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0102-7183-b979-18e4fb7d9549_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_019d6f32-0102-76eb-856d-0095ff909e9c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Financial Instruments Measured at Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d6f32-0102-766c-9e22-bdb201d2c45b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common stockholders - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_019d6f32-0103-70b3-9ed5-7fdb8541e2fe_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_019d6f32-0102-7e4c-9f73-de19c4e8ec24_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019d6f32-0102-7505-9b2d-e4f736bede0a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_ProceedsFromIssuanceOfCommonStockNet_019d6f32-0102-7acf-9e32-fa276773a75a_terseLabel_en-US" xlink:label="lab_mlys_ProceedsFromIssuanceOfCommonStockNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate net proceeds</link:label>
    <link:label id="lab_mlys_ProceedsFromIssuanceOfCommonStockNet_label_en-US" xlink:label="lab_mlys_ProceedsFromIssuanceOfCommonStockNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance Of Common Stock, Net</link:label>
    <link:label id="lab_mlys_ProceedsFromIssuanceOfCommonStockNet_documentation_en-US" xlink:label="lab_mlys_ProceedsFromIssuanceOfCommonStockNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance Of Common Stock, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_ProceedsFromIssuanceOfCommonStockNet" xlink:href="mlys-20260331.xsd#mlys_ProceedsFromIssuanceOfCommonStockNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_ProceedsFromIssuanceOfCommonStockNet" xlink:to="lab_mlys_ProceedsFromIssuanceOfCommonStockNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019d6f32-0102-72cc-9d08-4c3da839346a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d6f32-0102-7c89-a78b-de1176e5c7e6_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross proceeds of sale of stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_019d6f32-0102-74fc-9b03-169cd01926c9_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Disclosure of Non-Cash Financing Activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments_019d6f32-0102-7b91-ad18-1ad40968010e_terseLabel_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First commercial milestone payments</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments_label_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, First Commercial Sale Maximum Aggregate Milestone Payments</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments_documentation_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, First Commercial Sale Maximum Aggregate Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" xlink:to="lab_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0102-7974-874c-699b274bb28b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_019d6f32-0103-7082-8075-6f1d32ccd940_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_019d6f32-0102-7392-9293-aa9b3c6ac0df_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d6f32-0102-744f-bfbe-9a29ec88d265_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid, other current assets, and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_019d6f32-019f-7288-9786-a7141244c25a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019d6f32-0102-7811-b64f-47366c595087_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d6f32-0102-7ff0-b234-446ae2ae8979_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019d6f32-019f-7fed-967a-75cf8651c139_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_019d6f32-0103-7050-83ef-1de037ca52a4_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent_019d6f32-0102-729f-bfbc-7c17247570d7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents and Investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_019d6f32-0103-7250-9c08-ce19a5736073_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_019d6f32-0102-730c-9b5f-5246d17471a7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_019d6f32-0103-719b-ae2d-043092f59db2_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019d6f32-0102-73ed-83d8-3901384d1592_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_019d6f32-0102-720e-9534-58d5124fbd70_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments_019d6f32-0102-700b-b3d4-0e12eb0962ef_terseLabel_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Second commercial milestone payment</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments_label_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Second Commercial Sale Maximum Aggregate Milestone Payments</link:label>
    <link:label id="lab_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments_documentation_en-US" xlink:label="lab_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Second Commercial Sale Maximum Aggregate Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments" xlink:to="lab_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_019d6f32-019f-78c2-8b5f-46c57c715588_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0102-705a-b468-a3882c16d53f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019d6f32-0102-77cc-89e7-9993c77c9036_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_019d6f32-0103-7e33-8ed5-b0cb66a30367_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_019d6f32-0102-78f9-9989-f5d37aa5ad1e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_019d6f32-0103-7b80-a78e-ddbe22b56600_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_019d6f32-0102-7558-8865-c4daca74d475_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6f32-0102-78d7-8f12-936368ba8594_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of offering costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_mlys_A2020EquityIncentivePlanMember_019d6f32-0102-754d-b22d-1a5f8994f644_verboseLabel_en-US" xlink:label="lab_mlys_A2020EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2020 Plan</link:label>
    <link:label id="lab_mlys_A2020EquityIncentivePlanMember_label_en-US" xlink:label="lab_mlys_A2020EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2020 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_mlys_A2020EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_mlys_A2020EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2020 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2020EquityIncentivePlanMember" xlink:href="mlys-20260331.xsd#mlys_A2020EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mlys_A2020EquityIncentivePlanMember" xlink:to="lab_mlys_A2020EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_019d6f32-0102-79c8-880d-d7729109275e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019d6f32-019f-7c25-b04b-b9cd0f42d0b3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0102-78de-9676-c31203f17566_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0102-7141-be7f-5b7d72f73c2c_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_019d6f32-0102-7de8-8ca9-a6b2638958bb_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_019d6f32-0102-70f4-b205-28c4e9434625_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_019d6f32-0102-7bd7-9129-1d5b755e742a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019d6f32-0102-7107-989e-f79f42786832_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6f32-019f-7a89-89cf-8630cf40d3e0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_019d6f32-0102-70f9-9e4a-43c7d9579a2d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional fees and other</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>mlys-20260331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d6f31-ff89-7928-a1ca-06ccbd9e4802,g:1233a744-2d7f-4bba-93f2-58a8edc900ae-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.mineralystx.com/role/Cover" xlink:type="simple" xlink:href="mlys-20260331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019d6f32-0050-7e5a-bd8d-891ac3ede27b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_DocumentType_019d6f32-0050-7e5a-bd8d-891ac3ede27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_019dbe76-aab6-7e71-bf38-380636a8be5d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_DocumentQuarterlyReport_019dbe76-aab6-7e71-bf38-380636a8be5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019d6f32-0050-7ae4-bf4b-240eb86f599d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_DocumentPeriodEndDate_019d6f32-0050-7ae4-bf4b-240eb86f599d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019d6f32-0050-717e-b35a-c0958b7afc3b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_DocumentTransitionReport_019d6f32-0050-717e-b35a-c0958b7afc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019d6f32-0050-75d2-b105-1eb5715c938a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityFileNumber_019d6f32-0050-75d2-b105-1eb5715c938a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019d6f32-0050-7d7f-b343-532724e3110a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityRegistrantName_019d6f32-0050-7d7f-b343-532724e3110a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019d6f32-0050-7659-82df-c68eba4dd218" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019d6f32-0050-7659-82df-c68eba4dd218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019d6f32-0050-7ebc-8123-a375b254a470" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityTaxIdentificationNumber_019d6f32-0050-7ebc-8123-a375b254a470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019d6f32-0050-7bef-bdc0-98cc01a17d19" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityAddressAddressLine1_019d6f32-0050-7bef-bdc0-98cc01a17d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_019d6f32-0050-7f94-b8bf-d73027d10ec8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityAddressAddressLine2_019d6f32-0050-7f94-b8bf-d73027d10ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019d6f32-0050-799c-b192-6f2c5f9993b6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityAddressCityOrTown_019d6f32-0050-799c-b192-6f2c5f9993b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019d6f32-0050-7726-9dd0-7f3090c64552" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityAddressStateOrProvince_019d6f32-0050-7726-9dd0-7f3090c64552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019d6f32-0050-76a8-b869-ba4ee2a1977b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityAddressPostalZipCode_019d6f32-0050-76a8-b869-ba4ee2a1977b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019d6f32-0050-7775-9042-b012a89ac489" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_CityAreaCode_019d6f32-0050-7775-9042-b012a89ac489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019d6f32-0050-7143-a6dd-842e994196f1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_LocalPhoneNumber_019d6f32-0050-7143-a6dd-842e994196f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019d6f32-0050-7e06-b0c0-0955b99a09d5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_Security12bTitle_019d6f32-0050-7e06-b0c0-0955b99a09d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019d6f32-0050-75cd-a7b5-b6621323171c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_TradingSymbol_019d6f32-0050-75cd-a7b5-b6621323171c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019d6f32-0050-7f10-829a-88b88c1482fa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_SecurityExchangeName_019d6f32-0050-7f10-829a-88b88c1482fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019d6f32-0050-71d7-b105-d897974e203b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityCurrentReportingStatus_019d6f32-0050-71d7-b105-d897974e203b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019d6f32-0050-75d2-a31c-fa41fe174daf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityInteractiveDataCurrent_019d6f32-0050-75d2-a31c-fa41fe174daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019d6f32-0050-7824-b605-c9fc19d304a7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityFilerCategory_019d6f32-0050-7824-b605-c9fc19d304a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_019d6f32-0050-7b6e-af63-7eb98e65b6ed" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntitySmallBusiness_019d6f32-0050-7b6e-af63-7eb98e65b6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019d6f32-0050-711e-8abe-9b14173f22aa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityEmergingGrowthCompany_019d6f32-0050-711e-8abe-9b14173f22aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_019d6f32-0050-7c26-8674-63f68a89e4e3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityExTransitionPeriod_019d6f32-0050-7c26-8674-63f68a89e4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019d6f32-0050-7768-9e95-c63ed092aee2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityShellCompany_019d6f32-0050-7768-9e95-c63ed092aee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019d6f32-0050-7038-aa5f-1197f953e642" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019d6f32-0050-7038-aa5f-1197f953e642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019d6f32-0050-76b8-bee2-7700adfc6710" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_EntityCentralIndexKey_019d6f32-0050-76b8-bee2-7700adfc6710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019d6f32-0050-7ac5-a2ea-9e5346bb8ca2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_DocumentFiscalYearFocus_019d6f32-0050-7ac5-a2ea-9e5346bb8ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019d6f32-0050-71f4-a26c-01b5ec3569a9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019d6f32-0050-71f4-a26c-01b5ec3569a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019d6f32-0050-72f8-baff-6c273362548d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_AmendmentFlag_019d6f32-0050-72f8-baff-6c273362548d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019d6f32-0050-7ee6-a2db-7c040f397fd2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d6f32-0050-7206-9896-1cdce56f1969" xlink:to="loc_dei_CurrentFiscalYearEndDate_019d6f32-0050-7ee6-a2db-7c040f397fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedBalanceSheets" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CondensedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019d6f32-0050-7e32-8068-e8006c736953" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_019d6f32-0050-793c-9054-0a810d582b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019d6f32-0050-7e32-8068-e8006c736953" xlink:to="loc_us-gaap_AssetsAbstract_019d6f32-0050-793c-9054-0a810d582b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_019d6f32-0050-766b-b161-c40cb484e141" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019d6f32-0050-793c-9054-0a810d582b7e" xlink:to="loc_us-gaap_AssetsCurrentAbstract_019d6f32-0050-766b-b161-c40cb484e141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0050-7091-abbf-6a094811ca8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019d6f32-0050-766b-b161-c40cb484e141" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0050-7091-abbf-6a094811ca8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesCurrent_019d6f32-0050-7a07-8db8-9f09e3ba7d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019d6f32-0050-766b-b161-c40cb484e141" xlink:to="loc_us-gaap_DebtSecuritiesCurrent_019d6f32-0050-7a07-8db8-9f09e3ba7d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d6f32-0050-71e3-aeee-73be1ee11901" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019d6f32-0050-766b-b161-c40cb484e141" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d6f32-0050-71e3-aeee-73be1ee11901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d6f32-0050-7cf0-adc5-294a183bd5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019d6f32-0050-766b-b161-c40cb484e141" xlink:to="loc_us-gaap_AssetsCurrent_019d6f32-0050-7cf0-adc5-294a183bd5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d6f32-0050-7f32-a6ca-5a9948d03e55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019d6f32-0050-793c-9054-0a810d582b7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019d6f32-0050-7f32-a6ca-5a9948d03e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019d6f32-0050-7a41-90d3-89708b5e1ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019d6f32-0050-793c-9054-0a810d582b7e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019d6f32-0050-7a41-90d3-89708b5e1ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019d6f32-0050-7634-abd9-6b186166117e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019d6f32-0050-793c-9054-0a810d582b7e" xlink:to="loc_us-gaap_Assets_019d6f32-0050-7634-abd9-6b186166117e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d6f32-0050-77d0-81b5-a5a57671e8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019d6f32-0050-7e32-8068-e8006c736953" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d6f32-0050-77d0-81b5-a5a57671e8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_019d6f32-0050-73cc-8225-d0958469d86a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d6f32-0050-77d0-81b5-a5a57671e8d2" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_019d6f32-0050-73cc-8225-d0958469d86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019d6f32-0050-7537-8827-8539a80e3582" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019d6f32-0050-73cc-8225-d0958469d86a" xlink:to="loc_us-gaap_AccountsPayableCurrent_019d6f32-0050-7537-8827-8539a80e3582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0050-7b6a-8f90-79d0c25bce6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019d6f32-0050-73cc-8225-d0958469d86a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0050-7b6a-8f90-79d0c25bce6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d6f32-0050-7b20-aab8-3140ebc77b08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019d6f32-0050-73cc-8225-d0958469d86a" xlink:to="loc_us-gaap_LiabilitiesCurrent_019d6f32-0050-7b20-aab8-3140ebc77b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019d6f32-0050-71dd-a267-fcc86c29917c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d6f32-0050-77d0-81b5-a5a57671e8d2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019d6f32-0050-71dd-a267-fcc86c29917c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019d6f32-0050-7f71-b567-805ea5c86285" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d6f32-0050-77d0-81b5-a5a57671e8d2" xlink:to="loc_us-gaap_EquityAbstract_019d6f32-0050-7f71-b567-805ea5c86285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019d6f32-0050-7eee-a0d9-3be2c416cb22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019d6f32-0050-7f71-b567-805ea5c86285" xlink:to="loc_us-gaap_CommonStockValue_019d6f32-0050-7eee-a0d9-3be2c416cb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019d6f32-0050-70b9-bc20-62711d56f1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019d6f32-0050-7f71-b567-805ea5c86285" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019d6f32-0050-70b9-bc20-62711d56f1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d6f32-0050-7c31-ab49-47f5f3a958a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019d6f32-0050-7f71-b567-805ea5c86285" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d6f32-0050-7c31-ab49-47f5f3a958a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d6f32-0050-7c14-98ef-3506f0d3c949" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019d6f32-0050-7f71-b567-805ea5c86285" xlink:to="loc_us-gaap_StockholdersEquity_019d6f32-0050-7c14-98ef-3506f0d3c949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d6f32-0050-7ab4-94b1-ee2487c5d2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d6f32-0050-77d0-81b5-a5a57671e8d2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d6f32-0050-7ab4-94b1-ee2487c5d2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CondensedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019d6f32-0050-72aa-b6a5-0046f2d10731" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019d6f32-0050-70ce-a995-f06a442a8f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019d6f32-0050-72aa-b6a5-0046f2d10731" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019d6f32-0050-70ce-a995-f06a442a8f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019d6f32-0050-73a7-823e-c17a3ed71d90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019d6f32-0050-72aa-b6a5-0046f2d10731" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019d6f32-0050-73a7-823e-c17a3ed71d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019d6f32-0050-7d26-9711-ea124d2fab50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019d6f32-0050-72aa-b6a5-0046f2d10731" xlink:to="loc_us-gaap_CommonStockSharesIssued_019d6f32-0050-7d26-9711-ea124d2fab50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019d6f32-0050-7421-97a8-1214c1b665ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019d6f32-0050-72aa-b6a5-0046f2d10731" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019d6f32-0050-7421-97a8-1214c1b665ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedStatementsofOperations" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CondensedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_019d6f32-0050-72a6-8ece-d4058779107c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:to="loc_us-gaap_OperatingExpensesAbstract_019d6f32-0050-72a6-8ece-d4058779107c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d6f32-0050-7240-bd99-d291f30e03c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019d6f32-0050-72a6-8ece-d4058779107c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d6f32-0050-7240-bd99-d291f30e03c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d6f32-0050-745d-bd23-2110f649104d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019d6f32-0050-72a6-8ece-d4058779107c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d6f32-0050-745d-bd23-2110f649104d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d6f32-0050-77b4-81ca-05c97d6a933a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019d6f32-0050-72a6-8ece-d4058779107c" xlink:to="loc_us-gaap_OperatingExpenses_019d6f32-0050-77b4-81ca-05c97d6a933a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d6f32-0050-765e-8841-81ad4338eced" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d6f32-0050-765e-8841-81ad4338eced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019d6f32-0050-76f4-b7fb-5f1f1d8bff84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019d6f32-0050-76f4-b7fb-5f1f1d8bff84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d6f32-0050-746f-be96-d5ea60c3b1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019d6f32-0050-746f-be96-d5ea60c3b1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019d6f32-0050-7fa3-a90d-f4824100a9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019d6f32-0050-7fa3-a90d-f4824100a9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6f32-0050-70df-8a25-506fb70a4f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:to="loc_us-gaap_NetIncomeLoss_019d6f32-0050-70df-8a25-506fb70a4f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019d6f32-0050-7a17-95cb-e5e39a76ecc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:to="loc_us-gaap_EarningsPerShareBasic_019d6f32-0050-7a17-95cb-e5e39a76ecc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019d6f32-0050-7cce-aeaf-f6cb9a0b186d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019d6f32-0050-7cce-aeaf-f6cb9a0b186d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d6f32-0050-7e4a-b3c6-45c0223e0b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d6f32-0050-7e4a-b3c6-45c0223e0b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d6f32-0050-7977-83f3-c86518f4d6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d6f32-0050-78eb-9528-a9364d32df41" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d6f32-0050-7977-83f3-c86518f4d6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019d6f32-0050-731b-8f1a-41b421e60b32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019d6f32-0050-747e-81a1-51019f095853" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019d6f32-0050-731b-8f1a-41b421e60b32" xlink:to="loc_us-gaap_StatementTable_019d6f32-0050-747e-81a1-51019f095853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019d6f32-0050-7801-958d-401d6161d572" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-747e-81a1-51019f095853" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019d6f32-0050-7801-958d-401d6161d572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d6f32-0050-748c-b890-54080ec91dce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d6f32-0050-7801-958d-401d6161d572" xlink:to="loc_us-gaap_EquityComponentDomain_019d6f32-0050-748c-b890-54080ec91dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019d6f32-0050-7cc1-a1d6-43f7a6900348" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019d6f32-0050-748c-b890-54080ec91dce" xlink:to="loc_us-gaap_CommonStockMember_019d6f32-0050-7cc1-a1d6-43f7a6900348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019d6f32-0050-74b7-9820-5253653cc1db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019d6f32-0050-748c-b890-54080ec91dce" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019d6f32-0050-74b7-9820-5253653cc1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019d6f32-0050-7e5a-a2e8-2c65bae8812d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019d6f32-0050-748c-b890-54080ec91dce" xlink:to="loc_us-gaap_RetainedEarningsMember_019d6f32-0050-7e5a-a2e8-2c65bae8812d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78fc-8827-e846b60b22a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-747e-81a1-51019f095853" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78fc-8827-e846b60b22a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-75a3-b38d-aa96f838745c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78fc-8827-e846b60b22a0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-75a3-b38d-aa96f838745c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PublicOfferingMember_019dbee4-62c0-7776-92f3-7fc3acc5e171" xlink:href="mlys-20260331.xsd#mlys_PublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-75a3-b38d-aa96f838745c" xlink:to="loc_mlys_PublicOfferingMember_019dbee4-62c0-7776-92f3-7fc3acc5e171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AtTheMarketMember_019d6f32-0050-7956-a3bc-f2d50cb9d89f" xlink:href="mlys-20260331.xsd#mlys_AtTheMarketMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-75a3-b38d-aa96f838745c" xlink:to="loc_mlys_AtTheMarketMember_019d6f32-0050-7956-a3bc-f2d50cb9d89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019d6f32-0050-7021-81e6-c2e59215b0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-747e-81a1-51019f095853" xlink:to="loc_us-gaap_StatementLineItems_019d6f32-0050-7021-81e6-c2e59215b0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-7021-81e6-c2e59215b0c7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019d6f32-0050-7273-b144-0ef8c8c56d18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019d6f32-0050-7273-b144-0ef8c8c56d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d6f32-0050-76a0-9c94-9d7e2cbc75f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockholdersEquity_019d6f32-0050-76a0-9c94-9d7e2cbc75f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6f32-0050-7b33-baa4-49528ae78fba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6f32-0050-7b33-baa4-49528ae78fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6f32-0050-77cd-82ab-9544b511a1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6f32-0050-77cd-82ab-9544b511a1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d6f32-0050-7c88-9814-40db54cc9fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d6f32-0050-7c88-9814-40db54cc9fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019d6f32-0050-765f-acbf-a3b992060798" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019d6f32-0050-765f-acbf-a3b992060798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019d6f32-0050-7667-8e4f-f6df7495748d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019d6f32-0050-7667-8e4f-f6df7495748d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6f32-0050-74b0-8355-3f6a5aba3800" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_NetIncomeLoss_019d6f32-0050-74b0-8355-3f6a5aba3800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019d6f32-0050-79fd-a5dc-bbac42afdfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019d6f32-0050-79fd-a5dc-bbac42afdfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d6f32-0050-7886-b761-cdaa0aa956e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d6f32-0050-77d9-bdd8-2dcdad36cad0" xlink:to="loc_us-gaap_StockholdersEquity_019d6f32-0050-7886-b761-cdaa0aa956e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019d6f32-0050-77dd-b423-8333eb294fed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019d6f32-0050-7768-82a1-ca65e7063828" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019d6f32-0050-77dd-b423-8333eb294fed" xlink:to="loc_us-gaap_StatementTable_019d6f32-0050-7768-82a1-ca65e7063828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78b1-99fe-f9e0f06d9d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-7768-82a1-ca65e7063828" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78b1-99fe-f9e0f06d9d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-7a6c-b5c5-e8472a9d8a12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-78b1-99fe-f9e0f06d9d5e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-7a6c-b5c5-e8472a9d8a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PublicOfferingMember_019dbee2-627c-7a98-b36e-f268c5a9a4c2" xlink:href="mlys-20260331.xsd#mlys_PublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-7a6c-b5c5-e8472a9d8a12" xlink:to="loc_mlys_PublicOfferingMember_019dbee2-627c-7a98-b36e-f268c5a9a4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AtTheMarketMember_019d6f32-0050-79b1-816c-e1dd1bf17474" xlink:href="mlys-20260331.xsd#mlys_AtTheMarketMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-7a6c-b5c5-e8472a9d8a12" xlink:to="loc_mlys_AtTheMarketMember_019d6f32-0050-79b1-816c-e1dd1bf17474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019d6f32-0050-7d81-a7c6-26f17d527b62" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-7768-82a1-ca65e7063828" xlink:to="loc_us-gaap_StatementLineItems_019d6f32-0050-7d81-a7c6-26f17d527b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019d6f32-0050-7df7-9522-f70622c4d3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-7d81-a7c6-26f17d527b62" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019d6f32-0050-7df7-9522-f70622c4d3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_019d6f32-0050-7267-86c3-15a9a99e1c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019d6f32-0050-73cc-9935-8bd61644f4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019d6f32-0050-7267-86c3-15a9a99e1c2c" xlink:to="loc_us-gaap_StatementTable_019d6f32-0050-73cc-9935-8bd61644f4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-7873-86bf-3b752ec182e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-73cc-9935-8bd61644f4ef" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-7873-86bf-3b752ec182e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78ba-9485-b7ddfcd3efae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0050-7873-86bf-3b752ec182e0" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78ba-9485-b7ddfcd3efae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AtTheMarketMember_019d6f32-0050-716f-8752-394b9def8c3b" xlink:href="mlys-20260331.xsd#mlys_AtTheMarketMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78ba-9485-b7ddfcd3efae" xlink:to="loc_mlys_AtTheMarketMember_019d6f32-0050-716f-8752-394b9def8c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PublicOfferingMember_019dbefb-2946-7081-9498-ec6f1378b551" xlink:href="mlys-20260331.xsd#mlys_PublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0050-78ba-9485-b7ddfcd3efae" xlink:to="loc_mlys_PublicOfferingMember_019dbefb-2946-7081-9498-ec6f1378b551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d6f32-0050-73cc-9935-8bd61644f4ef" xlink:to="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7ad8-9ff6-4b80226c0133" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7ad8-9ff6-4b80226c0133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6f32-0050-7feb-bcbc-5e8b151092ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7ad8-9ff6-4b80226c0133" xlink:to="loc_us-gaap_NetIncomeLoss_019d6f32-0050-7feb-bcbc-5e8b151092ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7ad8-9ff6-4b80226c0133" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019d6f32-0050-7b7b-ae00-2bb9c42b067b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:to="loc_us-gaap_ShareBasedCompensation_019d6f32-0050-7b7b-ae00-2bb9c42b067b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019d6f32-0050-7f21-adfa-287c30875672" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019d6f32-0050-7f21-adfa-287c30875672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019d6f32-0051-781e-aa47-7a499a787db9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019d6f32-0051-781e-aa47-7a499a787db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0051-767f-85dd-6cd9f78a7c88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7670-b1bf-0a1c98e9e663" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0051-767f-85dd-6cd9f78a7c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_019d6f32-0051-7daa-99f5-a2e029b37a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0051-767f-85dd-6cd9f78a7c88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_019d6f32-0051-7daa-99f5-a2e029b37a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d6f32-0051-7782-bf43-fee31f98d36e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0051-767f-85dd-6cd9f78a7c88" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d6f32-0051-7782-bf43-fee31f98d36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019d6f32-0051-7fc7-8dd0-c55e779524ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_019d6f32-0051-767f-85dd-6cd9f78a7c88" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019d6f32-0051-7fc7-8dd0-c55e779524ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-7be3-a2b6-f39a7ef8fe8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d6f32-0050-7ad8-9ff6-4b80226c0133" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-7be3-a2b6-f39a7ef8fe8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0051-7973-9ced-3fccb5533967" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0051-7973-9ced-3fccb5533967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_019d6f32-0051-7055-9300-e6304ffdd767" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0051-7973-9ced-3fccb5533967" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_019d6f32-0051-7055-9300-e6304ffdd767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_019d6f32-0051-77f8-827b-fed2a50579b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0051-7973-9ced-3fccb5533967" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_019d6f32-0051-77f8-827b-fed2a50579b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6f32-0051-7c7a-9557-c5578c41b5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d6f32-0051-7973-9ced-3fccb5533967" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d6f32-0051-7c7a-9557-c5578c41b5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d6f32-0051-7178-9ead-a46a705e53f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019d6f32-0051-7178-9ead-a46a705e53f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019d6f32-0051-7bf1-a56f-2c0a3ec33d67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019d6f32-0051-7bf1-a56f-2c0a3ec33d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_019d6f32-0051-7c65-9bd7-210fb805aad5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_019d6f32-0051-7c65-9bd7-210fb805aad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0051-7336-bbd2-3525d4cfe9d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d6f32-0051-7752-ab30-0dfa32d2cd67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d6f32-0051-7336-bbd2-3525d4cfe9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6f32-0051-7b97-9288-2ed8a01f4f36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d6f32-0051-7b97-9288-2ed8a01f4f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d6f32-0051-7b35-b5b5-9dfa99e18905" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d6f32-0051-7b35-b5b5-9dfa99e18905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d6f32-0051-7114-9586-d14042e950e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d6f32-0051-7114-9586-d14042e950e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_019d6f32-0051-719c-af97-d8a0265b067c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d6f32-0050-794a-bf8e-fa1d0e5d3332" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_019d6f32-0051-719c-af97-d8a0265b067c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_019d6f32-0051-712c-8797-495c8c77c720" xlink:href="mlys-20260331.xsd#mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_019d6f32-0051-719c-af97-d8a0265b067c" xlink:to="loc_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction_019d6f32-0051-712c-8797-495c8c77c720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CondensedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="mlys-20260331.xsd#CondensedStatementsofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CondensedStatementsofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_019d6f32-0051-7ce3-be3a-26feb239f1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesCurrent_019d6f32-0051-7f01-a8b5-7e3720fa8b87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019d6f32-0051-7ce3-be3a-26feb239f1d7" xlink:to="loc_us-gaap_DebtSecuritiesCurrent_019d6f32-0051-7f01-a8b5-7e3720fa8b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_019d6f32-0051-79ae-976d-bcab4bab0cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsAndCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019d6f32-0051-7ce3-be3a-26feb239f1d7" xlink:to="loc_us-gaap_InvestmentsAndCash_019d6f32-0051-79ae-976d-bcab4bab0cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/NatureofBusiness" xlink:type="simple" xlink:href="mlys-20260331.xsd#NatureofBusiness"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/NatureofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d6f32-0051-7664-b727-d6071f8e105a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_019d6f32-0051-702a-b6a1-dbc72998c448" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d6f32-0051-7664-b727-d6071f8e105a" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_019d6f32-0051-702a-b6a1-dbc72998c448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="mlys-20260331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7c2e-894f-cd4036751622" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_019d6f32-0051-75b9-8eb4-0e86912c06d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7c2e-894f-cd4036751622" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_019d6f32-0051-75b9-8eb4-0e86912c06d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="mlys-20260331.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019d6f32-0051-78d7-879e-434d9e1b6acb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_019d6f32-0051-757a-a64e-0b9227760213" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019d6f32-0051-78d7-879e-434d9e1b6acb" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_019d6f32-0051-757a-a64e-0b9227760213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mlys-20260331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019d6f32-0051-74f3-8bd7-6ea1e8f1a1db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019d6f32-0051-7172-9838-008d59c8845e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019d6f32-0051-74f3-8bd7-6ea1e8f1a1db" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019d6f32-0051-7172-9838-008d59c8845e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="mlys-20260331.xsd#AccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/AccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019d6f32-0051-767d-9fd5-63eba78f332f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_019d6f32-0051-704b-9e92-5e30b9d5ed46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d6f32-0051-767d-9fd5-63eba78f332f" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_019d6f32-0051-704b-9e92-5e30b9d5ed46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CapitalStock" xlink:type="simple" xlink:href="mlys-20260331.xsd#CapitalStock"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CapitalStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019d6f32-0051-7e0b-8c66-04be0c0e1059" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019d6f32-0051-759f-ae66-52ecfe086837" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019d6f32-0051-7e0b-8c66-04be0c0e1059" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019d6f32-0051-759f-ae66-52ecfe086837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="mlys-20260331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d6f32-0051-7ec6-9b97-3a31b6eb5ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019d6f32-0051-7b4a-bd4e-15f3ccdc6b73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d6f32-0051-7ec6-9b97-3a31b6eb5ff9" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019d6f32-0051-7b4a-bd4e-15f3ccdc6b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mlys-20260331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019d6f32-0051-79c0-933c-14357d03cc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019d6f32-0051-79c0-933c-14357d03cc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_019d6f32-0051-7a37-808a-d24a60d17d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_019d6f32-0051-7a37-808a-d24a60d17d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_019d6f32-0051-745e-b18d-51bf25517468" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_UseOfEstimates_019d6f32-0051-745e-b18d-51bf25517468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_019d6f32-0051-7b4e-baea-e601d31fcd25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_019d6f32-0051-7b4e-baea-e601d31fcd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_019d6f32-0051-77a8-97b8-7301f7b669c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_019d6f32-0051-77a8-97b8-7301f7b669c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_019d6f32-0051-74be-a740-0b28801a5cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_019d6f32-0051-74be-a740-0b28801a5cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_019d6f32-0051-70dc-b042-4db4184903cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_019d6f32-0051-70dc-b042-4db4184903cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_019d6f32-0051-7e34-a770-c2577b7bb1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_019d6f32-0051-7e34-a770-c2577b7bb1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_019d6f32-0051-743e-9a0d-e71575726dca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_019d6f32-0051-743e-9a0d-e71575726dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_019d6f32-0051-7662-a55e-310e3ef5c9af" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_019d6f32-0051-7662-a55e-310e3ef5c9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019d6f32-0051-715b-aee8-d1aceb204b13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7b14-ae0b-989269cc6edf" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019d6f32-0051-715b-aee8-d1aceb204b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mlys-20260331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-71e1-abd8-9bc2f5146525" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_019d6f32-0051-7a04-a855-b8436e2c9357" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-71e1-abd8-9bc2f5146525" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_019d6f32-0051-7a04-a855-b8436e2c9357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019d6f32-0051-7dc5-8f73-5d245e73c31a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-71e1-abd8-9bc2f5146525" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019d6f32-0051-7dc5-8f73-5d245e73c31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="mlys-20260331.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019d6f32-0051-75dc-b310-fc2e22430eef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_019d6f32-0051-76d1-aa7e-9c050ab04fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019d6f32-0051-75dc-b310-fc2e22430eef" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_019d6f32-0051-76d1-aa7e-9c050ab04fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesTextBlock_019d6f32-0051-78ac-ae57-ca052ce5a7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HeldToMaturitySecuritiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019d6f32-0051-75dc-b310-fc2e22430eef" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesTextBlock_019d6f32-0051-78ac-ae57-ca052ce5a7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="mlys-20260331.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019d6f32-0051-7d03-94cc-e7fd0c3a8d16" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019d6f32-0051-7f46-a136-33c0d205abc4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d6f32-0051-7d03-94cc-e7fd0c3a8d16" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019d6f32-0051-7f46-a136-33c0d205abc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CapitalStockTables" xlink:type="simple" xlink:href="mlys-20260331.xsd#CapitalStockTables"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CapitalStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019d6f32-0051-7006-a342-2cef933d5678" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock_019d6f32-0051-73f6-bd6b-b0829989167f" xlink:href="mlys-20260331.xsd#mlys_ScheduleOfCommonStockAuthorizedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019d6f32-0051-7006-a342-2cef933d5678" xlink:to="loc_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock_019d6f32-0051-73f6-bd6b-b0829989167f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="mlys-20260331.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d6f32-0051-7472-89f5-d2114e84eb19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_019d6f32-0051-73c7-96ef-f741d8ee7c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d6f32-0051-7472-89f5-d2114e84eb19" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_019d6f32-0051-73c7-96ef-f741d8ee7c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019d6f32-0051-777f-a894-c89151f5f14e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d6f32-0051-7472-89f5-d2114e84eb19" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019d6f32-0051-777f-a894-c89151f5f14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/NatureofBusinessDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#NatureofBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/NatureofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d6f32-0051-745a-8446-a8b7763e7d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d6f32-0051-7b0f-a0e9-6eed63bbd65b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d6f32-0051-745a-8446-a8b7763e7d5d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d6f32-0051-7b0f-a0e9-6eed63bbd65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_019d6f32-0051-7bf8-9232-5d1394f72b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsAndCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d6f32-0051-745a-8446-a8b7763e7d5d" xlink:to="loc_us-gaap_InvestmentsAndCash_019d6f32-0051-7bf8-9232-5d1394f72b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6f32-0051-7171-8d92-ed5c695f8705" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d6f32-0051-745a-8446-a8b7763e7d5d" xlink:to="loc_us-gaap_NetIncomeLoss_019d6f32-0051-7171-8d92-ed5c695f8705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-7697-8f01-1bafe67ecbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d6f32-0051-745a-8446-a8b7763e7d5d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d6f32-0051-7697-8f01-1bafe67ecbfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_019d6f32-0051-7804-8f3d-c7d3f139b68a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d6f32-0051-745a-8446-a8b7763e7d5d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_019d6f32-0051-7804-8f3d-c7d3f139b68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7184-9f5b-c52168920fee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019d6f32-0051-72f1-a3e7-674dd9113c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7184-9f5b-c52168920fee" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019d6f32-0051-72f1-a3e7-674dd9113c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-70b6-96ba-f086e3ea7d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_019d6f32-0051-71c3-8f60-144a9400d54a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-70b6-96ba-f086e3ea7d3b" xlink:to="loc_us-gaap_RestrictedCash_019d6f32-0051-71c3-8f60-144a9400d54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7d6f-b14f-14a876281ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_019d6f32-0051-7dda-8c3e-4740be65aa04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7d6f-b14f-14a876281ecc" xlink:to="loc_us-gaap_Cash_019d6f32-0051-7dda-8c3e-4740be65aa04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_019d6f32-0051-7497-99e5-6c3ff9b88b89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7d6f-b14f-14a876281ecc" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_019d6f32-0051-7497-99e5-6c3ff9b88b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0051-7fb8-823d-2d84e60b5049" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7d6f-b14f-14a876281ecc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d6f32-0051-7fb8-823d-2d84e60b5049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesDeferredOfferingCostsDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#SummaryofSignificantAccountingPoliciesDeferredOfferingCostsDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesDeferredOfferingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-735a-9382-f77015e27561" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_019d6f32-0051-7c67-852f-d5cecc7d00f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-735a-9382-f77015e27561" xlink:to="loc_us-gaap_DeferredOfferingCosts_019d6f32-0051-7c67-852f-d5cecc7d00f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7cba-8e6a-2f9aaae4d024" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-74a1-9b98-bf2e17d6d68a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d6f32-0051-7cba-8e6a-2f9aaae4d024" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-74a1-9b98-bf2e17d6d68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d6f32-0051-76f9-9e25-406a4deaf987" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-74a1-9b98-bf2e17d6d68a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d6f32-0051-76f9-9e25-406a4deaf987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-70b8-8141-64fb408fd0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d6f32-0051-76f9-9e25-406a4deaf987" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-70b8-8141-64fb408fd0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d6f32-0051-7815-b974-207fd94d14d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-70b8-8141-64fb408fd0e1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d6f32-0051-7815-b974-207fd94d14d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf13-0ab4-79fe-9616-2c72be65caff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-70b8-8141-64fb408fd0e1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf13-0ab4-79fe-9616-2c72be65caff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_019d6f32-0051-799a-befb-03e6939afff6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d6f32-0051-70b8-8141-64fb408fd0e1" xlink:to="loc_us-gaap_RestrictedStockMember_019d6f32-0051-799a-befb-03e6939afff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7bd5-a013-fdf8931c317a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-74a1-9b98-bf2e17d6d68a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7bd5-a013-fdf8931c317a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019d6f32-0051-7400-9254-4af74d68d7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7bd5-a013-fdf8931c317a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019d6f32-0051-7400-9254-4af74d68d7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019d6f32-0051-7691-8251-87c0df28b499" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7edd-8856-fa8aa13b5d39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019d6f32-0051-7691-8251-87c0df28b499" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7edd-8856-fa8aa13b5d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_019d6f32-0051-7fe9-8f80-bf31b04e7d00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7edd-8856-fa8aa13b5d39" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_019d6f32-0051-7fe9-8f80-bf31b04e7d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019d6f32-0051-7b5f-856d-3748ad88ba10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019d6f32-0051-7fe9-8f80-bf31b04e7d00" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019d6f32-0051-7b5f-856d-3748ad88ba10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_019d6f32-0051-7e21-a93d-75b67af4071f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019d6f32-0051-7b5f-856d-3748ad88ba10" xlink:to="loc_us-gaap_MoneyMarketFundsMember_019d6f32-0051-7e21-a93d-75b67af4071f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019d6f32-0051-7786-a623-b0b21160c078" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7edd-8856-fa8aa13b5d39" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019d6f32-0051-7786-a623-b0b21160c078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019d6f32-0051-7623-8415-7f5eb1e02df7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019d6f32-0051-7786-a623-b0b21160c078" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019d6f32-0051-7623-8415-7f5eb1e02df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019d6f32-0051-7c95-b76d-a43f89140514" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019d6f32-0051-7623-8415-7f5eb1e02df7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019d6f32-0051-7c95-b76d-a43f89140514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7b58-90cc-3cc4de18851e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7edd-8856-fa8aa13b5d39" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7b58-90cc-3cc4de18851e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019d6f32-0051-71b6-9fae-505861dc20ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7b58-90cc-3cc4de18851e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019d6f32-0051-71b6-9fae-505861dc20ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019d6f32-0051-7f93-806f-08f3031bbe58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7608-bec3-f295c5f6737b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019d6f32-0051-7f93-806f-08f3031bbe58" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7608-bec3-f295c5f6737b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_019d6f32-0051-72ea-96e8-cea7842c0e87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7608-bec3-f295c5f6737b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_019d6f32-0051-72ea-96e8-cea7842c0e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_019d6f32-0051-7081-bdc4-505896dd6002" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_019d6f32-0051-72ea-96e8-cea7842c0e87" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_019d6f32-0051-7081-bdc4-505896dd6002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_019d6f32-0051-7372-92d7-1452acc8bcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_019d6f32-0051-7081-bdc4-505896dd6002" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_019d6f32-0051-7372-92d7-1452acc8bcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_019d6f32-0051-7443-9384-10486f682b60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_019d6f32-0051-7081-bdc4-505896dd6002" xlink:to="loc_us-gaap_InvestmentsMember_019d6f32-0051-7443-9384-10486f682b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7266-8abf-bc2bd533cce7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_019d6f32-0051-7608-bec3-f295c5f6737b" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7266-8abf-bc2bd533cce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract_019d6f32-0051-75fb-8e94-4c6b27b874dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7266-8abf-bc2bd533cce7" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract_019d6f32-0051-75fb-8e94-4c6b27b874dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent_019d6f32-0051-7fad-92fe-bc3363dcb86c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract_019d6f32-0051-75fb-8e94-4c6b27b874dd" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent_019d6f32-0051-7fad-92fe-bc3363dcb86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_019d6f32-0051-7030-8d94-d79f86d00b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract_019d6f32-0051-75fb-8e94-4c6b27b874dd" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_019d6f32-0051-7030-8d94-d79f86d00b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract_019d6f32-0051-72dc-a1d3-7bc414c58f93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_019d6f32-0051-7266-8abf-bc2bd533cce7" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract_019d6f32-0051-72dc-a1d3-7bc414c58f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent_019d6f32-0051-7051-8538-2e41b64392c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract_019d6f32-0051-72dc-a1d3-7bc414c58f93" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent_019d6f32-0051-7051-8538-2e41b64392c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_019d6f32-0051-7b6b-8813-77d7804ec442" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract_019d6f32-0051-72dc-a1d3-7bc414c58f93" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_019d6f32-0051-7b6b-8813-77d7804ec442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019d6f32-0051-7950-b981-bdccfd5ecc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019d6f32-0051-7950-b981-bdccfd5ecc3c" xlink:to="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019d6f32-0051-7512-a4ec-af46713bfbda" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:to="loc_srt_CounterpartyNameAxis_019d6f32-0051-7512-a4ec-af46713bfbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d6f32-0051-72bb-8067-7745704e201e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_019d6f32-0051-7512-a4ec-af46713bfbda" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d6f32-0051-72bb-8067-7745704e201e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_TanabeMember_019d6f32-0051-7e0a-a153-81fc1bc23629" xlink:href="mlys-20260331.xsd#mlys_TanabeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d6f32-0051-72bb-8067-7745704e201e" xlink:to="loc_mlys_TanabeMember_019d6f32-0051-7e0a-a153-81fc1bc23629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019d6f32-0051-7b5a-a34e-c5f88b85f461" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019d6f32-0051-7b5a-a34e-c5f88b85f461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d6f32-0051-73c3-be6c-8e7f15fa6123" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d6f32-0051-7b5a-a34e-c5f88b85f461" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d6f32-0051-73c3-be6c-8e7f15fa6123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019d6f32-0051-778b-9912-e4bc20996700" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d6f32-0051-73c3-be6c-8e7f15fa6123" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_019d6f32-0051-778b-9912-e4bc20996700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d6f32-0051-7799-b408-45285ad7f4ae" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:to="loc_srt_RangeAxis_019d6f32-0051-7799-b408-45285ad7f4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d6f32-0051-76c7-ac83-34612a701ac1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019d6f32-0051-7799-b408-45285ad7f4ae" xlink:to="loc_srt_RangeMember_019d6f32-0051-76c7-ac83-34612a701ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d6f32-0051-78f5-ad5a-dede13d4c8ce" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d6f32-0051-76c7-ac83-34612a701ac1" xlink:to="loc_srt_MaximumMember_019d6f32-0051-78f5-ad5a-dede13d4c8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019d6f32-0051-7797-8108-6d017ba61b0f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d6f32-0051-76c7-ac83-34612a701ac1" xlink:to="loc_srt_MinimumMember_019d6f32-0051-7797-8108-6d017ba61b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_019d6f32-0051-7d28-9d3c-cee538e3aac5" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee_019d6f32-0051-7440-a4ff-752febf8455d" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee_019d6f32-0051-7440-a4ff-752febf8455d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments_019d6f32-0051-78c7-abc8-76247d95d744" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments_019d6f32-0051-78c7-abc8-76247d95d744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments_019d6f32-0051-7432-9a38-03bb7fa58732" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments_019d6f32-0051-7432-9a38-03bb7fa58732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments_019d6f32-0051-7584-b420-1b05f6affbd0" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments_019d6f32-0051-7584-b420-1b05f6affbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage_019d6f32-0051-7f64-afbc-5bad53703d48" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage_019d6f32-0051-7f64-afbc-5bad53703d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod_019d6f32-0051-7571-8003-a70382f4511a" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod_019d6f32-0051-7571-8003-a70382f4511a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod_019d6f32-0051-7408-8d67-69489afcf657" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod_019d6f32-0051-7408-8d67-69489afcf657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod_019d6f32-0051-73e3-b141-bd3bf10bbe64" xlink:href="mlys-20260331.xsd#mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_019d6f32-0051-75ec-a41f-b731f78bb6ae" xlink:to="loc_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod_019d6f32-0051-73e3-b141-bd3bf10bbe64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019d6f32-0051-78d8-965c-752e18d5b0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AccruedResearchAndDevelopmentCostsCurrent_019d6f32-0051-71c8-8fac-e51ffa16d31b" xlink:href="mlys-20260331.xsd#mlys_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d6f32-0051-78d8-965c-752e18d5b0ea" xlink:to="loc_mlys_AccruedResearchAndDevelopmentCostsCurrent_019d6f32-0051-71c8-8fac-e51ffa16d31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_019d6f32-0051-7f58-9044-a0516f838329" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d6f32-0051-78d8-965c-752e18d5b0ea" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_019d6f32-0051-7f58-9044-a0516f838329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019d6f32-0051-7f35-ab3e-d93d1747e894" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d6f32-0051-78d8-965c-752e18d5b0ea" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019d6f32-0051-7f35-ab3e-d93d1747e894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0051-7419-84f9-6bbde0ac5d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d6f32-0051-78d8-965c-752e18d5b0ea" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019d6f32-0051-7419-84f9-6bbde0ac5d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#CapitalStockScheduleofAuthorizedSharesofCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019d6f32-0051-7ff9-afcd-917ebf7f1b61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019d6f32-0051-7ff9-afcd-917ebf7f1b61" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d6f32-0051-7e8a-a75a-330932d00691" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:to="loc_us-gaap_AwardTypeAxis_019d6f32-0051-7e8a-a75a-330932d00691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7295-b150-da4ab6f6ca1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019d6f32-0051-7e8a-a75a-330932d00691" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7295-b150-da4ab6f6ca1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d6f32-0051-74d4-af3c-2a4db776338c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7295-b150-da4ab6f6ca1d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d6f32-0051-74d4-af3c-2a4db776338c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019d6f32-0051-7b22-b091-8fcb8488433a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7295-b150-da4ab6f6ca1d" xlink:to="loc_us-gaap_EmployeeStockMember_019d6f32-0051-7b22-b091-8fcb8488433a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf34-c885-7411-a379-f86d59c38d00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-7295-b150-da4ab6f6ca1d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf34-c885-7411-a379-f86d59c38d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d6f32-0051-7e0a-be12-534519a61deb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:to="loc_us-gaap_PlanNameAxis_019d6f32-0051-7e0a-be12-534519a61deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d6f32-0051-7296-8363-e195f72d3314" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019d6f32-0051-7e0a-be12-534519a61deb" xlink:to="loc_us-gaap_PlanNameDomain_019d6f32-0051-7296-8363-e195f72d3314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_EquityIncentivePlan2023Member_019d6f32-0051-7228-b2a4-9adad863f613" xlink:href="mlys-20260331.xsd#mlys_EquityIncentivePlan2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d6f32-0051-7296-8363-e195f72d3314" xlink:to="loc_mlys_EquityIncentivePlan2023Member_019d6f32-0051-7228-b2a4-9adad863f613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_EquityIncentivePlan2025Member_019d6f32-0051-74a2-9f01-a00ae66430cb" xlink:href="mlys-20260331.xsd#mlys_EquityIncentivePlan2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d6f32-0051-7296-8363-e195f72d3314" xlink:to="loc_mlys_EquityIncentivePlan2025Member_019d6f32-0051-74a2-9f01-a00ae66430cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019d6f32-0051-7906-abe3-5c7df34f69d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019d6f32-0051-7906-abe3-5c7df34f69d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019d6f32-0051-70d6-a3cd-0338b108de1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019d6f32-0051-7906-abe3-5c7df34f69d9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019d6f32-0051-70d6-a3cd-0338b108de1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PreFundedWarrantMember_019d6f32-0051-7acf-969d-59268a3f780b" xlink:href="mlys-20260331.xsd#mlys_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019d6f32-0051-70d6-a3cd-0338b108de1b" xlink:to="loc_mlys_PreFundedWarrantMember_019d6f32-0051-7acf-969d-59268a3f780b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7e4f-998e-53283406cb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-79d4-8eb5-19b4196b6e47" xlink:to="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7e4f-998e-53283406cb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019d6f32-0051-7766-9139-71d31cb7d82d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7e4f-998e-53283406cb5e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019d6f32-0051-7766-9139-71d31cb7d82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#CapitalStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/CapitalStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019d6f32-0051-7808-a6f1-f9a61c872c98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-7029-862a-ba27aac07661" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019d6f32-0051-7808-a6f1-f9a61c872c98" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-7029-862a-ba27aac07661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0051-7b46-a982-e094ab297177" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-7029-862a-ba27aac07661" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0051-7b46-a982-e094ab297177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0051-7f51-b967-ecea79a184cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d6f32-0051-7b46-a982-e094ab297177" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0051-7f51-b967-ecea79a184cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_AtTheMarketMember_019d6f32-0051-7d57-a891-ef7dbf411da1" xlink:href="mlys-20260331.xsd#mlys_AtTheMarketMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0051-7f51-b967-ecea79a184cb" xlink:to="loc_mlys_AtTheMarketMember_019d6f32-0051-7d57-a891-ef7dbf411da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_PriorATMAgreementMember_019ddf26-4d99-7983-bb58-19f559288ad5" xlink:href="mlys-20260331.xsd#mlys_PriorATMAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d6f32-0051-7f51-b967-ecea79a184cb" xlink:to="loc_mlys_PriorATMAgreementMember_019ddf26-4d99-7983-bb58-19f559288ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d6f32-0051-7349-a4da-c34be8ff6563" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-7029-862a-ba27aac07661" xlink:to="loc_srt_RangeAxis_019d6f32-0051-7349-a4da-c34be8ff6563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d6f32-0051-76dd-954b-57019e2fdc53" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019d6f32-0051-7349-a4da-c34be8ff6563" xlink:to="loc_srt_RangeMember_019d6f32-0051-76dd-954b-57019e2fdc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d6f32-0051-77c4-8e9a-6e1977d204cd" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d6f32-0051-76dd-954b-57019e2fdc53" xlink:to="loc_srt_MaximumMember_019d6f32-0051-77c4-8e9a-6e1977d204cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019d6f32-0051-7029-862a-ba27aac07661" xlink:to="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_SaleOfStockConsiderationReceivableOnTransaction_019d6f32-0051-728b-a6fc-ec85086ab40b" xlink:href="mlys-20260331.xsd#mlys_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_mlys_SaleOfStockConsiderationReceivableOnTransaction_019d6f32-0051-728b-a6fc-ec85086ab40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d6f32-0051-7cdd-97d8-d6943047497a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d6f32-0051-7cdd-97d8-d6943047497a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_SaleOfStockPricePerShareWeightedAveragePrice_019dbfe5-31cc-7b17-82a7-f61e6b032384" xlink:href="mlys-20260331.xsd#mlys_SaleOfStockPricePerShareWeightedAveragePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_mlys_SaleOfStockPricePerShareWeightedAveragePrice_019dbfe5-31cc-7b17-82a7-f61e6b032384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_ProceedsFromIssuanceOfCommonStockNet_019d6f32-0051-7123-b532-547d8d20785a" xlink:href="mlys-20260331.xsd#mlys_ProceedsFromIssuanceOfCommonStockNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_mlys_ProceedsFromIssuanceOfCommonStockNet_019d6f32-0051-7123-b532-547d8d20785a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019dd311-eac0-7228-b4de-02aea799134d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019dd311-eac0-7228-b4de-02aea799134d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale_019d6f32-0051-70c1-888c-e6b9605f4fa5" xlink:href="mlys-20260331.xsd#mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale_019d6f32-0051-70c1-888c-e6b9605f4fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d6f32-0051-793c-b323-b4b9bc92dcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019d6f32-0051-7d6e-aab8-de8267a6d642" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d6f32-0051-793c-b323-b4b9bc92dcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#StockBasedCompensationScheduleofOptionsbyPlanDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d6f32-0051-70fa-8281-5b38169b93e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-788a-8935-fdb16f15a07b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d6f32-0051-70fa-8281-5b38169b93e5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-788a-8935-fdb16f15a07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d6f32-0051-7016-b757-957fce44c3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-788a-8935-fdb16f15a07b" xlink:to="loc_us-gaap_PlanNameAxis_019d6f32-0051-7016-b757-957fce44c3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d6f32-0051-7998-8418-1e972e9b322d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019d6f32-0051-7016-b757-957fce44c3e8" xlink:to="loc_us-gaap_PlanNameDomain_019d6f32-0051-7998-8418-1e972e9b322d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2023IncentiveAwardPlanMember_019d6f32-0051-7166-aa00-15896eb452d4" xlink:href="mlys-20260331.xsd#mlys_A2023IncentiveAwardPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d6f32-0051-7998-8418-1e972e9b322d" xlink:to="loc_mlys_A2023IncentiveAwardPlanMember_019d6f32-0051-7166-aa00-15896eb452d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2025IncentiveAwardPlanMember_019d6f32-0051-7c46-b4a4-22e45ceca912" xlink:href="mlys-20260331.xsd#mlys_A2025IncentiveAwardPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d6f32-0051-7998-8418-1e972e9b322d" xlink:to="loc_mlys_A2025IncentiveAwardPlanMember_019d6f32-0051-7c46-b4a4-22e45ceca912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2020EquityIncentivePlanMember_019d6f32-0051-7f8b-a57c-be0de9323542" xlink:href="mlys-20260331.xsd#mlys_A2020EquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d6f32-0051-7998-8418-1e972e9b322d" xlink:to="loc_mlys_A2020EquityIncentivePlanMember_019d6f32-0051-7f8b-a57c-be0de9323542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d6f32-0051-764c-869f-58b46e2933bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-788a-8935-fdb16f15a07b" xlink:to="loc_us-gaap_AwardTypeAxis_019d6f32-0051-764c-869f-58b46e2933bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-75a5-b65f-980b6deefb83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019d6f32-0051-764c-869f-58b46e2933bc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-75a5-b65f-980b6deefb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_019d6f32-0051-7c21-9ae3-b91f90fa58bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-75a5-b65f-980b6deefb83" xlink:to="loc_us-gaap_RestrictedStockMember_019d6f32-0051-7c21-9ae3-b91f90fa58bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf45-dbdc-729e-b5d4-4d2034d04f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d6f32-0051-75a5-b65f-980b6deefb83" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019dbf45-dbdc-729e-b5d4-4d2034d04f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7b67-964c-e4c82404fd28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0051-788a-8935-fdb16f15a07b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7b67-964c-e4c82404fd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d6f32-0051-781a-9b5f-5bf5613887e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7b67-964c-e4c82404fd28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d6f32-0051-781a-9b5f-5bf5613887e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_019d6f32-0051-76f3-99d9-512defd60f63" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7b67-964c-e4c82404fd28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_019d6f32-0051-76f3-99d9-512defd60f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d6f32-0051-7dce-b94c-f8ce7d1a72ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0051-7b67-964c-e4c82404fd28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d6f32-0051-7dce-b94c-f8ce7d1a72ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019dbf4b-6573-71f7-9f0d-391e726d0b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dbf4b-6573-792a-9b3f-8e38e548a020" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019dbf4b-6573-71f7-9f0d-391e726d0b5e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dbf4b-6573-792a-9b3f-8e38e548a020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019dbf4b-b7aa-791f-9372-59e1799e1037" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dbf4b-6573-792a-9b3f-8e38e548a020" xlink:to="loc_us-gaap_AwardTypeAxis_019dbf4b-b7aa-791f-9372-59e1799e1037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dbf4b-b7aa-79ac-ab1b-a0fb19cb21bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019dbf4b-b7aa-791f-9372-59e1799e1037" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dbf4b-b7aa-79ac-ab1b-a0fb19cb21bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019dbf4b-b7aa-796d-a45e-e98590f1d0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019dbf4b-b7aa-79ac-ab1b-a0fb19cb21bb" xlink:to="loc_us-gaap_EmployeeStockMember_019dbf4b-b7aa-796d-a45e-e98590f1d0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019dbf4b-b7aa-7381-871c-e43933b7737a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dbf4b-6573-792a-9b3f-8e38e548a020" xlink:to="loc_us-gaap_PlanNameAxis_019dbf4b-b7aa-7381-871c-e43933b7737a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019dbf4b-b7aa-7aa1-b3f2-2cf3030ac69a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019dbf4b-b7aa-7381-871c-e43933b7737a" xlink:to="loc_us-gaap_PlanNameDomain_019dbf4b-b7aa-7aa1-b3f2-2cf3030ac69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_A2023EmployeeStockPurchasePlanMember_019dbf4b-b7aa-707c-9356-16b8dcc554e1" xlink:href="mlys-20260331.xsd#mlys_A2023EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019dbf4b-b7aa-7aa1-b3f2-2cf3030ac69a" xlink:to="loc_mlys_A2023EmployeeStockPurchasePlanMember_019dbf4b-b7aa-707c-9356-16b8dcc554e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dbf4b-b7aa-720a-a17d-a52930695899" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019dbf4b-6573-792a-9b3f-8e38e548a020" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dbf4b-b7aa-720a-a17d-a52930695899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019dbf4b-b7aa-7f22-971a-a5e7f9504dca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dbf4b-b7aa-720a-a17d-a52930695899" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019dbf4b-b7aa-7f22-971a-a5e7f9504dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_019dbf4b-b7aa-7046-871f-ad0836e159f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019dbf4b-b7aa-720a-a17d-a52930695899" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_019dbf4b-b7aa-7046-871f-ad0836e159f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails" xlink:type="simple" xlink:href="mlys-20260331.xsd#StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d6f32-0102-70cc-8ba8-1d41dffd6e64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0102-7611-bc8d-6f2dd62a0274" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d6f32-0102-70cc-8ba8-1d41dffd6e64" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0102-7611-bc8d-6f2dd62a0274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_019d6f32-0102-7b86-916b-fbf6fcdd514d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0102-7611-bc8d-6f2dd62a0274" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_019d6f32-0102-7b86-916b-fbf6fcdd514d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7252-ab14-e089b673599b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019d6f32-0102-7b86-916b-fbf6fcdd514d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7252-ab14-e089b673599b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019d6f32-0102-7b35-8f27-e41e45c3b1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7252-ab14-e089b673599b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019d6f32-0102-7b35-8f27-e41e45c3b1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019d6f32-0102-747b-b08c-59a23cc53468" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019d6f32-0102-7252-ab14-e089b673599b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019d6f32-0102-747b-b08c-59a23cc53468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0102-795c-b3bd-749d7c5ea4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d6f32-0102-7611-bc8d-6f2dd62a0274" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0102-795c-b3bd-749d7c5ea4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d6f32-0102-7ee4-9103-407dc96ba901" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d6f32-0102-795c-b3bd-749d7c5ea4f7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d6f32-0102-7ee4-9103-407dc96ba901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mlys_CatalysPacificFundLPMember" xlink:href="mlys-20260331.xsd#mlys_CatalysPacificFundLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_mlys_CatalysPacificFundLPMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>mlys-20260331_g1.jpg
<TEXT>
begin 644 mlys-20260331_g1.jpg
M_]C_X0#H17AI9@  34T *@    @ !@$2  ,    !  $   $:  4    !
M5@$;  4    !    7@$H  ,    !  (   (3  ,    !  $  (=I  0    !
M    9@        !(     0   $@    !  B0   '    !# R,C&1 0 '
M! $" P"2A@ '    $@   ,R@   '    !# Q,#"@ 0 #     0 !  "@ @ $
M     0  !QR@ P $     0   MBD!@ #     0          05-#24D   !3
M8W)E96YS:&]T  #_X@(@24-#7U!23T9)3$4  0$   (087!P; 0   !M;G1R
M4D="(%A96B 'Z@ %  0 "0 S  EA8W-P05!03     !!4%!,
M            ]M8  0    #3+6%P<&P
M                                  ID97-C    _    #9C<')T   !
M-    %!W='!T   !A    !1R6%E:   !F    !1G6%E:   !K    !1B6%E:
M   !P    !1R5%)#   !U    !!C:&%D   !Y    "QB5%)#   !U    !!G
M5%)#   !U    !!M;'5C          $    ,96Y54P   !H    < %8 00 R
M #< -0 Y "  4P!E '( :0!E ',  &UL=6,          0    QE;E53
M-    !P 0P!O '  >0!R &D 9P!H '0 ( !! '  < !L &4 ( !) &X 8P N
M "P (  R #  ,@ V6%E:(        /;6  $     TRU865H@        ;Z(
M #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /A
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MT]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^@$  P$! 0$! 0$! 0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H _]#^_B@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M9NO?\^FD?^ ]Y_\ )]'._(.1>?X?Y!_PLW7O^?32/_ >\_\ D^CG?D'(O/\
M#_(/^%FZ]_SZ:1_X#WG_ ,GT<[\@Y%Y_A_D'_"S=>_Y]-(_\![S_ .3Z.=^0
M<B\_P_R#_A9NO?\ /II'_@/>?_)]'._(.1>?X?Y!_P +-U[_ )]-(_\  >\_
M^3Z.=^0<B\_P_P @_P"%FZ]_SZ:1_P" ]Y_\GT<[\@Y%Y_A_D'_"S=>_Y]-(
M_P# >\_^3Z.=^0<B\_P_R#_A9NO?\^FD?^ ]Y_\ )]'._(.1>?X?Y!_PLW7O
M^?32/_ >\_\ D^CG?D'(O/\ #_(/^%FZ]_SZ:1_X#WG_ ,GT<[\@Y%Y_A_D'
M_"S=>_Y]-(_\![S_ .3Z.=^0<B\_P_R#_A9NO?\ /II'_@/>?_)]'._(.1>?
MX?Y!_P +-U[_ )]-(_\  >\_^3Z.=^0<B\_P_P @_P"%FZ]_SZ:1_P" ]Y_\
MGT<[\@Y%Y_A_D'_"S=>_Y]-(_P# >\_^3Z.=^0<B\_P_R#_A9NO?\^FD?^ ]
MY_\ )]'._(.1>?X?Y!_PLW7O^?32/_ >\_\ D^CG?D'(O/\ #_(/^%FZ]_SZ
M:1_X#WG_ ,GT<[\@Y%Y_A_D'_"S=>_Y]-(_\![S_ .3Z.=^0<B\_P_R#_A9N
MO?\ /II'_@/>?_)]'._(.1>?X?Y'YZ?L,_\ !0OXK_M2_$']NSPIXO\ !_P\
M\/:;^RQ^U_XZ_9T\%S>&[3Q(M[K_ (:\(:=I=U!KOB>74_$=_!+KEY-?2>:-
M*MM+L(HD1$M6;,A;DU;;9,2BG??1V^[Y'Z%_\+-U[_GTTC_P'O/_ )/I<[\A
M\B\_P_R#_A9NO?\ /II'_@/>?_)]'._(.1>?X?Y!_P +-U[_ )]-(_\  >\_
M^3Z.=^0<B\_P_P @_P"%FZ]_SZ:1_P" ]Y_\GT<[\@Y%Y_A_D'_"S=>_Y]-(
M_P# >\_^3Z.=^0<B\_P_R#_A9NO?\^FD?^ ]Y_\ )]'._(.1>?X?Y!_PLW7O
M^?32/_ >\_\ D^CG?D'(O/\ #_(/^%FZ]_SZ:1_X#WG_ ,GT<[\@Y%Y_A_D'
M_"S=>_Y]-(_\![S_ .3Z.=^0<B\_P_R#_A9NO?\ /II'_@/>?_)]'._(.1>?
MX?Y!_P +-U[_ )]-(_\  >\_^3Z.=^0<B\_P_P @_P"%FZ]_SZ:1_P" ]Y_\
MGT<[\@Y%Y_A_D'_"S=>_Y]-(_P# >\_^3Z.=^0<B\_P_R#_A9NO?\^FD?^ ]
MY_\ )]'._(.1>?X?Y!_PLW7O^?32/_ >\_\ D^CG?D'(O/\ #_(/^%FZ]_SZ
M:1_X#WG_ ,GT<[\@Y%Y_A_D'_"S=>_Y]-(_\![S_ .3Z.=^0<B\_P_R#_A9N
MO?\ /II'_@/>?_)]'._(.1>?X?Y!_P +-U[_ )]-(_\  >\_^3Z.=^0<B\_P
M_P @_P"%FZ]_SZ:1_P" ]Y_\GT<[\@Y%Y_A_D'_"S=>_Y]-(_P# >\_^3Z.=
M^0<B\_P_R#_A9NO?\^FD?^ ]Y_\ )]'._(.1>?X?Y!_PLW7O^?32/_ >\_\
MD^CG?D'(O/\ #_(/^%FZ]_SZ:1_X#WG_ ,GT<[\@Y%Y_A_D'_"S=>_Y]-(_\
M![S_ .3Z.=^0<B\_P_R#_A9NO?\ /II'_@/>?_)]'._(.1>?X?Y!_P +-U[_
M )]-(_\  >\_^3Z.=^0<B\_P_P @_P"%FZ]_SZ:1_P" ]Y_\GT<[\@Y%Y_A_
MD'_"S=>_Y]-(_P# >\_^3Z.=^0<B\_P_R#_A9NO?\^FD?^ ]Y_\ )]'._(.1
M>?X?Y!_PLW7O^?32/_ >\_\ D^CG?D'(O/\ #_(/^%FZ]_SZ:1_X#WG_ ,GT
M<[\@Y%Y_A_D'_"S=>_Y]-(_\![S_ .3Z.=^0<B\_P_R#_A9NO?\ /II'_@/>
M?_)]'._(.1>?X?Y'YY?MD?\ !0WXK_LV_M!?L ?"GPQX.^'FO>'/VM/CUKWP
MA\<7FO6GB0:UX>TRS\+)K.G:OX4N=/\ $=I8PWT=Z2MY#J^FZM;W=KB*#[#*
M/M!I2;3VT%R+3?\ I>A^AO\ PLW7O^?32/\ P'O/_D^IYWY#Y%Y_A_D'_"S=
M>_Y]-(_\![S_ .3Z.=^0<B\_P_R#_A9NO?\ /II'_@/>?_)]'._(.1>?X?Y!
M_P +-U[_ )]-(_\  >\_^3Z.=^0<B\_P_P @_P"%FZ]_SZ:1_P" ]Y_\GT<[
M\@Y%Y_A_D'_"S=>_Y]-(_P# >\_^3Z.=^0<B\_P_R#_A9NO?\^FD?^ ]Y_\
M)]'._(.1>?X?Y!_PLW7O^?32/_ >\_\ D^CG?D'(O/\ #_(/^%FZ]_SZ:1_X
M#WG_ ,GT<[\@Y%Y_A_D'_"S=>_Y]-(_\![S_ .3Z.=^0<B\_P_R#_A9NO?\
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M.=^0<B\_P_R#_A9NO?\ /II'_@/>?_)]'._(.1>?X?Y!_P +-U[_ )]-(_\
M >\_^3Z.=^0<B\_P_P @_P"%FZ]_SZ:1_P" ]Y_\GT<[\@Y%Y_A_D'_"S=>_
MY]-(_P# >\_^3Z.=^0<B\_P_R#_A9NO?\^FD?^ ]Y_\ )]'._(.1>?X?Y!_P
MLW7O^?32/_ >\_\ D^CG?D'(O/\ #_(/^%FZ]_SZ:1_X#WG_ ,GT<[\@Y%Y_
MA_D'_"S=>_Y]-(_\![S_ .3Z.=^0<B\_P_R#_A9NO?\ /II'_@/>?_)]'._(
M.1>?X?Y!_P +-U[_ )]-(_\  >\_^3Z.=^0<B\_P_P @_P"%FZ]_SZ:1_P"
M]Y_\GT<[\@Y%Y_A_D'_"S=>_Y]-(_P# >\_^3Z.=^0<B\_P_R#_A9NO?\^FD
M?^ ]Y_\ )]'._(.1>?X?Y!_PLW7O^?32/_ >\_\ D^CG?D'(O/\ #_(/^%FZ
M]_SZ:1_X#WG_ ,GT<[\@Y%Y_A_D'_"S=>_Y]-(_\![S_ .3Z.=^0<B\_P_R/
MST^-'_!0OXK_  S_ ."B'[%O['VE^#_AYJ'@/]IGX>?M#>*_%/B2_M/$@\7>
M']2^#OA:W\0:+#H$MOXCBT8V.J22M;:I#J.D7<XC"O:74# J6I.SVTL+E2:6
MNM_P^1^A?_"S=>_Y]-(_\![S_P"3Z7._(?(O/\/\@_X6;KW_ #Z:1_X#WG_R
M?1SOR#D7G^'^0?\ "S=>_P"?32/_  'O/_D^CG?D'(O/\/\ (/\ A9NO?\^F
MD?\ @/>?_)]'._(.1>?X?Y!_PLW7O^?32/\ P'O/_D^CG?D'(O/\/\@_X6;K
MW_/II'_@/>?_ "?1SOR#D7G^'^0?\+-U[_GTTC_P'O/_ )/HYWY!R+S_  _R
M#_A9NO?\^FD?^ ]Y_P#)]'._(.1>?X?Y!_PLW7O^?32/_ >\_P#D^CG?D'(O
M/\/\@_X6;KW_ #Z:1_X#WG_R?1SOR#D7G^'^0?\ "S=>_P"?32/_  'O/_D^
MCG?D'(O/\/\ (/\ A9NO?\^FD?\ @/>?_)]'._(.1>?X?Y!_PLW7O^?32/\
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M #Z:1_X#WG_R?1SOR#D7G^'^0?\ "S=>_P"?32/_  'O/_D^CG?D'(O/\/\
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M<3E"UZRAPK':61E!QE2.*:F[I:=!."2Z[?UT/9:T,PH * "@ H __]+^_B@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _GU_X*;_\IC?^
M"!__ 'E+_P#66O -3+X7\OS*A\2_KH?JE6)L% !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^('_!'S_D
ML_\ P6)_[2B_&K_TS^':J7V?\*)CU_Q,_;^I*"@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /P\_X*
MJ?\ )YW_  18_P"SU_$7_J 1U<=I>GZ,3Z>OZ,_<.H&% !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0!^=?_!7+_E&+^W9_V;+\5/\ U&KNFMUZH3V?H_R/:?V$O^3(/V-O^S5/
MV>?_ %47A"A[OU8+9>B_(^JZ0PH * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@#\0/VL?\ E.+_ ,$F?^R+?MR?
M^JULJI?#+Y?F2_BC\_R/V_J2@H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H U_#_ /R'M$_["^F_
M^ED--;KU0GL_1_D?4-;F 4 % !0 4 ?_T_[^* "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@#^?7_@IO_RF-_X('_\ >4O_ -9:\ U,OA?R
M_,J'Q+^NA^J58FP4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % 'X@?\$?/^2S_P#!8G_M*+\:O_3/X=JI
M?9_PHF/7_$S]OZDH* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H _#S_@JI_P GG?\ !%C_ +/7\1?^
MH!'5QVEZ?HQ/IZ_HS]PZ@84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'YU_\%<O^48O[=G_9
MLOQ4_P#4:NZ:W7JA/9^C_(]I_82_Y,@_8V_[-4_9Y_\ 51>$*'N_5@MEZ+\C
MZKI#"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * /Q _:Q_P"4XO\ P29_[(M^W)_ZK6RJE\,OE^9+^*/S_(_;
M^I*"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@#7\/\ _(>T3_L+Z;_Z60TUNO5">S]'^1]0UN8!
M0 4 % !0!__4_OXH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * /Y]?^"F__*8W_@@?_P!Y2_\ UEKP#4R^%_+\RH?$OZZ'ZI5B;!0 4 %
M!0 4 % !0 4 % !0 4 ?C+_P4]_X*?\ QO\ V"/'GPO\(?"K]B;QK^U+IWC[
MPCJ_B35?$7A?6?%VEVOA>]TW65TN+1;F/PY\+O'L$L]S ?MP>XO;&41LJK:N
MG[T_HW!7!.6<4X3&XC'<1X?)9X7$0HPHU:>'FZT94^=U%[;&89I)^[91DM/B
MZ+Y;/^(,5DU;#TL/E57'QK4I3E.$JD53<9<O)[F'K*]M=6O0_&W6O^#I7X\Z
M%XWL/ >K?\$X+C0O%U]=:38VW@+6OBKXRM/&^H7NM211Z39V&CW/P8LM3>ZU
MEKFVCTFWCT6YEO))HA;)<F:-:_0J?@CE53#2Q-/B[VE"*G)XJG@L-+#0C3_B
M.4UCY02IJ,N=^T2C;6UCYF7B#BX5(TI9&X5&XI4I8BHJDG)VBHQ>%4KRT45R
MN[VN?H7^PK_P6I_:3_:V_:G^%W[/GC__ ()P_$;X#>$O'X\;?VM\6-=\1>/;
M[2?"?_"*?#KQ;XUL#=VFM?!3PEIDHUW4O#=GX:@^T^(=.\NZUF"2$W<Z16%U
M\GQ/X<9/D&1XW-L+Q=A<SKX3ZM[/ TZ6%C.O[?%X?#2Y73S"M->RA6E6?+2E
M[M-I\JO*/LY1Q5CLRS##X*KDE;"4ZWM>;$2G5<:?LZ%2JKJ6%IQ]^4%35YQU
MDK7=D_Z(:_(S[8_'?_@K'_P4,_:3_8,C_9\/[/G[)VL?M)K\5_$OB72_%5]:
M6'C+4;/P\=!?PLNC^%+.+P3IFJ7EKXJ\<C7=3.@7>JQ-:(/#]V+'2/$4HO8=
M-_0N ^$LGXI_M;^U<\AE'U"C1G0CS8>$JGM%6]I7E]9E",L/AO90]K&FU+]Y
M'FJ45RN?S/$6=8[)U@OJ672QWUFI.$VE4:AR>SY::]DI-5*O,^1R5O<=HSU4
M?UVT:]N=3T?2M2O-,N]$O-0TVQO;K1K][>2^TBYNK6*>?3+U[.6XM'N["61K
M6X>UGFMVFB<P2R1%7/P%2$85*D(SC5C"<H1J034:D8R:4XJ24E&:7,DTG9JZ
M3/I(-RA&3BX-QBW!VO%M)N+MI>.SMIIH:504?D__ ,%G?VQ?C'^PO^Q/JWQX
M^!4GAB+Q[:?$KP!X4AD\7:&?$.D+I7B.YU"/4LZ:+VPW7)2TC6"8SXBRY\MB
M05^\\.>'LNXFXCCE>:*L\*\%BJ]J%7V,_:4?9\GO\LM/>=U;70^<XHS/%91E
M4L7@_9JLJ]&FO:0YX\LV^;W;K733L>Z_\$SOVA/B%^U9^PM^SM^T'\5FT1_B
M#\3/"FL:MXF?PYIAT;16O+#QEXET&%K#3&N;LVD9L=)M3)']HD!G\V1=JN$7
MR^-,IPF1<3YME. 5183!UJ4**JS]I449X6A5?-.T>;WJDK:+2RZ'9D.,K9AE
M&"QF(Y?;5Z<I5.2/+&ZJS@K1UMI%'W77RYZX4 % !0 4 % !0 4 % !0 4 %
M 'X@?\$?/^2S_P#!8G_M*+\:O_3/X=JI?9_PHF/7_$S]OZDH* "@ H * "@
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M]GR>_P LM/>=U;70^<XHS/%91E4L7@_9JLJ]&FO:0YX\LV^;W;K733L>Z_\
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M_*8W_@@?_P!Y2_\ UEKP#4R^%_+\RH?$OZZ'ZI5B;!0 4 % !0 4 % !0 4
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M%3!N=2K.-.G!?4H*\IR:C%7LM6C]I/\ @KU_P4,_X)M^*/V!/VD/AG>_M!_
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M[&#:252E[&%-*[49_5IJ4.DK+F7VQ^TU^T9^TY_P5*_X) K^TW^R7\4_"GP
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M1+3/^"T/A7X,^*OVF?!FM?MZZAXA^'?]C?M$07>IKX.T^^N_A#IFJ^';D_\
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M%/>X3_Y)W*_^O-3_ -/U3]7*^$/H@H * "@ H * "@ H * /Q _:Q_Y3B_\
M!)G_ +(M^W)_ZK6RJE\,OE^9+^*/S_(_;^I*"@ H * "@ H * "@ H * "@
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M "@ H * /Y]?^"F__*8W_@@?_P!Y2_\ UEKP#4R^%_+\RH?$OZZ'ZI5B;!0
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ME> H5(YMB<?C:U>"5.I7I3INE[.I*==4DI5(I-1C&3JR7OVUU:^WOVTV5O\
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M5 JC\5\3VWX@YY?_ )_98OE'*\OBON22/ON$$EPUER7\F)?WXS$-_B?SB_\
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MY*F)J<CMWY.1V\KGW#^V;\+?AS\%?^"6_P"V9\+_ (2^"O#GP\^'OA#]B/\
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MPTC_ (*6_P#!,-DU*XT7XH?%GX>^'_[7G;R)8?"WPL\9ZEXKT77[2+,<L?\
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MR4(\^$]Z348ZX-16KTUDU%>>A]-_\'%O[>O[07PS\?\ [-/[*WP%^,-_\#/
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M "@ H * "@ H * "@ H * "@ H * "@ H * /Y]?^"F__*8W_@@?_P!Y2_\
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M/K,Z,[>Q]IR\GLJ%&U_:RYK\VRM;6_RS^U[_ ,&\'[!O[67Q.\1?&*.7XG?
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M /_0_OXH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /Y]?
M^"F__*8W_@@?_P!Y2_\ UEKP#4R^%_+\RH?$OZZ'ZI5B;!0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M".KCM+T_1B?3U_1G[AU PH * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * /ENQ_8H_94TW]HN?]K:P^"/@VU_:0NIK
MRXG^+D46H#Q3)-J'A1_ U[*7-^; /<^$I)-"E86(+63L/]:QDKW)<29[/)XY
M!/,L1+)XJ*6 ?L_8I0K_ %F*^#GM&NE42Y]TNFAY\<JR^.->8QPM)8YWOB%S
M<[O3]D^O+K3]W;;S/J2O#/0"@ H * "@#\Z_^"N7_*,7]NS_ +-E^*G_ *C5
MW36Z]4)[/T?Y'M/["7_)D'[&W_9JG[//_JHO"%#W?JP6R]%^1]5TAA0 4 %
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M*;_\IC?^"!__ 'E+_P#66O -3+X7\OS*A\2_KH?JE6)L% !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^
M('_!'S_DL_\ P6)_[2B_&K_TS^':J7V?\*)CU_Q,_;^I*"@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* /P\_X*J?\ )YW_  18_P"SU_$7_J 1U<=I>GZ,3Z>OZ,_<.H&% !0 4 %
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M*/X>?_$T?ZNY5_T565?^ 5?\P_M#$_\ 0LQ/WK_Y$/\ AZ]^VK_TA+_;>_\
M"C^'G_Q-'^KN5?\ 1595_P" 5?\ ,/[0Q/\ T+,3]Z_^1#_AZ]^VK_TA+_;>
M_P#"C^'G_P 31_J[E7_1595_X!5_S#^T,3_T+,3]Z_\ D0_X>O?MJ_\ 2$O]
MM[_PH_AY_P#$T?ZNY5_T565?^ 5?\P_M#$_]"S$_>O\ Y$/^'KW[:O\ TA+_
M &WO_"C^'G_Q-'^KN5?]%5E7_@%7_,/[0Q/_ $+,3]Z_^1#_ (>O?MJ_](2_
MVWO_  H_AY_\31_J[E7_ $565?\ @%7_ ##^T,3_ -"S$_>O_D0_X>O?MJ_]
M(2_VWO\ PH_AY_\ $T?ZNY5_T565?^ 5?\P_M#$_]"S$_>O_ )$/^'KW[:O_
M $A+_;>_\*/X>?\ Q-'^KN5?]%5E7_@%7_,/[0Q/_0LQ/WK_ .1#_AZ]^VK_
M -(2_P!M[_PH_AY_\31_J[E7_1595_X!5_S#^T,3_P!"S$_>O_D0_P"'KW[:
MO_2$O]M[_P */X>?_$T?ZNY5_P!%5E7_ (!5_P P_M#$_P#0LQ/WK_Y$/^'K
MW[:O_2$O]M[_ ,*/X>?_ !-'^KN5?]%5E7_@%7_,/[0Q/_0LQ/WK_P"1#_AZ
M]^VK_P!(2_VWO_"C^'G_ ,31_J[E7_1595_X!5_S#^T,3_T+,3]Z_P#D0_X>
MO?MJ_P#2$O\ ;>_\*/X>?_$T?ZNY5_T565?^ 5?\P_M#$_\ 0LQ/WK_Y$/\
MAZ]^VK_TA+_;>_\ "C^'G_Q-'^KN5?\ 1595_P" 5?\ ,/[0Q/\ T+,3]Z_^
M1#_AZ]^VK_TA+_;>_P#"C^'G_P 31_J[E7_1595_X!5_S#^T,3_T+,3]Z_\
MD0_X>O?MJ_\ 2$O]M[_PH_AY_P#$T?ZNY5_T565?^ 5?\P_M#$_]"S$_>O\
MY$/^'KW[:O\ TA+_ &WO_"C^'G_Q-'^KN5?]%5E7_@%7_,/[0Q/_ $+,3]Z_
M^1#_ (>O?MJ_](2_VWO_  H_AY_\31_J[E7_ $565?\ @%7_ ##^T,3_ -"S
M$_>O_D0_X>O?MJ_](2_VWO\ PH_AY_\ $T?ZNY5_T565?^ 5?\P_M#$_]"S$
M_>O_ )$/^'KW[:O_ $A+_;>_\*/X>?\ Q-'^KN5?]%5E7_@%7_,/[0Q/_0LQ
M/WK_ .1#_AZ]^VK_ -(2_P!M[_PH_AY_\31_J[E7_1595_X!5_S#^T,3_P!"
MS$_>O_D0_P"'KW[:O_2$O]M[_P */X>?_$T?ZNY5_P!%5E7_ (!5_P P_M#$
M_P#0LQ/WK_Y$/^'KW[:O_2$O]M[_ ,*/X>?_ !-'^KN5?]%5E7_@%7_,/[0Q
M/_0LQ/WK_P"1#_AZ]^VK_P!(2_VWO_"C^'G_ ,31_J[E7_1595_X!5_S#^T,
M3_T+,3]Z_P#D0_X>O?MJ_P#2$O\ ;>_\*/X>?_$T?ZNY5_T565?^ 5?\P_M#
M$_\ 0LQ/WK_Y$/\ AZ]^VK_TA+_;>_\ "C^'G_Q-'^KN5?\ 1595_P" 5?\
M,/[0Q/\ T+,3]Z_^1#_AZ]^VK_TA+_;>_P#"C^'G_P 31_J[E7_1595_X!5_
MS#^T,3_T+,3]Z_\ D0_X>O?MJ_\ 2$O]M[_PH_AY_P#$T?ZNY5_T565?^ 5?
M\P_M#$_]"S$_>O\ Y$/^'KW[:O\ TA+_ &WO_"C^'G_Q-'^KN5?]%5E7_@%7
M_,/[0Q/_ $+,3]Z_^1#_ (>O?MJ_](2_VWO_  H_AY_\31_J[E7_ $565?\
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MS_ /^'E'[>7_ $@__;D_\'WP_P#_ (FCV?G^'_!#G7G^ ?\ #RC]O+_I!_\
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M>7_2#_\ ;D_\'WP__P#B:/9^?X?\$.=>?X!_P\H_;R_Z0?\ [<G_ (/OA_\
M_$T>S\_P_P""'.O/\ _X>4?MY?\ 2#_]N3_P??#_ /\ B:/9^?X?\$.=>?X!
M_P /*/V\O^D'_P"W)_X/OA__ /$T>S\_P_X(<Z\_P#_AY1^WE_T@_P#VY/\
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MA>"=4\'@_!S7=<TO1 /ACXNU&[_T>\\:Z1!!Y^NVUA&L&F^?;1,TCR_+TXC
MXG#PP\Z]*=&.)HQK8=SC;VM%_#4@KWY)?9=K/H94Z]*;J*$E)PFXS4?LR_E?
MFNJZ'ZE_\/*/V\O^D'_[<G_@^^'_ /\ $US>S\_P_P"":\Z\_P  _P"'E'[>
M7_2#_P#;D_\ !]\/_P#XFCV?G^'_  0YUY_@'_#RC]O+_I!_^W)_X/OA_P#_
M !-'L_/\/^"'.O/\ _X>4?MY?](/_P!N3_P??#__ .)H]GY_A_P0YUY_@'_#
MRC]O+_I!_P#MR?\ @^^'_P#\31[/S_#_ ((<Z\_P#_AY1^WE_P!(/_VY/_!]
M\/\ _P")H]GY_A_P0YUY_@'_  \H_;R_Z0?_ +<G_@^^'_\ \31[/S_#_@AS
MKS_ /^'E'[>7_2#_ /;D_P#!]\/_ /XFCV?G^'_!#G7G^ ?\/*/V\O\ I!_^
MW)_X/OA__P#$T>S\_P /^"'.O/\  /\ AY1^WE_T@_\ VY/_  ??#_\ ^)H]
MGY_A_P $.=>?X!_P\H_;R_Z0?_MR?^#[X?\ _P 31[/S_#_@ASKS_ /^'E'[
M>7_2#_\ ;D_\'WP__P#B:/9^?X?\$.=>?X!_P\H_;R_Z0?\ [<G_ (/OA_\
M_$T>S\_P_P""'.O/\ _X>4?MY?\ 2#_]N3_P??#_ /\ B:/9^?X?\$.=>?X!
M_P /*/V\O^D'_P"W)_X/OA__ /$T>S\_P_X(<Z\_P#_AY1^WE_T@_P#VY/\
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MWE_T@_\ VY/_  ??#_\ ^)H]GY_A_P $.=>?X!_P\H_;R_Z0?_MR?^#[X?\
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M^ ?\/*/V\O\ I!_^W)_X/OA__P#$T>S\_P /^"'.O/\  /\ AY1^WE_T@_\
MVY/_  ??#_\ ^)H]GY_A_P $.=>?X!_P\H_;R_Z0?_MR?^#[X?\ _P 31[/S
M_#_@ASKS_ /^'E'[>7_2#_\ ;D_\'WP__P#B:/9^?X?\$.=>?X!_P\H_;R_Z
M0?\ [<G_ (/OA_\ _$T>S\_P_P""'.O/\ _X>4?MY?\ 2#_]N3_P??#_ /\
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MN3D\_P  4TDEKLCUS_AY1^WE_P!(/_VY/_!]\/\ _P")I>S\_P /^"/G7G^
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M]J7*KRLNR1^I?_#RC]O+_I!_^W)_X/OA_P#_ !-<WL_/\/\ @FO.O/\  /\
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MG7G^ ?\ #RC]O+_I!_\ MR?^#[X?_P#Q-'L_/\/^"'.O/\ _X>4?MY?](/\
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M]?\ >5G_ -9)\&T ?NY0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'X:_\$<_^2U_\%E/^TIWQK_\
M3%X9KZ[B?_=.%_\ LG\)^IY>7?Q,Q_[#JI^Y5?(GJ!0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^&O[6O_*='_@DA_P!D
M1_;L_P#5:Z=7UV6_\DCQ)_V%95_ZD1/+Q'_(TR__ *]XG_TVS]RJ^1/4"@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@#__U/[^* "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_P#C0'^M?_4!_P"77_WL'_$0_P#]6@?^9_\ _P 2='_$FG_5Q_\ S3__ ,:
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M?_>P?\1#_P#U:!_YG_\ _$G1_P 2:?\ 5Q__ #3_ /\ &@/]:_\ J _\NO\
M[V#_ (B'_P#JT#_S/_\ ^).C_B33_JX__FG_ /XT!_K7_P!0'_EU_P#>P?\
M$0__ -6@?^9__P#Q)T?\2:?]7'_\T_\ _&@/]:_^H#_RZ_\ O8/^(A__ *M
M_P#,_P#_ .).C_B33_JX_P#YI_\ ^- ?ZU_]0'_EU_\ >P?\1#__ %:!_P"9
M_P#_ ,2='_$FG_5Q_P#S3_\ \: _UK_Z@/\ RZ_^]@_XB'_^K0/_ #/_ /\
MB3H_XDT_ZN/_ .:?_P#C0'^M?_4!_P"77_WL'_$0_P#]6@?^9_\ _P 2='_$
MFG_5Q_\ S3__ ,: _P!:_P#J _\ +K_[V#_B(?\ ^K0/_,__ /XDZ/\ B33_
M *N/_P":?_\ C0'^M?\ U ?^77_WL'_$0_\ ]6@?^9__ /Q)T?\ $FG_ %<?
M_P T_P#_ !H#_6O_ *@/_+K_ .]@_P"(A_\ ZM _\S__ /B3H_XDT_ZN/_YI
M_P#^- ?ZU_\ 4!_Y=?\ WL'_ !$/_P#5H'_F?_\ \2='_$FG_5Q__-/_ /QH
M#_6O_J _\NO_ +V#_B(?_P"K0/\ S/\ _P#B3H_XDT_ZN/\ ^:?_ /C0'^M?
M_4!_Y=?_ 'L'_$0__P!6@?\ F?\ _P#$G1_Q)I_U<?\ \T__ /&@/]:_^H#_
M ,NO_O8/^(A__JT#_P S_P#_ (DZ/^)-/^KC_P#FG_\ XT!_K7_U ?\ EU_]
M[!_Q$/\ _5H'_F?_ /\ $G1_Q)I_U<?_ ,T__P#&@/\ 6O\ Z@/_ "Z_^]@_
MXB'_ /JT#_S/_P#^).C_ (DT_P"KC_\ FG__ (T!_K7_ -0'_EU_][!_Q$/_
M /5H'_F?_P#\2='_ !)I_P!7'_\ -/\ _P : _UK_P"H#_RZ_P#O8/\ B(?_
M .K0/_,__P#XDZ/^)-/^KC_^:?\ _C0'^M?_ % ?^77_ -[!_P 1#_\ U:!_
MYG__ /$G1_Q)I_U<?_S3_P#\: _UK_Z@/_+K_P"]@_XB'_\ JT#_ ,S_ /\
MXDZ/^)-/^KC_ /FG_P#XT!_K7_U ?^77_P![!_Q$/_\ 5H'_ )G_ /\ Q)T?
M\2:?]7'_ /-/_P#QH#_6O_J _P#+K_[V#_B(?_ZM _\ ,_\ _P").C_B33_J
MX_\ YI__ .- ?ZU_]0'_ )=?_>P?\1#_ /U:!_YG_P#_ !)T?\2:?]7'_P#-
M/_\ QH#_ %K_ .H#_P NO_O8/^(A_P#ZM _\S_\ _B3H_P")-/\ JX__ )I_
M_P"- ?ZU_P#4!_Y=?_>P?\1#_P#U:!_YG_\ _$G1_P 2:?\ 5Q__ #3_ /\
M&@/]:_\ J _\NO\ [V#_ (B'_P#JT#_S/_\ ^).C_B33_JX__FG_ /XT!_K7
M_P!0'_EU_P#>P?\ $0__ -6@?^9__P#Q)T?\2:?]7'_\T_\ _&@/]:_^H#_R
MZ_\ O8/^(A__ *M _P#,_P#_ .).C_B33_JX_P#YI_\ ^- ?ZU_]0'_EU_\
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MN/\ ^:?_ /C0'^M?_4!_Y=?_ 'L'_$0__P!6@?\ F?\ _P#$G1_Q)I_U<?\
M\T__ /&@/]:_^H#_ ,NO_O8/^(A__JT#_P S_P#_ (DZ/^)-/^KC_P#FG_\
MXT!_K7_U ?\ EU_][!_Q$/\ _5H'_F?_ /\ $G1_Q)I_U<?_ ,T__P#&@/\
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M_P"7OM.;VGM/^G=/EY?9^=[]+:_I97X>>P% !0 4 % !0 4 % !0 4 % !0
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M52G;+:^.4?92I4J2Q,JD)3=L/&H\+3YZEU[L4JC]=\()\0M,UGQ%?^-;Q?\
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M .G+1Z_T_P#HT_\ )M*'_8Q7_JER0_,LW_Y&&)_Z^U/_ $[,XFOZ!/,"@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _I8_P"#=_\ YN__ .[?
M_P#WME?P_P#3+_YMQ_W=_P#[ZY]API_S'_\ <K_[L']+%?P^?8!0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M'X:_M:_\IT?^"2'_ &1']NS_ -5KIU?79;_R2/$G_85E7_J1$\O$?\C3+_\
MKWB?_3;/W*KY$]0* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /__6_OXH * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MRA.LJ/V%5G3]QR^;EOS/8[BO(/J0H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H _"/\ ;\_Y3<?\&_7_ 'E9_P#62?!M '[N4 %
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MZ)A^%W#FO&J8:=*AAL1)QY,4JKII7YE[&I[.7,K)*[^&S>G;8G#YA1Q.-S#
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MS3#92X5?K&)H5\1":4?91AA_9\RD^924G[1<J4&M'>QM5RGI!0 4 % !0 4
M% !0!_G"_'O_ )/>_P""C?\ V?M^T'_Z<M'K_3_Z-/\ R;2A_P!C%?\ JER0
M_,LW_P"1AB?^OM3_ -.S.)K^@3S H _3C]M+]DWX3_ ?]E_]AKXM^!!XE'BW
M]H/X:Q^*OB!_;.LQZAIAU1O!/P[UX_V)9+8VS:;;?;_$VI_N6GNCY/V>/?\
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M\!&-*C7PT*T</B/;0C5G1?)*KA:V'Q&'5.G6P^(]^E3E33J<6:Y=A:%#"XS
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M^P7_ &%X;_T] _H8_P""A/A/_@F+H/[5FHZK^UEXB^,.L?%'XFZ%X3N+O3?
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MPQG/"^(Q5"EFF#R?]UCLH6)M&G1>(IM0HU'/W*=62S3"RK)8>>(INM1F=-+
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M +E?_=@_I8K^'S[ * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@#\(_P!OS_E-Q_P;]?\ >5G_ -9)\&T
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M_P#D8X+_ +":7_I2/</^"O/_ "D2_:(_Z[?"W_U2GPWKY7Z.7_)F>#/\.?\
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M /!>S_D\OP1_V;MX+_\ 5@?%2OI?HC_\FSS3_LL\S_\ 5/D!S\3_ /(PI_\
M8)3_ /3M<^=/^"0/_*13]G?_ 'OBO_ZH_P")=?:?2._Y,QQEZ</_ /K4Y&<F
M0?\ (VPG_<?_ -1JQZK^VC<_\%!(_P!K']H5/!EQ^V.G@\?%?QA_PB:^&)?C
M6OAH>&?[4F.@_P#"/+I3#2QH7]E?9#I']FC^S_[/^S_8_P#1O+KY[PQAX//P
M]X->9P\-7F7^K^7?V@\='A=X[Z]["/UOZY]87M_K?M_:?6/;_OO;<_M/?N;9
MB\S^O8OV;Q_L_;SY.3ZQR<E_=Y.73EY;<MM+6MH?&7@']FW]I/X_?M%>#?A7
MXAT#XC:=\4OB=J,.HW?B#XH:7XJM=8MM M"RZQX[UJ\\210ZO>Z3H%AI]S))
M>&:22YFL8M(L9)-0EM;9_P!-S?C?@CA#@O,\_P %B\EKY!D5&5"G@\AKY?4P
MT\742^K93AJ6!E+#4L1BZM:$52Y8QA&J\152HQG->?2PF+Q6+IT)1JJM6:?/
M64U)17Q5).7O.,$M_+E6MD?TZ?MBZ%H?[8/[.GQL_8P^"/Q=U[Q;\=OV7[/X
M;:IXOTJ^O(/[0^+%[X9T%I6T#7;Z+R[;Q!?:K>1M<:NUHEO;:-\5=.T"TUC[
M!'7\*>&V+Q7AOQIPOXF\4\.87+N$^.ZN=T,MKTJ4_8\/TL=BU%8O"4I7GA*6
M'IM0PRFYSQ.05L74PWM78^SS"$<PPF(R[#UY3Q.#5&52+:O7<(_#)_:;?Q6T
MC64%*Q^6/_!,.">U_8C_ ."L=K<PRVUS;? F]@N+>>-X9X)X?A7\=(Y89H9
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M*Q'$,:-G[>,E2MM/3$4^9>4G*+_[>/$_^"'7[.WQF\'?M+_$3XC>/?A7X_\
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M]^CF.2UJ;]UKX:E.$K;.UI)Q;0LM=LNSZW\M1?)TZR?X'&_\$'?^2Z_M _\
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M'B<1XW$XKA_*KY/0RS+Y8A5,%R8M59N'LJZY%AW1IRA3DI>T4[M6Y-+3B=>
MHTZ>.Q/^U3Q%=4W&K>ERJ_-#7GYI)N-N7ETZ_P ISG_!OA<0V7[<W_!>;P[=
MNMMKEK^VC'=SZ9-^[NTMD^+O[5EG),(FP7CAN4\F9DW"%Y(!)M\^'??&>N4\
M(R6L7EC2DMO]VRYK7TV_X LITQ.9QZ_6-NNE2NMO(^#KKX#_ !Q^*'_!QO\
MM^?"+PG^W9XR_8C^*_C_ ,#:'XH\!>./!_A+3?$VI_%GP:G@?X.>)-,^%^F6
M^K>*?#"32:#X,A@UB2.QN+V:2/X=:VYMHH]*N3%ZZQF$P_!63XFIE%/-</1J
M2IU:-2;A'#U/:XFG+$2Y:=2W-5O%72_CQU]XY?959YOBJ<<5+#U)1O&<8IN<
M>6G)4TKQVA9Z?R,]Q_; _8$'P>_:?_X)XM^W=_P66^/7QE^)EU^T9X8U/]E?
MP#?_ +,)\4:M?>.-,^('PPDO;:TG\,?$S49_"EEK^NCP/I$VOZA8W%JDXBE@
MM[IM/N(AR9;G"Q6 SG^R>&,'A:"P52./JK'JG%4G1KVNIX>/M'"'M9*":TT;
M7,C3$87V=?"?6<PJU)^U3H1]AS/F4H=JCY;OE5VGMMH>B_';5=&^&7_!U[^S
M-XB^*]S:Z1H/Q"_9K@T3X3:SK;Q0:;'KVO\ PZ^+W@71[&RNIMT27^M^,++Q
M%X7TZ#=#//K/B&SM8U+7T'GXX2+K^'F.AATY3HXURQ$8J[Y88C#5I-I=(47"
MI)ZI1@^VEU;0SVC*I91E2_=MVM=TZD%\W.\5YM>1]+?\'3GCSP%H'_!,+4O
M_B'Q)H.G^-O'_P 8?AG_ ,*]\,WMU;_V_P"(I?"NM+JWBB\T+3CNO);;0=#D
M9M9U..-+.P34;*QNKF.XUC3[:\X/#^C6GGJJPIS=*CA:_MJB7N0]I'EIJ3VO
M.2]V.[Y6TK1;6^=R@L%RMI2E4AR1ZOEU=EY+=[*Z75(_;3]C#_DSS]E#_LVK
MX%?^JN\+5\MFO_(SS'_L/QG_ *D5#T<+_NV'_P"O%'_TW$^E:X#<* "@ H *
M "@ H * "@ H * "@ H _]'^_B@ H * "@ H * "@ H * "@ H * "@ H *
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M4>"C["<5[.5^6,ND.563O;R)J83%5:^%JRC&]-1]J^:.^G-:VYZ[_P %#O\
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M0 4 % ']+'_!N_\ \W?_ /=O_P#[VROX?^F7_P VX_[N_P#]]<^PX4_YC_\
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M)5*52MAW+XHT9J,?.RY;J_:_+T44??O[ O\ P33_ &6_^";_ (+\4^%?V>=
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H _I8_X-W_ /F[_P#[M_\ _>V5_#_TR_\ FW'_
M '=__OKGV'"G_,?_ -RO_NP?TL5_#Y]@% !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?AK^UK_P IT?\ @DA_
MV1']NS_U6NG5]=EO_)(\2?\ 85E7_J1$\O$?\C3+_P#KWB?_ $VS]RJ^1/4"
M@ H * "@ H * "@ H * "@ H * "@ H * .0\;?#WP#\3-%_X1KXC^!_"'Q
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M?ZKY?_S^QG_@RC_\SA_PX)_8[_Z*3^TM_P"%C\+O_G-T?\3=^)/_ $).!_\
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M??\ T2A_JOE__/[&?^#*/_S.'_#@G]CO_HI/[2W_ (6/PN_^<W1_Q-WXD_\
M0DX'_P##;GW_ -$H?ZKY?_S^QG_@RC_\SA_PX)_8[_Z*3^TM_P"%C\+O_G-T
M?\3=^)/_ $).!_\ PVY]_P#1*'^J^7_\_L9_X,H__,X?\."?V._^BD_M+?\
MA8_"[_YS='_$W?B3_P!"3@?_ ,-N??\ T2A_JOE__/[&?^#*/_S.'_#@G]CO
M_HI/[2W_ (6/PN_^<W1_Q-WXD_\ 0DX'_P##;GW_ -$H?ZKY?_S^QG_@RC_\
MSA_PX)_8[_Z*3^TM_P"%C\+O_G-T?\3=^)/_ $).!_\ PVY]_P#1*'^J^7_\
M_L9_X,H__,X?\."?V._^BD_M+?\ A8_"[_YS='_$W?B3_P!"3@?_ ,-N??\
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M?ZKY?_S^QG_@RC_\SA_PX)_8[_Z*3^TM_P"%C\+O_G-T?\3=^)/_ $).!_\
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M )&F7_\ 7O$_^FV?N57R)Z@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?__4
M_OXH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /PC_ &_/
M^4W'_!OU_P!Y6?\ UDGP;0!^[E !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?AK_P1S_Y+7_P64_[2
MG?&O_P!,7AFOKN)_]TX7_P"R?PGZGEY=_$S'_L.JG[E5\B>H% !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'X:_M:_\IT?^
M"2'_ &1']NS_ -5KIU?79;_R2/$G_85E7_J1$\O$?\C3+_\ KWB?_3;/W*KY
M$]0* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * /__5_OXH * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * /YN/^"Q=A^T!J?\ P5'_ ."&UA^R
MIKOPR\,?M$7'_#S'_A6^O?&?3M>U?X6:?Y7[/'PPF\8?\)9IOA96\0W/VKP/
M'XBLM!_LT?N/$4^E3WG^@Q7%>KE<\E@ZO]L4<?53]G[#ZC4HPY;*I[3VBJVY
MK_NN3EDK6G>^B.;$+%M1^JRH1WY_;1D[_#R\O+M;WKW3Z6/??^$!_P"#B?\
MZ+W_ ,$L?_#:_M"__&:]GVW!'_0'Q!_X-P?_ ,L.3DSC_G[@?_ :O_R(?\(#
M_P '$_\ T7O_ ()8_P#AM?VA?_C-'MN"/^@/B#_P;@__ )8')G'_ #]P/_@-
M7_Y$/^$!_P"#B?\ Z+W_ ,$L?_#:_M"__&:/;<$?] ?$'_@W!_\ RP.3./\
MG[@?_ :O_P B'_" _P#!Q/\ ]%[_ ."6/_AM?VA?_C-'MN"/^@/B#_P;@_\
MY8')G'_/W _^ U?_ )$/^$!_X.)_^B]_\$L?_#:_M"__ !FCVW!'_0'Q!_X-
MP?\ \L#DSC_G[@?_  &K_P#(A_P@/_!Q/_T7O_@EC_X;7]H7_P",T>VX(_Z
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M@/B#_P &X/\ ^6!R9Q_S]P/_ (#5_P#D0_X0'_@XG_Z+W_P2Q_\ #:_M"_\
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M_" _\'$__1>_^"6/_AM?VA?_ (S1[;@C_H#X@_\ !N#_ /E@<F<?\_<#_P"
MU?\ Y$/^$!_X.)_^B]_\$L?_  VO[0O_ ,9H]MP1_P! ?$'_ (-P?_RP.3./
M^?N!_P# :O\ \B'_  @/_!Q/_P!%[_X)8_\ AM?VA?\ XS1[;@C_ * ^(/\
MP;@__E@<F<?\_<#_ . U?_D0_P"$!_X.)_\ HO?_  2Q_P##:_M"_P#QFCVW
M!'_0'Q!_X-P?_P L#DSC_G[@?_ :O_R(?\(#_P '$_\ T7O_ ()8_P#AM?VA
M?_C-'MN"/^@/B#_P;@__ )8')G'_ #]P/_@-7_Y$/^$!_P"#B?\ Z+W_ ,$L
M?_#:_M"__&:/;<$?] ?$'_@W!_\ RP.3./\ G[@?_ :O_P B'_" _P#!Q/\
M]%[_ ."6/_AM?VA?_C-'MN"/^@/B#_P;@_\ Y8')G'_/W _^ U?_ )$/^$!_
MX.)_^B]_\$L?_#:_M"__ !FCVW!'_0'Q!_X-P?\ \L#DSC_G[@?_  &K_P#(
MA_P@/_!Q/_T7O_@EC_X;7]H7_P",T>VX(_Z ^(/_  ;@_P#Y8')G'_/W _\
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M /1>_P#@EC_X;7]H7_XS1[;@C_H#X@_\&X/_ .6!R9Q_S]P/_@-7_P"1#_A
M?^#B?_HO?_!+'_PVO[0O_P 9H]MP1_T!\0?^#<'_ /+ Y,X_Y^X'_P !J_\
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M_:%_^,T>VX(_Z ^(/_!N#_\ E@<F<?\ /W _^ U?_D0_X0'_ (.)_P#HO?\
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M_" _\'$__1>_^"6/_AM?VA?_ (S1[;@C_H#X@_\ !N#_ /E@<F<?\_<#_P"
MU?\ Y$/^$!_X.)_^B]_\$L?_  VO[0O_ ,9H]MP1_P! ?$'_ (-P?_RP.3./
M^?N!_P# :O\ \B'_  @/_!Q/_P!%[_X)8_\ AM?VA?\ XS1[;@C_ * ^(/\
MP;@__E@<F<?\_<#_ . U?_D0_P"$!_X.)_\ HO?_  2Q_P##:_M"_P#QFCVW
M!'_0'Q!_X-P?_P L#DSC_G[@?_ :O_R(?\(#_P '$_\ T7O_ ()8_P#AM?VA
M?_C-'MN"/^@/B#_P;@__ )8')G'_ #]P/_@-7_Y$/^$!_P"#B?\ Z+W_ ,$L
M?_#:_M"__&:/;<$?] ?$'_@W!_\ RP.3./\ G[@?_ :O_P B'_" _P#!Q/\
M]%[_ ."6/_AM?VA?_C-'MN"/^@/B#_P;@_\ Y8')G'_/W _^ U?_ )$/^$!_
MX.)_^B]_\$L?_#:_M"__ !FCVW!'_0'Q!_X-P?\ \L#DSC_G[@?_  &K_P#(
MA_P@/_!Q/_T7O_@EC_X;7]H7_P",T>VX(_Z ^(/_  ;@_P#Y8')G'_/W _\
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M /1>_P#@EC_X;7]H7_XS1[;@C_H#X@_\&X/_ .6!R9Q_S]P/_@-7_P"1#_A
M?^#B?_HO?_!+'_PVO[0O_P 9H]MP1_T!\0?^#<'_ /+ Y,X_Y^X'_P !J_\
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M_:%_^,T>VX(_Z ^(/_!N#_\ E@<F<?\ /W _^ U?_D0_X0'_ (.)_P#HO?\
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M/B#_ ,&X/_Y8')G'_/W _P#@-7_Y$/\ A ?^#B?_ *+W_P $L?\ PVO[0O\
M\9H]MP1_T!\0?^#<'_\ + Y,X_Y^X'_P&K_\B'_" _\ !Q/_ -%[_P""6/\
MX;7]H7_XS1[;@C_H#X@_\&X/_P"6!R9Q_P _<#_X#5_^1#_A ?\ @XG_ .B]
M_P#!+'_PVO[0O_QFCVW!'_0'Q!_X-P?_ ,L#DSC_ )^X'_P&K_\ (A_P@/\
MP<3_ /1>_P#@EC_X;7]H7_XS1[;@C_H#X@_\&X/_ .6!R9Q_S]P/_@-7_P"1
M#_A ?^#B?_HO?_!+'_PVO[0O_P 9H]MP1_T!\0?^#<'_ /+ Y,X_Y^X'_P !
MJ_\ R(?\(#_P<3_]%[_X)8_^&U_:%_\ C-'MN"/^@/B#_P &X/\ ^6!R9Q_S
M]P/_ (#5_P#D0_X0'_@XG_Z+W_P2Q_\ #:_M"_\ QFCVW!'_ $!\0?\ @W!_
M_+ Y,X_Y^X'_ ,!J_P#R(?\ " _\'$__ $7O_@EC_P"&U_:%_P#C-'MN"/\
MH#X@_P#!N#_^6!R9Q_S]P/\ X#5_^1#_ (0'_@XG_P"B]_\ !+'_ ,-K^T+_
M /&:/;<$?] ?$'_@W!__ "P.3./^?N!_\!J__(A_P@/_  <3_P#1>_\ @EC_
M .&U_:%_^,T>VX(_Z ^(/_!N#_\ E@<F<?\ /W _^ U?_D0_X0'_ (.)_P#H
MO?\ P2Q_\-K^T+_\9H]MP1_T!\0?^#<'_P#+ Y,X_P"?N!_\!J__ "(?\(#_
M ,'$_P#T7O\ X)8_^&U_:%_^,T>VX(_Z ^(/_!N#_P#E@<F<?\_<#_X#5_\
MD0_X0'_@XG_Z+W_P2Q_\-K^T+_\ &:/;<$?] ?$'_@W!_P#RP.3./^?N!_\
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M?N!_\!J__(A_P@/_  <3_P#1>_\ @EC_ .&U_:%_^,T>VX(_Z ^(/_!N#_\
ME@<F<?\ /W _^ U?_D0_X0'_ (.)_P#HO?\ P2Q_\-K^T+_\9H]MP1_T!\0?
M^#<'_P#+ Y,X_P"?N!_\!J__ "(?\(#_ ,'$_P#T7O\ X)8_^&U_:%_^,T>V
MX(_Z ^(/_!N#_P#E@<F<?\_<#_X#5_\ D0_X0'_@XG_Z+W_P2Q_\-K^T+_\
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M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0!^&O_!'/_DM?_!93_M*=\:__ $Q>&:^NXG_W3A?_ +)_
M"?J>7EW\3,?^PZJ?N57R)Z@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 ?AK^UK_RG1_X)(?\ 9$?V[/\ U6NG5]=EO_)(
M\2?]A65?^I$3R\1_R-,O_P"O>)_]-L_<JOD3U H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H __]?^_B@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MU_9F*QM+ZM[;GQ-6IS>V]G;WY1M;V4[_  WO==K'V5_Q$/\ _5H'_F?_ /\
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M]7'_ /-/_P#QH#_6O_J _P#+K_[V#_B(?_ZM _\ ,_\ _P").C_B33_JX_\
MYI__ .- ?ZU_]0'_ )=?_>P?\1#_ /U:!_YG_P#_ !)T?\2:?]7'_P#-/_\
MQH#_ %K_ .H#_P NO_O8/^(A_P#ZM _\S_\ _B3H_P")-/\ JX__ )I__P"-
M ?ZU_P#4!_Y=?_>P?\1#_P#U:!_YG_\ _$G1_P 2:?\ 5Q__ #3_ /\ &@/]
M:_\ J _\NO\ [V#_ (B'_P#JT#_S/_\ ^).C_B33_JX__FG_ /XT!_K7_P!0
M'_EU_P#>P?\ $0__ -6@?^9__P#Q)T?\2:?]7'_\T_\ _&@/]:_^H#_RZ_\
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M_5Q__-/_ /QH#_6O_J _\NO_ +V#_B(?_P"K0/\ S/\ _P#B3H_XDT_ZN/\
M^:?_ /C0'^M?_4!_Y=?_ 'L'_$0__P!6@?\ F?\ _P#$G1_Q)I_U<?\ \T__
M /&@/]:_^H#_ ,NO_O8/^(A__JT#_P S_P#_ (DZ/^)-/^KC_P#FG_\ XT!_
MK7_U ?\ EU_][!_Q$/\ _5H'_F?_ /\ $G1_Q)I_U<?_ ,T__P#&@/\ 6O\
MZ@/_ "Z_^]@_XB'_ /JT#_S/_P#^).C_ (DT_P"KC_\ FG__ (T!_K7_ -0'
M_EU_][!_Q$/_ /5H'_F?_P#\2='_ !)I_P!7'_\ -/\ _P : _UK_P"H#_RZ
M_P#O8/\ B(?_ .K0/_,__P#XDZ/^)-/^KC_^:?\ _C0'^M?_ % ?^77_ -[!
M_P 1#_\ U:!_YG__ /$G1_Q)I_U<?_S3_P#\: _UK_Z@/_+K_P"]@_XB'_\
MJT#_ ,S_ /\ XDZ/^)-/^KC_ /FG_P#XT!_K7_U ?^77_P![!_Q$/_\ 5H'_
M )G_ /\ Q)T?\2:?]7'_ /-/_P#QH#_6O_J _P#+K_[V#_B(?_ZM _\ ,_\
M_P").C_B33_JX_\ YI__ .- ?ZU_]0'_ )=?_>P?\1#_ /U:!_YG_P#_ !)T
M?\2:?]7'_P#-/_\ QH#_ %K_ .H#_P NO_O8/^(A_P#ZM _\S_\ _B3H_P")
M-/\ JX__ )I__P"- ?ZU_P#4!_Y=?_>P?\1#_P#U:!_YG_\ _$G1_P 2:?\
M5Q__ #3_ /\ &@/]:_\ J _\NO\ [V#_ (B'_P#JT#_S/_\ ^).C_B33_JX_
M_FG_ /XT!_K7_P!0'_EU_P#>P?\ $0__ -6@?^9__P#Q)T?\2:?]7'_\T_\
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MH'_F?_\ \2='_$FG_5Q__-/_ /QH#_6O_J _\NO_ +V#_B(?_P"K0/\ S/\
M_P#B3H_XDT_ZN/\ ^:?_ /C0'^M?_4!_Y=?_ 'L'_$0__P!6@?\ F?\ _P#$
MG1_Q)I_U<?\ \T__ /&@/]:_^H#_ ,NO_O8/^(A__JT#_P S_P#_ (DZ/^)-
M/^KC_P#FG_\ XT!_K7_U ?\ EU_][!_Q$/\ _5H'_F?_ /\ $G1_Q)I_U<?_
M ,T__P#&@/\ 6O\ Z@/_ "Z_^]@_XB'_ /JT#_S/_P#^).C_ (DT_P"KC_\
MFG__ (T!_K7_ -0'_EU_][!_Q$/_ /5H'_F?_P#\2='_ !)I_P!7'_\ -/\
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M_P#C0'^M?_4!_P"77_WL'_$0_P#]6@?^9_\ _P 2='_$FG_5Q_\ S3__ ,:
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M?_>P?\1#_P#U:!_YG_\ _$G1_P 2:?\ 5Q__ #3_ /\ &@/]:_\ J _\NO\
M[V#_ (B'_P#JT#_S/_\ ^).C_B33_JX__FG_ /XT!_K7_P!0'_EU_P#>P?\
M$0__ -6@?^9__P#Q)T?\2:?]7'_\T_\ _&@/]:_^H#_RZ_\ O8/^(A__ *M
M_P#,_P#_ .).C_B33_JX_P#YI_\ ^- ?ZU_]0'_EU_\ >P?\1#__ %:!_P"9
M_P#_ ,2='_$FG_5Q_P#S3_\ \: _UK_Z@/\ RZ_^]@_XB'_^K0/_ #/_ /\
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M_4!_Y=?_ 'L>2?"/]M/_ (;W_P""O/\ P3S^)_\ PK7_ (51_P *E\*?M3>
MO[#_ .$Q_P"$Z_M__A/_ ((^*_$/]J_VE_PBO@[^RO[)_P"$(^Q_8?[/U+[?
M_:?G_;++[%Y%W\7XF^!O_$*/#[,<P_UH_M[^T<XRG!>Q_L3^R_8W=>O[3VG]
MK9C[3_=^7DY(?'?F]VSTP6:_VGFF$_V?V'LJ=?\ Y>^TO>F_^G=.UOF?U9U_
M*9]8% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '__T/[^* "@ H * "@ H *
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M=7_9XSJ582/3Z^C/K H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * /\X7X]_\ )[W_  4;_P"S]OV@_P#TY:/7^G_T:?\ DVE#_L8K
M_P!4N2'YEF__ ",,3_U]J?\ IV9Q-?T">8% !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'Z*?\ !)'_ )21?LK_ /88^,/_
M *S;\::_FGZ5O_)K(_\ 9391_P"F,P/<X=_Y&E+_ *]UO_3;/[G*_P U3]$"
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@#__1_OXH * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M']KPVGA__A3\_BMO""2C78?^$D%\NIR:)]M;0S"/^):=8B?3@RW;7WF#[2;
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M+78Z\+E\L3A<7BHU(P6$CS2@XMN?NN6C3LOAMJCXOK]./."@ H * "@#[/\
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MIU(-R6B;L>9C<!B,!.%/$**E.//'DDI+ENX]-M4?,M?='$% !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 ?HI_P21_Y21?LK_\ 88^,/_K-OQIK
M^:?I6_\ )K(_]E-E'_IC,#W.'?\ D:4O^O=;_P!-L_N<K_-4_1 H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /PC_ &_/^4W'_!OU
M_P!Y6?\ UDGP;0!^[E !0 4 % !0!\]?'7QS!X-O/AY'-\+D^(S:IXA=+.62
MTCNI-#O;9K$0'2]VF:B5UR\^TF33EW68D&GS8F.PO!\+QGG$,IJY#&?#:S]X
MG'M49.DJDL'6INBH?5O]GQ#6,JNIS4%^Z4E0G:6EZ?YMX@9_3R2MPU&?"<>)
MGB\S:HSE1C5E@*])T/9_5+X7$M8^M[3GPR_<*2PU3W_=;I_A+\<? %I^SO\
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MY5+FMUM:ZW/@#_@I#^QUI/P$_:$^'GQL^$<-G??LZ_M">)= \6>"]0T/RY]
M\/>(M6N[/6]1\-V,]KFTCT35K2X'B?P5Y?DP2:+<WNE6$3P^&YKB3]?\%/$G
M$<6\&YSPMQ%*I2XSX.P.,R[,J.*O#%XS!8>G5PM'&U83_>/%8:I#ZAF=^:4<
M3"E7JM2QL8+RLWR^.%Q5+$4$GA,5.,Z;C;DA-M2<%;3E:]^GLN5N,=('7?\
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MX5_8Q\J?T\?LQ_$O0?\ @F1^PW^S/XO\56-G%XR_:X^./AGQ5XR6^CQ>Z/\
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M[^/;GP7\!O!MSXEB3Q-X-\-G3(-<^$7PJBTN3/B_Q%H"78N9-+OEQ8-=-!Y
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MJ^IZ=')^T3\:7DCL+^ZLTD<?$?Q(H=TMY8U9@H"AF!. !TK^E/#["X7$>'W
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M%J_,LU_Y&>8_]A^,_P#4BH?0X7_=L/\ ]>*/_IN)]*UP&X4 % !0 4 % !0
M4 % !0 4 % !0!__T_[^* "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MQOBQ_P $_?V]/$G@;X4^"?@A_P %'O\ @FIXOT>/]H_X4:CX;O\ XC_#+6_
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M36DZ,X2ZCS2C.AD66TJBY9QJQYHO1Q<J=:?*UTE'FM)=&FCS_P#X+Q_\E[^
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^BG_!)'_E)%^R
MO_V&/C#_ .LV_&FOYI^E;_R:R/\ V4V4?^F,P/<X=_Y&E+_KW6_]-L_N<K_-
M4_1 H * "@ H * "@ H _C _:A\5?\.@/^#A6/\ ;7^+6F:[8?LB?MP^!+KP
MGX@^(FEV%WJ5CX4OM4\/>"=+\:6VH06%L\]]<>%OB-X!\(>/]9TFV@EU)O _
MB,7NBP:UJVFOI\GZA@*?^LG!O]EX=P>8Y554X49-1<U&=65)QN[+VE"K4HQD
M[1]K!J3C%W7SE:7]GYM]8FFJ&(C9RLWRW45+9?9G&,FE=\CT6R/Z<];_ ."B
MG[!?AWX;3?%[5/VQ?V;8_AU#I1U@>([/XP^!M52ZM?(6X6WTS3-)UF]UG5M7
ME5TBM_#^EZ==Z]<7;I80:;)>NMN?@XY)G$ZZPT<LQWMG+EY'AJL;.]KN4HJ$
M8_WY24$M>:Q[3Q>%4.?ZQ1Y$KW52+V71)MM^25_(_'O_ ()C_MS_ +7W_!63
M6O\ @I%K=S!I/AK]BR/3O'OP@_93O[SP1%X7\37FM^+T\06V@3ZSXC@N=0DU
M#5?"_@7^P=2\;64?VJ'2M6\8Z7%;S3K" ?IL]RG+>'(9'%<T\TYZ.)S"U5U*
M?)2Y'-1IM1Y8U*O-&D[*\:4CS\%B<1COKCT6'M.G0]SE=Y7Y;R76,+<ZZ.2L
M?-W_  ; _M._!+X0_LM_'/\ 8\^,WCCP=\%?VA?A!^TGX_UOQ3\/_B7K^C>!
M=>U#2]5T#POH=U>VD'B2_P!/?5]2\+Z_X'\2^'?%MEIZ33^&(M.T.35TMHM8
MT^2?MX\P&+Q./PF986C5Q6#Q&!I0A6P\)5H1E&=2:3=.,E&-2%:$J;;M4O+E
MORLQR6M2IT:N'J3C3JPK2;A-J#:<8K3FM?E<&I)?"K7W1SY^)?@O]NC_ (.C
M?@+X_P#V9M:TWX@_#;]C_P#9M\0>'OBW\4? ]S!K/A&ZO;3PC\<;2>73_$NF
MR76D:S8GQ1\<_!_P[DO;6X\BYNK36+>RFNX=.65J]A5RG@'%TL=%T:V98V$L
M/AZJ<:D4ZF%LG3:3C+DPE2ORM72Y;V;L+GABLZI2HM2AAZ34ZD-8NT:G5:-<
MU2,+_):'K/P__P"5L3XY?]F7Z1_ZKOX/UC5_Y-WA?^QC+_U*Q!I#_D>U?^P=
M?^D4AO\ P<= ?\-*?\$33CD?MG7 !]CX]_9SR/T'Y#TI<#_[EQ1_V+8_^FL:
M+./XV6_]?Y?^E4#]!O\ @X< /_!'+]L[(_Y@_P '/T_:*^$)'Y$ CTKQ.#?^
M2ERO_'B/_4/$'9FW_(OQ'I3_ /3M,_$O_@J[_P JQ'_!.[_L7_V(O_5%>):^
MKX=_Y+O._P#%FG_J92/-Q_\ R)L'Z8;_ -,R/Z%?@;_P4]_80G_8A\%?M%C]
MI?X4P^ ?!GP:\.:AXKT^[\9^'+/QWX?U70?"UM!J'@G4_ ESJD7B2W\=MJ5A
M/H^F>%_L+7VNZ@UH-"&I6>H:?=W/QN,R'-_[6K8/ZCB/:U<745.2I3=&49U&
MXU564?9^RY9*4IWM"-^?E::7JT\=A?JT:WMH<L:<;KFBIII?!R7OS75DNO32
MS/Y\/^"'WPW\;:M_P1@_X*W_ !0;P_>Z7I'[0UA^U4/AIH[12QQZI#H_[/FN
M:5=WFC*T?EW.GMXDURY\)I=P22J^J>%]2LF"26+;OLN*J])<3\-X?F3E@IX!
MUY:>[SXRFTI=GR052S2]V<7LSR<LA+^S<?.UE4C6Y%WY:+3MY7?+?O%KH?4O
M_!$W6_"?[0W_  0"\?\ [*/PW\>>'[KXYS?!S]MCX<7W@C2_$&D/XZ\/ZM\2
M=5^)3^%M7E\.1WC:S9:?<I\0_##V.JW-E#9275Y##%.7*9\[BF%3!<84,PK4
MIQPGUK*JRK.$O92C0C0]I%3MRN2]C.\4[I*]K'1ESC5RJ="$HNK[+$PY$US)
MSY^5\O1/G5GL?EY_P1,_84_8(_;%_9BET7XL_MC_ +5/P-_:4^%_C+QOH'Q&
M^"7A/]I?0OA#I=AI2:S?:SHOB?PO\/\ Q#X0N]1CTJ72[I['Q/=V]W=_9/%N
MD:^^IQZ<;BVCD^@XIS;.,LQREALLP&+P->E2E1Q53 SQ$N?E4)4ZE6G52YKJ
M]--*].45'FY7;ARW"X3$4;3Q%>E6A*2G3C6C326ZE&+B]+:2[-.]M#]5?^"+
MGPY_X)Z>"_\ @HS^VOH?[%NN_M8?&+Q;\*?AK:_#WXH?M%?%GXK?#OXG?!KQ
MQ'K/B_PE=6UGX2U3PUX>T;Q'JVO?VUX,U6PT7Q#?SW>BWVB^$?$<FF236=UI
MMS)\_P 45\YJY)E<LTAE^&IXBO[:A@L/AZ]#%4>2E55ZD:E2<(PY*L7."2E&
M52"=FI([<MAA(XS$+#NO4<(<DJTZD)TY)RC\/+&+O>.CU3496Z'G7_!"SXL_
M##X0_P#!0K_@N1\,?BE\0O!/P\\:^(OVR[C4O"^B>,O%6@^&KOQ5::7\8?VE
MK#5'\,Q:Q?V<FMG3I]<\/&Z6P29DCU_1Y "MY'6W%N'KXG)N%*V'H5:U*&6V
MG.E3G-4^;#8!QY^5/DNH3M>WP2[$Y9.%/%9E"<XPD\1[JDU&_+4K)VO:]KK;
MN?#?QJ_9?_9WUG_@X?\ VO/A-^VU\?OC;^S?X1^/G@O0/B3\"/BMX$^*-A\%
MK+Q?K&L>&/A_?VWA'6/&NO:!JFDMX8@&C^/O!^A&YEL+*Y\7^ ;;P[!=W&M7
M6GV4WJX3'XV/!N6XC*L'A<=5PE25#%X>K0>*=.$)UHNI&E"<9^T=Z-25KM4Z
MKFURIM<U2A2_M7$4\35J48U5STJD9JG=N,9<KE)-<J]Z"_O1278]P_:-_8C_
M ."47[*O[9'[!OPGD^-W[>O[5O[07Q*^.O@>Y^&7A+0/VF_A3\0K?X6ZM!XX
M\#_\(YXM^(-KK'@VVNO#_AC7M4GM[G=IUW8W^J:+X7UZ\BN((=+2Z3EP6:\0
MYAEN;8CZIE&78.AA*OMJD\!B:/UB/LJO/3HN-6TIPBFM4U&4X*SO8TK8; T,
M1A:?M,57JSJ1Y$J]-^S?-#E<O<T3?9IVCZ'KG[8?COPM^Q]_P<Z_LO\ Q_\
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M3BVG*HHT,NQ$,+'!Y7Q8H\C4:=&E"AE'$564X4X93#+<TK5</A.'L5]9]<\
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M!^U'XD\%0_#O6OBA_P )C\0)?MO@Z#3]'TN+2/\ A"YO%4GP\MBEAH&DV_\
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MFGSU)7O=W:37/1P6&P]256C25.<TXR<93M9M2:4'+DCK%?#%6V5D>#?M)?\
M!#S_ ()A_M7?$S5?C%\7OV9=*D^(_B+4/[3\6>(_ WC3XA?#3_A+[^1_,N[_
M ,2Z/X"\5>']!U+5]2DW2ZKXA.EQ^(]3GDDN+W5YKAO-KLP/%>?9?0CAL/CI
M>PIQY:<*M*C7]G'I&$JM.4U&*TC#FY(I)1BDK&5;+,%7FZDZ/OOXG"4H<WJH
MM1OW=KOJS[5_9@_9"_9K_8O^'C?"S]F#X1>%_A#X(GU&76-0T[0?[2O]2US5
MY5$1U3Q+XG\0W^L>*O$^HQVZQV=M>^(=:U.YM+"&"PM9(;*"&!/+Q^98[-*W
MUC'XF>)JJ*C%RY8QA%?9A3IQA3IKJU"$;O5ZG30P]'#QY*-.-.-[M+=OS;NW
MY7>BT6A\V?'W_@D-_P $Y?VGOC/'^T-\:_V9/#WBCXS"^T/5+GQWI'C/XH>
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@#\(_P!OS_E-Q_P;]?\ >5G_ -9)\&T ?NY0 4 % !0 4 %
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MM;"UM[&QMK>RLK2&.VM+.TACMK6UMX4$<,%O;PJD4,,4:JD<4:*B(H55  %
MCSO3O@K\&]'^)6M?&?2?A+\,]+^,/B33UTGQ%\5].\!^%K+XE:_I26VEV2:9
MK7CJVTJ+Q1JFGI9Z'HEHME?:I/;+;:/I< C$6GVB0@=+=.W0D\/?!OX0^$?'
M/BKXG^%/A5\-_#'Q+\=1K#XW^(?A[P-X8T7QSXQB1K9TB\5>+=-TNVU_Q#&K
MV=FZIJ^H7:JUK;, #!%M N]NB(_$WP6^#GC7QMX3^)?C+X3?#/Q;\1O 6W_A
M!?'_ (F\!^%M>\;>"]ERUXG_  B?BK5-*NM=\.;+QWNE_L>_L]MR[3C$K%J
M+7PU^$GPI^#.@W/A;X/_  R^'OPH\,7NK7.O7GASX:^"_#?@70;O7+RVLK*[
MUJYTCPOINEZ?/JUU9Z=I]I<ZC+;M>3VUA902S-%:P(@%V]]>A!\.?@W\(/@[
M;ZY:?"/X5?#?X66OB;56UWQ);?#GP-X8\$6_B'6W0QMK&N0^&=+TR/5M59"4
M;4+]9[LH2IFQQ0%V]SAO#_[)?[*OA/XE7/QG\*_LS?L^^&?C#>W=[J%Y\5_#
M_P &?ASHWQ*N[_4A(NHWMSXZT[PW;>*)[N_665;VYEU1IKH22"=Y [9!W;T;
M=O4N_$O]E[]F?XT:_;^*OC%^SM\"_BQXHM-+M]#M/$GQ+^$G@#QWK]KHEI<W
ME[:Z/;ZQXH\/ZIJ$.EVUYJ.H7=OI\=PMI#<WUY/'"LMS,S@*4EHFTO)M&A\+
MOV<_V>_@?>:OJ/P5^!/P:^$&H>(+:ULM>OOA=\,/!/@"\UNSL99I[*TU>Y\)
MZ'I,VI6UG-<3S6L%X\T5O+--)"B-(Y(#;>[;]6>NO:6LEQ;W<EM;R75HD\=K
M<O#&UQ;1W/EBY2WF93)"EP(81.L;*)?*CWAMBXATJ<IPJRIPE4I*<:=1PBYT
MU4Y?:*$VN:"GR1YU%I2Y8WO9&4J-*52G6E2IRJT5.-*K*$74I1J\OM(TYM<T
M%4Y(<ZBTI\D>:_*K,O+"QU&%+?4+*TO[>.[L+^."\MX;J&.^TJ^M]3TR\2*=
M'1;O3=2L[34+"X51-9WUK;W=N\<\$4BS5HT:\%3KTJ5:$:E&M&%6G"I"-;#5
MJ>(P]51FFE4P^(I4J]&:7-2K4Z=6#C.$6IKX?#XF$:>)H4<13C6P^(C3KTH5
M81KX2O2Q6%KQC.,HJMAL51HXG#U$N>C7I4JU-QJ4XR3[FTM;R-8KNVM[J))[
M6Z2*YACGC2ZL;F&]LKE4E5E6>SO+>"[M9@!);W,,,\+)+&C+52E3JQ4:M.%2
M*G3J*-2$9Q52C4C5HU$I)I3I580J4Y+WH5(1G%J44U56C2K14*U*G5A&I1JQ
MC5A&I&-7#U85Z%51DFE4H5J=.M1FES4ZM.%2#C.,6F7MA8ZE"EOJ-E:7]O'=
M6%\D%[;0W4*7NEWMOJ>F7B13HZ+=:=J5I::A87 42VE[:V]W;O'/!'(LU:-&
MO!4Z]*E6A&I1K*%6G"I!5<-6AB,/549II5*%>E2KT9I<U*M3A4@XSA%J:^'P
M^)@J>)H4<13C5P]>-.O2A5A&OA*]/%86LH3C**JX;$T:.(P]1+GHUZ5.K3<:
MD(R4MQ;P7<$UK=00W-K<PR6]Q;7$:307$$R&.:":&16CEAEC9HY(W5D=&*LI
M4D5<X0J0G3J0C4IU(RA.G.*E"<)+EE"<9)QE&46XRBTTT[-6+J4Z=6G.E5IP
MJTJL)4ZE*I&,Z=2G.+C.G.$DXRA.+<91DG&46TU86&&&WABM[>*."""-(8((
M46*&&&)0D<442!4CCC151$10J* J@  40A&G&,(1C"$(J$(02C&$8I*,8Q22
MC&*22222222L.$(4H0ITX1ITZ<8PITX14(0A!*,80C%*,8QBE&,8I)))))(E
MJB@H * "@ H * "@#_.%^/?_ ">]_P %&_\ L_;]H/\ ].6CU_I_]&G_ )-I
M0_[&*_\ 5+DA^99O_P C#$_]?:G_ *=F<37] GF!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^BG_  21_P"4D7[*_P#V
M&/C#_P"LV_&FOYI^E;_R:R/_ &4V4?\ IC,#W.'?^1I2_P"O=;_TVS^YRO\
M-4_1 H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H __UO[^* "@ H * "@ H *
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M /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\
M^KO_ /S7_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#Z
MN_\ _-?_ /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[
M_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_
M /S7_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\
M_-?_ /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\
MU_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7
M_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_
M /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\
M_P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_
M !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\
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M -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\
MU;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_ !V4?\3E_P#5
MN/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\ '91_Q.7_ -6X
M_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_
M ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_ !V4?\3E_P#5N/\
MS;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\ '91_Q.7_ -6X_P#-
MO_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V_
M_P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_ !V4?\3E_P#5N/\ S;__
M ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\ '91_Q.7_ -6X_P#-O_\
MQ7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%
M</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_ !V4?\3E_P#5N/\ S;__ ,5P
M_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\ '91_Q.7_ -6X_P#-O_\ Q7#_
M %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\
M53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5
M/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_
MZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J
M/_\ +7_[X#_B'?\ ^KO_ /S7_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H_
M_P M?_O@/^(=_P#ZN_\ _-?_ /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_ZC__
M "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\
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M /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\
M^KO_ /S7_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#Z
MN_\ _-?_ /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[
M_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_
M /S7_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\
M_-?_ /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\
MU_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7
M_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_
M /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\
M_P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_
M !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\
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M -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\
MU;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_ !V4?\3E_P#5
MN/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\ '91_Q.7_ -6X
M_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_
M ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_ !V4?\3E_P#5N/\
MS;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\ '91_Q.7_ -6X_P#-
MO_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V_
M_P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_ !V4?\3E_P#5N/\ S;__
M ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\ '91_Q.7_ -6X_P#-O_\
MQ7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%
M</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_ !V4?\3E_P#5N/\ S;__ ,5P
M_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\ '91_Q.7_ -6X_P#-O_\ Q7#_
M %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\
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M "U_^^ _XAW_ /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\
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M /J[_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\
M^KO_ /S7_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#Z
MN_\ _-?_ /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[
M_P#\U_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_
M /S7_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\
M_-?_ /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\
MU_\ _P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7
M_P#_ !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_
M /\ '91_Q.7_ -6X_P#-O_\ Q7#_ %4_ZC__ "U_^^ _XAW_ /J[_P#\U_\
M_P =E'_$Y?\ U;C_ ,V__P#%</\ 53_J/_\ +7_[X#_B'?\ ^KO_ /S7_P#_
M !V4?\3E_P#5N/\ S;__ ,5P_P!5/^H__P M?_O@/^(=_P#ZN_\ _-?_ /\
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M_*S6ECX _:N_X+T_L$?LF?&OQ#^SSK=Y\8?C-\6/!3-#\0?#?[/WPW'Q C\
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M0!^[E !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 ?AK_P $<_\ DM?_  64_P"TIWQK_P#3%X9KZ[B?
M_=.%_P#LG\)^IY>7?Q,Q_P"PZJ?N57R)Z@4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M\*YX*=E9<UWNV5C$HYO@915G))2:TOK..O?W?=]++9']8=?G1[P4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 ?S<?\%B_A'K/Q[_X*C_\$-O@[X>^+WQ-
M^ .M>-/^'F/V'XR?!?6(?#WQ3\%?\(Y^SQ\,/%%S_P (GK=S;W=O8_\ "1VF
MC3>%M=\RUF^T^'=9U2T3RWF61?5RO,J67.JZN68#,?:^SY5CJ3J>QY%43]DE
M))<_.N>ZE\$+6L<V(P\JZBHXBOA^6_\ !DH\U^7XM/L\NEK;L]]_X<Y_&O\
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M/[.J?]#''?\ @T/^'.?QK_Z3*?\ !4[_ ,/7H7_S,T_]9\)_T2_#_P#X2?\
M!#^SJG_0QQW_ (-#_ASG\:_^DRG_  5._P##UZ%_\S-'^L^$_P"B7X?_ /"3
M_@A_9U3_ *&.._\ !H?\.<_C7_TF4_X*G?\ AZ]"_P#F9H_UGPG_ $2_#_\
MX2?\$/[.J?\ 0QQW_@T/^'.?QK_Z3*?\%3O_  ]>A?\ S,T?ZSX3_HE^'_\
MPD_X(?V=4_Z&.._\&A_PYS^-?_293_@J=_X>O0O_ )F:/]9\)_T2_#__ (2?
M\$/[.J?]#''?^#0_X<Y_&O\ Z3*?\%3O_#UZ%_\ ,S1_K/A/^B7X?_\ "3_@
MA_9U3_H8X[_P:'_#G/XU_P#293_@J=_X>O0O_F9H_P!9\)_T2_#_ /X2?\$/
M[.J?]#''?^#0_P"'.?QK_P"DRG_!4[_P]>A?_,S1_K/A/^B7X?\ _"3_ ((?
MV=4_Z&.._P#!H?\ #G/XU_\ 293_ (*G?^'KT+_YF:/]9\)_T2_#_P#X2?\
M!#^SJG_0QQW_ (-#_ASG\:_^DRG_  5._P##UZ%_\S-'^L^$_P"B7X?_ /"3
M_@A_9U3_ *&.._\ !H?\.<_C7_TF4_X*G?\ AZ]"_P#F9H_UGPG_ $2_#_\
MX2?\$/[.J?\ 0QQW_@T/^'.?QK_Z3*?\%3O_  ]>A?\ S,T?ZSX3_HE^'_\
MPD_X(?V=4_Z&.._\&A_PYS^-?_293_@J=_X>O0O_ )F:/]9\)_T2_#__ (2?
M\$/[.J?]#''?^#0_X<Y_&O\ Z3*?\%3O_#UZ%_\ ,S1_K/A/^B7X?_\ "3_@
MA_9U3_H8X[_P:'_#G/XU_P#293_@J=_X>O0O_F9H_P!9\)_T2_#_ /X2?\$/
M[.J?]#''?^#0_P"'.?QK_P"DRG_!4[_P]>A?_,S1_K/A/^B7X?\ _"3_ ((?
MV=4_Z&.._P#!H?\ #G/XU_\ 293_ (*G?^'KT+_YF:/]9\)_T2_#_P#X2?\
M!#^SJG_0QQW_ (-#_ASG\:_^DRG_  5._P##UZ%_\S-'^L^$_P"B7X?_ /"3
M_@A_9U3_ *&.._\ !H?\.<_C7_TF4_X*G?\ AZ]"_P#F9H_UGPG_ $2_#_\
MX2?\$/[.J?\ 0QQW_@T/^'.?QK_Z3*?\%3O_  ]>A?\ S,T?ZSX3_HE^'_\
MPD_X(?V=4_Z&.._\&A_PYS^-?_293_@J=_X>O0O_ )F:/]9\)_T2_#__ (2?
M\$/[.J?]#''?^#0_X<Y_&O\ Z3*?\%3O_#UZ%_\ ,S1_K/A/^B7X?_\ "3_@
MA_9U3_H8X[_P:'_#G/XU_P#293_@J=_X>O0O_F9H_P!9\)_T2_#_ /X2?\$/
M[.J?]#''?^#0_P"'.?QK_P"DRG_!4[_P]>A?_,S1_K/A/^B7X?\ _"3_ ((?
MV=4_Z&.._P#!H?\ #G/XU_\ 293_ (*G?^'KT+_YF:/]9\)_T2_#_P#X2?\
M!#^SJG_0QQW_ (-#_ASG\:_^DRG_  5._P##UZ%_\S-'^L^$_P"B7X?_ /"3
M_@A_9U3_ *&.._\ !H?\.<_C7_TF4_X*G?\ AZ]"_P#F9H_UGPG_ $2_#_\
MX2?\$/[.J?\ 0QQW_@T/^'.?QK_Z3*?\%3O_  ]>A?\ S,T?ZSX3_HE^'_\
MPD_X(?V=4_Z&.._\&A_PYS^-?_293_@J=_X>O0O_ )F:/]9\)_T2_#__ (2?
M\$/[.J?]#''?^#0_X<Y_&O\ Z3*?\%3O_#UZ%_\ ,S1_K/A/^B7X?_\ "3_@
MA_9U3_H8X[_P:'_#G/XU_P#293_@J=_X>O0O_F9H_P!9\)_T2_#_ /X2?\$/
M[.J?]#''?^#0_P"'.?QK_P"DRG_!4[_P]>A?_,S1_K/A/^B7X?\ _"3_ ((?
MV=4_Z&.._P#!H?\ #G/XU_\ 293_ (*G?^'KT+_YF:/]9\)_T2_#_P#X2?\
M!#^SJG_0QQW_ (-#_ASG\:_^DRG_  5._P##UZ%_\S-'^L^$_P"B7X?_ /"3
M_@A_9U3_ *&.._\ !H?\.<_C7_TF4_X*G?\ AZ]"_P#F9H_UGPG_ $2_#_\
MX2?\$/[.J?\ 0QQW_@T/^'.?QK_Z3*?\%3O_  ]>A?\ S,T?ZSX3_HE^'_\
MPD_X(?V=4_Z&.._\&A_PYS^-?_293_@J=_X>O0O_ )F:/]9\)_T3'#__ (2?
M\$/[.J?]#''?^#0_X<Y_&O\ Z3*?\%3O_#UZ%_\ ,S1_K/A/^B7X?_\ "3_@
MA_9U3_H8X[_P:'_#G/XU_P#293_@J=_X>O0O_F9H_P!9\)_T2_#_ /X2?\$/
M[.J?]#''?^#0_P"'.?QK_P"DRG_!4[_P]>A?_,S1_K/A/^B7X?\ _"3_ ((?
MV=4_Z&.._P#!H?\ #G/XU_\ 293_ (*G?^'KT+_YF:/]9\)_T2_#_P#X2?\
M!#^SJG_0QQW_ (-#_ASG\:_^DRG_  5._P##UZ%_\S-'^L^$_P"B7X?_ /"3
M_@A_9U3_ *&.._\ !H?\.<_C7_TF4_X*G?\ AZ]"_P#F9H_UGPG_ $2_#_\
MX2?\$/[.J?\ 0QQW_@T/^'.?QK_Z3*?\%3O_  ]>A?\ S,T?ZSX3_HE^'_\
MPD_X(?V=4_Z&.._\&A_PYS^-?_293_@J=_X>O0O_ )F:/]9\)_T2_#__ (2?
M\$/[.J?]#''?^#0_X<Y_&O\ Z3*?\%3O_#UZ%_\ ,S1_K/A/^B7X?_\ "3_@
MA_9U3_H8X[_P:'_#G/XU_P#293_@J=_X>O0O_F9H_P!9\)_T2_#_ /X2?\$/
M[.J?]#''?^#0_P"'.?QK_P"DRG_!4[_P]>A?_,S1_K/A/^B7X?\ _"3_ ((?
MV=4_Z&.._P#!H?\ #G/XU_\ 293_ (*G?^'KT+_YF:/]9\)_T2_#_P#X2?\
M!#^SJG_0QQW_ (-#_ASG\:_^DRG_  5._P##UZ%_\S-'^L^$_P"B7X?_ /"3
M_@A_9U3_ *&.._\ !H?\.<_C7_TF4_X*G?\ AZ]"_P#F9H_UGPG_ $2_#_\
MX2?\$/[.J?\ 0QQW_@T/^'.?QK_Z3*?\%3O_  ]>A?\ S,T?ZSX3_HE^'_\
MPD_X(?V=4_Z&.._\&A_PYS^-?_293_@J=_X>O0O_ )F:/]9\)_T2_#__ (2?
M\$/[.J?]#''?^#0_X<Y_&O\ Z3*?\%3O_#UZ%_\ ,S1_K/A/^B7X?_\ "3_@
MA_9U3_H8X[_P:'_#G/XU_P#293_@J=_X>O0O_F9H_P!9\)_T2_#_ /X2?\$/
M[.J?]#''?^#0_P"'.?QK_P"DRG_!4[_P]>A?_,S1_K/A/^B7X?\ _"3_ ((?
MV=4_Z&.._P#!H?\ #G/XU_\ 293_ (*G?^'KT+_YF:/]9\)_T2_#_P#X2?\
M!#^SJG_0QQW_ (-#_ASG\:_^DRG_  5._P##UZ%_\S-'^L^$_P"B7X?_ /"3
M_@A_9U3_ *&.._\ !H?\.<_C7_TF4_X*G?\ AZ]"_P#F9H_UGPG_ $2_#_\
MX2?\$/[.J?\ 0QQW_@T/^'.?QK_Z3*?\%3O_  ]>A?\ S,T?ZSX3_HE^'_\
MPD_X(?V=4_Z&.._\&A_PYS^-?_293_@J=_X>O0O_ )F:/]9\)_T2_#__ (2?
M\$/[.J?]#''?^#0_X<Y_&O\ Z3*?\%3O_#UZ%_\ ,S1_K/A/^B7X?_\ "3_@
MA_9U3_H8X[_P:'_#G/XU_P#293_@J=_X>O0O_F9H_P!9\)_T2_#_ /X2?\$/
M[.J?]#''?^#0_P"'.?QK_P"DRG_!4[_P]>A?_,S1_K/A/^B7X?\ _"3_ ((?
MV=4_Z&.._P#!H?\ #G/XU_\ 293_ (*G?^'KT+_YF:/]9\)_T2_#_P#X2?\
M!#^SJG_0QQW_ (-#_ASG\:_^DRG_  5._P##UZ%_\S-'^L^$_P"B7X?_ /"3
M_@A_9U3_ *&.._\ !H?\.<_C7_TF4_X*G?\ AZ]"_P#F9H_UGPG_ $2_#_\
MX2?\$/[.J?\ 0QQW_@T/^'.?QK_Z3*?\%3O_  ]>A?\ S,T?ZSX3_HE^'_\
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M0H64U)R4G[S?NI1:V?5H_:FOE3T@H * "@ H * "@ H * "@ H * "@ H *
M"@ H _"/]OS_ )3<?\&_7_>5G_UDGP;0!^[E !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?AK_ ,$<
M_P#DM?\ P64_[2G?&O\ ],7AFOKN)_\ =.%_^R?PGZGEY=_$S'_L.JG[E5\B
M>H% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M'1I1H4H4H7Y*<5&-]79=]OR1[#7,:!0 4 % !0 4 % !0 4 % !0 4 % !0
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M3G&:4ER37.J<Y2I5HT_2Z\H^*"@ H * "@ H * "@ H * "@ H * "@ H *
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M?_S\#^W\V_Z"_P#RAAO_ )2'_#X#_@HK_P!'#_\ F)?@9_\ .RH_XEO\&/\
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M'P'_  45_P"CA_\ S$OP,_\ G94?\2W^#'_1&_\ FP\5_P#S\#^W\V_Z"_\
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M_P _ _M_-O\ H+_\H8;_ .4A_P /@/\ @HK_ -'#_P#F)?@9_P#.RH_XEO\
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M?]$;_P";#Q7_ //P/[?S;_H+_P#*&&_^4A_P^ _X**_]'#_^8E^!G_SLJ/\
MB6_P8_Z(W_S8>*__ )^!_;^;?]!?_E##?_*0_P"'P'_!17_HX?\ \Q+\#/\
MYV5'_$M_@Q_T1O\ YL/%?_S\#^W\V_Z"_P#RAAO_ )2'_#X#_@HK_P!'#_\
MF)?@9_\ .RH_XEO\&/\ HC?_ #8>*_\ Y^!_;^;?]!?_ )0PW_RD/^'P'_!1
M7_HX?_S$OP,_^=E1_P 2W^#'_1&_^;#Q7_\ /P/[?S;_ *"__*&&_P#E(?\
M#X#_ (**_P#1P_\ YB7X&?\ SLJ/^);_  8_Z(W_ ,V'BO\ ^?@?V_FW_07_
M .4,-_\ *0_X? ?\%%?^CA__ #$OP,_^=E1_Q+?X,?\ 1&_^;#Q7_P#/P/[?
MS;_H+_\ *&&_^4A_P^ _X**_]'#_ /F)?@9_\[*C_B6_P8_Z(W_S8>*__GX'
M]OYM_P!!?_E##?\ RD/^'P'_  45_P"CA_\ S$OP,_\ G94?\2W^#'_1&_\
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M "AAO_E(?\/@/^"BO_1P_P#YB7X&?_.RH_XEO\&/^B-_\V'BO_Y^!_;^;?\
M07_Y0PW_ ,I#_A\!_P %%?\ HX?_ ,Q+\#/_ )V5'_$M_@Q_T1O_ )L/%?\
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M?_S\#^W\V_Z"_P#RAAO_ )2'_#X#_@HK_P!'#_\ F)?@9_\ .RH_XEO\&/\
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M'P'_  45_P"CA_\ S$OP,_\ G94?\2W^#'_1&_\ FP\5_P#S\#^W\V_Z"_\
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M_P _ _M_-O\ H+_\H8;_ .4A_P /@/\ @HK_ -'#_P#F)?@9_P#.RH_XEO\
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MSC!9?A*OL)TZM3,<9F=&C3JSS2?+A_J5;#U(X:EA/;6I59QG+"PE%XL_._\
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M (*-_P#9^W[0?_IRT>O]/_HT_P#)M*'_ &,5_P"J7)#\RS?_ )&&)_Z^U/\
MT[,XFOZ!/,"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@#]%/\ @DC_ ,I(OV5_^PQ\8?\ UFWXTU_-/TK?^361_P"RFRC_
M -,9@>YP[_R-*7_7NM_Z;9_<Y7^:I^B!0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0!__4_OXH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MKXM1J8ET,4JL/;5IX7"U:GZ0CH,\G R?6OSP_CW\/+L+0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!_G"_'O_D][_@HW_V?M^T'_P"G
M+1Z_T_\ HT_\FTH?]C%?^J7)#\RS?_D88G_K[4_].S.)K^@3S H * "@#L_A
MUX$\0?%#Q]X*^&_A2V^U^)?'GBG0?".A6^&V/JGB#4[;2[,S,H/E6T4URLMU
M,1L@MTEFD*QQL1YF=9M@\AR?-,[S"?L\#E. Q>8XJ6EU0P="=>HHWWG*,'&$
M=Y3<8K5I&E&E*M5IT::O.K.-.*\Y-17HM=>R/H_]NG]GCP!^RO\ M!ZW\$/
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M2X<7!_":XHCF.;1PN<MU94_[-P/[K]\N2</9NHI5?]IJ\^'P_L;5:<O:P._
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M4<AP%7!Y=A<7+%<74ZE2C6HT<3A\RIX;ERJ658AY;A)U7BG1='#8?\B/ O\
MP34\17/_  7:N]6OOVU/@%JEQ%\?=9_:!U3PRWQ.CO/V@=8\/:EJEYXVU/X.
M:G\-[N&Y>7QA/X=O9O!7BC0+C4YK)/#<FH7#V3::?[*KYVMG$?\ 5M4O[/Q$
M%]6A@HU/9<N!A.*C06)5>_NT5)>UC42UTLT]3^5LW\0Z.%\%JL*?"6?.G0R.
M&0TJN%RR3R%8C"45@H9OA,=&:3PM2M2^NX.O"E&<\1.DH3C-\Y]Q:M^PI\!?
MVU_V>/VZ?@-^PA^R_P"%?V/_ (U:WJ_@_5+CQC?ZOKMQI_CG1="\<IKMS\(_
M$%_>07MS\.=)UFZTBVU9_#'AV%/#[Z[INE-J=F;+0H;A/U7Q0\-,3X18;@3/
M<RXRP_%6'SZA74\+A\-2P\L%66!P]98W ^SQ%7Z_@N7$^QCC*D:-3=1B_:V7
M^;_T0OV@^?\ CAXF\0X'CGA3B/+\E\-95:6$JXK$PQLX_7ZF.RBEB,;0^H9=
M"CQ'A%AG4EAYU<546"K8I4:\:D9.M]#?\$1_^"1VH?L_?LZ_'CX:_MFWGP?^
M-%K\3/B+X-\3VWP<T3Q'I_Q*\-?#34O!>EZ]IB>(+K5+)_L>E^-/$::M)9W)
MT1HY$T71[:UN]0N_/FLK+\/SGBZK_:.&QF08G%8*MAZ%6C/&4W[&I6A5E!ND
MX_:I1]G%J-1-<]I**<4S^Y>-_I$9S@>,<EXI\(.(N(N$LWRG*L=E=?B3+JU3
M*\=F&%S"KAZT\OJTXR;KY?1EAJ=14L9&<'B+5:=*$J-.H_Z2?"OA7PUX&\.:
M-X0\&Z#I/A?PMX=T^WTK0O#^A6%OIFD:3IUJFR"SL+&TCBM[>&,?PQH-S%G;
M+LS'XK$8BOBZ]7$XFK4KXBM-U*M:K)SJ5)O>4I2NV_R5DM$C^;LZSO..),VS
M#/L_S/'9SG6:XJKC<RS3,L35QF.QV*K.]2OB<37E.K5J2?64G:*48VC%)2Z9
MXC\/:U=:E8:/KVBZM?:-,+;6++3-4L;ZZTJX+2H+?4K>UGEFL9B\$R"*Z2)R
MT,JA<QL!B>6-N/$WANSUBT\.W?B#1+7Q!?Q>=8Z%<:K80:Q>P_O?WMIIDDZW
MMQ%^XF^>&!T_<R\_NWP )J7B?PUHM]INEZQXAT+2=3UB01:1IVI:M86-]JDI
MD2(1:;9W5Q%<7TGFR1QA+6.5O,=$QN8 @!9^*/#.H:O>^'K#Q%H5[KVF*7U'
M0[/5]/N=7T]%,:LU[IL-P]Y:*K2Q*6GAC ,D8/+KD =<^)?#EEK%EX>O-?T2
MTU_48_.T[0[G5;"WUB_A_>CS;+3)9TO;J/\ T>?YX('7]Q+S^[?: 4_%7C;P
M9X$T]-6\;^+O#'@W2I)1;QZEXJU_2O#VGO.1D0I>:O=V=LTI'(C60N1R%Q0!
MHV.O:'J>CQ>(=-UG2M0T":UDOH=<L=1L[O1Y;*(.9;N+4K>:2R>UB$<ADN%F
M,2"-RS@*< #=#\0Z!XFLO[2\-ZYH_B#3O->W^WZ'J=EJMEY\07S8/M5A-/!Y
ML8=-\>_>@9=RC(H 9IGB7PYK=WJ.GZ-X@T35[[1Y?(U:RTS5;"_N]+GWR1^3
MJ-M:SRS6,OF0RQ^7<I$^^*1<91@ #7EEB@4/-+'"ADBB#2NL:F6>5(((@S$#
MS)II(X8D'S22ND: NR@M)O1)O1NR5](J[>G1)-OLE?9%PISJ/EIPG4DHSFXP
MBY-0I0E4J3M%-\M.G"52<MH0C*4K1BVI*1!SVI^+?"FB?9O[9\3>'M(^V+*]
MI_:>LZ;8?:D@98YFMOM5S%YZPNRI*8MPC9E5L$@5O3PV)J\WLL/7J<EE+V=*
M<^6ZT4N6+Y;I:7M=+0]3!Y'G>8^U_L_)\TQWU=PC7^IY?B\3[%U(N5-5?849
M^S<XIR@IVYHIN-TC-7XC?#UW2-/'G@QI)"BQQKXHT,N[/@(J*+[+%R0$"@EL
M@"M/J&.7_,%B[+_J'K:)?]N=#L?"?%,8RG+AKB",(*3E)Y-F*C%0^)R;PUHJ
M-GS7M:VMK'7I+%(\L<<L;R0,J3HCJSPNT:2HDJJ28V:)TD57 )C=' VL#7+9
MI)M-)JZTT:3MIW5TUIU5NAX4J<X1A*4)QA43E3E*+4:D8R<&X-I*2C.,H-QN
ME*+CNFA6DC1HT>1$>9BD2,RJTKJC2,D:D@NRQQO(54$A$9L;5)"L];+1;^73
M7MK9"4)24G&,G&"4IM)M0BY1@G)I6BG*48INRYI1CNTA]!(4 % !0 4 % !0
M 4 ?YPOQ[_Y/>_X*-_\ 9^W[0?\ Z<M'K_3_ .C3_P FTH?]C%?^J7)#\RS?
M_D88G_K[4_\ 3LSB:_H$\P* /VM^)_@SP?;?\$0_V<O&MMX4\-6_C+4/CWKE
MA?\ BV#0M+B\37UBGC+X[PI97FO1VJZI<VB0V-E$MO-=/"L=G:H$"V\03^7L
MAS/,I_2FXTRN>88Z>64.$L+5HY=+%UY8&C5>5\)R=6EA'4^KTZCE5JR<X4U*
M]2H[WG*_T5:G37#>$J*$%-XJ2<U%<[7/B59RM=K1:7Z+L)^RWX,\'ZG_ ,$A
M/VX/%NI>%/#6H>*M$^(]E;:-XFOM"TN[\0:1;F#X1$P:9K,]K)J-A"3=W1,5
MK<Q(?M-Q\O[Z3<^/LSS*A](WPKRZAF&.HY?BLEJ3Q.!I8NO3P>(FI\16E7PL
M*BH5I+V=.TJD)-<D/Y8V>!ITWD&93<(.<:MHS<4Y15L/HI6NMWMW.6_X(_\
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M?$[7-1O@!IEOXC,-S8>#EO)B,6[Z?,NK^,;:4LBHW@YRQ*@HWXK])?BFKDO
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M",V_Y&6-_P"O\OT/B>OU$\X* "@ H * "@ H * "@ H * "@ H * "@ H *
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MS8? 8.IAZE&OBJ^(\'>/:&'A1A5C!R=2LU3@UISZ7T.E'[5?[.QP!\6_"/.
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MCZ%2I3G5<O:35-W5/F=",8-M)WM"^L5\5E=*[^+_ (^?\8@_\$KO@=\ 8/\
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M95J\L,+@_:9HZE7+9+$0J0K_ %?!UIUN;ZQ36+G+V,/4Q^%QV-J4JN#Q\*.
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M96'!4C!!'!'3BO[+X'37!7"":LUPOP^FGHTUE.$5K=+'R>+_ -ZQ/_816_\
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MD1FW_(RQO_7^1\4U^HGG!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_P")M3M?%VD7.I65O8>-Y=;FB@CM]2MI[L ^_?AQXO\ VB/^#<;_ (*1?\%
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M[6N[+IT^X@JQ%B>ZNKKR_M-S/<>4BQ1>?-)+Y4:*J)''YC-L1$1$5%PJJJJ
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MT/[^* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0G'.8U*F.J/D5.FZ57$QQ?[NABY57-2I83EI?'^ZIQC3O]&5\T?CH4 % !0
M@ 4 * H'0   ?0#@4 +0 4 (0",$ CT(R/RH 6@ H * "@ H * "@ H * "@
M H * "@ H * "@ H _SAOCVI_P"&W/\ @HTV#M/[>_[0B@XX)74M%) /3*AE
MR.P9?45_I]]&EK_B&M%75UF$6UU2>2Y*D[=G9V]'V/S+-_\ D88G_K[5_P#3
MLSB*_H(\P* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * /T4_P""2/\ RDB_97_[#'QA_P#6;?C37\T_2M_Y-9'_ +*;*/\
MTQF![G#O_(TI?]>ZW_IMG]SE?YJGZ(% !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % '_]'^_B@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _
M"/\ ;\_Y3<?\&_7_ 'E9_P#62?!M '[N4 % !0 4 % !0 4 % !0 4 % !0
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M@_\ PFH__(!_PQ?^QW_T:?\ LT_^&)^%W_S+4?\ $3?$G_HX7''_ (EF??\
MS>']G9?_ - .#_\ ":C_ /(!_P ,7_L=_P#1I_[-/_AB?A=_\RU'_$3?$G_H
MX7''_B69]_\ -X?V=E__ $ X/_PFH_\ R ?\,7_L=_\ 1I_[-/\ X8GX7?\
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M?A=_\RU'_$3?$G_HX7''_B69]_\ -X?V=E__ $ X/_PFH_\ R ?\,7_L=_\
M1I_[-/\ X8GX7?\ S+4?\1-\2?\ HX7''_B69]_\WA_9V7_] .#_ /":C_\
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M " ?\,7_ +'?_1I_[-/_ (8GX7?_ #+4?\1-\2?^CA<<?^)9GW_S>']G9?\
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M#_\ ":C_ /(!_P ,7_L=_P#1I_[-/_AB?A=_\RU'_$3?$G_HX7''_B69]_\
M-X?V=E__ $ X/_PFH_\ R ?\,7_L=_\ 1I_[-/\ X8GX7?\ S+4?\1-\2?\
MHX7''_B69]_\WA_9V7_] .#_ /":C_\ (!_PQ?\ L=_]&G_LT_\ AB?A=_\
M,M1_Q$WQ)_Z.%QQ_XEF??_-X?V=E_P#T X/_ ,)J/_R ?\,7_L=_]&G_ +-/
M_AB?A=_\RU'_ !$WQ)_Z.%QQ_P")9GW_ ,WA_9V7_P#0#@__  FH_P#R ?\
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M&G_LT_\ AB?A=_\ ,M1_Q$WQ)_Z.%QQ_XEF??_-X?V=E_P#T X/_ ,)J/_R
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M''_B69]_\WA_9V7_ /0#@_\ PFH__(!_PQ?^QW_T:?\ LT_^&)^%W_S+4?\
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M@'_#%_['?_1I_P"S3_X8GX7?_,M1_P 1-\2?^CA<<?\ B69]_P#-X?V=E_\
MT X/_P )J/\ \@'_  Q?^QW_ -&G_LT_^&)^%W_S+4?\1-\2?^CA<<?^)9GW
M_P WA_9V7_\ 0#@__":C_P#(!_PQ?^QW_P!&G_LT_P#AB?A=_P#,M1_Q$WQ)
M_P"CA<<?^)9GW_S>']G9?_T X/\ \)J/_P @'_#%_P"QW_T:?^S3_P"&)^%W
M_P RU'_$3?$G_HX7''_B69]_\WA_9V7_ /0#@_\ PFH__(!_PQ?^QW_T:?\
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M9?\ ] .#_P#":C_\@'_#%_['?_1I_P"S3_X8GX7?_,M1_P 1-\2?^CA<<?\
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M ?\ #%_['?\ T:?^S3_X8GX7?_,M1_Q$WQ)_Z.%QQ_XEF??_ #>']G9?_P!
M.#_\)J/_ ,@'_#%_['?_ $:?^S3_ .&)^%W_ ,RU'_$3?$G_ *.%QQ_XEF??
M_-X?V=E__0#@_P#PFH__ " ?\,7_ +'?_1I_[-/_ (8GX7?_ #+4?\1-\2?^
MCA<<?^)9GW_S>']G9?\ ] .#_P#":C_\@'_#%_['?_1I_P"S3_X8GX7?_,M1
M_P 1-\2?^CA<<?\ B69]_P#-X?V=E_\ T X/_P )J/\ \@'_  Q?^QW_ -&G
M_LT_^&)^%W_S+4?\1-\2?^CA<<?^)9GW_P WA_9V7_\ 0#@__":C_P#(!_PQ
M?^QW_P!&G_LT_P#AB?A=_P#,M1_Q$WQ)_P"CA<<?^)9GW_S>']G9?_T X/\
M\)J/_P @'_#%_P"QW_T:?^S3_P"&)^%W_P RU'_$3?$G_HX7''_B69]_\WA_
M9V7_ /0#@_\ PFH__(!_PQ?^QW_T:?\ LT_^&)^%W_S+4?\ $3?$G_HX7''_
M (EF??\ S>']G9?_ - .#_\ ":C_ /(!_P ,7_L=_P#1I_[-/_AB?A=_\RU'
M_$3?$G_HX7''_B69]_\ -X?V=E__ $ X/_PFH_\ R ?\,7_L=_\ 1I_[-/\
MX8GX7?\ S+4?\1-\2?\ HX7''_B69]_\WA_9V7_] .#_ /":C_\ ('Y(_'#X
M7?#/X0?\%N_^"5.@_";X=^!?A?H7B+X1?MM:OX@T7X=^$= \$Z3KNK:/\+%L
MM(U/6=.\-:?IEGJ>HZ79ZKJEIIU[>PSW-C;:E?P6TD45Y<))ZM;BOBGB'@S/
MZ.?\2Y_GE&AC<IJT:6<9SF.9TJ-3VW)[2E3QN(K1ISY9SCS02ERRDKV;1PRP
M^'H9I@/84*-'FIXF_LJ4*=[4W:_)%7/Z!*_,CV@H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H _]+^_B@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H _ ;_@I%XG\->"O^"S7_! GQ3XQ\0Z'X3\,:3_ ,/3_P"U/$?B;5K#
M0=!TW[=^RKX%TZQ^WZOJEQ:Z?9_;-0NK6QM?M%Q']HO+FWM8=\TT:-K2H5Z]
MU0HU:SC:ZI4YU+7O:Z@G:]G;T?8F4X0^.<8+IS24?SMY'[ ?\-4?LP_]''?
M;_P[_P /O_FAK?\ L['_ /0#C/\ PFK?_(&?UC#_ //^C_X,A_F'_#5'[,/_
M $<=\!O_  [_ ,/O_FAH_L['_P#0#C/_  FK?_(!]8P__/\ H_\ @R'^8?\
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M_FAH_L['_P#0#C/_  FK?_(!]8P__/\ H_\ @R'^8?\ #5'[,/\ T<=\!O\
MP[_P^_\ FAH_L['_ /0#C/\ PFK?_(!]8P__ #_H_P#@R'^8?\-4?LP_]''?
M ;_P[_P^_P#FAH_L['_] .,_\)JW_P @'UC#_P#/^C_X,A_F'_#5'[,/_1QW
MP&_\._\ #[_YH:/[.Q__ $ XS_PFK?\ R ?6,/\ \_Z/_@R'^8?\-4?LP_\
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M */_ (,A_F'_  U1^S#_ -''? ;_ ,._\/O_ )H:/[.Q_P#T XS_ ,)JW_R
M?6,/_P _Z/\ X,A_F'_#5'[,/_1QWP&_\._\/O\ YH:/[.Q__0#C/_":M_\
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MO_#O_#[_ .:&C^SL?_T XS_PFK?_ " ?6,/_ ,_Z/_@R'^8?\-4?LP_]''?
M;_P[_P /O_FAH_L['_\ 0#C/_":M_P#(!]8P_P#S_H_^#(?YGXJ_\$C/CW\"
M_#OQ=_X*[ZEX@^-'PFT+3O%/_!3WXV:OX8O]9^(W@_3++Q'I(T7PS$=3T&ZO
M=8@@U?3Q+^[^VZ>]Q;!_D\S=Q7U7$N#Q=3#<-1IX7$3E3R'"1J1A0J2=.6ON
MS2B^67D[,\W+ZU&-3'\U6G%2QM5QO.*37=7>J\UH?M5_PU1^S#_T<=\!O_#O
M_#[_ .:&OE?[.Q__ $ XS_PFK?\ R!Z7UC#_ //^C_X,A_F'_#5'[,/_ $<=
M\!O_  [_ ,/O_FAH_L['_P#0#C/_  FK?_(!]8P__/\ H_\ @R'^8?\ #5'[
M,/\ T<=\!O\ P[_P^_\ FAH_L['_ /0#C/\ PFK?_(!]8P__ #_H_P#@R'^8
M?\-4?LP_]''? ;_P[_P^_P#FAH_L['_] .,_\)JW_P @'UC#_P#/^C_X,A_F
M'_#5'[,/_1QWP&_\._\ #[_YH:/[.Q__ $ XS_PFK?\ R ?6,/\ \_Z/_@R'
M^8?\-4?LP_\ 1QWP&_\ #O\ P^_^:&C^SL?_ - .,_\ ":M_\@'UC#_\_P"C
M_P"#(?YA_P -4?LP_P#1QWP&_P##O_#[_P":&C^SL?\ ] .,_P#":M_\@'UC
M#_\ /^C_ .#(?YA_PU1^S#_T<=\!O_#O_#[_ .:&C^SL?_T XS_PFK?_ " ?
M6,/_ ,_Z/_@R'^8?\-4?LP_]''? ;_P[_P /O_FAH_L['_\ 0#C/_":M_P#(
M!]8P_P#S_H_^#(?YA_PU1^S#_P!''? ;_P ._P##[_YH:/[.Q_\ T XS_P )
MJW_R ?6,/_S_ */_ (,A_F'_  U1^S#_ -''? ;_ ,._\/O_ )H:/[.Q_P#T
M XS_ ,)JW_R ?6,/_P _Z/\ X,A_F'_#5'[,/_1QWP&_\._\/O\ YH:/[.Q_
M_0#C/_":M_\ (!]8P_\ S_H_^#(?YA_PU1^S#_T<=\!O_#O_  ^_^:&C^SL?
M_P! .,_\)JW_ ,@'UC#_ //^C_X,A_F'_#5'[,/_ $<=\!O_  [_ ,/O_FAH
M_L['_P#0#C/_  FK?_(!]8P__/\ H_\ @R'^8?\ #5'[,/\ T<=\!O\ P[_P
M^_\ FAH_L['_ /0#C/\ PFK?_(!]8P__ #_H_P#@R'^8?\-4?LP_]''? ;_P
M[_P^_P#FAH_L['_] .,_\)JW_P @'UC#_P#/^C_X,A_F'_#5'[,/_1QWP&_\
M._\ #[_YH:/[.Q__ $ XS_PFK?\ R ?6,/\ \_Z/_@R'^8?\-4?LP_\ 1QWP
M&_\ #O\ P^_^:&C^SL?_ - .,_\ ":M_\@'UC#_\_P"C_P"#(?YA_P -4?LP
M_P#1QWP&_P##O_#[_P":&C^SL?\ ] .,_P#":M_\@'UC#_\ /^C_ .#(?YA_
MPU1^S#_T<=\!O_#O_#[_ .:&C^SL?_T XS_PFK?_ " ?6,/_ ,_Z/_@R'^8?
M\-4?LP_]''? ;_P[_P /O_FAH_L['_\ 0#C/_":M_P#(!]8P_P#S_H_^#(?Y
MA_PU1^S#_P!''? ;_P ._P##[_YH:/[.Q_\ T XS_P )JW_R ?6,/_S_ */_
M (,A_F'_  U1^S#_ -''? ;_ ,._\/O_ )H:/[.Q_P#T XS_ ,)JW_R ?6,/
M_P _Z/\ X,A_F'_#5'[,/_1QWP&_\._\/O\ YH:/[.Q__0#C/_":M_\ (!]8
MP_\ S_H_^#(?YA_PU1^S#_T<=\!O_#O_  ^_^:&C^SL?_P! .,_\)JW_ ,@'
MUC#_ //^C_X,A_F'_#5'[,/_ $<=\!O_  [_ ,/O_FAH_L['_P#0#C/_  FK
M?_(!]8P__/\ H_\ @R'^8?\ #5'[,/\ T<=\!O\ P[_P^_\ FAH_L['_ /0#
MC/\ PFK?_(!]8P__ #_H_P#@R'^8?\-4?LP_]''? ;_P[_P^_P#FAH_L['_]
M .,_\)JW_P @'UC#_P#/^C_X,A_F'_#5'[,/_1QWP&_\._\ #[_YH:/[.Q__
M $ XS_PFK?\ R ?6,/\ \_Z/_@R'^8?\-4?LP_\ 1QWP&_\ #O\ P^_^:&C^
MSL?_ - .,_\ ":M_\@'UC#_\_P"C_P"#(?YA_P -4?LP_P#1QWP&_P##O_#[
M_P":&C^SL?\ ] .,_P#":M_\@'UC#_\ /^C_ .#(?YA_PU1^S#_T<=\!O_#O
M_#[_ .:&C^SL?_T XS_PFK?_ " ?6,/_ ,_Z/_@R'^8?\-4?LP_]''? ;_P[
M_P /O_FAH_L['_\ 0#C/_":M_P#(!]8P_P#S_H_^#(?YA_PU1^S#_P!''? ;
M_P ._P##[_YH:/[.Q_\ T XS_P )JW_R ?6,/_S_ */_ (,A_F'_  U/^S#_
M -''? ;_ ,._\/O_ )H:/[.S#_H QG_A+6_^0#ZQ0_Y_4?\ P9#_ ##_ (:H
M_9A_Z..^ W_AW_A]_P#-#1_9V/\ ^@'&?^$U;_Y /K&'_P"?]'_P9#_,/^&J
M/V8?^CCO@-_X=_X??_-#1_9V/_Z <9_X35O_ ) /K&'_ .?]'_P9#_,/^&J/
MV8?^CCO@-_X=_P"'W_S0T?V=C_\ H!QG_A-6_P#D ^L8?_G_ $?_  9#_,/^
M&J/V8?\ HX[X#?\ AW_A]_\ -#1_9V/_ .@'&?\ A-6_^0#ZQA_^?]'_ ,&0
M_P P_P"&J/V8?^CCO@-_X=_X??\ S0T?V=C_ /H!QG_A-6_^0#ZQA_\ G_1_
M\&0_S#_AJC]F'_HX[X#?^'?^'W_S0T?V=C_^@'&?^$U;_P"0#ZQA_P#G_1_\
M&0_S#_AJC]F'_HX[X#?^'?\ A]_\T-']G8__ * <9_X35O\ Y /K&'_Y_P!'
M_P &0_S#_AJC]F'_ *..^ W_ (=_X??_ #0T?V=C_P#H!QG_ (35O_D ^L8?
M_G_1_P#!D/\ ,/\ AJC]F'_HX[X#?^'?^'W_ ,T-']G8_P#Z <9_X35O_D ^
ML8?_ )_T?_!D/\P_X:H_9A_Z..^ W_AW_A]_\T-']G8__H!QG_A-6_\ D ^L
M8?\ Y_T?_!D/\P_X:H_9A_Z..^ W_AW_ (??_-#1_9V/_P"@'&?^$U;_ .0#
MZQA_^?\ 1_\ !D/\P_X:H_9A_P"CCO@-_P"'?^'W_P T-']G8_\ Z <9_P"$
MU;_Y /K&'_Y_T?\ P9#_ ##_ (:H_9A_Z..^ W_AW_A]_P#-#1_9V/\ ^@'&
M?^$U;_Y /K&'_P"?]'_P9#_,/^&J/V8?^CCO@-_X=_X??_-#1_9V/_Z <9_X
M35O_ ) /K&'_ .?]'_P9#_,/^&J/V8?^CCO@-_X=_P"'W_S0T?V=C_\ H!QG
M_A-6_P#D ^L8?_G_ $?_  9#_,/^&J/V8?\ HX[X#?\ AW_A]_\ -#1_9V/_
M .@'&?\ A-6_^0#ZQA_^?]'_ ,&0_P P_P"&J/V8?^CCO@-_X=_X??\ S0T?
MV=C_ /H!QG_A-6_^0#ZQA_\ G_1_\&0_S#_AJC]F'_HX[X#?^'?^'W_S0T?V
M=C_^@'&?^$U;_P"0#ZQA_P#G_1_\&0_S#_AJC]F'_HX[X#?^'?\ A]_\T-']
MG8__ * <9_X35O\ Y /K&'_Y_P!'_P &0_S#_AJC]F'_ *..^ W_ (=_X??_
M #0T?V=C_P#H!QG_ (35O_D ^L8?_G_1_P#!D/\ ,/\ AJC]F'_HX[X#?^'?
M^'W_ ,T-']G8_P#Z <9_X35O_D ^L8?_ )_T?_!D/\P_X:H_9A_Z..^ W_AW
M_A]_\T-']G8__H!QG_A-6_\ D ^L8?\ Y_T?_!D/\P_X:H_9A_Z..^ W_AW_
M (??_-#1_9V/_P"@'&?^$U;_ .0#ZQA_^?\ 1_\ !D/\P_X:H_9A_P"CCO@-
M_P"'?^'W_P T-']G8_\ Z <9_P"$U;_Y /K&'_Y_T?\ P9#_ ##_ (:H_9A_
MZ..^ W_AW_A]_P#-#1_9V/\ ^@'&?^$U;_Y /K&'_P"?]'_P9#_,/^&J/V8?
M^CCO@-_X=_X??_-#1_9V/_Z <9_X35O_ ) /K&'_ .?]'_P9#_,/^&J/V8?^
MCCO@-_X=_P"'W_S0T?V=C_\ H!QG_A-6_P#D ^L8?_G_ $?_  9#_,/^&J/V
M8?\ HX[X#?\ AW_A]_\ -#1_9V/_ .@'&?\ A-6_^0#ZQA_^?]'_ ,&0_P P
M_P"&J/V8?^CCO@-_X=_X??\ S0T?V=C_ /H!QG_A-6_^0#ZQA_\ G_1_\&0_
MS#_AJC]F'_HX[X#?^'?^'W_S0T?V=C_^@'&?^$U;_P"0#ZQA_P#G_1_\&0_S
M#_AJC]F'_HX[X#?^'?\ A]_\T-']G8__ * <9_X35O\ Y /K&'_Y_P!'_P &
M0_S#_AJC]F'_ *..^ W_ (=_X??_ #0T?V=C_P#H!QG_ (35O_D ^L8?_G_1
M_P#!D/\ ,/\ AJC]F'_HX[X#?^'?^'W_ ,T-']G8_P#Z <9_X35O_D ^L8?_
M )_T?_!D/\P_X:H_9A_Z..^ W_AW_A]_\T-']G8__H!QG_A-6_\ D ^L8?\
MY_T?_!D/\P_X:H_9A_Z..^ W_AW_ (??_-#1_9V/_P"@'&?^$U;_ .0#ZQA_
M^?\ 1_\ !D/\P_X:H_9A_P"CCO@-_P"'?^'W_P T-']G8_\ Z <9_P"$U;_Y
M /K&'_Y_T?\ P9#_ ##_ (:G_9A_Z..^ W_AW_A]_P#-#1_9V8?] .,_\):W
M_P @'UC#_P#/^C_X,A_F'_#4_P"S#_T<=\!O_#O_  ^_^:&C^SLP_P"@'&?^
M$M;_ .0#ZQA_^?\ 1_\ !D/\P_X:H_9A_P"CCO@-_P"'?^'W_P T-']G8_\
MZ <9_P"$U;_Y /K&'_Y_T?\ P9#_ ##_ (:H_9A_Z..^ W_AW_A]_P#-#1_9
MV/\ ^@'&?^$U;_Y /K&'_P"?]'_P9#_,/^&J/V8?^CCO@-_X=_X??_-#1_9V
M/_Z <9_X35O_ ) /K&'_ .?]'_P9#_,/^&J/V8?^CCO@-_X=_P"'W_S0T?V=
MC_\ H!QG_A-6_P#D ^L8?_G_ $?_  9#_,/^&J/V8?\ HX[X#?\ AW_A]_\
M-#1_9V/_ .@'&?\ A-6_^0#ZQA_^?]'_ ,&0_P P_P"&J/V8?^CCO@-_X=_X
M??\ S0T?V=C_ /H!QG_A-6_^0#ZQA_\ G_1_\&0_S#_AJC]F'_HX[X#?^'?^
M'W_S0T?V=C_^@'&?^$U;_P"0#ZQA_P#G_1_\&0_S#_AJC]F'_HX[X#?^'?\
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M ,&0_P P_P"&J/V8?^CCO@-_X=_X??\ S0T?V=C_ /H!QG_A-6_^0#ZQA_\
MG_1_\&0_S#_AJC]F'_HX[X#?^'?^'W_S0T?V=C_^@'&?^$U;_P"0#ZQA_P#G
M_1_\&0_S#_AJC]F'_HX[X#?^'?\ A]_\T-']G8__ * <9_X35O\ Y /K&'_Y
M_P!'_P &0_S#_AJC]F'_ *..^ W_ (=_X??_ #0T?V=C_P#H!QG_ (35O_D
M^L8?_G_1_P#!D/\ ,/\ AJC]F'_HX[X#?^'?^'W_ ,T-']G8_P#Z <9_X35O
M_D ^L8?_ )_T?_!D/\P_X:H_9A_Z..^ W_AW_A]_\T-']G8__H!QG_A-6_\
MD ^L8?\ Y_T?_!D/\P_X:H_9A_Z..^ W_AW_ (??_-#1_9V/_P"@'&?^$U;_
M .0#ZQA_^?\ 1_\ !D/\P_X:H_9A_P"CCO@-_P"'?^'W_P T-']G8_\ Z <9
M_P"$U;_Y /K&'_Y_T?\ P9#_ ##_ (:H_9A_Z..^ W_AW_A]_P#-#1_9V/\
M^@'&?^$U;_Y /K&'_P"?]'_P9#_,/^&J/V8?^CCO@-_X=_X??_-#1_9V/_Z
M<9_X35O_ ) /K&'_ .?]'_P9#_,/^&J/V8?^CCO@-_X=_P"'W_S0T?V=C_\
MH!QG_A-6_P#D ^L8?_G_ $?_  9#_,/^&J/V8?\ HX[X#?\ AW_A]_\ -#1_
M9V/_ .@'&?\ A-6_^0#ZQA_^?]'_ ,&0_P P_P"&J/V8?^CCO@-_X=_X??\
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M^C_X,A_F'_#5'[,/_1QWP&_\._\ #[_YH:/[.Q__ $ XS_PFK?\ R ?6,/\
M\_Z/_@R'^8?\-4?LP_\ 1QWP&_\ #O\ P^_^:&C^SL?_ - .,_\ ":M_\@'U
MC#_\_P"C_P"#(?YA_P -4?LP_P#1QWP&_P##O_#[_P":&C^SL?\ ] .,_P#"
M:M_\@'UC#_\ /^C_ .#(?YA_PU1^S#_T<=\!O_#O_#[_ .:&C^SL?_T XS_P
MFK?_ " ?6,/_ ,_Z/_@R'^8?\-4?LP_]''? ;_P[_P /O_FAH_L['_\ 0#C/
M_":M_P#(!]8P_P#S_H_^#(?YA_PU1^S#_P!''? ;_P ._P##[_YH:/[.Q_\
MT XS_P )JW_R ?6,/_S_ */_ (,A_F'_  U1^S#_ -''? ;_ ,._\/O_ )H:
M/[.Q_P#T XS_ ,)JW_R ?6,/_P _Z/\ X,A_F'_#5'[,/_1QWP&_\._\/O\
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MH:/[.Q__ $ XS_PFK?\ R ?6,/\ \_Z/_@R'^8?\-4?LP_\ 1QWP&_\ #O\
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M  U1^S#_ -''? ;_ ,._\/O_ )H:/[.Q_P#T XS_ ,)JW_R ?6,/_P _Z/\
MX,A_F=+X2^.?P2\?:PGA[P+\8OA9XTU^2">ZCT/PE\0?"7B/6)+6U4-<W":9
MH^KWEZT%NA#3S+ 8X5(,C*,5G4P>+HQYZN%Q%*"LN>I0J0BF]ES2BEKT*C5I
M3?+"K3D^T9Q;T\DSU2N<T"@ H * "@#_T_[^* "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M 'X\3?\ S14?ZU\1?]#7$_\ E/\ ^5A_9> _Z!H??/\ ^2#_ (<>_P#!)O\
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M1?\ 0UQ/_E/_ .5A_9> _P"@:'WS_P#D@_X<>_\ !)O_ *,;^#7_ 'X\3?\
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MF_\ HQOX-?\ ?CQ-_P#-%1_K7Q%_T-<3_P"4_P#Y6']EX#_H&A]\_P#Y(/\
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M]\__ )(/^''O_!)O_HQOX-?]^/$W_P T5'^M?$7_ $-<3_Y3_P#E8?V7@/\
MH&A]\_\ Y(/^''O_  2;_P"C&_@U_P!^/$W_ ,T5'^M?$7_0UQ/_ )3_ /E8
M?V7@/^@:'WS_ /D@_P"''O\ P2;_ .C&_@U_WX\3?_-%1_K7Q%_T-<3_ .4_
M_E8?V7@/^@:'WS_^2#_AQ[_P2;_Z,;^#7_?CQ-_\T5'^M?$7_0UQ/_E/_P"5
MA_9> _Z!H??/_P"2#_AQ[_P2;_Z,;^#7_?CQ-_\ -%1_K7Q%_P!#7$_^4_\
MY6']EX#_ *!H??/_ .2#_AQ[_P $F_\ HQOX-?\ ?CQ-_P#-%1_K7Q%_T-<3
M_P"4_P#Y6']EX#_H&A]\_P#Y(/\ AQ[_ ,$F_P#HQOX-?]^/$W_S14?ZU\1?
M]#7$_P#E/_Y6']EX#_H&A]\__D@_X<>_\$F_^C&_@U_WX\3?_-%1_K7Q%_T-
M<3_Y3_\ E8?V7@/^@:'WS_\ D@_X<>_\$F_^C&_@U_WX\3?_ #14?ZU\1?\
M0UQ/_E/_ .5A_9> _P"@:'WS_P#D@_X<>_\ !)O_ *,;^#7_ 'X\3?\ S14?
MZU\1?]#7$_\ E/\ ^5A_9> _Z!H??/\ ^2#_ (<>_P#!)S_HQOX-?]^/$O\
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M-_!K_OQXF_\ FBH_UKXB_P"AKB?_ "G_ /*P_LO ?] T/OG_ /)!_P ./?\
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M_*?_ ,K#^R\!_P! T/OG_P#)!_PX]_X)-_\ 1C?P:_[\>)O_ )HJ/]:^(O\
MH:XG_P I_P#RL/[+P'_0-#[Y_P#R0?\ #CW_ ()-_P#1C?P:_P"_'B;_ .:*
MC_6OB+_H:XG_ ,I__*P_LO ?] T/OG_\D'_#CW_@DW_T8W\&O^_'B;_YHJ/]
M:^(O^AKB?_*?_P K#^R\!_T#0^^?_P D'_#CW_@DW_T8W\&O^_'B;_YHJ/\
M6OB+_H:XG_RG_P#*P_LO ?\ 0-#[Y_\ R0?\./?^"3?_ $8W\&O^_'B;_P":
M*C_6OB+_ *&N)_\ *?\ \K#^R\!_T#0^^?\ \D'_  X]_P""3?\ T8W\&O\
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M-_\ 1C?P:_[\>)O_ )HJ/]:^(O\ H:XG_P I_P#RL/[+P'_0-#[Y_P#R0?\
M#CW_ ()-_P#1C?P:_P"_'B;_ .:*C_6OB+_H:XG_ ,I__*P_LO ?] T/OG_\
MD'_#CW_@DW_T8W\&O^_'B;_YHJ/]:^(O^AKB?_*?_P K#^R\!_T#0^^?_P D
M'_#CW_@DY_T8W\&O^_'B;_YHJ/\ 6OB+_H:XG_RG_P#*P_LS ?\ 0-#[Y_\
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M_LO ?] T/OG_ /)!_P ./?\ @DW_ -&-_!K_ +\>)O\ YHJ/]:^(O^AKB?\
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MP:_[\>)O_FBH_P!:^(O^AKB?_*?_ ,K#^R\!_P! T/OG_P#)!_PX]_X)-_\
M1C?P:_[\>)O_ )HJ/]:^(O\ H:XG_P I_P#RL/[+P'_0-#[Y_P#R0?\ #CW_
M ()-_P#1C?P:_P"_'B;_ .:*C_6OB+_H:XG_ ,I__*P_LO ?] T/OG_\D'_#
MCW_@DW_T8W\&O^_'B;_YHJ/]:^(O^AKB?_*?_P K#^R\!_T#0^^?_P D'_#C
MW_@DW_T8W\&O^_'B;_YHJ/\ 6OB+_H:XG_RG_P#*P_LO ?\ 0-#[Y_\ R0?\
M./?^"3?_ $8W\&O^_'B;_P":*C_6OB+_ *&N)_\ *?\ \K#^R\!_T#0^^?\
M\D'_  X]_P""3?\ T8W\&O\ OQXF_P#FBH_UKXB_Z&N)_P#*?_RL/[+P'_0-
M#[Y__)!_PX]_X)-_]&-_!K_OQXF_^:*C_6OB+_H:XG_RG_\ *P_LO ?] T/O
MG_\ )!_PX]_X)-_]&-_!K_OQXF_^:*C_ %KXB_Z&N)_\I_\ RL/[+P'_ $#0
M^^?_ ,D'_#CW_@DW_P!&-_!K_OQXF_\ FBH_UKXB_P"AKB?_ "G_ /*P_LO
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M&_@U_P!^/$W_ ,T5'^M?$7_0UQ/_ )3_ /E8?V7@/^@:'WS_ /D@_P"''O\
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M_D@_X<>_\$F_^C&_@U_WX\3?_-%1_K7Q%_T-<3_Y3_\ E8?V7@/^@:'WS_\
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M1?\ 0UQ/_E/_ .5A_9> _P"@:'WS_P#D@_X<>_\ !)O_ *,;^#7_ 'X\3?\
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MF_\ HQOX-?\ ?CQ-_P#-%1_K7Q%_T-<3_P"4_P#Y6']EX#_H&A]\_P#Y(/\
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M "@ H * "@ H * "@ H * "@ H * "@ H * /PC_ &_/^4W'_!OU_P!Y6?\
MUDGP;0!^[E !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 ?AK_P1S_Y+7_P64_[2G?&O_P!,7AFOKN)_
M]TX7_P"R?PGZGEY=_$S'_L.JG[E5\B>H% !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % 'X:_M:_\IT?^"2'_ &1']NS_ -5K
MIU?79;_R2/$G_85E7_J1$\O$?\C3+_\ KWB?_3;/W*KY$]0* "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * /__5_OXH * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * /PC_ &_/^4W'_!OU_P!Y6?\ UDGP;0!^[E !0 4 % !0
M 4 <?XJ\?>#O!#:6GBO7K+1&UJY:UTU;LR9N98_+$A_=1R>5##YL0FN)O+MX
MO,3S)%W"O SOBC(.&W@HYWFF&RYYA5=#"*NY+VLX\O._=C)4Z<.>'/5J<E*'
M-'FFKH]O)^&\\X@6+>39;B,>L!25;%.BH6I0:ERKWY1YZDU"?)2I\U2:A+E@
M[,["O?/$"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@#_ "G_ /@HK_RD:_X*"?\ 9Y'QT_\ 4KFK^]/!O_DB,#_BH_\ JMRX
M_(^(?^1I7_Q5/_3]4^/Z_5#PPH * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H _9[_@WW_P"4KW[-O_8)^.'_ *H;XE5^+>/?
M_) 5?^QOEOYUCZ7A/_D<4_\ KQ7_ /24?Z05?Q ?J84 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * /V>_X-]_\ E*]^S;_V"?CA_P"J&^)5?BWCW_R0
M%7_L;Y;^=8^EX3_Y'%/_ *\5_P#TE'^D%7\0'ZF% !0 4 % !0 4 % !0 4
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MAU"]G#Z?KLEI;:?.=7>*T:*\GCE66YM99_W*HCQ2^AX9\=U_&/)N.>',HR'
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H _"/\ ;\_Y3<?\&_7_ 'E9_P#62?!M '[N4 %
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MPRW.,JQG%6&Q#P?#-)8.O2X@H9I75>AE%&&*A1HK#2A]7Q2K>PPU*$X\QO\
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M]/!O_DB,#_BH_P#JMRX_(^(?^1I7_P 53_T_5/C^OU0\,* /Z<_^"BBM=_\
M! W_ ()77OA5?^**M?&%K:^(1$CF(>-1X3^*%O+)*5)C5_[8M/'2DORTLKA=
MN66OY]X&M#QH\1H8C_>Y87FH7M?ZG]8RZ5EUM[.6"VV27D?7YIKPSDKI_P )
M5&IVV]IRUE_Z4JI^5'_!(BWURY_X*7_L8Q^'@YOU^-GA^XG$:.[?V':6U_=>
M)R1'R$'AJ'5C*Q^2.(.\G[M6K]'\371CP!Q6Z]E#^R,1&-[)>VERQPZ]?;ND
MDN]DCQ<C4O[6R_DW^LT__ 5\?_DES^K_ /8JU3P[9?\ !>7_ (*Q:KHJ$Z1I
MOPD\#7%\EJJ&1M7TS1_A%_PE@C5W1#._B*WUC(>1%,Q.YD&<?S9Q;3KR\&?#
M6E5?[VIF>*C!RV5*I4S/ZM>RV5"5+9/3N?:Y>X+B;.I1^&.'BW;^9+#^T[?;
M4C\>/^"3'_!6K]M_XA?\%&?A=X.^-/QL\8?%GX??M"^*M9\(^+? OB&6WG\-
M:%=:WI.JWNA:QX%T6"T6P\$)X?URVL'DLO#UM8:;<^'QJ.GW=N3)!>6GZEXE
M>&?"&!X$S'%93E&%RS&Y'AJ6*PN,H)QQ%6-&I3C6I8RLY<^+=:BYI3KRG4C6
MY)Q>CC+PLDSO,:F:T88C$5*]+%5'3J4Y-<D7)/EE3C;EI<DK.U-17+=6VM^D
MO_!,_P#9'^%/PR_X*O?\%8OB!H.D^"=*7]F._M(OA$/$$XM_"7PXE^/=OXS\
M9W^H*4>-='TGPUHOAN[\+75[$\<VB^&=1U73H)52:9J^"X_XFS+,/#;PUP-:
MIC*G^L,&\S]@N;$X]9*\)A8T]OWM7$5J\,3"#357$4Z4VG9'K9/@:-'.\[JP
MC2C]3=J'-I3H_6?:3O\ W8PC!TVU\,&T>W?L6R?M(_";]H;Q1X[_ &N/^"NG
M[&7[1WP0^(^C^+++QS\)I_C5H%_IVGW^L0//HUS\/_#^L_V;X;\*6%E?(FDW
MN@Z<;/0;GPSJ&IVTNEW5ZFGS6_D\6+(<RR/#8/ACPQXLR'-\OJX6>"S*.3UJ
M<YPI-1JQQM>C[3$8F<H?O(5I\U:.(A3DJD8N:EOE[Q5#%3J8[/<NQ>&JQFJM
M!XJ,DN9/E]E"5H02>CC&T7!M6>EOE[]D+XJK^Q)_P3/_ ."RGQ _9AU?P]?V
M7P>_;<^.'ACX&>*-,O+/Q-X?M- U,_"7X=^!/%^C7A;4M*\0IH.AZWI_B+17
MN#J>C:O=:?:+>#4=-N)EG^@XGRW_ %N\0/"O!<0TJ].>:<(Y3B,XPTX2P]9U
MJ?\ :>.QF%JP]RI0]M6HSH54O9U:49RY>2I%6Y<#6_L[)\^JX.46J&8XB&&F
MFIQ4'["C3J1>L9\L9*<=XR:5[Q9X[_P24_:L^/\ ^V/^Q_\ \%8?A/\ M0_$
M_P 5?''P_H?[-^J>)O#5U\1=0'B75O#M[XF\!_%ZUUN'3M1U**>]2R:YT#PW
MJNCV+7'V'PYJFCB]T.VLKB]NI']7Q+X<R7A;BCPUS+A[+L-D]>MGU/#XB. I
M_5J=>%#&96Z3G3IN,.=1K5Z52?+SUZ=7DK2G&$4N;),;B<=@,[H8RM/$QC@Y
M3@ZS]HX.5*NG9RN[7C"45M&4;Q2;9^9WP4_X)U?\$Z_B)\(OAQX[^(G_  5U
M^&GPC\=>+?!VA:_XM^&&I?!MM9U#P%K^I6$-SJ7A6\U0?%72O[0N=&N7>REN
MAIMCY[1%_LL.=@^_S;CCCO YGC\'@/#+'9G@L-BJU'"YA3S54H8RA3FXT\1&
ME_9U3V<:L4I*//.U[<S/)P^5955H4JM7/*-"I.G&4Z+P_,Z4FM8-^VC?EVOR
MKT/MO]E6QTO2_P#@W0_X*=Z9H>L#Q#HFG?M8:O8Z/KZV<NG+KFEVC?LB6^GZ
MPNGSO)-8C4[2.&]%G-(\ML)O)D=G0D_)<23J5/'3P]J5J7L*L^&Z<ZM'F4_8
MU)+B9SI<Z24O9R;AS))2M=*QZ&#27">;J+YHK'VC*UN9)Y>D[=+K6W0_EQK^
MB#XX_K-_8ZT[_@H5XY_X)<?#/PQX.^,G[-?_  3$_92\/^);^[L_VFO$_CSQ
M)\,/BY\9)KG6_$5QJEZVNK>BRTW3=8\0SSQ)J\.K^#]?UV+PKIFCZ(][X36X
MBNOYJXIGP/A/$3'XC%93G_B#Q)6P\(3X?P^#P^897E48T</&E%4'#FG.G12?
MLW3Q5"B\34K55#$N+C]K@%FM3)J,*>(P>48&,VUC)U9T*]=\\[^^G9)RTO>G
M*2A&,;PNCUW_ (*GZ#+XG_X(:?!_6_'W[3/@3]M/QW\,?V@-#M--_:2\!WEI
MJMGX@$VJ_$3PR=*N]>@OM2N-8U#2_#.HV.B^(+N[F@O=7U+1M.U/5EO]0MAJ
MU]YGAS66'\8,UI8+A_&\)X+,,CJSGD&,A*E*C:G@*_M(T'"G&E3J5X3JT(14
MHTH5:E.ER0E[*&^<QY^',/*KBZ>85*.*BEBZ;YN9-U8\KEJY-0Y8R;LVXQ<K
MM<S/^"SG[8_[2O[+W[&?_!+;PI^SY\6O%7PBM?BK\%)M5\;:OX'O#H?B;4V^
M'/PV^ 4?AFPM_$MH$U?3M+C;QSKDVIV&GW-M%JLG]GB^\Z&S2(KPIX6R#B'B
MOQ%Q.=Y9ALSEEV;JEA*6,A[;#TUCL?G3Q$WAY7I3J/ZG15.<XR=)<_)9R;#/
ML?B\'EV24\+7J4%6PJE4E2?)-^RHX7D2FK227M)72:3TO>R/ OVL_B?XD_;O
M_P"#?OX6?M+?'5K;Q#\=?@%\>X/!<?Q%N[>VLM9\4:?-XAE\$7<SFW@MH9)=
M;T#7?"DGB81*4U;7O!HUZ<I<*\47M\,Y=A^#?&O,<@R=2H9-G62/%_4(N4J6
M&G&BL5%*[D[4:U'$K#W_ (5'%>QC[MF^;&UIYEPQ0Q>)M+$X7%>R5;12G&_(
M[Z+XHN'/_-*FI'ZT_ME_LW?&/X4_ ;]D_P#93_9%_;S_ &??V ?!7PH\"Q2^
M)X?%7Q+;X:>/?B;KELMA;QZ]9:S:J-7O/#]UK:^*=:\1&&>W@\3>(]>N)]<3
M4/L5I';?FG"F?95F6<\2\2<3\&9YQKB\RQCCAGALN68X++Z+YG["=*7[J%>%
M'ZM1H7C)X?#T8QH\G/+F]O,,)7H87 X+!9GA,KIT:7O\]?V%2M)67,I+WG'F
MYY2M;FG*\KV5OC3_ (*2W/@7QI\(?^"4VM_$+]HW]G3]H3]L7X2_M?\ P6^&
M_C;QE\&/'7AG7+OQ;X-\1:K?W>M>(I=&TN\&K?9YM0\%?#^]UJXN=)L])T_Q
M/JNJ_P!E1Z?!K,=M<_5\ QQF$S3Q&HX'(<]R3A7,^&<TQ^$PN;8.O0CA<70I
MPA2H*I4C[*ZAB\;"E&-252>'I4O:.;HN4?/S9TJE#)95,7A,5CZ&.H4:D\-5
MA)SISDVY<L?>M>G2NVE%3E*UN8_)+_@XZ_Y2=^.?^R4_"'_U&37Z7X$_\F\P
M7_8QS3_U)9XO%?\ R.*O_7FA_P"FT/\ ^#</_E)UX*_[)-\7?_4=BI>._P#R
M;W&?]C+*_P#U(#A3_D<4O^O-?_TV?2?[0G[1_P#P0$TOX^_'#3/B%_P3W_:5
M\2^/].^+_P 2['QQXCTSXN>,+#3?$'C"T\::U;^)M;T^Q@_:1T^"RL=5UJ.]
MOK2TAL+&*V@GCACL[9$$*?/Y)D/C54R;**F!XWR##X*>68">#H5,LPLYT,++
M"4GAZ,YO()N4Z=)PA*3G-R<6W*6YUXG%\,K$XA5,JQ<JBKU54DJ]1*4U4DI2
M26*5DY7:5E;L?F9^RI^W?H_[&G_!0FZ_:(_97\!^*O#/P"UWQUJGAO\ X43>
MZO?:]X@UOX$^)-8MT7P-?7U[JNMW.I>+;""'3M:\.W5SK&K?9O&&EZ7Y]]J=
M@+I+S]!XCX-J\5<$1R+B/&8?$9U1P=.O_;$*4*-&EG.'I/\ VR$(4Z,:>&G)
MSI5X1I4N;"U*B4:<N5P\C!9E'+\T^MX.G*&&E4E#ZLY.4GA9R7[IN[;FDE*#
M;E:I&-^9+7^I+_@I)=_#'_@D/^RQ^T5\;_V1?AOXH\(_&K_@H%\4[73=2\=2
M6)@L?@[?>(_#.IZQJ?\ 9(BT^Q;P8EA&OC'6?!/A2XEFO+'XA>*]6U2*>3P_
MX5L/#FF?SMP%',?$_B/(\IXGQV&Q64\$9=*<,&I*4LUC0Q%.C3]K><UB^=_5
M:6+Q*2A/!8:G3<56Q-2O4^RS;V.18+%8C TIPQ&:5N5U;-+#\\)2?+91]E;]
MY*E#=59MZQIJ$?SQ_P""''[17Q[UK]B/_@K#::Q\9?B;JMK\!?V6M!OO@E;Z
MEXU\07T/PEO(OAG^TW?QW/P[CN;^1?!\RWWA_0KS?H0L2;G1M+F.9+&V:/[C
MQ>R+):7%_AI*EE67TY9SQ'6AF[AA*$'F<'F'#U/EQW+!?6ER5ZT+5N=<M6HM
MIROY?#F)Q,LMSM.O6:PV#@\.G4FU0?L<8_W.O[O6$7[EM8Q[(ZW_ (-[=#\3
M?$[3/^"@_P"V_P"//'VD^)/VEM)\&Z;X'\$_&[X^>)-2UZS\'7LO@?Q+K6K>
M*?'WB'6+F\OX_#*G0/ %OKNLRSM=Z=X.\+ZGI=E-#I\]Y;R\WC=6P^7U.!^$
M<'@JM#A^KBYXO%Y/DN'A1GBH1QF'I4L-@J%*,(/$6K8UT**2C/%8BG4FG-0D
MJX7C.LLTS&I5C+%PI*G2Q.*FY*FW3FW4JSE=\BY*2E*]XTXRC\+L??G[#^G_
M !>^&'C;XNZ;^W3_ ,%6_P!CS]K?X!_&7P-XDT#Q)\.M6^.6A:O=:?KNMW$$
M+2>'8M=ETG3/#_A2_P!!O/$6AZQX5T>2QT5X+[3WL]-@?38-OQ?%\\LS#"97
M4X.\-N*>&<ZRK&8>OA\=3R6K1C.C1BW:O[!59U\3"M##UJ6(JQG53A-2J-5)
M7]/+O;4:E=9EGF7X["UZ<X3HRQ496E*R]Q2Y8P@X\T90C:-FK1T5OA'_ ()P
M_&37_P!CC_@CM_P5'^*'P/UC2M1U[X5?M/?$+0/AGXK5[36M,B;5M"^"WP\\
M/>-M/=X[K3-:.E6NMP>*='6ZAO-(U2YL[-+ZWNM.N)X9/L>/,JH<4^*7AWEV
M;TJD*&8\/8*MC\-:5&HU2K9MCJV$FO=J4E4E1>'J\KC5IQE+D<9Q37G93B)X
M#(,XK8:47*CC*D:,])1]Z.&I1J1W4N52YXWO&32OH8?_  24_:L^/_[8_P"Q
M_P#\%8?A/^U#\3_%7QQ\/Z'^S?JGB;PU=?$74!XEU;P[>^)O ?Q>M=;AT[4=
M2BGO4LFN= \-ZKH]BUQ]A\.:IHXO=#MK*XO;J1]O$OAS)>%N*/#7,N'LNPV3
MUZV?4\/B(X"G]6IUX4,9E;I.=.FXPYU&M7I5)\O/7IU>2M*<812C),;B<=@,
M[H8RM/$QC@Y3@ZS]HX.5*NG9RN[7C"45M&4;Q2;9Q?\ P1[_ &AO@[KG_!.S
MXZ_L4^"OVM/"O["G[8'C/XF7WBSPU\7_ !1)IV@_\)1I%\G@M;&'0O%FIZCH
MD"ZK/I^@:MX&FL=.UNV\5^';344\3>%['4;B6YB7K\4<CS2CQSDO%F*X9Q'&
M/"^$R^&%Q&5X93K_ %>K!XOGE6PM.G5?LU.O2Q:G4HRPU>5/ZOB)TXJ#,\BQ
M6'>58K+Z>.AEN.J5G.%>=H<\6J:2C4;C9VC*G924X*7/!-W(?^"DD'_!47X!
M?\$[=>_9X_;!\,_#W]KGX,:WX\\+Z[X4_;:T/QMKWCKQ+X ']O\ A_5O"]CK
M3:CIFB>($FU.9-:\-6'C/Q59WUE<V?C6;PE;^(=0_P")#;SO@)^'>=<<T<\X
M7KX[AC-J6#Q%'$\(U<)1P6'QO[FM2Q$J2IU*M!JFO8XB6$PTX2C+"+$RH0_?
M21FRSG#97+"X^%+'8>52$Z>81G*I*E[T7!-M1EK[T(SJ1::J."D_=1T7[5WP
MWTGXQ_\ !/O_ (-\OA#KTKP:%\4_B3\,?AQK4T4LL$D.D^-_^$,\,ZC)%- &
MFBD2SU.9HY(5,J, T8+ 5CPWCZF5<;>-N9T5S5<NP&-QU*-DTZF$CBZ\$T]&
MN:FKIZ6+QM%8C*^%Z$M(UJM.BWV51TX/\&<7_P %P_\ @HG^U!^SS^V%I?[*
MG[,'Q+\4?LY_"#]G#X>_#+3] \.?"J]_X12TUO4=:\)Z3XF@FU0Z?%"^H^']
M&T/4-"\+Z5X5O'NO#MK'HUY<&Q>XU*[KJ\(>!N'L[X6J<2<0Y?AL]S3/L;F%
M2M7S*'UF5&%+$U<,U3]I?V=:K6IUL14Q,.6O)U8QYTJ<3/B+-,9A<>L#@ZT\
M)A\'2HQA"@_9J3E3C/7EM>,8N,(P=X+E>EVSM?\ @I'K5O\ M<?L#?\ !)K_
M (*&^.-$T?3?CUXD^,'@_P"#'CK6=.M(-+N/%=K)J/C9[^_DL;>&"+^R_P#A
M*?A-J7B31K&)/LGA\>-M1M-.'V6]+'EX!I/ACC7Q)X&P=6K/)L/EF(S;!49R
ME4CAI*&$Y*:G)R?M/J^9T\/5FWS5OJE.4_>B7F\OKV5Y+FM2,5B95HX>I))1
M<U>I=V2M;GH2G%+2'M&EHSM?^#AW_@H9^UA^S]^UO\*/@M^SW\=O&/PF\(:%
M\%/"WQ*UVS\"7#:!J&J^//$/CGQ_I\B>(=52 3Z_HEOX:\,^&'M- GDN?#XE
MO=3^VVMU<3RQVW%X'<#\-9UPQF6;9WDV$S+$ULVQ& HSQL57A3P5#!X*:]A3
M;M0JO$8C$*5:*C6M"GRRC&*;UXIS3&X;'4,/A<34H0AAX59*D^1NK*I47OO[
M<5"$+1UAJ[IZV\7_ ."^NJ^"_'D__!)7X_\ Q@TK5+A?BW\"K'5_C7/X&BTB
MP\6:KX.C/P@\9Z[IGABXOHH]-@U2W7X@>-#X9CU'_B4V.H:DK/%%;O<!_6\%
MZ>*P2\2\ERJI3C_9F<SI91'&.K/#4L3_ ,*>%HSQ$8/VCIOZEA/;^S_>3A3W
M;4;<_$SA5_L/%5T[U\*GB/9\JFX+V%22A?1/]]4Y+^ZF_4[[XD_\%ROV//C%
MH?[17['/C7X7>/\ 1?V KS]FGPK\,_V?9/!5@UI\8;+QEX TZQ?2/MT5_P"(
M7LK&QGOH='MO#C:MJ]_I^G?\*]TB7Q+!JEGXOU^UL^/ >$'%&55LBXIPF8X*
MMQK'/\3F&>?6YJ65SPF.G-5?9\F'4I34'5E6]G2A.?UZJJ#IRPM!O2KQ%@:\
M,5@*E"K'*W@Z='"^S5L1&I147"]YV2YE%1O*27LH\UU.:7\D]?TN?$A0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M%_:F'^LT:+H_VK]16.7M73]SF^J_654]E&4W5]O9N'U?E/RE^(GP\^)7C;X
M?%RT_P""@-_\1K+P?8>+_#MU\.;W33HEWXNB^)2R:E;2KX2@E)TT^$;G2+BZ
M%V-0:WT1[:/S-%F_M"!HI/YUPM?CK*^$.,<?X]U.(O['H9G@(9 K8.OFE3B.
M=2O"=/)TY*A')YX1U95)U9TL![.FG@I3Q$'2G_7^1YYPAE?B)P5+Z-V'X7K9
MWB,FS.GQ/1K_ %^ADKX5Y<+4A+.JD5]8_MJEC*='V/U95,P527)CH?5ZD9Q^
M6O'OP]_:0\$?##]GC3/^">5U\=[[X-:A/XAU+7[SPX3;>+;CXX2:^+/69_B'
M%H!33[73H-'L]#M/#?FNWA:/2K>XEFG?4'U69_:P>(SS,.&.%<=X43XF?#N*
MGC'BE3_=9C#B6&*]CBX9I'!R=%4Z="GA8X)\SP;PRYN;VKKV_1<FSOPXS3BW
MQ'J?2.I< 4>-<-#+<-E]+,+5<FAP(LO]O@(\.3S#_:*N)J8VMCZF:<L8YK+&
M3I1A3CAHX2*^UO\ @JA^QI\ OB)_P34_;1_:#_:%_9U^!WC;]K3P?_P3?^/^
MH7_Q<U3X?>%-8\7Z#X^\$_LV>.-2LM0\.>)9-/EN;"3PSXGCFU#P[=:;-$FE
MW44-UI1M_*@*?V/E?U]99EZS3V;S/ZEA?[0=+E]F\;["'UGDY$H<OMN>W(E"
MWP+EL?Y<<2/)'Q#GKX:5:/#KSC,GD4<1[3VZR?ZY6_LU5O:WJ^T6#]CS>U;J
MW_B-SYF?#W_!L5^Q=^R3XB_X)>?L??M*Z[^SA\&M7_:!TSQ#\4M9T_XS:AX
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MK_T"TKWL@WSS_LH,P_\ 2,.>!G__ #)O^Q'@/_<IW%?0'SX4 % !0!_E/_\
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MH/FCK:-1N.TDGHLN(,7A\=F52OA9^THNG1BI\DX7<8)2]VI&$M'IK%>6@_\
MX(I_M-_!']D;]NSPI\8_V@_&;> ?AM8?#[XC:#?>)5\-^*_%0M=3UW0Q;:3
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M">SKKDJ0Y)^SP\>6\XQ4K.G+6'-'31GX>U^O'SH4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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ME33C*$=-5U3<7*-]6_V5_P"";?[?OPK_ &/?VAOAY_P3M^*'_!)WQ#_P2_\
M$W[1&K6[^ ]=L/&D_P 3_#GQ1\8BVDTW1O\ A(/%VM>&=(\0ZS#<7$"^&-)U
M:U\6?$.'2-<U&UT_4%T2WU&\O8_F,\R?$9G@JV<T.(89]3P47[6'LHT)8>E\
M4^2G3FZ<&E^\E%TJ+E"-US6BCT<'BJ>'JPPD\#+!.L_=?,YJ<ME=N*=OLI\T
MN5Z::V_JJK\]/<"@ H * "@ H * "@ H * "@ H * "@ H * /_2_OXH * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M]1U?5%_X5]JFE6NJ6-[X7L+K7]8CMH3J^AW":4^FZ5=Z'K$NGKJQ /F30O\
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MU70]*OD:VG\2WNN:K#82:CH$FB)XEO\ 1(+76]&73AH0!TO['_\ P1)_:/\
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MXOF5D]K;'YW5]P>6% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H _9[_@WW_P"4KW[-O_8)^.'_ *H;XE5^+>/?_) 5?^QOEOYU
MCZ7A/_D<4_\ KQ7_ /24?Z05?Q ?J84 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 ?_]3^_B@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _
M"/\ ;\_Y3<?\&_7_ 'E9_P#62?!M '[N4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^&O_!'/_DM?
M_!93_M*=\:__ $Q>&:^NXG_W3A?_ +)_"?J>7EW\3,?^PZJ?N57R)Z@4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MUM_\X:@ _P"(F+_@B/\ ]'K?^:X?M;?_ #AJ #_B)B_X(C_]'K?^:X?M;?\
MSAJ #_B)B_X(C_\ 1ZW_ )KA^UM_\X:@ _XB8O\ @B/_ -'K?^:X?M;?_.&H
M /\ B)B_X(C_ /1ZW_FN'[6W_P X:@ _XB8O^"(__1ZW_FN'[6W_ ,X:@ _X
MB8O^"(__ $>M_P":X?M;?_.&H /^(F+_ ((C_P#1ZW_FN'[6W_SAJ #_ (B8
MO^"(_P#T>M_YKA^UM_\ .&H /^(F+_@B/_T>M_YKA^UM_P#.&H /^(F+_@B/
M_P!'K?\ FN'[6W_SAJ #_B)B_P""(_\ T>M_YKA^UM_\X:@ _P"(F+_@B/\
M]'K?^:X?M;?_ #AJ #_B)B_X(C_]'K?^:X?M;?\ SAJ #_B)B_X(C_\ 1ZW_
M )KA^UM_\X:@ _XB8O\ @B/_ -'K?^:X?M;?_.&H /\ B)B_X(C_ /1ZW_FN
M'[6W_P X:@ _XB8O^"(__1ZW_FN'[6W_ ,X:@ _XB8O^"(__ $>M_P":X?M;
M?_.&H /^(F+_ ((C_P#1ZW_FN'[6W_SAJ #_ (B8O^"(_P#T>M_YKA^UM_\
M.&H /^(F+_@B/_T>M_YKA^UM_P#.&H /^(F+_@B/_P!'K?\ FN'[6W_SAJ #
M_B)B_P""(_\ T>M_YKA^UM_\X:@ _P"(F+_@B/\ ]'K?^:X?M;?_ #AJ #_B
M)B_X(C_]'K?^:X?M;?\ SAJ #_B)B_X(C_\ 1ZW_ )KA^UM_\X:@ _XB8O\
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M_P!'K?\ FN'[6W_SAJ #_B)B_P""(_\ T>M_YKA^UM_\X:@ _P"(F+_@B/\
M]'K?^:X?M;?_ #AJ #_B)B_X(C_]'K?^:X?M;?\ SAJ #_B)B_X(C_\ 1ZW_
M )KA^UM_\X:@ _XB8O\ @B/_ -'K?^:X?M;?_.&H /\ B)B_X(C_ /1ZW_FN
M'[6W_P X:@ _XB8O^"(__1ZW_FN'[6W_ ,X:@ _XB8O^"(__ $>M_P":X?M;
M?_.&H /^(F+_ ((C_P#1ZW_FN'[6W_SAJ #_ (B8O^"(_P#T>M_YKA^UM_\
M.&H /^(F+_@B/_T>M_YKA^UM_P#.&H /^(F+_@B/_P!'K?\ FN'[6W_SAJ #
M_B)B_P""(_\ T>M_YKA^UM_\X:@ _P"(F+_@B/\ ]'K?^:X?M;?_ #AJ #_B
M)B_X(C_]'K?^:X?M;?\ SAJ #_B)B_X(C_\ 1ZW_ )KA^UM_\X:@ _XB8O\
M@B/_ -'K?^:X?M;?_.&H /\ B)B_X(C_ /1ZW_FN'[6W_P X:@ _XB8O^"(_
M_1ZW_FN'[6W_ ,X:@ _XB8O^"(__ $>M_P":X?M;?_.&H /^(F+_ ((C_P#1
MZW_FN'[6W_SAJ #_ (B8O^"(_P#T>M_YKA^UM_\ .&H /^(F+_@B/_T>M_YK
MA^UM_P#.&H /^(F+_@B/_P!'K?\ FN'[6W_SAJ #_B)B_P""(_\ T>M_YKA^
MUM_\X:@ _P"(F+_@B/\ ]'K?^:X?M;?_ #AJ #_B)B_X(C_]'K?^:X?M;?\
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MB/\ ]'K?^:X?M;?_ #AJ #_B)B_X(C_]'K?^:X?M;?\ SAJ #_B)B_X(C_\
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MB/\ ]'K?^:X?M;?_ #AJ #_B)B_X(C_]'K?^:X?M;?\ SAJ #_B)B_X(C_\
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MB/\ ]'K?^:X?M;?_ #AJ #_B)B_X(C_]'K?^:X?M;?\ SAJ #_B)B_X(C_\
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MUOF=W_*G;K8_5C_B)B_X(C_]'K?^:X?M;?\ SAJ^=.\/^(F+_@B/_P!'K?\
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M&H /^(F+_@B/_P!'K?\ FN'[6W_SAJ #_B)B_P""(_\ T>M_YKA^UM_\X:@
M_P"(F+_@B/\ ]'K?^:X?M;?_ #AJ #_B)B_X(C_]'K?^:X?M;?\ SAJ #_B)
MB_X(C_\ 1ZW_ )KA^UM_\X:@ _XB8O\ @B/_ -'K?^:X?M;?_.&H /\ B)B_
MX(C_ /1ZW_FN'[6W_P X:@ _XB8O^"(__1ZW_FN'[6W_ ,X:@ _XB8O^"(__
M $>M_P":X?M;?_.&H /^(F+_ ((C_P#1ZW_FN'[6W_SAJ /I+]E'_@M/_P $
MSOVWOB_I_P !?V7_ -I3_A9WQ8U71-<\16'A3_A3GQ^\%^?HWANT%[K5Y_;G
MQ"^%?A/PU%]BM2)?L\VL1W5Q]RT@GD^2@#]2J "@ H * "@#_];^_B@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _"/\ ;\_Y3<?\&_7_
M 'E9_P#62?!M '[N4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0!^&O_!'/_DM?_!93_M*=\:__ $Q>
M&:^NXG_W3A?_ +)_"?J>7EW\3,?^PZJ?N57R)Z@4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H _"/\ ;\_Y3<?\&_7_ 'E9_P#62?!M '[N4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0!^&O_!'/_DM?_!93_M*=\:__ $Q>&:^NXG_W3A?_ +)_"?J>
M7EW\3,?^PZJ?N57R)Z@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 ?AK^UK_RG1_X)(?\ 9$?V[/\ U6NG5]=EO_)(\2?]
MA65?^I$3R\1_R-,O_P"O>)_]-L_<JOD3U H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H __]#^_B@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M8#_UI>*SL*_5#^. H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MX+[G_D['_@I7_P!I&/VCO_=0K^]/!O\ Y(C _P"*C_ZK<N/\AOIP?\G>RO\
M[(C ?^M+Q6=A7ZH?QP% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0!^Z'_  1;_P";D_\ NCG_ +U.OY;^DI_S1?\ W<?_ +P3_2#]GU_S=O\
M[L+_ -_0_="OY;/]( H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@#\-?VM?\ E.C_ ,$D/^R(_MV?^JUTZOKL
MM_Y)'B3_ +"LJ_\ 4B)Y>(_Y&F7_ /7O$_\ IMG[E5\B>H% !0 4 % !0 4
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M_P!0<*>#EG^_YG_U^G_Z>JG]'/[9W_)GG[5__9M7QU_]5=XIKXG*O^1GEO\
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MC9J4*E-W4:E.:TE!V:Z.+3C)1DG%=^'Q%+$TU5HRYH[=G%K>,ET:_*S6ECX
M_:N_X+T_L$?LF?&OQ#^SSK=Y\8?C-\6/!3-#\0?#?[/WPW'Q C\ 7<4=M/>:
M?XDUC4=>\,:.^HZ5!=1MKMEH-]K<^@7*3Z5K::?K5M/IL?LY=P?G&8X6&,@L
M-A</55Z,L96=)UH[*4(0A4DHRM[CFH*:M*-X-2?'7S7"X>HZ3]I4G'XE2@I*
M+[-N45==4KV>CLU8^S?V(?\ @H1^RK_P4,^'VK_$+]F'XACQ7;^%[ZTTOQOX
M3UC3+OPWX\\!ZCJ O'TJW\5^%]147-G!K$.GWTNBZO92ZAH.KBQU"'3=4N;K
M2]3M[/R\UR;,,EK1HXZC[/VB<J-2$E.C6C&W-[.:T;A=*46HSC>+<4I1;Z<-
MBZ&+@YT97Y=)1:M*';FCYVT:T=M'H[?"'CC_ (.'O^"9?PUF^.&F>./B/XY\
M/^*?@3\6-9^#&M>")? %[?>+_&/C'P_?^)--U>;P'I&DWU_]O\,6%UX6OX;K
MQ7XAG\,:%;3W>C65S>PW^KV-I+Z]+@O/:WU1TJ5"=/%X>.)C55:U.E3DH.*K
M.45RS:FK0@JDFE*RM%G++-L'#VJE*:=*;IN/)[TFFU[B3V]W>7+T/RA_X*H_
M\'#R>!_BA^R3X6_9!^(/Q8^&EEI_BKX9?$K]INRUOX0^ -03Q=\$?BEX(^$_
MQ4\-^']#NO%=MXM+Z['X*\6ZC;:M!X;N-$GM=7NGM(M;NE@L[U?H>'^"U4H9
MC/,J.&KMPKT,#R8FO'V6)P]7$8>I.:I^R]QU:<7'G4O=5W"+O$X,;FW+.@L/
M*I"SA.LG"#YJ=2-.<4K\VJBVG:VNS>Y_0_\ LE?\%,_V6?VQ_P!G;XH?M3?#
MW7/$_@CX,?!OQ%XF\._$+Q+\8= B\ C0&\(>#_#OCC7M8GCDU+4H3H-EH'B;
M3YC?_:0S7$=W;BWW0H9?B\QR''Y9C</E]:-.MB<3"G.C#"S=7G]I4G2A!>[#
MWW.#5K;6=SU\/C:&(HSKPYH4Z<G&3J)1MRQC)[-Z6DORL?G-'_P<Z_\ !,E_
M$#6O_&22?#U=;&A+\<'^!6JCX4/,;@0"Y%P-9/CI(?*/VS[)+X$CU@6H(.EB
MYQ;'V_\ 4//>2_\ L/M>3G^J_6E]86FUN3V5^E_:\E_M6U.3^VL%S6_?<M[>
MT]E[GY\__DE_(_9/QC^U3\$_"/[+_B?]L2V\60>-O@)X8^$^K_&D^+_ 'D>)
M4U[P%HNAS^(+B_\ #<45Q;Q:C=2V%M*D%E)<6LBWBM9W9M9HYEC^9I9=BJF8
M4\L=/V.,GB(X7V=:\.2K*2BE/1V5^J35M5=6/0E7IQH/$7YJ4:;J7AK>*5_=
MV^[3MH?D!XY_X.:/^"6G@KP;\/?%=MXS^*GCK4?B!H=WXB/@+P#\/;;6?&G@
M?3+35]5T<+\0H[[Q+I/ACPWJMP^C7>HQ>'U\3WWB"+0Y-.UJ]TNTT[5M+GN_
MI*7 F?5:M:FX8:E&C-4_;5:SC2K2<8R_<VIRJ3BN91YG3C#F3BFW&5O/EG6"
MC"$KU).2OR1@N:%G;W[R44W;1*3=K.R31^IO[%7[<W[./_!0'X.CXW?LT>,;
MCQ1X3MM=O/"OB'3M8TF[\/>*O!_BFPMK.^N?#_B?0;T>997O]GZCI^H6MQ:S
M7VE:A97D-QIVHW:>9Y?S^:93C<FQ/U7'4U"HX*I"4)*=.I3;:4J<ENKQ<6FH
MRBUK%:'=AL31Q5/VE&5TGRM-6E%VV:].UT^C/S'^-'_!R/\ \$V?A!\1_&/P
MXTN_^.'QNE^'M_=Z;XW\:? WX70^+/AYX=NM-O)=.U-Y?%.N^)_"<6JZ787T
M+V__  D'AZVUCP[J!V2Z-JNI6[K,?>PO ^>8FA3K26$PGM8J5.EBZ[IUI)J\
M?W=.G5Y6UKR3<9QVE&+5CBJ9Q@Z<W!>UJ<NCE2@G!-:;N4;^J3B^C9^EW[//
M[77[+O[?7[-NN?%_X&>/1\0?A'K6D^)_"OC!;.'6?#7BOPS>1Z(?^$F\*>(-
M'N4TWQ#X9\366EZA'-"4\H7-K=V&M^']1OM+O=-U.X\+&9;C\GQT,-BJ/L<3
M&5.I2ORSI5%S_NZD)*\)TW*-O*SA.*DG%=M*O0Q5!U*<N:FU*,MXR6GO1:T:
M=OPLT[69\)?\$%M+_8/T[]C/QA)_P3SO/CCJ'P5O?V@O'$_B&[^/\EC_ ,)J
M_P 2!X0^'B:M%:6VDP6>DVWAZU\,?\(A::;]CLH9IY(+J74)+N_,]U+Z_%\L
MV>9TEG*PBQ*P=+D6"YO9*A[6ORWY[RY^?VE[MJUK66ARY6L+]7E]4]K[/VLK
M^UMS<_+"_P .EN7EM8Y7]I;_ (.+_P#@F]^S5\5_$OP9EUWXM?'#QAX(N]0T
M[QS+\ / .G^-/#?A+4M&D:/7+"_\3:_XJ\':/JDFA%'76KCPM<^(-/TR>*XL
M+N\CU*SO+*WTP'!.=X[#PQ/+AL)3J).DL95E2J5(R^&2IPI5914OLJHH-JS2
MLTR:V;X.C-T[U*CC=2]E%2C&VZNY16G6UTC] OV'O^"AO[*7_!0_X?:I\0?V
M8/B*OBJ+PQ=6.G^./!VM:;=>&_'_ (!U'4X9[C3;7Q5X7U ">WM]3BM;S^R=
M=TN;5?#.LRZ?JEMI&MWUSI.IPV?C9KDN89+6C1Q]'V?M$W1J0DIT:T8V4G3F
MNL;KFA)1G%.+E!*4;]>&Q=#%P<J,K\MN:+7+*%]KK\FKQTT>A\<?%/\ X+Z_
M\$X?@GXV_:4^'/Q0^(OC#PEXU_9A\80^ ?%7AN[\%S7>L>._%LM]K>GRZ5\*
MM-TW4+V_\4PZ?/H-TVLZS?6V@Z!H<-UI4NKZK9+J=GYOJ8?@[.\52P-:A2HU
M*6/I>VIS56T:-/EA)/$.44H.2FN2$7.<K2M'W7;FGFN#IRK0G*494)<C7+K.
M6JM32>MN75OEBM-=3I_V$?\ @M_^PC_P4*^)U]\%?@QXA^(/A/XLPZ7J.MZ/
MX#^+G@V'PCJWBS2M%CDGUJX\+7>E:WXFT+4;G2+&/^T[W1YM6L]=&E>?J5OI
M<]EIFKS:=EF_"F;9-06*Q,*-7#<RA*MAJCJ1I2DTH*HI0ISBI/W5)1<.:T7)
M.44ZPN98;%3]E3YX3M=1J147)+?ELY+1:VNG;5+1V_7NOFST#Y5_;C^/^N_L
MJ_L@?M&?M'>%]"TCQ-XB^"_PH\5_$#1O#^O27D.BZOJ&@6#W5M8ZG)I\L%\E
ME-( LYM)HI]F1'(APP]'*<%#,,RP6!J2E3IXG$0HRG"W-&,GJXW35^UTUY'/
MBJKH8>K6BDW3@Y)/:Z[VMIZ%;]A+]H;7_P!K']CS]G7]I'Q3H&C^%_$7QF^&
M'A_QSK/A[P_+>S:+I%_JT<C3V>F2:C+/?-9QM'^Z^U32S!3AY'(W$S?!0R[,
M\;@:<Y3IX6O*E"<[<\HQM9RY4HW]$EY!A:KKX>C6DE%U(*34=D_*_0^LZ\XZ
M#^+7XLK\5_\ @O[_ ,%7/CI^QU>_%[QG\+_^"=W[$%_JNE^/?#WP\U."QO/B
M;XK\)^)6\%7]_-++;7>FZKXD\7^-;+Q#'X1U?7].UWP[X.^'_A2YO=$TK_A(
MM:O[C7?U'#?5^#N'<)F4<-3KYSFL8NE.LG:C"I3]K&-M)1ITJ3A[2,'&=6M-
M*4N2,5#YR?/FN.J8?G<,)AFU)0>LW&7+?:SE*2]UM-0@M%??[X^/'_!KU_P3
MQ\3?"Z_LOV;M.^(_[/7QRT/33?\ P^^*>G_%+QUXMB'C/3#]LT.\\6:'XLUK
M6+0V$E_% EW+X.'A/4[%=M[I=S#<6XBF\?!\>YS#$)XYT,9A)RM6H/#TJ=J3
MTDJ<J<8NZ6RJ>T3^%K6ZZJN281P_<\]*HE[LU.4O>6W,I-_^2\MCT7_@F;\0
MO^"@GB/_ ()H_M0?#S_@HS\._B9X9^,'P>\'?%3PIX2\>?%#2OL/B#XG_#>?
MX7:C-H]_J.IC*^+-;\-ZG;ZQH^H>+3+/=:]IK:#>ZI=ZCK+ZCJVHXYY0R>GG
MN75LEK8>IAL35P]2I1P\E*&'K+$1YDHK^'&<7&4:5DH-344H\L8O"SQ4L#B8
M8N$XSITZD8RFK.</9NVOVG%IWEU5MV?D)_P1Y_X*0_";_@FA_P $-_'WQ=\<
M?9_$OQ%\2?M8_&'PW\#?A';W?DZW\3O'W_"O/A T%J$B$EU8>$?#_P!HM=2\
M;>(Q"\6D:;);6-JMWXBUOP[I&J?1\2Y'B,\XJHX>E>%"GEV&GB\3;W*%+V^)
M[Z.I.SC2ANW>3M"$Y1X<OQ<,'EM2<K.;Q%14J?6<O9TO_)8Z.3Z:+=Q3_43_
M ((\_P#!-#XLO\1?$7_!57_@HZ)_%_[<OQZ,WB'P/X1\26>Q/V=_!&M6 L].
MMH-#N#)'X:\;7?AE[?0-.\/Q*LOPQ\#)!X2S;Z]J/BBTL_!XFSS#>QAP_DEJ
M>58.T*M2F_\ ?*L'=^\OCI*?ORF_X]6]36"@Y=V78.?,\=B_>Q-7WH1:_A1:
MLM/LR<=%%?!"T=[I?F%\6/V)_@'^WO\ \'//[9/P,_:/T+7/$/P\M_@+\._'
M,>G^'_$NJ^%+[_A(?#_[/O[,MCILYU31I8+PV\5OK=^)+7>(I6>-G!\I:][#
M9IB\HX#RW%X*4(5OK=:E><(U%R3QN-<ERRTO[JUZ'%4PU+%9UB*55-P]G"6C
MY7=4:-M5ZGV7^TM_P;&_!KP)X0UCXN_\$V/C!\>OV=OVHO &FWWB'X;P?\+-
MN[[PYXGU;3(7O[;PO_PD$=OI'C?PAJFMSV\&FZ;XEM_%MUI.FS2J^K^'M2MV
M::V\S <>8FM5CAL[PV#Q>7UFJ=>U!*<(R:7M'!N5*I""NY4_9J37PS35GT5L
MEIQBYX.I5I5H)N'OZ2:7PW7+*+>RES675'WG_P $$O\ @HWXZ_X*%_L?:I=?
M&Z6&;]HKX >-'^%7Q8U!;*#2KCQ= =,M]5\(>/[_ $6SM+.QT34]=LSJF@Z[
MI]I#%;R>)?".N:I;66F66I6FF6GC\7Y)2R;,HK"IK!8RE[?#INZIM/EJT8R;
M;E&#Y9Q;U4*D8MMQYGU97BY8O#OVEO:TI<D[:<RM>,K+17U3MI>+>FQ^X=?*
M'IA0 4 % !0!^$?[?G_*;C_@WZ_[RL_^LD^#: /W<H * "@ H 3 /!&1Z4 ?
MG);_  :_:QUG]JKQ]K_QJ^('PU\9?L5ZKX4N+.S^%?B#2]'U.Q:\8:=]F.HZ
M!JWAQK5!:Q17\=_?7FM3V]RTWF?8I$E @^[EFW#5#AO!T<JP6.P?%5*NI3S*
MC4J4Y\GOJ7)7IUT_?O!PC&E%Q2MS)KWOY^H\'>*>.\3\ZQG%V></YSX18O+Y
M4:/#&-PN&Q5&=6U#V*JY?B,#[*,J7+6C7KU<14A5DU)4I*5H?S1_\%;O%G_!
M6CP)_P %$?#/A_\ 9&/QZ\-_L]6FA?#:']E/P[^SC:>([3X':KHI\/:"^N0Z
MOI/@F.+P!J>K+X[EUZUU:S\7V["V\/MHT B7PG<Z7+=?4<-QX<Q625:V;RPE
M?,9U<1+-:V92A/'^T]I+E?M,0W74714.25-W<^?_ )>J5O"XV7&N5<487 \*
MT,;@.'\/AL#2X:P6049T,DC0C1IN</JN A#!)PQ3J*5.I#EC1]G%1^KR@G^E
M/[2/[(GPE\+_  !^/'Q__8I\">&= _X*N>+/A#I4:Z]X%U_Q'_PFMIXFUK_A
M'M-^,Y^$.F7>JMX=\-_%#6?AE/X[T;3+GX?VEAXFDU.^FL]$==1O29?YUX6^
MD]X,<3^(6&\+Z?BGPSF6+HYE5PE/(Y8J,(XRO0C5J8?!4<=5H4L%FM2E6C3G
M+!8;&8JK:E+GI6HR4/WOB?P(XYR'@;,N/\KX$S;+\[Q64TJSS;#TJKJT77]A
M3QV(I89593R^M5PKQ%*GB/J^'?-4Y:,U*I'F^>_^#?KX&_MI^)=)^..A?MW_
M  Y^*FN_ 2[$%QX3\(?M9^%_$.J7,GQ%CU#37DU7PWX>^+=G-J\.F+8KK"7]
MYIUK'ILFK%M[O>^:1^]<99GE^#J8.MP_C:>%S%7C4KY/75%_5G&5Z=2K@Y17
M-S<CC&3NH]+'XQX;<,9EG>%S/ \=Y++-<AERU</@.*\!]=I?7XSA:M0PN;4J
MC24554YPBHN>[YC]U_V</AS^U[X0^.GQLM/B_KOP_O/V794GL_@7X(\.Z9H%
MG_PCVEQZO$?#VG6NF:3HVGMIMEI7AY)['5+;4)+A+B\:Q>S,Z0R3)X&?8[A?
M$Y-E,LLHXR/$*<99QBZTZ\O;3]DU6G*I5JS]I.I7Y9TY4[<L%)2Y;J)ZOA[P
M]XK95QIQA1XLQ>1U?#9PJ4>#,FP.'P%..!P\<93>74*.%PF#H?5J.$RZ-2AB
MJ>(<E4K.A*C[14W47WY7Q9^ZA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0!_!?<_P#)V/\ P4K_ .TC'[1W_NH5_>G@W_R1&!_Q4?\
MU6Y<?Y#?3@_Y.]E?_9$8#_UI>*SL*_5#^. H _2O]H/X1_#;PM^PA^R[\2O#
M_@_2=*\=>,M92W\4>)K5)AJ.M0_V5XIF\N\9YFB*^;96K_NXH_F@3T.?Q;A#
MB#.L=XI\<Y+B\QQ%?*\MP[E@<%-Q]CAI>WP,;TTHJ5^6I-:MZ29_6WBAP-PE
MDWT:_!KB[*\BP6"XDS_,'2SG-Z*J_6LPI_5<YGR5^:I*G;FP]%^Y"/\ #B?/
MG[$O@OPM\0_VH_A+X-\:Z)9^(O"^N:GKL.K:+J"NUG?16WA#Q!?0),(GB<B*
M[M;>==KK\\2]N*^M\3<RQV3\"Y_F668FI@\=A:.$EA\31LJE)SS'!TI./,FM
M:<YP=UM)GYA]'GA_)>*O&3@?(.(<OH9KDV8XW,:>.R_$J3H8F%+(\SQ%.-10
ME"5H5Z-*HK27O0730]ZU_P :?LW?L\_M$_M)^$?''[-FD?%/0(_'L>G>!M,_
MMZ30K3P5INCMJBWUG9HUGJ+7$>I?;; DLZM%_9RC+^9\ORF#RWC/B_@[@O,,
MKXTQ&0XMY5*KFE;ZI'%3S*MB/8.E4J-5**@Z'LJMK)J7MGMRZ_I&9<0>$_A9
MXJ^+>1\1>$F XURR'$_U3AO!O-:N5T.'L)E]3'1Q&'H1^K8QUHXOZQA=92BZ
M?U-*\N?W?N&^\6_L<6W[&>C?M%?\,<>!7T?4/&$OAL>$1#HD7B&&]3Q#JNF?
M:&^("Z,=<N;$QV)NOLLB+&IE73Q!]G@2X;\PI9?XC3\2,3P=_P 1&S18BCET
M<9_:%\3+!RI/!X>MR+*'B5A:=5.I[/GBV_=]MS<\W!?T;B<]\!*/T?\ +O%7
M_B 7#<L%B\_GE"R)+ 0S.GB8YGCL+[5\5++WF=;#.GAO;>QE!13FL(J?LJ4:
MS^&?"WBW]G?]HC]IS]G'PMX*_9RT7X6^$9/%5SIGC70_[<EUVW\9Q:H+9[2.
M]"66FFWATQ+&<1"-W:5K^7)C$2[_ -1Q^7\8<'\$<98[,N,L3GN81P%.MEF*
M^J1PDLME0YU4=+]Y64Y5W5A>Z2BJ4=[Z?SADV=^%GBIXP>$^3</^$^7\%Y'/
M/)X+B'+5FE7,Z7$%/&.BZ,<1;#8-T882.'JJ*A*3J?69W<5!<WIO_!2K]B_1
M/@S=Z-\8/A)X>CT?X:ZP;30/%.@:<)Y+/PGXC2/RM-U& 2/-);Z/XC@B\B3>
MQAM-=MRK3;M<LK>/Q/!;Q)Q/$E/$\.\08MXC.L-[3%X'%UN55,?@F[UJ,N6,
M8RQ&"D^:-ES3PLU:-L+4D_LOI<?1^R[P^KY?QWP/E<<!PAF'L,LSC+,+[2=#
M(\WC#EPN*I\\JDZ6 S:E#D?,W"AF5*4743S'#48^?_ 3X1_#;Q-^P-^T[\3=
M>\(:3J?CWP=XC-IX8\3W*3'4M&MO[/\ !<ODVC),D(3S-0O&^>)SFXDYZ8]?
MBOB#.L%XL<$9'A,PKT,IS'!>TQN!@X^QQ,_:YE'FJ)Q<KVHTEI)? CY7PUX&
MX2S?Z,WC%QAF618+&<39!FU.AD^<554^MY?1=#A^3IT'&I&FHWQ6(?O4Y?Q9
M>5OS5K]I/Y*/8/@1\%O$O[0?Q/T#X4^$-1T+2M?\10ZS/9WWB2>_MM'A31-%
MO]<NA<S:9IVJWJM):Z=-% (K&4-.T:R&.,M(GSO%7$N"X1R/%Y]F%'%5\)@Y
M8:%2E@H49XB3Q.)I86')&O6P]*T9UHN7-5C:"=KNT7]WX:^'V;^*/&&6<$Y#
MBLMP69YK3Q]3#XC-JN*HX""R[+\3F-95JF#PF.Q$7*AA:D*7)AJB=5P4N2#<
MX\5X[\(:A\/O''C+P%J\]E=:MX(\5^(?"&IW6FO/)IUSJ'AK5[S1KV>PDN;>
MTN7LIKFRDDM7N+6VG:!HS+;PN6C7T\JS"CFV5Y;FN'A4IX?,\!@\PH0K*,:T
M*.-P]/$TH58PG4@JD85(J:A.<5)-1G)6;^>XDR+%<+\19]PUCJF'K8WAW.LT
MR+&5L)*I/"U<5E&.KY?B*F&G6I4*LL/.KAYRHRJT:-1TW%SI4Y7@N4KO/%/V
M(A^$'[,7[%/P4^'?CK]HGX=W'QI^-WQ4L8M<TCX?W6I-9Z+X<L4AM;RXM;B)
M"VGPPZ=;:GI]KJU_JECK\U]K;-::+:1Z?;7URG\Z2XAXW\2^)LXRO@_.(<-<
M,9#5EA<1FU.A[3$XRJY3IPG!NU64JTZ%:>'I4*N$C2PJ53$U'5G2@_[PI\">
M#WT?/#SA3B7Q5X5K>(/B)QKAH9EE_"];&O#9=E.%C"CB*E&O&#EAJ<,-1QF%
MHXW$XS#9I/$YBY8?+L/#"T<57C8E^&O[,/[;?P,^*/C;X%_"W_A1GQH^#NER
M>(;[PGH\_P!MTGQ)IHTW4M1M-.CM[9;'2[V'6?[*U*PLM0M-*TK5-+UB"T6_
M2;3+J".YA9UQOX8\49%EG%.>_P"M/#7$5>.#I8_$0]E7P5;VU&C.LY3=6M2E
MAO;T:M2C4KUZ%?#RJ>Q<:U.3AM/A'P>^D/X<<9\1>''!G_$-_$'@'!SS;$Y'
M@:OUG 9Q@UA,9BZ.$ITJ2PV#KQQ_U'%X;#XG#X+ XS!8^G0CBHU,%6I1J^-:
M7\(_AM-_P3.\1_%Z7P?I+_$NT^)D&CVWC I-_:T.F-XKT&R-FC^=Y'E&UN9X
M/]3NV2,-W3'TM;B#.H^->$X>CF.(623R26)EER<?J\JZP&)J*HUR\W-SPC+X
MK7BM#\_P7 W"53Z(>;<=SR+!2XNH<94\OHY\U5^NT\&\WRS#O#Q?M/9>S]C6
MJ4_X=^6;UV.]_9]_9?\ A3\$O@KJ?[4_[8VB+?Z3JNG"W^%_PEOVEM]0\03Z
ME TNF7EU8K+;3S:OK<4;/HMA,RVFCZ(+KQ)JZ[1 =-\GB[CC/N)N):' GASB
M72Q&'K<^>9_249T<)"C)1K4X5'&<8X?"R:6)JQ7M,1BN3!8?[7MOI_"_P=X*
M\._#W&>-'CUEZQ6!QN$5+@S@;$2G1Q6:U<73<\)B*V'C4HU*F-S"G%RR_#5&
MJ& R[V^;XZ+2HO";?[ VB?!GXC6_[9_Q8\?? _X?ZUI'@WPYH/B;P[X&ETF#
M4=)\,Z/-IGQ,U34=$\-R:VFH-87=U;>'-,M4UW;_ &E#/;_:H);?S98VY?%C
M$\29-/PUR#*>)\VPN(S+&8K!8S-(UY4<1C<1&ODF'HXG&1PKHJK3ISQE>;PM
M_82C/V<HSY8M>C]&7+O#_BJA](+C?B?PZX8S'!</91EV<95PY/!PQ6!RC 5,
M'QACL7EV42S%8N6%K5J64X.A#,K/&4ITO;4JE+GG!P?#CQ!_P3Q_:C\0V?PI
MO_@1K7[/WC;Q81H_@OQ;X>\4WM[IXUZY<)IU@VV>'2CJ&H3%+>RCUKPO>65U
M*_V(7UG=36CO6<X3Q?X%PE3/J7%6&XMRS+_]HS++\7@*5*K]4@KUJOP2KJE2
MBG*H\-C:=6G%>T]G4IQJ)9<)YG]%GQDS7#\%8KPUS'PMXBSQK </Y[E6>8G%
MX19G5FHX3"M>TIX+ZSBZCC2H1Q^2UZ%:<OJZQ.'K3H3?YT?M ?!;Q#^S[\6?
M%WPK\1RK>7'AV]4Z;JT<7D0:[H%]$MYH>M0PB6<0?;]/EA>YM!/.;"]%UI[S
M2R6KN?V/A+B7!\7</Y?GN#BZ<,92:K8=OFEA<72DZ6*PTI<L>;V5:,E"IR1]
MK2]G548QFD?RIXG>'^:>%_&^><%YM.->ME.(7U7&PA[.EF66XF$<1EV84Z?/
M4]E]:PE2G.K0]I4>%K^VPLJDYT92?C5?2'P(4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M1?U?ZOD=1-6G5C&K/UG.GRKY045;H[G['?\ !"[X"_"'X6?\$LOV7?\ A!_
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M4SZO_:E%3GE%*/\ 9]#$2QCHOZ\VZ-.'+5K2:4_RNM3 +FW-R";83PF<#.3
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M ,IT?^"2'_9$?V[/_5:Z=7UV6_\ )(\2?]A65?\ J1$\O$?\C3+_ /KWB?\
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M24H*+DY).I.7O)QBD[26S>I^L?[0'@#5_BM\!OC;\+?#USIMEK_Q)^$7Q)\
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M8K?_ ()!?MJ0011P00?#SP=###"BQQ0Q1?%7X?)'%%&@5(XXT4(B( J* J@
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M$G)N-2/,X.WO3]4KXG"U*&.J4Y3E*\)T5I!)1Y79PAKS<UU;6+M==/@#P?\
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MD^2A@\RKUI=(4:>7XGG<GLE*ZII/XISA35W-)Y^(52E'AOZO)Q]OC\[X8P&
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M,1A?K.$K5;T:WU?%TJ&*HJI'WE3KT:56*:4Z<)7BOIG4OCO\+)_^"<_A_P"
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M3E[]14W6JN5:I4G+RVO=/C0H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@#]T/^"+?_-R?_='/_>IU_+?TE/^:+_[N/\ ]X)_
MI!^SZ_YNW_W87_OZ'[H5_+9_I % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?AK^UK_RG1_X)(?]D1_;L_\
M5:Z=7UV6_P#)(\2?]A65?^I$3R\1_P C3+_^O>)_]-L_<JOD3U H * "@ H
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M\ZO#GHSC.'-&ZO'FBKJZNM"*E.-6G.E*_+4A*$K:.TERNW9VVT^1\2_L&_\
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M#^. H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /W0_P""+?\
MS<G_ -T<_P#>IU_+?TE/^:+_ .[C_P#>"?Z0?L^O^;M_]V%_[^A^Z%?RV?Z0
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % 'X:_M:_P#*='_@DA_V1']NS_U6NG5]=EO_ "2/$G_85E7_ *D1
M/+Q'_(TR_P#Z]XG_ --L_<JOD3U H * "@ H * "@ H * "@ H * "@ H *
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M0;B?_P"=8?\ #+W[2_\ T;O\=/\ PTGC_P#^9^C_ %YX)_Z+#A;_ ,2#*?\
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M_P#F?H_UYX)_Z+#A;_Q(,I_^:P_X@WXO?]&J\2/_ !!N)_\ YUA_PR]^TO\
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M6_\ $@RG_P":P_X@WXO?]&J\2/\ Q!N)_P#YUA_PR]^TO_T;O\=/_#2>/_\
MYGZ/]>>"?^BPX6_\2#*?_FL/^(-^+W_1JO$C_P 0;B?_ .=8?\,O?M+_ /1N
M_P =/_#2>/\ _P"9^C_7G@G_ *+#A;_Q(,I_^:P_X@WXO?\ 1JO$C_Q!N)__
M )UA_P ,O?M+_P#1N_QT_P##2>/_ /YGZ/\ 7G@G_HL.%O\ Q(,I_P#FL/\
MB#?B]_T:KQ(_\0;B?_YUA_PR]^TO_P!&[_'3_P -)X__ /F?H_UYX)_Z+#A;
M_P 2#*?_ )K#_B#?B]_T:KQ(_P#$&XG_ /G6'_#+W[2__1N_QT_\-)X__P#F
M?H_UYX)_Z+#A;_Q(,I_^:P_X@WXO?]&J\2/_ !!N)_\ YUA_PR]^TO\ ]&[_
M !T_\-)X_P#_ )GZ/]>>"?\ HL.%O_$@RG_YK#_B#?B]_P!&J\2/_$&XG_\
MG6'_  R]^TO_ -&[_'3_ ,-)X_\ _F?H_P!>>"?^BPX6_P#$@RG_ .:P_P"(
M-^+W_1JO$C_Q!N)__G6'_#+W[2__ $;O\=/_  TGC_\ ^9^C_7G@G_HL.%O_
M !(,I_\ FL/^(-^+W_1JO$C_ ,0;B?\ ^=8?\,O?M+_]&[_'3_PTGC__ .9^
MC_7G@G_HL.%O_$@RG_YK#_B#?B]_T:KQ(_\ $&XG_P#G6'_#+W[2_P#T;O\
M'3_PTGC_ /\ F?H_UYX)_P"BPX6_\2#*?_FL/^(-^+W_ $:KQ(_\0;B?_P"=
M8?\ #+W[2_\ T;O\=/\ PTGC_P#^9^C_ %YX)_Z+#A;_ ,2#*?\ YK#_ (@W
MXO?]&J\2/_$&XG_^=8?\,O?M+_\ 1N_QT_\ #2>/_P#YGZ/]>>"?^BPX6_\
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MTGC_ /\ F?H_UYX)_P"BPX6_\2#*?_FL/^(-^+W_ $:KQ(_\0;B?_P"=8?\
M#+W[2_\ T;O\=/\ PTGC_P#^9^C_ %YX)_Z+#A;_ ,2#*?\ YK#_ (@WXO?]
M&J\2/_$&XG_^=8?\,O?M+_\ 1N_QT_\ #2>/_P#YGZ/]>>"?^BPX6_\ $@RG
M_P":P_X@WXO?]&J\2/\ Q!N)_P#YUA_PR]^TO_T;O\=/_#2>/_\ YGZ/]>>"
M?^BPX6_\2#*?_FL/^(-^+W_1JO$C_P 0;B?_ .=8?\,O?M+_ /1N_P =/_#2
M>/\ _P"9^C_7G@G_ *+#A;_Q(,I_^:P_X@WXO?\ 1JO$C_Q!N)__ )UA_P ,
MO?M+_P#1N_QT_P##2>/_ /YGZ/\ 7G@G_HL.%O\ Q(,I_P#FL/\ B#?B]_T:
MKQ(_\0;B?_YUA_PR]^TO_P!&[_'3_P -)X__ /F?H_UYX)_Z+#A;_P 2#*?_
M )K#_B#?B]_T:KQ(_P#$&XG_ /G6'_#+W[2__1N_QT_\-)X__P#F?H_UYX)_
MZ+#A;_Q(,I_^:P_X@WXO?]&J\2/_ !!N)_\ YUA_PR]^TO\ ]&[_ !T_\-)X
M_P#_ )GZ/]>>"?\ HL.%O_$@RG_YK#_B#?B]_P!&J\2/_$&XG_\ G6'_  R]
M^TO_ -&[_'3_ ,-)X_\ _F?H_P!>>"?^BPX6_P#$@RG_ .:P_P"(-^+W_1JO
M$C_Q!N)__G6'_#+W[2__ $;O\=/_  TGC_\ ^9^C_7G@G_HL.%O_ !(,I_\
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MX6_\2#*?_FL/^(-^+W_1JO$C_P 0;B?_ .=8?\,O?M+_ /1N_P =/_#2>/\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_P!,7AFOKN)_]TX7_P"R?PGZGEY=_$S'_L.JG[E5\B>H% !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'X:_M:_\IT?^"2'_
M &1']NS_ -5KIU?79;_R2/$G_85E7_J1$\O$?\C3+_\ KWB?_3;/W*KY$]0*
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M!R#_ **W"_\ ANQ'_P N#Z[C?^A74_\ !]/_ .0#_AY/_P %.O\ I!C\;O\
MQ+/X&?\ RBH_L'(/^BMPO_ANQ'_RX/KN-_Z%=3_P?3_^0#_AY/\ \%.O^D&/
MQN_\2S^!G_RBH_L'(/\ HK<+_P"&[$?_ "X/KN-_Z%=3_P 'T_\ Y /^'D__
M  4Z_P"D&/QN_P#$L_@9_P#**C^P<@_Z*W"_^&[$?_+@^NXW_H5U/_!]/_Y
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M[_Q+/X&?_**C^P<@_P"BMPO_ (;L1_\ +@^NXW_H5U/_  ?3_P#D _X>3_\
M!3K_ *08_&[_ ,2S^!G_ ,HJ/[!R#_HK<+_X;L1_\N#Z[C?^A74_\'T__D _
MX>3_ /!3K_I!C\;O_$L_@9_\HJ/[!R#_ **W"_\ ANQ'_P N#Z[C?^A74_\
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M_H5U/_!]/_Y /^'D_P#P4Z_Z08_&[_Q+/X&?_**C^P<@_P"BMPO_ (;L1_\
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MO_ANQ'_RX/KN-_Z%=3_P?3_^0#_AY/\ \%.O^D&/QN_\2S^!G_RBH_L'(/\
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M !+/X&?_ "BH_L'(/^BMPO\ X;L1_P#+@^NXW_H5U/\ P?3_ /D _P"'D_\
MP4Z_Z08_&[_Q+/X&?_**C^P<@_Z*W"_^&[$?_+@^NXW_ *%=3_P?3_\ D _X
M>3_\%.O^D&/QN_\ $L_@9_\ **C^P<@_Z*W"_P#ANQ'_ ,N#Z[C?^A74_P#!
M]/\ ^0#_ (>3_P#!3K_I!C\;O_$L_@9_\HJ/[!R#_HK<+_X;L1_\N#Z[C?\
MH5U/_!]/_P"0#_AY/_P4Z_Z08_&[_P 2S^!G_P HJ/[!R#_HK<+_ .&[$?\
MRX/KN-_Z%=3_ ,'T_P#Y /\ AY/_ ,%.O^D&/QN_\2S^!G_RBH_L'(/^BMPO
M_ANQ'_RX/KN-_P"A74_\'T__ ) /^'D__!3K_I!C\;O_ !+/X&?_ "BH_L'(
M/^BMPO\ X;L1_P#+@^NXW_H5U/\ P?3_ /D _P"'D_\ P4Z_Z08_&[_Q+/X&
M?_**C^P<@_Z*W"_^&[$?_+@^NXW_ *%=3_P?3_\ D _X>3_\%.O^D&/QN_\
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M%.O^D&/QN_\ $L_@9_\ **C^P<@_Z*W"_P#ANQ'_ ,N#Z[C?^A74_P#!]/\
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MD_\ P4Z_Z08_&[_Q+/X&?_**C^P<@_Z*W"_^&[$?_+@^NXW_ *%=3_P?3_\
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M^'D__!3K_I!C\;O_ !+/X&?_ "BH_L'(/^BMPO\ X;L1_P#+@^NXW_H5U/\
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M !+/X&?_ "BH_L'(/^BMPO\ X;L1_P#+@^NXW_H5U/\ P?3_ /D _P"'D_\
MP4Z_Z08_&[_Q+/X&?_**C^P<@_Z*W"_^&[$?_+@^NXW_ *%=3_P?3_\ D _X
M>3_\%.O^D&/QN_\ $L_@9_\ **C^P<@_Z*W"_P#ANQ'_ ,N#Z[C?^A74_P#!
M]/\ ^0#_ (>3_P#!3K_I!C\;O_$L_@9_\HJ/[!R#_HK<+_X;L1_\N#Z[C?\
MH5U/_!]/_P"0#_AY/_P4Z_Z08_&[_P 2S^!G_P HJ/[!R#_HK<+_ .&[$?\
MRX/KN-_Z%=3_ ,'T_P#Y /\ AY/_ ,%.O^D&/QN_\2S^!G_RBH_L'(/^BMPO
M_ANQ'_RX/KN-_P"A74_\'T__ ) /^'D__!3K_I!C\;O_ !+/X&?_ "BH_L'(
M/^BMPO\ X;L1_P#+@^NXW_H5U/\ P?3_ /D _P"'D_\ P4Z_Z08_&[_Q+/X&
M?_**C^P<@_Z*W"_^&[$?_+@^NXW_ *%=3_P?3_\ D _X>3_\%.O^D&/QN_\
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M!R#_ **W"_\ ANQ'_P N#Z[C?^A74_\ !]/_ .0#_AY/_P %.O\ I!C\;O\
MQ+/X&?\ RBH_L'(/^BMPO_ANQ'_RX/KN-_Z%=3_P?3_^0#_AY/\ \%.O^D&/
MQN_\2S^!G_RBH_L'(/\ HK<+_P"&[$?_ "X/KN-_Z%=3_P 'T_\ Y /^'D__
M  4Z_P"D&/QN_P#$L_@9_P#**C^P<@_Z*W"_^&[$?_+@^NXW_H5U/_!]/_Y
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M[_Q+/X&?_**C^P<@_P"BMPO_ (;L1_\ +@^NXW_H5U/_  ?3_P#D _X>3_\
M!3K_ *08_&[_ ,2S^!G_ ,HJ/[!R#_HK<+_X;L1_\N#Z[C?^A74_\'T__D _
MX>3_ /!3K_I!C\;O_$L_@9_\HJ/[!R#_ **W"_\ ANQ'_P N#Z[C?^A74_\
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M_H5U/_!]/_Y /^'D_P#P4Z_Z08_&[_Q+/X&?_**C^P<@_P"BMPO_ (;L1_\
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MO_ANQ'_RX/KN-_Z%=3_P?3_^0#_AY/\ \%.O^D&/QN_\2S^!G_RBH_L'(/\
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M@9_\HJ/[!R#_ **W"_\ ANQ'_P N#Z[C?^A74_\ !]/_ .0#_AY/_P %.O\
MI!C\;O\ Q+/X&?\ RBH_L'(/^BMPO_ANQ'_RX/KN-_Z%=3_P?3_^0#_AY/\
M\%.O^D&/QN_\2S^!G_RBH_L'(/\ HK<+_P"&[$?_ "X/KN-_Z%=3_P 'T_\
MY /^'D__  4Z_P"D&/QN_P#$L_@9_P#**C^P<@_Z*W"_^&[$?_+@^NXW_H5U
M/_!]/_Y /^'D_P#P4Z_Z08_&[_Q+/X&?_**C^P<@_P"BMPO_ (;L1_\ +@^N
MXW_H5U/_  ?3_P#D _X>3_\ !3K_ *08_&[_ ,2S^!G_ ,HJ/[!R#_HK<+_X
M;L1_\N#Z[C?^A74_\'T__D _X>3_ /!3K_I!C\;O_$L_@9_\HJ/[!R#_ **W
M"_\ ANQ'_P N#Z[C?^A74_\ !]/_ .0#_AY/_P %.O\ I!C\;O\ Q+/X&?\
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M^'D__!3K_I!C\;O_ !+/X&?_ "BH_L'(/^BMPO\ X;L1_P#+@^NXW_H5U/\
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M !+/X&?_ "BH_L'(/^BMPO\ X;L1_P#+@^NXW_H5U/\ P?3_ /D _P"'D_\
MP4Z_Z08_&[_Q+/X&?_**C^P<@_Z*W"_^&[$?_+@^NXW_ *%=3_P?3_\ D _X
M>3_\%.O^D&/QN_\ $L_@9_\ **C^P<@_Z*W"_P#ANQ'_ ,N#Z[C?^A74_P#!
M]/\ ^0#_ (>3_P#!3K_I!C\;O_$L_@9_\HJ/[!R#_HK<+_X;L1_\N#Z[C?\
MH5U/_!]/_P"0#_AY/_P4Z_Z08_&[_P 2S^!G_P HJ/[!R#_HK<+_ .&[$?\
MRX/KN-_Z%=3_ ,'T_P#Y /\ AY/_ ,%.O^D&/QN_\2S^!G_RBH_L'(/^BMPO
M_ANQ'_RX/KN-_P"A74_\'T__ ) /^'D__!3K_I!C\;O_ !+/X&?_ "BH_L'(
M/^BMPO\ X;L1_P#+@^NXW_H5U/\ P?3_ /D _P"'D_\ P4Z_Z08_&[_Q+/X&
M?_**C^P<@_Z*W"_^&[$?_+@^NXW_ *%=3_P?3_\ D _X>3_\%.O^D&/QN_\
M$L_@9_\ **C^P<@_Z*W"_P#ANQ'_ ,N#Z[C?^A74_P#!]/\ ^0#_ (>3_P#!
M3K_I!C\;O_$L_@9_\HJ/[!R#_HK<+_X;L1_\N#Z[C?\ H5U/_!]/_P"0#_AY
M/_P4Z_Z08_&[_P 2S^!G_P HJ/[!R#_HK<+_ .&[$?\ RX/KN-_Z%=3_ ,'T
M_P#Y /\ AY/_ ,%.O^D&/QN_\2S^!G_RBH_L'(/^BMPO_ANQ'_RX/KN-_P"A
M74_\'T__ ) /^'D__!3K_I!C\;O_ !+/X&?_ "BH_L'(/^BMPO\ X;L1_P#+
M@^NXW_H5U/\ P?3_ /D _P"'D_\ P4Z_Z08_&[_Q+/X&?_**C^P<@_Z*W"_^
M&[$?_+@^NXW_ *%=3_P?3_\ D _X>3_\%.O^D&/QN_\ $L_@9_\ **C^P<@_
MZ*W"_P#ANQ'_ ,N#Z[C?^A74_P#!]/\ ^0#_ (>3_P#!3K_I!C\;O_$L_@9_
M\HJ/[!R#_HK<+_X;L1_\N#Z[C?\ H5U/_!]/_P"0#_AY/_P4Z_Z08_&[_P 2
MS^!G_P HJ/[!R#_HK<+_ .&[$?\ RX/KN-_Z%=3_ ,'T_P#Y /\ AY/_ ,%.
MO^D&/QN_\2S^!G_RBH_L'(/^BMPO_ANQ'_RX/KN-_P"A74_\'T__ ) /^'D_
M_!3K_I!C\;O_ !+/X&?_ "BH_L'(/^BMPO\ X;L1_P#+@^NXW_H5U/\ P?3_
M /D _P"'D_\ P4Z_Z08_&[_Q+/X&?_**C^P<@_Z*W"_^&[$?_+@^NXW_ *%=
M3_P?3_\ D _X>3_\%.O^D&/QN_\ $L_@9_\ **C^P<@_Z*W"_P#ANQ'_ ,N#
MZ[C?^A74_P#!]/\ ^0#_ (>3_P#!3K_I!C\;O_$L_@9_\HJ/[!R#_HK<+_X;
ML1_\N#Z[C?\ H5U/_!]/_P"0/HW]E?\ ;/\ VTOC3\6['P%\>/\ @F#\5/V5
M? E]HFMWW_"V_$7QS^&7Q)T6SUG3;9;K3M"OM \)Z=9:K -;1+F"VU3S'MK>
M\CM[::,F\1TX<PRK*L+AI5L'G^'S"M&4%]6AA*U"3C)V<HSG.4?<T;C;57=]
M#:AB<34J*%7 SH0L_P!XZL9I-;*RBM^Y^GM?/G<% !0 4 % '__1_OXH * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'X:_M:_\IT?^"2'_ &1'
M]NS_ -5KIU?79;_R2/$G_85E7_J1$\O$?\C3+_\ KWB?_3;/W*KY$]0* "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * /__2_OXH * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * /PC_ &_/^4W'_!OU_P!Y6?\ UDGP;0!^[E !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M6\3/^B:_\S&0?_/4/^)N/H]?]'!_\U3C?_Z&@_X>4_L4_P#1:/\ S'/Q9_\
MF$H_X@MXF?\ 1-?^9C(/_GJ'_$W'T>O^C@_^:IQO_P#0T'_#RG]BG_HM'_F.
M?BS_ /,)1_Q!;Q,_Z)K_ ,S&0?\ SU#_ (FX^CU_T<'_ ,U3C?\ ^AH/^'E/
M[%/_ $6C_P QS\6?_F$H_P"(+>)G_1-?^9C(/_GJ'_$W'T>O^C@_^:IQO_\
M0T'_  \I_8I_Z+1_YCGXL_\ S"4?\06\3/\ HFO_ #,9!_\ /4/^)N/H]?\
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M8Y^+/_S"4?\ $%O$S_HFO_,QD'_SU#_B;CZ/7_1P?_-4XW_^AH/^'E/[%/\
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M#_YJG&__ -#0?\/*?V*?^BT?^8Y^+/\ \PE'_$%O$S_HFO\ S,9!_P#/4/\
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MO_,QD'_SU#_B;CZ/7_1P?_-4XW_^AH]T^"W[2GP4_:&_X27_ (4]XT_X2_\
MX1#^QO\ A(O^*<\6>'_[._M_^U?[(_Y&C0=$^U_:_P"Q-3_X\?M/D?9O])\G
MSK?S?EN)>"N)N#_J7^L66_V=_:'UCZG_ +9E^+]M]4]A]8_W'%8GV?L_K-#^
M+R<W/[G-RSY?TCP^\7/#SQ3_ +7_ -0^(/[=_L+ZA_:O_"3G>5_5?[3^N_4?
M^1SEN7>W]O\ V=C/]V]M[+V/[[V?M*7/[I7RQ^D!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'X:_M:_\IT?
M^"2'_9$?V[/_ %6NG5]=EO\ R2/$G_85E7_J1$\O$?\ (TR__KWB?_3;/W*K
MY$]0* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * /_3_OXH * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@#]T/^"+?_-R?_='/_>IU_+?TE/\ FB_^
M[C_]X)_I!^SZ_P";M_\ =A?^_H?NA7\MG^D 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^&O[6O_*='_@DA
M_P!D1_;L_P#5:Z=7UV6_\DCQ)_V%95_ZD1/+Q'_(TR__ *]XG_TVS]RJ^1/4
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@#__U/[^* "@ H * "@ H * /B7]
MG'_@H)^S=^U5\<OVE_V=OA#K?B;4?B9^R7XNO/!'QBL=9\*:EH>EZ=KUAXI\
M3^#;J+0]6N_]&UVWCUWPAK, N;3"/!';W";HIU(]7&Y-C<OPF!QN(C35#,:<
M:N&<*BE)PE3A57/%:P?)4CH^NG0YJ.+HUZE:C3;YZ$G&HG%I)J3CH^NL6?5O
MCWQKH/PU\"^-/B-XJFGMO"_@#PGXC\:^)+BUMI;VYM]!\*Z/>:[K$UM9P S7
M<\6GV%P\-M"#+/(JQ1@LP%>=1I3KUJ5"FDZE:I3I4TW9<]22A%-[)7:UZ&\Y
M*G"4Y?#"+D[=HJ[T]$?/W[&?[9_P,_;S^"UO\?/V>-5U_6/AW<^)M>\(QW?B
M3P[?>%]3&M>&VM5U.%M+U#]^(4^V6YAN 3',&.TY1@.W-,KQ>3XKZGC(PC6]
MG"I:G-3CR3OR^\M+^Z].AEA\12Q5/VM%MPYG'5<KNK7T^:/JZO.-PH * "@
MH * "@"":YM[<Q">>& S.(H1-+'$99#PL<0=EWN>,(N6/84)/HMNW0">@ H
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MN/\ ]X)_I!^SZ_YNW_W87_OZ'[H5_+9_I % !0 4 % !0 4 % !0 4 % !0
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M-MOB%\0/BU\0;;P[H/C;XD:;8)+\0O#?P/\ !M]\0? ^MZYH/A_51<Z-I?B
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M>$/C?\2O#FJ>#O@AH%MX*^'$%GX?\'> O%^K^-]3LE2WMK?5KP>)+IM=U*3
MEM],MYYY-RN1MQ9E<\NS:CA%B\9F$ZN$H3C4Q<W6KN4ZM:G&E%[\JY%R1[R:
M,\LQ"KX651TZ5!1J33C2CR0LHPDY-='KJ_(^&?#7_!:#_@IC^W9XU^*.I_\
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M>R_+\=@L;F.*Q^9_6<)B''V%"I*7)2]]OF:J/DI-*T%"G[KOK\,#^8S]J?\
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M@_XU.GZAJOA"]M7NY];\3R:2MQJ,.A2>(C<:8(;29K75+:;29Y+FSM7E1I?
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M%<W-_$25/F3@O9T[P]WFW9^A=?EY[P4 % !0 4 % !0 4 % !0 4 % !0 4
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MJ<93G)123G)ZOXGCO(\)PQQQQEPUE\\15P'#W%?$61X*IBYTZF*J83*<WQF
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MXM:--/5-/1KH-IB"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MAJT*,HISC*/+=O6W1';C<:\/A*>)HQC/VCI\JG=+EG%R3LFG>R6E]#X0U_\
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MZEH^MZ-\._$6HZ5JFG7<-BLMK?:??6T%W:7$3+)!/#'(A#*#7RN7<0YY4S#
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M">(Q<986$U:7+/$U*\7%=IT8U*D7I>$T]FK\\'[3/:CIZJG2:J-;>[3C!_\
M@,W&+71Q\COO^"-P'_#ZK_@NB<#(^*-J <<@'XH?$#(![ [5R.^!Z"LN)O\
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M\3:4SI)JFEV6J1Z)=ZEJ,UE<7]X[Z)^GZ(2IKGY'M8_J6_99\<^(_B=^S3\
M?B-XPNXM0\5^._@[\.?%WB6^AM;>QAO-=\0^$]*U35+F*SM(XK6UCGO;J:1+
M>WBC@A5A'$BHJJ&9/=G\X_Q]_P""C'_!23]N_P#;W^,O["W_  24\0?#+X5>
M#/V9[R[\/?&C]I+XB>';'6;:#QII%YJ>D:[IL3:KH/CVVAT&/Q'H6K^&/#D^
ME^![NZUO5-,U*[EO[?1Y-+O'7IT_JUM#11C&*E+6^R7;Y?=T_ [C]A;_ (*3
M?M^? S]O_1?^"8?_  58TWP3XK\<_%/2-1U;X!?M%^ ;#3_#NC^+[C3-*U'5
MHK*ZTRPT/PU8ZQH'B+^QM?T/2M=B\/\ AO5--\7:.FA7&CZK9ZF-4TL5]G\K
M=@<(N/-"]E:Z_K^OT^+_ /ANC_@M3^U=_P %2/VROV)_V/OVD_@K\/='^!GC
M?XRWGAFV^*?PW\(?V;:^!/ ?Q+C\&Z=I":UI_P -?%NLZAJL,.JZ5''/J,!:
MYBM[FXO+YKHYG->EON'RP4(MI[=-/+^NW0^S?^"9W_!4[]N+_AXG\1_^"4__
M  4DT'X=:[\:/#OA[5]:\"_%SX6Z1_8UMK%[H7A:Q\>-::W:6@L="U/PUXG\
M 7,WB/PWX@T_P_X7U/3+ZQ.B:WI%[/JZ/H!?6SMY6_K^D*4(\JE"]NW;^M#\
MZ/V&/VT_^"_G_!23QG\=-,_9W_:P_9W\&Z9\(/%FJ:5=V_Q0^&'A+3WDLQJ\
MMK8QZ?)H/PE\5/<F&$PI(]X\$AVY+.<FC7R^[_@C:IQM=/;OY']/W_!.WX??
M\%*_A]X0^)%I_P %*/CI\#OCGXSU'Q+I%S\,=4^"&B+HFFZ#X7BTN6/6=/UZ
M)/A)\)A-?W.K&&XM7^P:SMMT<?;H,B O^NQG+ETY4UZGV5\1?$'BVS71?#/P
M^30O^$R\47_V:WU#Q*MU<:-X9T*VBDGUSQ7=Z5836E[K\FDPK##IWA^WO])7
M6-8OM.LKS6M%L);K5+3U\JPV!FZ^+S3ZR\!@Z?-*E@W"&(Q>)DU'#8*%:I"I
M3PJK2O*KB94JSH4*=6I3P^(J1A1GR8B=5<E+#\GMJDK<U2[A2IKXZKA%ISY5
MI&FG%2FXJ4X1O)<9K'@[XL>$M)NO$7AWXQ^+?'.K:1#+J,GA?Q[X?^&0T'Q#
M;VL9GNM(MI? _@7P-JVC:A?11-::1JC:M?6FEW<L-YJ.F:S!%/:77HT,?DF.
MKQPN*R# Y90KN-*.,RS$YO\ 6,)*3Y85YK,<RS&CB*5-OGKT51ISK0BZ=*MA
MY.,X8RHXJE!U*>,JUY07,Z5>GAE3J**NX)T*%&=-NUHRYFHNSE&:5GC^)_BC
MK?B?7?A'X \$:M!X2NOBEI/B;Q!JWC:*WT[79?#^F>#+33_[<\,^%(]4MY]#
MN_'MUJ>KVR:=/K6DZOI%EHNB^*=5N=!U*2P@M#O@LFPV#PV>9GF-"6.ADU;"
M86AESE5PT<56S"=7ZMB\:Z,HXF&6PHT)RJPPU>A7J5Z^"HPQ-*-24R*F)G5G
MA,/0FJ,L3&I4E6Y8S=.-%1YZ5)37)[=RDN5SC."A"K+V<N5(O:_HGQ2^&MO_
M ,)?HWQ%\>?%FRL9[=O$/@;Q/X>^']U>ZAI )2XE\'2> ?!'@>^M/$*L\;B/
M49=6TF:WCD L+>9?.?/"XC)LWE]0KY3E>1U:D9+"9C@\5FE.G2K6O&./69YC
MF5*>%M%J].-"NI-?OI1?*G4AB<,O;1Q-?%1BU[2A4IX=N4>OL?J]"@XU/)\T
M+?93U.G^-'B/Q3I?@BVTKP)?V^A_$'X@ZYH?@/P;JMY:6>H?\([J?B.1WU;Q
M2FE7X-EK%UX&\)V?B3QI!HUY'+9ZK-X<%A>1-9SSXXN'\)@JV83K9E3EB,KR
MO#8C,L?1ISG2^M4<*DJ&#]M2_>4(9CC:F$R^5>#C.A'%>U@U.,37&5*D**C0
MDJ=?$3A0HRDE+V<JGQ5.1^[)T:2J5E!Z2=/E>C-7X/>.6^(?P[\.^(KP"#Q
MD5[H'C+3_+,#Z1X[\):G>^%/'6CM"54JNE^+]%UJP@E51#=06\=U:E[::)VP
MSW+5E6:8K"T_>PK=/$X"K?F5?+<;1IXW+JZDM&ZN!Q&'J26\)2<)6E%HO!U_
MK&'IU'I45Z=:.W)7I2=*M"W]VK":71I)K2QZ;7D'2% !0 4 % !0!_!?<_\
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MCYP%B?[+X8J9SB,'FM7#XS XNE-U\SC2A@\WR"NZOM\/3Q&.H1I5:^&<L/\
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M5*IBU*BL1S0IXF=.-632D_VWA_!>'.7^/&-\8_\ B9;@?&XC.L=CZ&(X;=#
M8:G6R?'819;EV22S:7%<XJ.64:.6.EBY8&-.I7RZE6GAZ<)2IQ_+G_@H+\&A
M\&/VG?'-C8VOV;PUXXD3XC>& D8C@6S\3S7$NK6<"(/*BATSQ-!KEA;6Z']U
M8063%(UD11^Y>$?$?^LG ^5U:M3GQN5Q>38Z[O+VF!C".'J2;UE*M@986K.3
MWJRJ*[<6S^-OI0< ?\0_\8>),+AJ/L<HXBG'BO)DHJ--8;.:E6IC:%*,?<IT
M\'G%+,L)1I+X,-1P[Y8J<4?$]?II_/84 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0!^Z'_!%O_FY/_NCG_O4Z_EOZ2G_ #1?
M_=Q_^\$_T@_9]?\ -V_^["_]_0_="OY;/]( H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#\-?VM?^4Z/_!)#
M_LB/[=G_ *K73J^NRW_DD>)/^PK*O_4B)Y>(_P"1IE__ %[Q/_IMG[E5\B>H
M% !0 4 % !0 4 % '\8VK^-M'_X)A_\ !S;\1/B5\<M33P%\ ?V[?AC/I?AW
MXF:VJV'@ZRG\;Z=\/KR>;7=7F?[!IL&E?&KX7MX>UC4)ID7P_IGB+2/$.NG2
M] OYKQ/T^-*6?<"4*&$C[;&9363E0AK4?L76248[R<L+7YXQ7Q2BX0YI)(^=
M<E@LYE.I[M+$QLINRBN=1=WT256%FWLO>>A_8YJGBCPSHGAR\\8ZUXBT+2/"
M.G:3)K^H>*=4U?3]/\.6&A0VWVV76KS6[JXBTRUTF*S'VN349KE+-+8>>TPB
M^:OS.-.I.:I0ISE4<N2-.,6YN=[<B@ES.5].5*]]+'T+<5'F;2BE=R;2BEWO
MLE;KL?@K^Q7_ ,%1_BC_ ,%2?&O_  4B^%_P>^%OAO3O@)\$_"7COP+\#OCI
MHVJ>(!J_Q,\5>)CXL\/?#J]:SUF"PTZQCU[1]#N_%_D1?9K[1K6\T*+4X[9K
MT$_89GD&&X?I9'B,37J/&8FK1JXO"2C3Y*%.G[.==)PNWR2E&E>[4K2:V/*P
MV-J8UXR%.G%4J<9QI5$W>;?,H:/172YO[NB9\W?\&F7C'P1/^P-\8OA=87-G
M9?%#P#^T_P"+]8^(_A69_)\16-KXL\$^ K#PKK^I:;(D=S:V.I+X1UOP[9/*
MI#:AX/UF [)+9T'9XB4JJS?"UVG["K@*<*,_L-TZM9U()]X^UA)^52)ED4H_
M5JL-.>-=N4>J3A!1;79\K2_PL\X^,6MZ%\5?^#L;]E:/X.W5MJE]\#OV:-?T
M7X_:EHKK>VNAZU!\,OVBKF[L]?>W_=1W:Z%\2?AEX7G#22FQU75-,LKA8+RT
MEABWPT)X?P\Q_P!:3C'%8V$L'&6CE%U\&HN">MN>A7J+O"+DKIW<5'&IGM#V
M>]*DU5:Z-0JZ/_MV<(_AN=M\/P#_ ,'8GQPR!Q^QAI)''0_\*Z^#XR/0X)''
M8D=*BK_R;O"_]C&7_J5B"H?\CVK_ -@Z_P#3=(C_ .#CN*(_M,?\$2Y3&AE3
M]LN\B20J-ZQ3>/\ ]F]I8U;&0DC00EU'#&)"1\HPN!_]QXH7_4MA^%''"SC^
M-EO_ %_E_P"E4#]!O^#A^*.7_@CC^V:LB+(HTGX,2!74,!)#^T;\'Y8G /1H
MY421#U5U5AR!7B<&:<2Y7_BQ*_\ ++$([,V_Y%^(]*?_ *=IGXG_ /!5\EO^
M#8G_ ()VDDD_\(]^Q O)SPOP(\2*H^BJ JCH  !P*^KX=_Y+O._\6:?^IE(\
MW'_\B;!^F&_],R/ZL_@/\8_@[/\ L<?"KXV:?X[\'R?!+3?@%X6\6W'CRUU"
MS/@_3_!_AWP5:R:U?7%U'^XL[70H=-OK75;*6.*YTJYL+O3+RUM[RUFMH_S[
M&87$_P!JXG"^QJ?6I8VI3C1Y7[252=5\B2Z\]XN+VDFI)V:9[E*I2^K0JJ4?
M9*E%\WV5%1U^ZUFNEK6OH?R6?\$.M"U?4/\ @C7_ ,%GO%>C:5>6?@/QQ:_M
M1V?P\TWR=BO/8?LPZE+?6]C"-ID\JRU_PQIK-%$(C<6C6R.TMO-'#^B\53@N
M)N%Z4FO;4IX!UGY2Q\%&_P X5'\_0\'+$_[.S&25HM5E%>E!W2^3BC[Q_P""
M/%GK7C[_ (-M/%_@GX;WID^(%S\%/V\?!.B+9*\UWIWCK7]9^,ESX:M_)CPY
MO"?$.@WT$2?,R7EN5R6 KQ^)'&CQQ2JUE:DL5E%65]G2A'#*;]/W<T_1G5@+
MRR>48?%[+%127\S=1I:>J/SJ_P""&7['7[3_ .U/^PMH&N_LZ_\ !7SXO?LT
M:5X)\=^._"_B[]GOP'\,/#GB6Q^'>OW/B"\U^UOI;^X^(6@ZE<Q^-M&U2Q\3
MPWMWI$$+75WJ.E6D]R-&F,?M\5YG@,OS64,;PWAL?*K1I3IXRM7E!UH**@XV
M]A.*]E*+A92>G+)I<R.3+,/6KX9.CF$Z*C*2E1C!/D=[I_''XEKMW70_1K_@
MDE^SM\'_ ()?\%4/VX4@_;^^)'[9G[56E_"Q/"G[1UMXE^ MWX$T'3]77Q5\
M-YK36;OXF6OC'Q/X=U_Q3HATI/"<OARTBM[N&;_A(A-)Y_A^_B'B<1XW$XKA
M_*KY/0RS+Y8A5,%R8M59N'LJZY%AW1IRA3DI>T4[M6Y-+3B=> HTZ>.Q/^U3
MQ%=4W&K>ERJ_-#7GYI)N-N7ETZ_RG.?\&^%Q#9?MS?\ !>;P[=NMMKEK^VC'
M=SZ9-^[NTMD^+O[5EG),(FP7CAN4\F9DW"%Y(!)M\^'??&>N4\(R6L7EC2DM
MO]VRYK7TV_X LITQ.9QZ_6-NNE2NMO(^#KKX#_''XH?\'&_[?GPB\)_MV>,O
MV(_BOX_\#:'XH\!>./!_A+3?$VI_%GP:G@?X.>)-,^%^F6^K>*?#"32:#X,A
M@UB2.QN+V:2/X=:VYMHH]*N3%ZZQF$P_!63XFIE%/-</1J2IU:-2;A'#U/:X
MFG+$2Y:=2W-5O%72_CQU]XY?959YOBJ<<5+#U)1O&<8IN<>6G)4TKQVA9Z?R
M,]Q_; _8$'P>_:?_ .">+?MW?\%EOCU\9?B9=?M&>&-3_97\ W_[,)\4:M?>
M.-,^('PPDO;:TG\,?$S49_"EEK^NCP/I$VOZA8W%JDXBE@M[IM/N(AR9;G"Q
M6 SG^R>&,'A:"P52./JK'JG%4G1KVNIX>/M'"'M9*":TT;7,C3$87V=?"?6<
MPJU)^U3H1]AS/F4H=JCY;OE5VGMMH>B_';5=&^&7_!U[^S-XB^*]S:Z1H/Q"
M_9K@T3X3:SK;Q0:;'KVO_#KXO>!='L;*ZFW1)?ZWXPLO$7A?3H-T,\^L^(;.
MUC4M?0>?CA(NOX>8Z&'3E.CC7+$1BKOEAB,-6DVETA1<*DGJE&#[:75M#/:,
MJEE&5+]VW:UW3J07S<[Q7FUY'TM_P=.>// 6@?\ !,+4O _B'Q)H.G^-O'_Q
MA^&?_"O?#-[=6_\ ;_B*7PKK2ZMXHO-"TX[KR6VT'0Y&;6=3CC2SL$U&RL;J
MYCN-8T^VO.#P_HUIYZJL*<W2HX6O[:HE[D/:1Y::D]KSDO=CN^5M*T6UOG<H
M+!<K:4I5(<D>KY=79>2W>RNEU2/VT_8P_P"3//V4/^S:O@5_ZJ[PM7RV:_\
M(SS'_L/QG_J14/1PO^[8?_KQ1_\ 3<3Z5K@-PH * "@ H * "@ H * "@ H
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MYQPLK6<_V!B<37_LQXS^S_K:Q.7XO .'UQ87&_5W%8MU%+ZI6NX*/)9W6/\
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M!XWX9XR67K-?]7,UP^9?V<\5]2^N*A>]#ZW]7Q?U=S4FE5^K5^1V?LI+0O\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 ?NA_P $6_\ FY/_ +HY_P"]3K^6_I*?\T7_ -W'_P"\$_T@_9]?
M\W;_ .["_P#?T/W0K^6S_2 * "@ H * "@ H * "@ H * "@ H * "@ H *
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M.+2::LTU=-/1IK9IK2QB>#/ /@7X<Z0/#_P]\%^$O F@K*9UT3P9X<T?POI
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@#]T/^"+?_-R?_='/_>IU_+?TE/^:+_[N/\ ]X)_
MI!^SZ_YNW_W87_OZ'[H5_+9_I % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?AK^UK_RG1_X)(?]D1_;L_\
M5:Z=7UV6_P#)(\2?]A65?^I$3R\1_P C3+_^O>)_]-L_<JOD3U H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_P!#Q\"__"F\?_\ SLJ^C_XF)X)_Z%?%/_A%E/\ \^S\*_XD.\7O^BC\-_\
MP[\3_P#T'A_PY[_:7_Z'CX%_^%-X_P#_ )V5'_$Q/!/_ $*^*?\ PBRG_P"?
M8?\ $AWB]_T4?AO_ .'?B?\ ^@\/^'/?[2__ $/'P+_\*;Q__P#.RH_XF)X)
M_P"A7Q3_ .$64_\ S[#_ (D.\7O^BC\-_P#P[\3_ /T'A_PY[_:7_P"AX^!?
M_A3>/_\ YV5'_$Q/!/\ T*^*?_"+*?\ Y]A_Q(=XO?\ 11^&_P#X=^)__H/#
M_ASW^TO_ -#Q\"__  IO'_\ \[*C_B8G@G_H5\4_^$64_P#S[#_B0[Q>_P"B
MC\-__#OQ/_\ 0>'_  Y[_:7_ .AX^!?_ (4WC_\ ^=E1_P 3$\$_]"OBG_PB
MRG_Y]A_Q(=XO?]%'X;_^'?B?_P"@\/\ ASW^TO\ ]#Q\"_\ PIO'_P#\[*C_
M (F)X)_Z%?%/_A%E/_S[#_B0[Q>_Z*/PW_\ #OQ/_P#0>'_#GO\ :7_Z'CX%
M_P#A3>/_ /YV5'_$Q/!/_0KXI_\ "+*?_GV'_$AWB]_T4?AO_P"'?B?_ .@\
M/^'/?[2__0\? O\ \*;Q_P#_ #LJ/^)B>"?^A7Q3_P"$64__ #[#_B0[Q>_Z
M*/PW_P##OQ/_ /0>'_#GO]I?_H>/@7_X4WC_ /\ G94?\3$\$_\ 0KXI_P#"
M+*?_ )]A_P 2'>+W_11^&_\ X=^)_P#Z#P_X<]_M+_\ 0\? O_PIO'__ ,[*
MC_B8G@G_ *%?%/\ X193_P#/L/\ B0[Q>_Z*/PW_ /#OQ/\ _0>'_#GO]I?_
M *'CX%_^%-X__P#G94?\3$\$_P#0KXI_\(LI_P#GV'_$AWB]_P!%'X;_ /AW
MXG_^@\/^'/?[2_\ T/'P+_\ "F\?_P#SLJ/^)B>"?^A7Q3_X193_ //L/^)#
MO%[_ **/PW_\._$__P!!X?\ #GO]I?\ Z'CX%_\ A3>/_P#YV5'_ !,3P3_T
M*^*?_"+*?_GV'_$AWB]_T4?AO_X=^)__ *#P_P"'/?[2_P#T/'P+_P#"F\?_
M /SLJ/\ B8G@G_H5\4_^$64__/L/^)#O%[_HH_#?_P ._$__ -!X?\.>_P!I
M?_H>/@7_ .%-X_\ _G94?\3$\$_]"OBG_P (LI_^?8?\2'>+W_11^&__ (=^
M)_\ Z#P_X<]_M+_]#Q\"_P#PIO'_ /\ .RH_XF)X)_Z%?%/_ (193_\ /L/^
M)#O%[_HH_#?_ ,._$_\ ]!X?\.>_VE_^AX^!?_A3>/\ _P"=E1_Q,3P3_P!"
MOBG_ ,(LI_\ GV'_ !(=XO?]%'X;_P#AWXG_ /H/#_ASW^TO_P!#Q\"__"F\
M?_\ SLJ/^)B>"?\ H5\4_P#A%E/_ ,^P_P")#O%[_HH_#?\ \._$_P#]!X?\
M.>_VE_\ H>/@7_X4WC__ .=E1_Q,3P3_ -"OBG_PBRG_ .?8?\2'>+W_ $4?
MAO\ ^'?B?_Z#P_X<]_M+_P#0\? O_P *;Q__ /.RH_XF)X)_Z%?%/_A%E/\
M\^P_XD.\7O\ HH_#?_P[\3__ $'A_P .>_VE_P#H>/@7_P"%-X__ /G94?\
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M^$64_P#S[#_B0[Q>_P"BC\-__#OQ/_\ 0>'_  Y[_:7_ .AX^!?_ (4WC_\
M^=E1_P 3$\$_]"OBG_PBRG_Y]A_Q(=XO?]%'X;_^'?B?_P"@\/\ ASW^TO\
M]#Q\"_\ PIO'_P#\[*C_ (F)X)_Z%?%/_A%E/_S[#_B0[Q>_Z*/PW_\ #OQ/
M_P#0>'_#GO\ :7_Z'CX%_P#A3>/_ /YV5'_$Q/!/_0KXI_\ "+*?_GV'_$AW
MB]_T4?AO_P"'?B?_ .@\/^'/?[2__0\? O\ \*;Q_P#_ #LJ/^)B>"?^A7Q3
M_P"$64__ #[#_B0[Q>_Z*/PW_P##OQ/_ /0>'_#GO]I?_H>/@7_X4WC_ /\
MG94?\3$\$_\ 0KXI_P#"+*?_ )]A_P 2'>+W_11^&_\ X=^)_P#Z#P_X<]_M
M+_\ 0\? O_PIO'__ ,[*C_B8G@G_ *%?%/\ X193_P#/L/\ B0[Q>_Z*/PW_
M /#OQ/\ _0>'_#GO]I?_ *'CX%_^%-X__P#G94?\3$\$_P#0KXI_\(LI_P#G
MV'_$AWB]_P!%'X;_ /AWXG_^@\/^'/?[2_\ T/'P+_\ "F\?_P#SLJ/^)B>"
M?^A7Q3_X193_ //L/^)#O%[_ **/PW_\._$__P!!X?\ #GO]I?\ Z'CX%_\
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M>/@7_P"%-X__ /G94?\ $Q/!/_0KXI_\(LI_^?8?\2'>+W_11^&__AWXG_\
MH/#_ (<]_M+_ /0\? O_ ,*;Q_\ _.RH_P")B>"?^A7Q3_X193_\^P_XD.\7
MO^BC\-__  [\3_\ T'A_PY[_ &E_^AX^!?\ X4WC_P#^=E1_Q,3P3_T*^*?_
M  BRG_Y]A_Q(=XO?]%'X;_\ AWXG_P#H/#_ASW^TO_T/'P+_ /"F\?\ _P [
M*C_B8G@G_H5\4_\ A%E/_P ^P_XD.\7O^BC\-_\ P[\3_P#T'A_PY[_:7_Z'
MCX%_^%-X_P#_ )V5'_$Q/!/_ $*^*?\ PBRG_P"?8?\ $AWB]_T4?AO_ .'?
MB?\ ^@\/^'/?[2__ $/'P+_\*;Q__P#.RH_XF)X)_P"A7Q3_ .$64_\ S[#_
M (D.\7O^BC\-_P#P[\3_ /T'A_PY[_:7_P"AX^!?_A3>/_\ YV5'_$Q/!/\
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M_P#PIO'_ /\ .RH_XF)X)_Z%?%/_ (193_\ /L/^)#O%[_HH_#?_ ,._$_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % '__2_OXH * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * /PC_ &_/^4W'_!OU_P!Y6?\ UDGP;0!^[E !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 ?AK_P1S_Y+7_P64_[2G?&O_P!,7AFOKN)_]TX7_P"R?PGZGEY=_$S'_L.J
MG[E5\B>H% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % 'X:_M:_\IT?^"2'_ &1']NS_ -5KIU?79;_R2/$G_85E7_J1$\O$
M?\C3+_\ KWB?_3;/W*KY$]0* "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /__3
M_OXH * "@ H P/%5OXBN_"_B2T\(:A8:1XLN= UBW\+ZKJMHU_I>F>(IM.N(
M]$U#4K%"KWEA9:DUM<WEHA#7%O%)"I!<5=-TU4INK%RI*<74C%VE*FFN>,7T
M;C=)]&*5^62BTI6?*VKI.VC:[)]#\5/^$!_X.)_^B]_\$L?_  VO[0O_ ,9K
MZOVW!'_0'Q!_X-P?_P L/,Y,X_Y^X'_P&K_\B'_" _\ !Q/_ -%[_P""6/\
MX;7]H7_XS1[;@C_H#X@_\&X/_P"6!R9Q_P _<#_X#5_^1#_A ?\ @XG_ .B]
M_P#!+'_PVO[0O_QFCVW!'_0'Q!_X-P?_ ,L#DSC_ )^X'_P&K_\ (A_P@/\
MP<3_ /1>_P#@EC_X;7]H7_XS1[;@C_H#X@_\&X/_ .6!R9Q_S]P/_@-7_P"1
M#_A ?^#B?_HO?_!+'_PVO[0O_P 9H]MP1_T!\0?^#<'_ /+ Y,X_Y^X'_P !
MJ_\ R(?\(#_P<3_]%[_X)8_^&U_:%_\ C-'MN"/^@/B#_P &X/\ ^6!R9Q_S
M]P/_ (#5_P#D0_X0'_@XG_Z+W_P2Q_\ #:_M"_\ QFCVW!'_ $!\0?\ @W!_
M_+ Y,X_Y^X'_ ,!J_P#R(?\ " _\'$__ $7O_@EC_P"&U_:%_P#C-'MN"/\
MH#X@_P#!N#_^6!R9Q_S]P/\ X#5_^1#_ (0'_@XG_P"B]_\ !+'_ ,-K^T+_
M /&:/;<$?] ?$'_@W!__ "P.3./^?N!_\!J__(A_P@/_  <3_P#1>_\ @EC_
M .&U_:%_^,T>VX(_Z ^(/_!N#_\ E@<F<?\ /W _^ U?_D0_X0'_ (.)_P#H
MO?\ P2Q_\-K^T+_\9H]MP1_T!\0?^#<'_P#+ Y,X_P"?N!_\!J__ "(?\(#_
M ,'$_P#T7O\ X)8_^&U_:%_^,T>VX(_Z ^(/_!N#_P#E@<F<?\_<#_X#5_\
MD0_X0'_@XG_Z+W_P2Q_\-K^T+_\ &:/;<$?] ?$'_@W!_P#RP.3./^?N!_\
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M_P#AM?VA?_C-'MN"/^@/B#_P;@__ )8')G'_ #]P/_@-7_Y$/^$!_P"#B?\
MZ+W_ ,$L?_#:_M"__&:/;<$?] ?$'_@W!_\ RP.3./\ G[@?_ :O_P B'_"
M_P#!Q/\ ]%[_ ."6/_AM?VA?_C-'MN"/^@/B#_P;@_\ Y8')G'_/W _^ U?_
M )$/^$!_X.)_^B]_\$L?_#:_M"__ !FCVW!'_0'Q!_X-P?\ \L#DSC_G[@?_
M  &K_P#(A_P@/_!Q/_T7O_@EC_X;7]H7_P",T>VX(_Z ^(/_  ;@_P#Y8')G
M'_/W _\ @-7_ .1#_A ?^#B?_HO?_!+'_P -K^T+_P#&:/;<$?\ 0'Q!_P"#
M<'_\L#DSC_G[@?\ P&K_ /(A_P (#_P<3_\ 1>_^"6/_ (;7]H7_ .,T>VX(
M_P"@/B#_ ,&X/_Y8')G'_/W _P#@-7_Y$/\ A ?^#B?_ *+W_P $L?\ PVO[
M0O\ \9H]MP1_T!\0?^#<'_\ + Y,X_Y^X'_P&K_\B'_" _\ !Q/_ -%[_P""
M6/\ X;7]H7_XS1[;@C_H#X@_\&X/_P"6!R9Q_P _<#_X#5_^1#_A ?\ @XG_
M .B]_P#!+'_PVO[0O_QFCVW!'_0'Q!_X-P?_ ,L#DSC_ )^X'_P&K_\ (A_P
M@/\ P<3_ /1>_P#@EC_X;7]H7_XS1[;@C_H#X@_\&X/_ .6!R9Q_S]P/_@-7
M_P"1#_A ?^#B?_HO?_!+'_PVO[0O_P 9H]MP1_T!\0?^#<'_ /+ Y,X_Y^X'
M_P !J_\ R(?\(#_P<3_]%[_X)8_^&U_:%_\ C-'MN"/^@/B#_P &X/\ ^6!R
M9Q_S]P/_ (#5_P#D0_X0'_@XG_Z+W_P2Q_\ #:_M"_\ QFCVW!'_ $!\0?\
M@W!__+ Y,X_Y^X'_ ,!J_P#R(?\ " _\'$__ $7O_@EC_P"&U_:%_P#C-'MN
M"/\ H#X@_P#!N#_^6!R9Q_S]P/\ X#5_^1#_ (0'_@XG_P"B]_\ !+'_ ,-K
M^T+_ /&:/;<$?] ?$'_@W!__ "P.3./^?N!_\!J__(A_P@/_  <3_P#1>_\
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M9Q_S]P/_ (#5_P#D0_X0'_@XG_Z+W_P2Q_\ #:_M"_\ QFCVW!'_ $!\0?\
M@W!__+ Y,X_Y^X'_ ,!J_P#R(?\ " _\'$__ $7O_@EC_P"&U_:%_P#C-'MN
M"/\ H#X@_P#!N#_^6!R9Q_S]P/\ X#5_^1#_ (0'_@XG_P"B]_\ !+'_ ,-K
M^T+_ /&:/;<$?] ?$'_@W!__ "P.3./^?N!_\!J__(A_P@/_  <3_P#1>_\
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M>VX(_P"@/B#_ ,&X/_Y8')G'_/W _P#@-7_Y$/\ A ?^#B?_ *+W_P $L?\
MPVO[0O\ \9H]MP1_T!\0?^#<'_\ + Y,X_Y^X'_P&K_\B'_" _\ !Q/_ -%[
M_P""6/\ X;7]H7_XS1[;@C_H#X@_\&X/_P"6!R9Q_P _<#_X#5_^1#_A ?\
M@XG_ .B]_P#!+'_PVO[0O_QFCVW!'_0'Q!_X-P?_ ,L#DSC_ )^X'_P&K_\
M(A_P@/\ P<3_ /1>_P#@EC_X;7]H7_XS1[;@C_H#X@_\&X/_ .6!R9Q_S]P/
M_@-7_P"1#_A ?^#B?_HO?_!+'_PVO[0O_P 9H]MP1_T!\0?^#<'_ /+ Y,X_
MY^X'_P !J_\ R(?\(#_P<3_]%[_X)8_^&U_:%_\ C-'MN"/^@/B#_P &X/\
M^6!R9Q_S]P/_ (#5_P#D0_X0'_@XG_Z+W_P2Q_\ #:_M"_\ QFCVW!'_ $!\
M0?\ @W!__+ Y,X_Y^X'_ ,!J_P#R(?\ " _\'$__ $7O_@EC_P"&U_:%_P#C
M-'MN"/\ H#X@_P#!N#_^6!R9Q_S]P/\ X#5_^1#_ (0'_@XG_P"B]_\ !+'_
M ,-K^T+_ /&:/;<$?] ?$'_@W!__ "P.3./^?N!_\!J__(GS'^SU^P=_P73_
M &9?$_[17BSX;?M _P#!-I]2_:?^-WB#]H#XDP^(O!OQ[U2RA\?>)K2SL]6_
MX1J*#1;";2]$EBL;=HM-NKC4G@D#%+H*VRN_&YQPCCZ>"IU\'GG+@,+#!T.2
M>$B_8T_AY_WKYI>:2]#"CA<TH.M*%7!_OJCJSNJK7-+>WN*R\CZ<_P"$!_X.
M)_\ HO?_  2Q_P##:_M"_P#QFN#VW!'_ $!\0?\ @W!__+#?DSC_ )^X'_P&
MK_\ (A_P@/\ P<3_ /1>_P#@EC_X;7]H7_XS1[;@C_H#X@_\&X/_ .6!R9Q_
MS]P/_@-7_P"1#_A ?^#B?_HO?_!+'_PVO[0O_P 9H]MP1_T!\0?^#<'_ /+
MY,X_Y^X'_P !J_\ R(?\(#_P<3_]%[_X)8_^&U_:%_\ C-'MN"/^@/B#_P &
MX/\ ^6!R9Q_S]P/_ (#5_P#D0_X0'_@XG_Z+W_P2Q_\ #:_M"_\ QFCVW!'_
M $!\0?\ @W!__+ Y,X_Y^X'_ ,!J_P#R(?\ " _\'$__ $7O_@EC_P"&U_:%
M_P#C-'MN"/\ H#X@_P#!N#_^6!R9Q_S]P/\ X#5_^1#_ (0'_@XG_P"B]_\
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MP.3./^?N!_\  :O_ ,B'_" _\'$__1>_^"6/_AM?VA?_ (S1[;@C_H#X@_\
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MG'_/W _^ U?_ )$/^$!_X.)_^B]_\$L?_#:_M"__ !FCVW!'_0'Q!_X-P?\
M\L#DSC_G[@?_  &K_P#(A_P@/_!Q/_T7O_@EC_X;7]H7_P",T>VX(_Z ^(/_
M  ;@_P#Y8')G'_/W _\ @-7_ .1#_A ?^#B?_HO?_!+'_P -K^T+_P#&:/;<
M$?\ 0'Q!_P"#<'_\L#DSC_G[@?\ P&K_ /(A_P (#_P<3_\ 1>_^"6/_ (;7
M]H7_ .,T>VX(_P"@/B#_ ,&X/_Y8')G'_/W _P#@-7_Y$/\ A ?^#B?_ *+W
M_P $L?\ PVO[0O\ \9H]MP1_T!\0?^#<'_\ + Y,X_Y^X'_P&K_\B'_" _\
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M]MP1_P! ?$'_ (-P?_RP.3./^?N!_P# :O\ \B'_  @/_!Q/_P!%[_X)8_\
MAM?VA?\ XS1[;@C_ * ^(/\ P;@__E@<F<?\_<#_ . U?_D0_P"$!_X.)_\
MHO?_  2Q_P##:_M"_P#QFCVW!'_0'Q!_X-P?_P L#DSC_G[@?_ :O_R(?\(#
M_P '$_\ T7O_ ()8_P#AM?VA?_C-'MN"/^@/B#_P;@__ )8')G'_ #]P/_@-
M7_Y$/^$!_P"#B?\ Z+W_ ,$L?_#:_M"__&:/;<$?] ?$'_@W!_\ RP.3./\
MG[@?_ :O_P B'_" _P#!Q/\ ]%[_ ."6/_AM?VA?_C-'MN"/^@/B#_P;@_\
MY8')G'_/W _^ U?_ )$/^$!_X.)_^B]_\$L?_#:_M"__ !FCVW!'_0'Q!_X-
MP?\ \L#DSC_G[@?_  &K_P#(A_P@/_!Q/_T7O_@EC_X;7]H7_P",T>VX(_Z
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M@/B#_P &X/\ ^6!R9Q_S]P/_ (#5_P#D0_X0'_@XG_Z+W_P2Q_\ #:_M"_\
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M_(A_P@/_  <3_P#1>_\ @EC_ .&U_:%_^,T>VX(_Z ^(/_!N#_\ E@<F<?\
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M #]P/_@-7_Y$/^$!_P"#B?\ Z+W_ ,$L?_#:_M"__&:/;<$?] ?$'_@W!_\
MRP.3./\ G[@?_ :O_P B'_" _P#!Q/\ ]%[_ ."6/_AM?VA?_C-'MN"/^@/B
M#_P;@_\ Y8')G'_/W _^ U?_ )$/^$!_X.)_^B]_\$L?_#:_M"__ !FCVW!'
M_0'Q!_X-P?\ \L#DSC_G[@?_  &K_P#(A_P@/_!Q/_T7O_@EC_X;7]H7_P",
MT>VX(_Z ^(/_  ;@_P#Y8')G'_/W _\ @-7_ .1#_A ?^#B?_HO?_!+'_P -
MK^T+_P#&:/;<$?\ 0'Q!_P"#<'_\L#DSC_G[@?\ P&K_ /(A_P (#_P<3_\
M1>_^"6/_ (;7]H7_ .,T>VX(_P"@/B#_ ,&X/_Y8')G'_/W _P#@-7_Y$/\
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M1_T!\0?^#<'_ /+ Y,X_Y^X'_P !J_\ R(?\(#_P<3_]%[_X)8_^&U_:%_\
MC-'MN"/^@/B#_P &X/\ ^6!R9Q_S]P/_ (#5_P#D0_X0'_@XG_Z+W_P2Q_\
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M ,'$_P#T7O\ X)8_^&U_:%_^,T>VX(_Z ^(/_!N#_P#E@<F<?\_<#_X#5_\
MD0_X0'_@XG_Z+W_P2Q_\-K^T+_\ &:/;<$?] ?$'_@W!_P#RP.3./^?N!_\
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M_P#AM?VA?_C-'MN"/^@/B#_P;@__ )8')G'_ #]P/_@-7_Y$/^$!_P"#B?\
MZ+W_ ,$L?_#:_M"__&:/;<$?] ?$'_@W!_\ RP.3./\ G[@?_ :O_P B'_"
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M9Q_S]P/_ (#5_P#D0_X0'_@XG_Z+W_P2Q_\ #:_M"_\ QFCVW!'_ $!\0?\
M@W!__+ Y,X_Y^X'_ ,!J_P#R(?\ " _\'$__ $7O_@EC_P"&U_:%_P#C-'MN
M"/\ H#X@_P#!N#_^6!R9Q_S]P/\ X#5_^1#_ (0'_@XG_P"B]_\ !+'_ ,-K
M^T+_ /&:/;<$?] ?$'_@W!__ "P.3./^?N!_\!J__(A_P@/_  <3_P#1>_\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@#_U?[^* "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H _];^_B@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * /_7_OXH * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@#_T/[^* "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H _]'^_B@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * /_2_OXH * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@#_T_[^* "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H _]3^_B@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * /_5_OXH * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@#_UO[^* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M[.G2G9V][WHW;S.E&G2D\/BU4K2FJ6&]A_M,U!7E-4^:R@EK=R6G31VTH?\
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M%/-*-2;I^PQ<).E.M14Z'+]9A33E^X7->4G%7BI*%]-C"_X),?\ !1OXD?\
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M!3PW_P %&_!7[!/Q!_9W^.'B#X2_ ']D_4?@A\'_ !?XE^*W@_1=&L[GPO\
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M/_!+#X(_'_\ :R\<_%3XP?$;XD?'7XV?";P+H>B:9JOQ2^.'QD\<-^T+\5-
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M<KU9W4:4UFV,JNG)0EAZ$85'!J,FK<T8SM9M65TGT5]C\+H/V(OVFH_V /\
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MU5J$W/)%&C-QH27/:#:I*-&"7/I[EG%)<UK-=T?F;_P6*^%?Q'TS1?\ @O\
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M&T#6=<M!H^O7WB.71-#2WDL+A[GS*N:O"YEPM0QV+X8IX?"9LL54P_#\$J&
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MM-U*]"5/WVF^7JDE=)7>LN916EW_ $5U^='OA0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % '__1_OXH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
I4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Apr. 27, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MINERALYS THERAPEUTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-1966887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">150 N. Radnor Chester Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite F200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Radnor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">378-6240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MLYS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,498,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001933414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Document Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 112,779<span></span>
</td>
<td class="nump">$ 172,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesCurrent', window );">Investments</a></td>
<td class="nump">533,281<span></span>
</td>
<td class="nump">483,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">6,410<span></span>
</td>
<td class="nump">4,751<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">652,470<span></span>
</td>
<td class="nump">661,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">360<span></span>
</td>
<td class="nump">382<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">652,862<span></span>
</td>
<td class="nump">661,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="nump">2,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">13,602<span></span>
</td>
<td class="nump">13,096<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">14,718<span></span>
</td>
<td class="nump">15,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 4)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 500,000,000 shares authorized as of March&#160;31, 2026 and December&#160;31, 2025; 82,454,950 and 81,536,557 shares issued and outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,134,644<span></span>
</td>
<td class="nump">1,103,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(496,508)<span></span>
</td>
<td class="num">(457,169)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">638,144<span></span>
</td>
<td class="nump">646,693<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 652,862<span></span>
</td>
<td class="nump">$ 661,806<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized (in shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued (in shares)</a></td>
<td class="nump">82,454,950<span></span>
</td>
<td class="nump">81,536,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding (in shares)</a></td>
<td class="nump">82,454,950<span></span>
</td>
<td class="nump">81,536,557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 24,365<span></span>
</td>
<td class="nump">$ 37,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">20,975<span></span>
</td>
<td class="nump">6,568<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">45,340<span></span>
</td>
<td class="nump">44,447<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(45,340)<span></span>
</td>
<td class="num">(44,447)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">5,996<span></span>
</td>
<td class="nump">2,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income, net</a></td>
<td class="nump">6,001<span></span>
</td>
<td class="nump">2,236<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (39,339)<span></span>
</td>
<td class="num">$ (42,211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders - basic (in USD per share)</a></td>
<td class="num">$ (0.47)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders - diluted (in USD per share)</a></td>
<td class="num">$ (0.47)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders - basic (in shares)</a></td>
<td class="nump">82,834,752<span></span>
</td>
<td class="nump">53,163,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted (in shares)</a></td>
<td class="nump">82,834,752<span></span>
</td>
<td class="nump">53,163,551<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Stockholders&#8217; Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Public Offering</div></th>
<th class="th"><div>At the Market</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Public Offering</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>At the Market</div>
</th>
<th class="th"><div>Additional &#8232;Paid-In Capital</div></th>
<th class="th">
<div>Additional &#8232;Paid-In Capital </div>
<div>Public Offering</div>
</th>
<th class="th">
<div>Additional &#8232;Paid-In Capital </div>
<div>At the Market</div>
</th>
<th class="th"><div>Accumulated &#8232;Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,821,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="nump">$ 191,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 493,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (302,518)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,907,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from stock option exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from stock option exercises</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(42,211)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42,211)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,876,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="nump">$ 341,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">686,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(344,729)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2025</a></td>
<td class="nump">81,536,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,536,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2025</a></td>
<td class="nump">$ 646,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,103,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(457,169)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">568,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from stock option exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from stock option exercises</a></td>
<td class="nump">4,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (39,339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,339)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2026</a></td>
<td class="nump">82,454,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,454,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2026</a></td>
<td class="nump">$ 638,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,134,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (496,508)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Stockholders&#8217; Equity (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_PublicOfferingMember', window );">Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,509<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_AtTheMarketMember', window );">At the Market</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Offering costs</a></td>
<td class="nump">$ 82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=mlys_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_AtTheMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=mlys_AtTheMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (39,339)<span></span>
</td>
<td class="num">$ (42,211)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,548<span></span>
</td>
<td class="nump">3,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion of discount on held-to-maturity securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,625)<span></span>
</td>
<td class="num">(1,046)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Accrued interest receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">289<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid, other current assets, and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,948)<span></span>
</td>
<td class="num">(4,396)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(402)<span></span>
</td>
<td class="num">(1,546)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(39,471)<span></span>
</td>
<td class="num">(45,487)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchases of marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(347,443)<span></span>
</td>
<td class="num">(127,876)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities', window );">Maturities of marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">302,500<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(44,943)<span></span>
</td>
<td class="num">(92,876)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock option exercises</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,055<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of shelf offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,272<span></span>
</td>
<td class="nump">189,279<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(60,142)<span></span>
</td>
<td class="nump">50,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - beginning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">172,921<span></span>
</td>
<td class="nump">114,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - ending</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">112,779<span></span>
</td>
<td class="nump">165,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Disclosure of Non-Cash Financing Activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Public offering and shelf offering costs included in accounts payable and accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_AtTheMarketMember', window );">At the Market</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock pursuant to ATM Agreement, net of issuance costs and Proceeds from issuance of common stock public offering, net of offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,218<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_PublicOfferingMember', window );">Public Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock pursuant to ATM Agreement, net of issuance costs and Proceeds from issuance of common stock public offering, net of offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 189,166<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cash and cash equivalents as of March&#160;31, 2026 exclude investments of $533.3&#160;million. Cash, cash equivalents, and investments amounted to $646.1&#160;million as of March&#160;31, 2026.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering Costs Incurred During Noncash or Partial Noncash Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_AtTheMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=mlys_AtTheMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=mlys_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesCurrent', window );">Investments</a></td>
<td class="nump">$ 533,281<span></span>
</td>
<td class="nump">$ 483,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Cash, cash equivalents, and investments</a></td>
<td class="nump">$ 646,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Nature of Business</a></td>
<td class="text">Nature of Business<div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mineralys Therapeutics, Inc. (the Company) is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company&#8217;s product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. The Company has completed two pivotal clinical trials of lorundrostat for hypertension, one Phase 2 clinical trial in hypertensive participants with chronic kidney disease, and one Phase 2 clinical trial in hypertensive participants with obstructive sleep apnea. The Company submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in December&#160;2025 for lorundrostat for the treatment of hypertension in combination with other antihypertensive drugs. The FDA accepted the NDA submission and provided the Company with a Prescription Drug User Fee Act target date of December&#160;22, 2026 for lorundrostat. The Company was incorporated as a Delaware corporation in May 2019, and it is headquartered in Radnor, Pennsylvania. The Company&#8217;s operations to date have been limited to business planning, raising capital, in-licensing, conducting preclinical and clinical trials, and performing research and development and other activities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception, the Company has not generated any revenue from product sales or other sources and has incurred significant operating losses and negative cash flows from operations. The Company&#8217;s primary uses of cash to date have been to fund research and development activities, business planning, establishing and maintaining the Company&#8217;s intellectual property portfolio, hiring personnel, raising capital, and providing general and administrative support for these operations. As of March&#160;31, 2026, the Company had an accumulated deficit of $496.5&#160;million and cash, cash equivalents, and investments of $646.1 million. For the three months ended March&#160;31, 2026, the Company had a net loss of $39.3&#160;million and net cash used in operating activities of $39.5&#160;million.</span></div>Since inception, the Company has funded its operations by raising aggregate gross proceeds of approximately $1.1 billion from the sale of the Company&#8217;s common stock, convertible preferred stock, pre-funded warrants, and convertible notes. The Company has a limited operating history, and the sales and income potential of its business is unproven. The Company expects to continue to incur substantial losses for the foreseeable future as a result of the Company&#8217;s research and development and other activities. Additional funding will be required to continue with the Company&#8217;s planned research and development and commercial launch activities. The Company expects to finance its operations through equity offerings, debt financings, and other capital sources, including potential strategic collaborations, licensing, and other similar arrangements. The Company believes that its cash, cash equivalents, and investments as of March&#160;31, 2026 will be sufficient to allow the Company to fund operations for at least twelve months from the issuance date of these condensed financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480922/205-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481034/205-10-S45-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and applicable rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules and regulations, certain footnotes or other financial information normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the Company&#8217;s financial information. These unaudited condensed financial statements should be read in </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">conjunction with the audited financial statements and related notes in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2025.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable guidance is meant to refer to authoritative U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) of the Financial Accounting Standards Board (FASB).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in one operating segment for the purposes of assessing performance, making operating decisions, and allocating Company resources. The Company&#8217;s chief operating decision maker (CODM) is its chief executive officer, who considers net loss to evaluate overall expenses associated with conducting research and development activities, which includes evaluating the progress of ongoing clinical trials and the planning and execution of current and future research and development and other activities. Further, the CODM reviews and utilizes functional expenses (research and development and general and administrative) as reported in the statements of operations to manage the Company&#8217;s operations. Other segment items included in net loss are interest income, net and other income (expense). These measures of performance, significant expenses, and other items are each reflected in the condensed statements of operations. The accounting policies of the segment are the same as those described below. The measure of segment assets is reported on the condensed balance sheets as total assets. All assets are held in the United States.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Estimates have been used in the following areas, among others: research and development accruals and income taxes. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">All highly liquid investments that have maturities of 90 days or less at the date of purchase are classified as cash equivalents. The Company&#8217;s cash and cash equivalents balances as of March&#160;31, 2026 and December&#160;31, 2025 include cash balances and amounts held primarily in interest-bearing money market accounts and U.S. Treasury bills. As of March&#160;31, 2026 and December&#160;31, 2025, the Company did not have any restricted cash balances. The following table provides a reconciliation of cash and cash equivalents as reported in the condensed statements of cash flows to the condensed balance sheets (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"></td><td style="width:69.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.426%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">111,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">171,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">112,779&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">172,921&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no significant off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts, or other hedging arrangements. Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash balances in several accounts with three financial institutions that, from time to time, are in excess of federally insured limits. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to disclose information on all assets and liabilities reported at fair value that enables an assessment of the inputs used in determining the reported fair values. ASC Topic 820, Fair Value Measurement, establishes a hierarchy of inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the observable inputs be used when available. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy applies only to the valuation inputs used in determining the reported fair value and is not a measure of the investment credit quality. The three levels of the fair value hierarchy are described below: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; quoted prices in active markets for identical assets and liabilities</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; other significant observable inputs (including quoted prices for similar assets and liabilities, interest rates, credit risk, etc.)</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; significant unobservable inputs (including the Company&#8217;s own assumptions in determining the fair value of assets and liabilities)</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For certain financial instruments, including cash and cash equivalents, prepaid expenses, accounts payable, and certain accrued liabilities, the recorded amount approximates estimated fair value due to their relatively short maturity period. Refer to Note 3. &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">for additional details of the Company&#8217;s financial instruments.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally invests its excess cash in money market funds and investment-grade short- and long-term fixed-income debt securities, such as U.S. Treasury bills. Such investments are included in cash and cash equivalents and investments in the condensed balance sheets. The Company determines the appropriate classification of securities at the time of purchase and re-evaluates such designation as of each balance sheet date. Securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are carried at amortized cost, adjusted for the accretion of discounts using the interest method.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company invested in marketable securities during the three months ended March&#160;31, 2026 and 2025, and no impairment charges were recorded. For held-to-maturity investments, the Company periodically reviews each individual security position that has an unrealized loss, or impairment, to determine if that impairment is other-than-temporary. If the Company believes an impairment of a security position is other than temporary, based on available quantitative and qualitative information as of the report date, the loss will be recognized within total other income, net in the Company&#8217;s condensed statements of operations, and a new cost basis in the investment will be established.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Offering Costs</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain legal, professional, accounting, and other third-party fees that are directly associated with in-process equity issuances as deferred offering costs until such equity issuances are consummated. After consummation of the equity issuance, these costs are recorded as a reduction in the capitalized amount associated with the equity issuance. Should the equity issuance be abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the condensed statements of operations. Deferred offering costs as of each of March&#160;31, 2026 and December&#160;31, 2025 were $0.2&#160;million. Such costs are classified in other assets on the condensed balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its stock-based compensation awards in accordance with ASC Topic 718, Compensation &#8211; Stock Compensation (ASC 718). ASC 718 requires share-based payment arrangements to be recognized in the condensed statements of operations based on their grant date fair values. The Company&#8217;s stock-based awards are subject only to service-based vesting conditions. The Company measures restricted common stock awards using the difference, if any, between the purchase price per share of the award and the fair value of the Company&#8217;s common stock at the date of the grant or modification. Restricted stock unit awards are measured at the grant date fair value based on the closing price of the Company&#8217;s common stock on the date of the grant. The Company estimates the fair value of its stock option awards using the Black-Scholes option pricing model, which requires the input of assumptions, including (i)&#160;the expected stock price volatility, (ii)&#160;the calculation of the expected term of the award, (iii)&#160;the risk-free interest rate, and (iv)&#160;expected dividends. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Volatility</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Due to the Company&#8217;s limited operating history and a lack of company-specific historical and implied volatility data, the Company has based its estimate of expected volatility on the historical volatility of a group of similar publicly-traded companies. The Company believes that the companies in the group were most representative of the Company and had characteristics similar to its own, including stage of product development, a focus on the life sciences industry, and other economic and industry characteristics. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company uses the simplified method to calculate the expected term, as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term for options granted, and utilizes the contractual term for options granted. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividends </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; To date, the Company has not issued any dividends and does not expect to issue dividends over the life of the options and therefore has estimated the dividend yield to be zero.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the Company&#8217;s initial public offering of its common stock in February 2023, the Company determines the fair market value of its common stock using the closing price of its common stock as reported on the Nasdaq Global Select Market.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense related to time-based awards, including restricted stock units, is recognized on a straight-line basis by recognizing the grant date fair value over the requisite service period, which is generally the vesting term. Management evaluates its award grants and modifications and will adjust the fair value if any are determined to be spring-loaded. The Company accounts for forfeitures as they occur.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Loss Per Share </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s basic net loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share attributable to common stockholders is computed by giving effect to all potential common stock equivalents outstanding for the period, determined using the treasury stock method. For purposes of this calculation, unvested restricted stock awards, restricted stock units, and stock options to purchase common stock are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive. The weighted-average number of common shares used in the basic and diluted net loss per share attributable to common stockholders calculations includes the weighted-average pre-funded warrants outstanding during the period, as they are exercisable at any time for nominal cash consideration. The following table sets forth the </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">potential common shares excluded from the calculation of net loss per share attributable to common stockholders because their inclusion would be anti-dilutive: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,420,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,778,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">702,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">64,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">309,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,188,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,087,345&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard-setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#160;(ASU 2024-03), and in January 2025, the FASB issued ASU 2025-01, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require the Company to disclose additional information about specific expense categories in the notes to the financial statements on an annual and interim basis.&#160;ASU 2024-03 is effective for the Company's fiscal year 2027 and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of ASU 2024-03 on its disclosures. While the Company expects that additional disaggregated disclosures will be required upon adoption, the guidance will not affect the recognition or measurement of expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments<div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents financial instruments measured at fair value on a recurring basis based on the fair value hierarchy as of March&#160;31, 2026 and December&#160;31, 2025 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">111,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">161,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers within the fair value hierarchy during the periods presented.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following methods and assumptions were used by the Company in estimating the fair values of each class of financial instrument disclosed herein:</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Money Market Funds &#8212; The carrying amounts of money market funds reported as cash and cash equivalents in the condensed balance sheets approximate their fair values due to their short-term nature. The fair values of money market funds are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury Bills &#8212; As of March&#160;31, 2026 and December&#160;31, 2025, the Company had short-term U.S. Treasury bills. Fair values of these securities are determined by Level 2 inputs utilizing quoted prices </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(unadjusted) in active markets for similar assets. The following table presents information about the Company&#8217;s investments in held-to-maturity U.S. Treasury bills as of each reported date (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Original Maturities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">between 3 and 12 months</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">533,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">533,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Original Maturities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">less than 3 months</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">between 3 and 12 months</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">483,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">483,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">493,662&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">493,839&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tanabe License Agreement </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company entered into an exclusive license agreement (the Tanabe License) with Tanabe Pharma Corporation (Tanabe) (formerly Mitsubishi Tanabe Pharma Corporation), pursuant to which Tanabe granted the Company an exclusive, worldwide, royalty-bearing, sublicensable license under Tanabe&#8217;s patent and other intellectual property rights to exploit products incorporating lorundrostat (formerly MT-4129) (Lorundrostat Product) for the prevention, treatment, diagnosis, detection, monitoring, or predisposition testing with respect to indications, diseases, and conditions in humans. Pursuant to the Tanabe License, the Company paid Tanabe a $1.0&#160;million upfront fee and development milestone payments of $9.0&#160;million in the aggregate. The Company has remaining obligations to pay Tanabe commercial milestone payments of up to $155.0&#160;million in the aggregate upon first commercial sale and upon meeting certain annual sales targets, as well as additional commercial milestone payments of up to $10.0&#160;million for a second indication. Additionally, the Company is obligated to pay Tanabe tiered royalties at percentages ranging from the mid-single digits to ten percent (10%) of aggregate net sales of each Lorundrostat Product on a Lorundrostat Product-by-Lorundrostat Product and country-by-country basis, until the later of (i) the expiration of the last-to-expire valid Tanabe patent claim covering a Lorundrostat Product, (ii) ten years from the first commercial sale of a Lorundrostat Product, or (iii) the expiration of regulatory exclusivity in such country. Such royalties are subject to reduction under specified conditions, including lack of patent coverage and generic competition.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no remaining development milestone obligations under the Tanabe License and did not incur any development or commercial expenses pursuant to the Tanabe License during the three months ended March&#160;31, 2026 and 2025.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated to use commercially reasonable efforts to conduct and complete the development activities and to file for regulatory approval for at least one Lorundrostat Product in a major market country and consider in good faith developing at least one Lorundrostat Product in a non-major market country. If the Company elects to sublicense its rights under the Tanabe License to a third party with respect to exploitation of lorundrostat or any Lorundrostat Product in certain countries in Asia, the Company has agreed to negotiate such a sublicense first, for a specified period of time, with Tanabe, if Tanabe notifies the Company that it would like to obtain such a sublicense. The Company also agreed not to commercialize any competing product prior to three years following the first commercial sale of the first Lorundrostat Product in any country without Tanabe&#8217;s prior consent.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unless terminated earlier, the Tanabe License will continue until the expiration of all of the Company&#8217;s royalty obligations to Tanabe. The Company may terminate the Tanabe License for any or no reason upon 90 or 180 days&#8217; prior written notice to Tanabe, depending on whether the Lorundrostat Product has received </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">regulatory approval. Tanabe may terminate the Tanabe License if the Company or its affiliates or sublicensees initiate a challenge to the patent rights licensed to the Company by Tanabe. In addition, either party may terminate the Tanabe License in the event of an uncured material breach by or bankruptcy of the other party, subject to certain notice and cure periods, or upon the other party&#8217;s bankruptcy or insolvency.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company was not subject to any material legal proceedings during the three months ended March&#160;31, 2026 and 2025, and no material legal proceedings are currently pending or threatened.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Agreements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners, and other parties with respect to certain matters including, but not limited to, losses arising from breach of such agreements or intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with officers of the Company and members of its board of directors that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as officers or directors. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not aware of any claims under indemnification arrangements, and it has not accrued any material liabilities related to such obligations in its condensed financial statements as of March&#160;31, 2026 and December&#160;31, 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">Accrued Liabilities<div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,096&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Stock</a></td>
<td class="text">Capital Stock<div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, the Company had reserved authorized shares of common stock for future issuance as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,420,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under the 2023 Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,866,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under the ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,067,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">702,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-funded warrants issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">549,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under the 2025 Inducement Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">539,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,147,149&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">At-the-Market Equity Offering Sales Agreements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;10, 2025, the Company entered into an ATM Equity Offering Sales Agreement (the ATM Agreement) with BofA Securities, Inc., Evercore Group L.L.C., and Goldman Sachs &amp; Co. LLC, pursuant to which the Company may sell shares of its common stock having an aggregate offering price of up to $300.0&#160;million from time to time. During the three months ended March&#160;31, 2026, the Company sold pursuant to the ATM Agreement an aggregate of 568,320 shares of common stock at a weighted-average price of $35.66 per share for aggregate net proceeds of approximately $20.2&#160;million after deducting commissions and offering expenses. There were no sales of common stock pursuant to the ATM Agreement during the three months ended March&#160;31, 2025. From inception of the ATM Agreement and through March&#160;31, 2026, the Company sold an aggregate of 2,720,508 shares of common stock at a weighted-average price of $41.45 per share for aggregate net proceeds of approximately $112.4&#160;million after deducting commissions and offering expenses. As of March&#160;31, 2026, approximately $187.2&#160;million of shares remained available for sale pursuant to the ATM Agreement. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;21, 2024, the Company entered into an ATM Equity Offering Sales Agreement (the Prior ATM Agreement) with BofA Securities, Inc. and Evercore Group L.L.C. Effective November&#160;9, 2025, the Prior ATM Agreement was terminated in connection with the execution of the ATM Agreement. There were no sales of common stock pursuant to the Prior ATM Agreement during each of the three months ended March&#160;31, 2026 and March&#160;31, 2025. From inception of the Prior ATM Agreement and through its termination effective November&#160;9, 2025, the Company sold an aggregate of 1,914,040 shares of common stock at a weighted-average price of $14.32 per share for aggregate net proceeds of approximately $27.3&#160;million after deducting commissions and offering expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Incentive Award Plan</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants equity awards under the 2023 Incentive Award Plan (the 2023 Plan). During the three months ended March 31, 2026, the Company began granting restricted stock units under the 2023 Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Employment Inducement Incentive Award Plan</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains the 2025 Employment Inducement Incentive Award Plan (the 2025 Inducement Plan), under which non&#8209;qualified stock options and restricted stock units may be granted in connection with the commencement of employment. During the three months ended March 31, 2026, the Company began granting restricted stock units under the 2025 Inducement Plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Equity Incentive Plan (the 2020 Plan) continues to govern the terms of outstanding awards, although no new awards are granted under the plan.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, the Company had the following balances by plan:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Unvested<br/>Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Unvested<br/>Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares Available<br/>for Grant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2023 Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,841,701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">568,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,866,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025 Inducement Plan</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">325,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">134,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">539,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2020 Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">253,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">64,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,420,692&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">64,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">702,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,406,670&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains the 2023 Employee Stock Purchase Plan (the ESPP) under which eligible employees may purchase shares of common stock through payroll deductions. As of March&#160;31, 2026, the Company had 2,067,084 shares available for issuance, and 57,839 cumulative shares had been issued under the ESPP.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was allocated as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,645&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=mlys_CatalysPacificFundLPMember', window );">Catalys Pacific Fund, LP [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">The material terms of this Rule 10b5-1 trading arrangement are described below:<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Name and Title</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Action Taken</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Type of Trading Arrangement</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Nature of Trading Arrangement</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Duration of Trading Arrangement</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Number of Securities</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Catalys Pacific Fund, LP</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adoption January&#160;9, 2026</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trading plan intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sale of the Company&#8217;s common stock pursuant to the terms of the plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2026 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">to </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;31, 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Catalys Pacific Fund, LP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Catalys Pacific Fund, LP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">January&#160;9, 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">March&#160;31, 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">446 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=mlys_CatalysPacificFundLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=mlys_CatalysPacificFundLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and applicable rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules and regulations, certain footnotes or other financial information normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the Company&#8217;s financial information. These unaudited condensed financial statements should be read in </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">conjunction with the audited financial statements and related notes in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2025.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable guidance is meant to refer to authoritative U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) of the Financial Accounting Standards Board (FASB).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in one operating segment for the purposes of assessing performance, making operating decisions, and allocating Company resources. The Company&#8217;s chief operating decision maker (CODM) is its chief executive officer, who considers net loss to evaluate overall expenses associated with conducting research and development activities, which includes evaluating the progress of ongoing clinical trials and the planning and execution of current and future research and development and other activities. Further, the CODM reviews and utilizes functional expenses (research and development and general and administrative) as reported in the statements of operations to manage the Company&#8217;s operations. Other segment items included in net loss are interest income, net and other income (expense). These measures of performance, significant expenses, and other items are each reflected in the condensed statements of operations. The accounting policies of the segment are the same as those described below. The measure of segment assets is reported on the condensed balance sheets as total assets. All assets are held in the United States.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates </span></div>The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Estimates have been used in the following areas, among others: research and development accruals and income taxes.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span></div>All highly liquid investments that have maturities of 90 days or less at the date of purchase are classified as cash equivalents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk </span></div>The Company has no significant off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts, or other hedging arrangements. Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash balances in several accounts with three financial institutions that, from time to time, are in excess of federally insured limits.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to disclose information on all assets and liabilities reported at fair value that enables an assessment of the inputs used in determining the reported fair values. ASC Topic 820, Fair Value Measurement, establishes a hierarchy of inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the observable inputs be used when available. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy applies only to the valuation inputs used in determining the reported fair value and is not a measure of the investment credit quality. The three levels of the fair value hierarchy are described below: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; quoted prices in active markets for identical assets and liabilities</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; other significant observable inputs (including quoted prices for similar assets and liabilities, interest rates, credit risk, etc.)</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; significant unobservable inputs (including the Company&#8217;s own assumptions in determining the fair value of assets and liabilities)</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For certain financial instruments, including cash and cash equivalents, prepaid expenses, accounts payable, and certain accrued liabilities, the recorded amount approximates estimated fair value due to their relatively short maturity period. Refer to Note 3. &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">for additional details of the Company&#8217;s financial instruments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally invests its excess cash in money market funds and investment-grade short- and long-term fixed-income debt securities, such as U.S. Treasury bills. Such investments are included in cash and cash equivalents and investments in the condensed balance sheets. The Company determines the appropriate classification of securities at the time of purchase and re-evaluates such designation as of each balance sheet date. Securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are carried at amortized cost, adjusted for the accretion of discounts using the interest method.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company invested in marketable securities during the three months ended March&#160;31, 2026 and 2025, and no impairment charges were recorded. For held-to-maturity investments, the Company periodically reviews each individual security position that has an unrealized loss, or impairment, to determine if that impairment is other-than-temporary. If the Company believes an impairment of a security position is other than temporary, based on available quantitative and qualitative information as of the report date, the loss will be recognized within total other income, net in the Company&#8217;s condensed statements of operations, and a new cost basis in the investment will be established.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Offering Costs</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Offering Costs</span></div>The Company capitalizes certain legal, professional, accounting, and other third-party fees that are directly associated with in-process equity issuances as deferred offering costs until such equity issuances are consummated. After consummation of the equity issuance, these costs are recorded as a reduction in the capitalized amount associated with the equity issuance. Should the equity issuance be abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the condensed statements of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its stock-based compensation awards in accordance with ASC Topic 718, Compensation &#8211; Stock Compensation (ASC 718). ASC 718 requires share-based payment arrangements to be recognized in the condensed statements of operations based on their grant date fair values. The Company&#8217;s stock-based awards are subject only to service-based vesting conditions. The Company measures restricted common stock awards using the difference, if any, between the purchase price per share of the award and the fair value of the Company&#8217;s common stock at the date of the grant or modification. Restricted stock unit awards are measured at the grant date fair value based on the closing price of the Company&#8217;s common stock on the date of the grant. The Company estimates the fair value of its stock option awards using the Black-Scholes option pricing model, which requires the input of assumptions, including (i)&#160;the expected stock price volatility, (ii)&#160;the calculation of the expected term of the award, (iii)&#160;the risk-free interest rate, and (iv)&#160;expected dividends. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Volatility</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Due to the Company&#8217;s limited operating history and a lack of company-specific historical and implied volatility data, the Company has based its estimate of expected volatility on the historical volatility of a group of similar publicly-traded companies. The Company believes that the companies in the group were most representative of the Company and had characteristics similar to its own, including stage of product development, a focus on the life sciences industry, and other economic and industry characteristics. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company uses the simplified method to calculate the expected term, as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term for options granted, and utilizes the contractual term for options granted. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. </span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividends </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; To date, the Company has not issued any dividends and does not expect to issue dividends over the life of the options and therefore has estimated the dividend yield to be zero.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the closing of the Company&#8217;s initial public offering of its common stock in February 2023, the Company determines the fair market value of its common stock using the closing price of its common stock as reported on the Nasdaq Global Select Market.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense related to time-based awards, including restricted stock units, is recognized on a straight-line basis by recognizing the grant date fair value over the requisite service period, which is generally the vesting term. Management evaluates its award grants and modifications and will adjust the fair value if any are determined to be spring-loaded. The Company accounts for forfeitures as they occur.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Loss Per Share </span></div>The Company&#8217;s basic net loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share attributable to common stockholders is computed by giving effect to all potential common stock equivalents outstanding for the period, determined using the treasury stock method. For purposes of this calculation, unvested restricted stock awards, restricted stock units, and stock options to purchase common stock are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive. The weighted-average number of common shares used in the basic and diluted net loss per share attributable to common stockholders calculations includes the weighted-average pre-funded warrants outstanding during the period, as they are exercisable at any time for nominal cash consideration.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard-setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#160;(ASU 2024-03), and in January 2025, the FASB issued ASU 2025-01, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require the Company to disclose additional information about specific expense categories in the notes to the financial statements on an annual and interim basis.&#160;ASU 2024-03 is effective for the Company's fiscal year 2027 and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of ASU 2024-03 on its disclosures. While the Company expects that additional disaggregated disclosures will be required upon adoption, the guidance will not affect the recognition or measurement of expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text">The following table provides a reconciliation of cash and cash equivalents as reported in the condensed statements of cash flows to the condensed balance sheets (in thousands):<div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"><tr><td style="width:1.0%"></td><td style="width:69.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.426%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">111,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">171,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">112,779&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">172,921&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potential Common Shares Excluded From Calculation of Net Loss Per Share</a></td>
<td class="text">The following table sets forth the <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">potential common shares excluded from the calculation of net loss per share attributable to common stockholders because their inclusion would be anti-dilutive: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,420,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,778,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">702,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">64,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">309,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,188,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,087,345&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule Financial Instruments Measured at Fair Value Hierarchy</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents financial instruments measured at fair value on a recurring basis based on the fair value hierarchy as of March&#160;31, 2026 and December&#160;31, 2025 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">111,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">161,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesTextBlock', window );">Schedule of Held-to-Maturity U.S. Treasury Bills</a></td>
<td class="text">The following table presents information about the Company&#8217;s investments in held-to-maturity U.S. Treasury bills as of each reported date (in thousands):<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Original Maturities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">between 3 and 12 months</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">533,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">533,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Original Maturities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">less than 3 months</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">between 3 and 12 months</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">483,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">483,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">493,662&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">493,839&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5B<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5B<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,602&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,096&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock', window );">Schedule of Authorized Shares of Common Stock</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, the Company had reserved authorized shares of common stock for future issuance as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,420,692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under the 2023 Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,866,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under the ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,067,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">702,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-funded warrants issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">549,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under the 2025 Inducement Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">539,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,147,149&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_ScheduleOfCommonStockAuthorizedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Common Stock Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_ScheduleOfCommonStockAuthorizedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Options by Plan</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, the Company had the following balances by plan:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Unvested<br/>Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Unvested<br/>Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares Available<br/>for Grant</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2023 Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,841,701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">568,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,866,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025 Inducement Plan</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">325,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">134,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">539,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2020 Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">253,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">64,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,420,692&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">64,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">702,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,406,670&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Reported in Statement of Operations</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was allocated as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.401%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,645&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">38 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 496,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496,508<span></span>
</td>
<td class="nump">$ 457,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Cash, cash equivalents, and investments</a></td>
<td class="nump">646,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">39,339<span></span>
</td>
<td class="nump">$ 42,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="nump">$ 39,471<span></span>
</td>
<td class="nump">$ 45,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from issuance of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Segment Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 1,150<span></span>
</td>
<td class="nump">$ 1,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">111,629<span></span>
</td>
<td class="nump">171,891<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Total cash and cash equivalents</a></td>
<td class="nump">$ 112,779<span></span>
</td>
<td class="nump">$ 172,921<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Deferred Offering Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480341/340-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Potential Common Shares Excluded From Calculation of Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total (in shares)</a></td>
<td class="nump">8,188,354<span></span>
</td>
<td class="nump">7,087,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total (in shares)</a></td>
<td class="nump">7,420,692<span></span>
</td>
<td class="nump">6,778,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Unvested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total (in shares)</a></td>
<td class="nump">702,948<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Unvested restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total (in shares)</a></td>
<td class="nump">64,714<span></span>
</td>
<td class="nump">309,028<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value Hierarchy (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 111,629<span></span>
</td>
<td class="nump">$ 161,943<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Schedule of Held-to-Maturity U.S. Treasury Bills (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 493,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent', window );">Cash and cash equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent', window );">Cash and cash equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent', window );">Cash and cash equivalents and Investments</a></td>
<td class="nump">$ 533,281<span></span>
</td>
<td class="nump">483,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent', window );">Cash and cash equivalents and Investments</a></td>
<td class="nump">$ 533,211<span></span>
</td>
<td class="nump">$ 483,891<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - Tanabe - Collaborative Arrangement, Transaction with Party to Collaborative Arrangement - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee', window );">Upfront fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments', window );">Development milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments', window );">First commercial milestone payments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">155,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments', window );">Second commercial milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod', window );">Non-compete period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mlys_TanabeMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage', window );">Royalties percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod', window );">Termination period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mlys_TanabeMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod', window );">Termination period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Developmental Maximum Aggregate Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement Rights And Obligations Expiration Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, First Commercial Sale Maximum Aggregate Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement Rights And Obligations, Non-compete Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement Rights And Obligations Royalty Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Second Commercial Sale Maximum Aggregate Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement Rights And Obligations, Termination Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Upfront Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mlys_TanabeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mlys_TanabeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_AccruedResearchAndDevelopmentCostsCurrent', window );">Research and development expenses</a></td>
<td class="nump">$ 4,587<span></span>
</td>
<td class="nump">$ 3,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Compensation and benefits</a></td>
<td class="nump">2,312<span></span>
</td>
<td class="nump">5,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees and other</a></td>
<td class="nump">6,703<span></span>
</td>
<td class="nump">4,096<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 13,602<span></span>
</td>
<td class="nump">$ 13,096<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_AccruedResearchAndDevelopmentCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Research And Development Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_AccruedResearchAndDevelopmentCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital Stock - Schedule of Authorized Shares of Common Stock (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">14,147,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=mlys_PreFundedWarrantMember', window );">Pre-funded warrants issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">549,755<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_EquityIncentivePlan2023Member', window );">Shares available for grant under the 2023 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">2,866,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_EquityIncentivePlan2025Member', window );">Shares available for grant under the 2025 Inducement Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">539,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Common stock options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">7,420,692<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Shares available for grant under the ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">2,067,084<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total (in shares)</a></td>
<td class="nump">702,948<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=mlys_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=mlys_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mlys_EquityIncentivePlan2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mlys_EquityIncentivePlan2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mlys_EquityIncentivePlan2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mlys_EquityIncentivePlan2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">20 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Nov. 09, 2025</div></th>
<th class="th"><div>Nov. 10, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_AtTheMarketMember', window );">At the Market</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="nump">568,320<span></span>
</td>
<td class="nump">2,720,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_SaleOfStockPricePerShareWeightedAveragePrice', window );">Price per share (in USD per share)</a></td>
<td class="nump">$ 35.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_ProceedsFromIssuanceOfCommonStockNet', window );">Aggregate net proceeds</a></td>
<td class="nump">$ 20.2<span></span>
</td>
<td class="nump">$ 112.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in USD per share)</a></td>
<td class="nump">$ 41.45<span></span>
</td>
<td class="nump">$ 41.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale', window );">Common shares available for sale</a></td>
<td class="nump">$ 187.2<span></span>
</td>
<td class="nump">$ 187.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_AtTheMarketMember', window );">At the Market | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlys_SaleOfStockConsiderationReceivableOnTransaction', window );">Maximum aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_PriorATMAgreementMember', window );">Prior ATM Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,914,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds of sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Aggregate Offering Price Of Remaining Common Shares Available For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_ProceedsFromIssuanceOfCommonStockNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_ProceedsFromIssuanceOfCommonStockNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_SaleOfStockConsiderationReceivableOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Consideration Receivable On Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_SaleOfStockConsiderationReceivableOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlys_SaleOfStockPricePerShareWeightedAveragePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Price Per Share, Weighted Average Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlys_SaleOfStockPricePerShareWeightedAveragePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlys_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_AtTheMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=mlys_AtTheMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=mlys_PriorATMAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=mlys_PriorATMAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Options by Plan (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding (in shares)</a></td>
<td class="nump">7,420,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant (in shares)</a></td>
<td class="nump">3,406,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Unvested Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Unvested Restricted Stock (in shares)</a></td>
<td class="nump">64,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Unvested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Unvested Restricted Stock (in shares)</a></td>
<td class="nump">702,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_A2023IncentiveAwardPlanMember', window );">2023 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding (in shares)</a></td>
<td class="nump">6,841,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant (in shares)</a></td>
<td class="nump">2,866,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_A2023IncentiveAwardPlanMember', window );">2023 Plan | Unvested Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Unvested Restricted Stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_A2023IncentiveAwardPlanMember', window );">2023 Plan | Unvested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Unvested Restricted Stock (in shares)</a></td>
<td class="nump">568,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_A2025IncentiveAwardPlanMember', window );">2025 Inducement Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding (in shares)</a></td>
<td class="nump">325,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant (in shares)</a></td>
<td class="nump">539,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_A2025IncentiveAwardPlanMember', window );">2025 Inducement Plan | Unvested Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Unvested Restricted Stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_A2025IncentiveAwardPlanMember', window );">2025 Inducement Plan | Unvested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Unvested Restricted Stock (in shares)</a></td>
<td class="nump">134,908<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_A2020EquityIncentivePlanMember', window );">2020 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding (in shares)</a></td>
<td class="nump">253,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_A2020EquityIncentivePlanMember', window );">2020 Plan | Unvested Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Unvested Restricted Stock (in shares)</a></td>
<td class="nump">64,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mlys_A2020EquityIncentivePlanMember', window );">2020 Plan | Unvested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Unvested Restricted Stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mlys_A2023IncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mlys_A2023IncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mlys_A2025IncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mlys_A2025IncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mlys_A2020EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mlys_A2020EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">3,406,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock | Shares available for grant under the ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">2,067,084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Cumulative shares issued (in shares)</a></td>
<td class="nump">57,839<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mlys_A2023EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mlys_A2023EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock-Based Compensation Reported in Statement of Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total</a></td>
<td class="nump">$ 6,548<span></span>
</td>
<td class="nump">$ 3,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total</a></td>
<td class="nump">2,476<span></span>
</td>
<td class="nump">1,628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total</a></td>
<td class="nump">$ 4,072<span></span>
</td>
<td class="nump">$ 2,017<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>79</ContextCount>
  <ElementCount>160</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>31</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CondensedBalanceSheets</Role>
      <ShortName>Condensed Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CondensedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CondensedStatementsofOperations</Role>
      <ShortName>Condensed Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Statements of Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Statements of Stockholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Statements of Stockholders??? Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Condensed Statements of Stockholders??? Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CondensedStatementsofCashFlows</Role>
      <ShortName>Condensed Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Statement - Condensed Statements of Cash Flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CondensedStatementsofCashFlowsParenthetical</Role>
      <ShortName>Condensed Statements of Cash Flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/NatureofBusiness</Role>
      <ShortName>Nature of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/AccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Capital Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CapitalStock</Role>
      <ShortName>Capital Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.mineralystx.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mineralystx.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mineralystx.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mineralystx.com/role/AccruedLiabilities</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Capital Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CapitalStockTables</Role>
      <ShortName>Capital Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mineralystx.com/role/CapitalStock</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mineralystx.com/role/StockBasedCompensation</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Nature of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/NatureofBusinessDetails</Role>
      <ShortName>Nature of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.mineralystx.com/role/NatureofBusiness</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Summary of Significant Accounting Policies - Deferred Offering Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesDeferredOfferingCostsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Deferred Offering Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potential Common Shares Excluded From Calculation of Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Potential Common Shares Excluded From Calculation of Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value Hierarchy (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails</Role>
      <ShortName>Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value Hierarchy (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Fair Value of Financial Instruments - Schedule of Held-to-Maturity U.S. Treasury Bills (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails</Role>
      <ShortName>Fair Value of Financial Instruments - Schedule of Held-to-Maturity U.S. Treasury Bills (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.mineralystx.com/role/CommitmentsandContingencies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.mineralystx.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Capital Stock - Schedule of Authorized Shares of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails</Role>
      <ShortName>Capital Stock - Schedule of Authorized Shares of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Capital Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/CapitalStockNarrativeDetails</Role>
      <ShortName>Capital Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Stock-Based Compensation - Schedule of Options by Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Options by Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="mlys-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Reported in Statement of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock-Based Compensation Reported in Statement of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="mlys-20260331.htm">mlys-20260331.htm</File>
    <File>mlys-20260331.xsd</File>
    <File>mlys-20260331_cal.xml</File>
    <File>mlys-20260331_def.xml</File>
    <File>mlys-20260331_lab.xml</File>
    <File>mlys-20260331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mlys-20260331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="249">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="11">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>57
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mlys-20260331.htm": {
   "nsprefix": "mlys",
   "nsuri": "http://www.mineralystx.com/20260331",
   "dts": {
    "inline": {
     "local": [
      "mlys-20260331.htm"
     ]
    },
    "schema": {
     "local": [
      "mlys-20260331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "mlys-20260331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mlys-20260331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mlys-20260331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mlys-20260331_pre.xml"
     ]
    }
   },
   "keyStandard": 145,
   "keyCustom": 15,
   "axisStandard": 14,
   "axisCustom": 0,
   "memberStandard": 16,
   "memberCustom": 12,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2025": 5,
    "http://xbrl.sec.gov/ecd/2025": 1
   },
   "contextCount": 79,
   "entityCount": 1,
   "segmentCount": 31,
   "elementCount": 344,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 249,
    "http://xbrl.sec.gov/dei/2025": 31,
    "http://xbrl.sec.gov/ecd/2025": 11
   },
   "report": {
    "R1": {
     "role": "http://www.mineralystx.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.mineralystx.com/role/CondensedBalanceSheets",
     "longName": "9952151 - Statement - Condensed Balance Sheets",
     "shortName": "Condensed Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.mineralystx.com/role/CondensedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Condensed Balance Sheets (Parenthetical)",
     "shortName": "Condensed Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.mineralystx.com/role/CondensedStatementsofOperations",
     "longName": "9952153 - Statement - Condensed Statements of Operations",
     "shortName": "Condensed Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity",
     "longName": "9952154 - Statement - Condensed Statements of Stockholders\u2019 Equity",
     "shortName": "Condensed Statements of Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical",
     "longName": "9952155 - Statement - Condensed Statements of Stockholders\u2019 Equity (Parenthetical)",
     "shortName": "Condensed Statements of Stockholders\u2019 Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.mineralystx.com/role/CondensedStatementsofCashFlows",
     "longName": "9952156 - Statement - Condensed Statements of Cash Flows",
     "shortName": "Condensed Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.mineralystx.com/role/CondensedStatementsofCashFlowsParenthetical",
     "longName": "9952157 - Statement - Condensed Statements of Cash Flows (Parenthetical)",
     "shortName": "Condensed Statements of Cash Flows (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R9": {
     "role": "http://www.mineralystx.com/role/NatureofBusiness",
     "longName": "9952158 - Disclosure - Nature of Business",
     "shortName": "Nature of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.mineralystx.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952159 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.mineralystx.com/role/FairValueofFinancialInstruments",
     "longName": "9952160 - Disclosure - Fair Value of Financial Instruments",
     "shortName": "Fair Value of Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.mineralystx.com/role/CommitmentsandContingencies",
     "longName": "9952161 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.mineralystx.com/role/AccruedLiabilities",
     "longName": "9952162 - Disclosure - Accrued Liabilities",
     "shortName": "Accrued Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.mineralystx.com/role/CapitalStock",
     "longName": "9952163 - Disclosure - Capital Stock",
     "shortName": "Capital Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.mineralystx.com/role/StockBasedCompensation",
     "longName": "9952164 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9955512 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsTables",
     "longName": "9955513 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.mineralystx.com/role/AccruedLiabilitiesTables",
     "longName": "9955514 - Disclosure - Accrued Liabilities (Tables)",
     "shortName": "Accrued Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.mineralystx.com/role/CapitalStockTables",
     "longName": "9955515 - Disclosure - Capital Stock (Tables)",
     "shortName": "Capital Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "mlys:ScheduleOfCommonStockAuthorizedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "mlys:ScheduleOfCommonStockAuthorizedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.mineralystx.com/role/StockBasedCompensationTables",
     "longName": "9955516 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.mineralystx.com/role/NatureofBusinessDetails",
     "longName": "9955517 - Disclosure - Nature of Business (Details)",
     "shortName": "Nature of Business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-34",
      "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails",
     "longName": "9955518 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)",
     "shortName": "Summary of Significant Accounting Policies - Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails",
     "longName": "9955519 - Disclosure - Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)",
     "shortName": "Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RestrictedCash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RestrictedCash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails",
     "longName": "9955520 - Disclosure - Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesDeferredOfferingCostsDetails",
     "longName": "9955521 - Disclosure - Summary of Significant Accounting Policies - Deferred Offering Costs (Details)",
     "shortName": "Summary of Significant Accounting Policies - Deferred Offering Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DeferredOfferingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DeferredOfferingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails",
     "longName": "9955522 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potential Common Shares Excluded From Calculation of Net Loss Per Share (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Potential Common Shares Excluded From Calculation of Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails",
     "longName": "9955523 - Disclosure - Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value Hierarchy (Details)",
     "shortName": "Fair Value of Financial Instruments - Schedule of Financial Instruments Measured at Fair Value Hierarchy (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-41",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-41",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails",
     "longName": "9955524 - Disclosure - Fair Value of Financial Instruments - Schedule of Held-to-Maturity U.S. Treasury Bills (Details)",
     "shortName": "Fair Value of Financial Instruments - Schedule of Held-to-Maturity U.S. Treasury Bills (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955525 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-46",
      "name": "mlys:CollaborativeArrangementRightsAndObligationsUpfrontFee",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-46",
      "name": "mlys:CollaborativeArrangementRightsAndObligationsUpfrontFee",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.mineralystx.com/role/AccruedLiabilitiesDetails",
     "longName": "9955526 - Disclosure - Accrued Liabilities (Details)",
     "shortName": "Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "mlys:AccruedResearchAndDevelopmentCostsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "mlys:AccruedResearchAndDevelopmentCostsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails",
     "longName": "9955527 - Disclosure - Capital Stock - Schedule of Authorized Shares of Common Stock (Details)",
     "shortName": "Capital Stock - Schedule of Authorized Shares of Common Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "mlys:ScheduleOfCommonStockAuthorizedTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "mlys:ScheduleOfCommonStockAuthorizedTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.mineralystx.com/role/CapitalStockNarrativeDetails",
     "longName": "9955528 - Disclosure - Capital Stock - Narrative (Details)",
     "shortName": "Capital Stock - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-23",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-23",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails",
     "longName": "9955529 - Disclosure - Stock-Based Compensation - Schedule of Options by Plan (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Options by Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails",
     "longName": "9955530 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-72",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails",
     "longName": "9955531 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Reported in Statement of Operations (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Stock-Based Compensation Reported in Statement of Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mlys-20260331.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "mlys_A2020EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "A2020EquityIncentivePlanMember",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2020 Plan",
        "label": "2020 Equity Incentive Plan [Member]",
        "documentation": "2020 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_A2023EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "A2023EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for grant under the ESPP",
        "label": "2023 Employee Stock Purchase Plan [Member]",
        "documentation": "2023 Employee Stock Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_A2023IncentiveAwardPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "A2023IncentiveAwardPlanMember",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2023 Plan",
        "label": "2023 Incentive Award Plan [Member]",
        "documentation": "2023 Incentive Award Plan"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_A2025IncentiveAwardPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "A2025IncentiveAwardPlanMember",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025 Inducement Plan",
        "label": "2025 Incentive Award Plan [Member]",
        "documentation": "2025 Incentive Award Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/AccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Liabilities",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r25",
      "r701"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r507"
     ]
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accretion of discount on held-to-maturity securities",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedEmployeeBenefitsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/AccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/AccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation and benefits",
        "label": "Accrued Employee Benefits, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.mineralystx.com/role/AccruedLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/AccruedLiabilitiesDetails",
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/AccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/AccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees and other",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "mlys_AccruedResearchAndDevelopmentCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "AccruedResearchAndDevelopmentCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/AccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/AccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses",
        "label": "Accrued Research And Development Costs, Current",
        "documentation": "Accrued Research And Development Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r507",
      "r729"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional \u2028Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r632",
      "r633",
      "r634",
      "r635",
      "r709",
      "r731"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r206"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r46"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r530",
      "r540",
      "r550",
      "r582"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r533",
      "r543",
      "r553",
      "r585"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r534",
      "r544",
      "r554",
      "r578",
      "r586",
      "r590",
      "r598"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r243",
      "r252"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r55",
      "r71",
      "r85",
      "r86",
      "r87",
      "r117",
      "r124",
      "r133",
      "r134",
      "r143",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r265",
      "r267",
      "r325",
      "r351",
      "r352",
      "r357",
      "r415",
      "r477",
      "r478",
      "r483",
      "r507",
      "r509",
      "r510",
      "r521",
      "r668",
      "r669",
      "r714"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r75",
      "r85",
      "r86",
      "r87",
      "r143",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r265",
      "r267",
      "r325",
      "r507",
      "r668",
      "r669",
      "r714"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_AtTheMarketMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "AtTheMarketMember",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails",
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At the Market",
        "label": "At the Market [Member]",
        "documentation": "At the Market"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position Location, Balance [Axis]",
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r324",
      "r497",
      "r498",
      "r610",
      "r726"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position Location, Balance [Domain]",
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r324",
      "r497",
      "r498",
      "r610",
      "r726"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r627"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails": {
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r359",
      "r391",
      "r410",
      "r507",
      "r509",
      "r510",
      "r521",
      "r612"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets",
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Total cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r69",
      "r463"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r710",
      "r711"
     ]
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsLineItems",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails",
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Line Items]",
        "label": "Cash and Cash Equivalents [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsMember",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents - beginning",
        "periodEndLabel": "Cash and cash equivalents - ending",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r38",
      "r84"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r38"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails": {
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r725"
     ]
    },
    "mlys_CatalysPacificFundLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "CatalysPacificFundLPMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Catalys Pacific Fund, LP [Member]",
        "documentation": "Catalys Pacific Fund, LP"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails",
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r119",
      "r172",
      "r178",
      "r179",
      "r180",
      "r182",
      "r185",
      "r190",
      "r192",
      "r285",
      "r384",
      "r385",
      "r386",
      "r387",
      "r484",
      "r609",
      "r628",
      "r629"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "mlys_CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development milestone payments",
        "label": "Collaborative Arrangement, Rights and Obligations, Developmental Maximum Aggregate Milestone Payments",
        "documentation": "Collaborative Arrangement, Rights and Obligations, Developmental Maximum Aggregate Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_CollaborativeArrangementRightsAndObligationsExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "CollaborativeArrangementRightsAndObligationsExpirationPeriod",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration period",
        "label": "Collaborative Arrangement Rights And Obligations Expiration Period",
        "documentation": "Collaborative Arrangement Rights And Obligations Expiration Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First commercial milestone payments",
        "label": "Collaborative Arrangement, Rights and Obligations, First Commercial Sale Maximum Aggregate Milestone Payments",
        "documentation": "Collaborative Arrangement, Rights and Obligations, First Commercial Sale Maximum Aggregate Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_CollaborativeArrangementRightsAndObligationsNonCompetePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "CollaborativeArrangementRightsAndObligationsNonCompetePeriod",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-compete period",
        "label": "Collaborative Arrangement Rights And Obligations, Non-compete Period",
        "documentation": "Collaborative Arrangement Rights And Obligations, Non-compete Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_CollaborativeArrangementRightsAndObligationsRoyaltyPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "CollaborativeArrangementRightsAndObligationsRoyaltyPercentage",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalties percentage",
        "label": "Collaborative Arrangement Rights And Obligations Royalty Percentage",
        "documentation": "Collaborative Arrangement Rights And Obligations Royalty Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second commercial milestone payment",
        "label": "Collaborative Arrangement, Rights and Obligations, Second Commercial Sale Maximum Aggregate Milestone Payments",
        "documentation": "Collaborative Arrangement, Rights and Obligations, Second Commercial Sale Maximum Aggregate Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_CollaborativeArrangementRightsAndObligationsTerminationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "CollaborativeArrangementRightsAndObligationsTerminationPeriod",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination period",
        "label": "Collaborative Arrangement Rights And Obligations, Termination Period",
        "documentation": "Collaborative Arrangement Rights And Obligations, Termination Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_CollaborativeArrangementRightsAndObligationsUpfrontFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "CollaborativeArrangementRightsAndObligationsUpfrontFee",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront fee",
        "label": "Collaborative Arrangement, Rights and Obligations, Upfront Fee",
        "documentation": "Collaborative Arrangement, Rights and Obligations, Upfront Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement."
       }
      }
     },
     "auth_ref": [
      "r704"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 4)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r51",
      "r358",
      "r401"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r150",
      "r151",
      "r458",
      "r665",
      "r667"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r512",
      "r513",
      "r515",
      "r516",
      "r517",
      "r518",
      "r632",
      "r633",
      "r635",
      "r709",
      "r728",
      "r731"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock par value (in USD per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r402"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheetsParenthetical",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r28",
      "r402",
      "r421",
      "r731",
      "r732"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.0001 par value; 500,000,000 shares authorized as of March\u00a031, 2026 and December\u00a031, 2025; 82,454,950 and 81,536,557 shares issued and outstanding as of March\u00a031, 2026 and December\u00a031, 2025, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r170",
      "r175",
      "r360",
      "r507"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r322"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r89",
      "r90",
      "r165",
      "r180",
      "r339",
      "r345",
      "r355",
      "r464",
      "r465",
      "r466",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r705",
      "r706",
      "r707",
      "r708"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets",
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlowsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investments",
        "terseLabel": "Investments",
        "label": "Debt Securities, Current",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading), classified as current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r140",
      "r141",
      "r349"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents and Investments",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r349",
      "r644",
      "r648"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesHeldToMaturityFairValueAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated Fair Value",
        "label": "Debt Securities, Held-to-Maturity, Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesHeldToMaturityFairValueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesHeldToMaturityFairValueCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails": {
       "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents and Investments",
        "label": "Debt Securities, Held-to-Maturity, Fair Value, Current",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), classified as current."
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredChargesPolicyTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Offering Costs",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_DeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesDeferredOfferingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs",
        "label": "Deferred Offering Costs",
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r664"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r82",
      "r117",
      "r125",
      "r134",
      "r467",
      "r477",
      "r478"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r208",
      "r239",
      "r240",
      "r241",
      "r491"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Options by Plan",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share attributable to common stockholders - basic (in USD per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r81",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r103",
      "r107",
      "r109",
      "r111",
      "r112",
      "r113",
      "r116",
      "r168",
      "r242",
      "r260",
      "r263",
      "r298",
      "r299",
      "r350",
      "r366",
      "r472"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share attributable to common stockholders - diluted (in USD per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r81",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r103",
      "r109",
      "r111",
      "r112",
      "r113",
      "r116",
      "r168",
      "r242",
      "r260",
      "r263",
      "r298",
      "r299",
      "r350",
      "r366",
      "r472"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r115"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares available for grant under the ESPP",
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails",
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding options",
        "verboseLabel": "Common stock options outstanding",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r60",
      "r61",
      "r62",
      "r78",
      "r79",
      "r80",
      "r91",
      "r92",
      "r93",
      "r95",
      "r102",
      "r104",
      "r106",
      "r118",
      "r144",
      "r145",
      "r146",
      "r167",
      "r193",
      "r242",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r263",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r338",
      "r365",
      "r372",
      "r373",
      "r374",
      "r389",
      "r440"
     ]
    },
    "mlys_EquityIncentivePlan2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "EquityIncentivePlan2023Member",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for grant under the 2023 Plan",
        "label": "Equity Incentive Plan 2023 [Member]",
        "documentation": "Equity Incentive Plan 2023"
       }
      }
     },
     "auth_ref": []
    },
    "mlys_EquityIncentivePlan2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "EquityIncentivePlan2025Member",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for grant under the 2025 Inducement Plan",
        "label": "Equity Incentive Plan 2025 [Member]",
        "documentation": "Equity Incentive Plan 2025"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r530",
      "r540",
      "r550",
      "r582"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r527",
      "r537",
      "r547",
      "r579"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Financial Instruments Measured at Fair Value Hierarchy",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r710",
      "r711"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r310",
      "r311",
      "r313",
      "r318",
      "r340",
      "r341",
      "r342",
      "r462",
      "r481",
      "r482",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r500",
      "r502",
      "r506"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r302",
      "r306",
      "r308",
      "r309",
      "r310",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r348",
      "r500",
      "r503"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r195",
      "r200",
      "r201",
      "r301",
      "r311",
      "r318",
      "r340",
      "r462",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r500",
      "r506"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r310",
      "r311",
      "r313",
      "r318",
      "r340",
      "r341",
      "r342",
      "r462",
      "r481",
      "r482",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r500",
      "r502",
      "r506"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r534",
      "r544",
      "r554",
      "r586"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r534",
      "r544",
      "r554",
      "r586"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r534",
      "r544",
      "r554",
      "r586"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r534",
      "r544",
      "r554",
      "r586"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r534",
      "r544",
      "r554",
      "r586"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r424"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "HeldToMaturitySecuritiesFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Debt Securities, Held-to-Maturity, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r142",
      "r301",
      "r310",
      "r319",
      "r320",
      "r323",
      "r349",
      "r356"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "HeldToMaturitySecuritiesTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Held-to-Maturity U.S. Treasury Bills",
        "label": "Debt Securities, Held-to-Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r270",
      "r275",
      "r276",
      "r284",
      "r305",
      "r307",
      "r312",
      "r326",
      "r327",
      "r328",
      "r369",
      "r371",
      "r425",
      "r461",
      "r462",
      "r492",
      "r493",
      "r498",
      "r499",
      "r501",
      "r506",
      "r702",
      "r703",
      "r727"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r149",
      "r270",
      "r275",
      "r276",
      "r284",
      "r305",
      "r307",
      "r312",
      "r326",
      "r327",
      "r328",
      "r369",
      "r371",
      "r425",
      "r461",
      "r462",
      "r492",
      "r493",
      "r498",
      "r499",
      "r501",
      "r506",
      "r702",
      "r703",
      "r727"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedInterestReceivableNet",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accrued interest receivable",
        "label": "Increase (Decrease) in Accrued Interest Receivable, Net",
        "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid, other current assets, and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r534",
      "r544",
      "r554",
      "r578",
      "r586",
      "r590",
      "r598"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r526",
      "r602"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r526",
      "r602"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r526",
      "r602"
     ]
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income, net",
        "label": "Interest Income (Expense), Nonoperating",
        "documentation": "Amount of interest income (expense) classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r496",
      "r624",
      "r639"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r380",
      "r381",
      "r382",
      "r383",
      "r446",
      "r447"
     ]
    },
    "us-gaap_InvestmentsAndCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentsAndCash",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlowsParenthetical",
      "http://www.mineralystx.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, cash equivalents, and investments",
        "label": "Investments and Cash",
        "documentation": "Sum of investments and unrestricted cash as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r725"
     ]
    },
    "us-gaap_InvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentsMember",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investments [Member]",
        "documentation": "Assets held for their financial return, rather than for the entity's operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r52",
      "r362",
      "r507",
      "r509",
      "r510",
      "r628",
      "r631",
      "r663",
      "r713"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r68",
      "r85",
      "r86",
      "r87",
      "r143",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r266",
      "r267",
      "r268",
      "r325",
      "r507",
      "r668",
      "r714",
      "r715"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "mlys_MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale",
     "crdr": "credit",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common shares available for sale",
        "label": "Maximum Aggregate Offering Price Of Remaining Common Shares Available For Sale",
        "documentation": "Maximum Aggregate Offering Price Of Remaining Common Shares Available For Sale"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails",
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r123",
      "r152",
      "r153",
      "r154",
      "r155",
      "r203",
      "r234",
      "r235",
      "r236",
      "r253",
      "r304",
      "r346",
      "r368",
      "r370",
      "r377",
      "r393",
      "r394",
      "r445",
      "r448",
      "r449",
      "r450",
      "r451",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r460",
      "r480",
      "r484",
      "r490",
      "r492",
      "r494",
      "r495",
      "r502",
      "r503",
      "r504",
      "r505",
      "r508",
      "r670",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r123",
      "r152",
      "r153",
      "r154",
      "r155",
      "r203",
      "r234",
      "r235",
      "r236",
      "r253",
      "r304",
      "r346",
      "r368",
      "r370",
      "r377",
      "r393",
      "r394",
      "r445",
      "r448",
      "r449",
      "r450",
      "r451",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r460",
      "r480",
      "r484",
      "r490",
      "r492",
      "r494",
      "r495",
      "r502",
      "r503",
      "r504",
      "r508",
      "r670",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r672",
      "r673"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows",
      "http://www.mineralystx.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "negatedLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.mineralystx.com/role/CondensedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows",
      "http://www.mineralystx.com/role/CondensedStatementsofOperations",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity",
      "http://www.mineralystx.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "negatedTerseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r40",
      "r53",
      "r62",
      "r66",
      "r76",
      "r77",
      "r80",
      "r85",
      "r86",
      "r87",
      "r88",
      "r94",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r105",
      "r106",
      "r110",
      "r143",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r168",
      "r171",
      "r173",
      "r176",
      "r242",
      "r260",
      "r263",
      "r299",
      "r325",
      "r364",
      "r422",
      "r438",
      "r439",
      "r468",
      "r470",
      "r471",
      "r519",
      "r668"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r534",
      "r544",
      "r554",
      "r578",
      "r586"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r638"
     ]
    },
    "mlys_OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public offering and shelf offering costs included in accounts payable and accrued liabilities",
        "label": "Offering Costs Incurred During Noncash or Partial Noncash Transaction",
        "documentation": "Offering Costs Incurred During Noncash or Partial Noncash Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r471"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r468",
      "r471",
      "r474",
      "r637",
      "r639",
      "r640",
      "r641",
      "r642"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r611",
      "r626"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/NatureofBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Business",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r63",
      "r64",
      "r65",
      "r378",
      "r379"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Line Items]",
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Table]",
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense)",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r496"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r532",
      "r542",
      "r552",
      "r584"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r535",
      "r545",
      "r555",
      "r587"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r535",
      "r545",
      "r555",
      "r587"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of shelf offering costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Held-to-Maturity Securities",
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r139"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r571"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "mlys_PreFundedWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "PreFundedWarrantMember",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-funded warrants issued and outstanding",
        "label": "Pre-Funded Warrant [Member]",
        "documentation": "Pre-Funded Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "mlys_PriorATMAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "PriorATMAgreementMember",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior ATM Agreement",
        "label": "Prior ATM Agreement [Member]",
        "documentation": "Prior ATM Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock pursuant to ATM Agreement, net of issuance costs and Proceeds from issuance of common stock public offering, net of offering costs",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "mlys_ProceedsFromIssuanceOfCommonStockNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "ProceedsFromIssuanceOfCommonStockNet",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate net proceeds",
        "label": "Proceeds From Issuance Of Common Stock, Net",
        "documentation": "Proceeds From Issuance Of Common Stock, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of equity",
        "label": "Proceeds from Issuance or Sale of Equity",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r384"
     ]
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturities of marketable securities",
        "label": "Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities",
        "documentation": "The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r643"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from stock option exercises",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r337",
      "r354",
      "r363",
      "r507"
     ]
    },
    "mlys_PublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "PublicOfferingMember",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Offering",
        "label": "Public Offering [Member]",
        "documentation": "Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails",
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r123",
      "r152",
      "r153",
      "r154",
      "r155",
      "r194",
      "r203",
      "r234",
      "r235",
      "r236",
      "r241",
      "r253",
      "r304",
      "r343",
      "r344",
      "r346",
      "r368",
      "r370",
      "r377",
      "r393",
      "r394",
      "r445",
      "r448",
      "r449",
      "r450",
      "r451",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r460",
      "r480",
      "r484",
      "r490",
      "r492",
      "r494",
      "r495",
      "r502",
      "r503",
      "r504",
      "r505",
      "r508",
      "r513",
      "r666",
      "r670",
      "r712",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails",
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r123",
      "r152",
      "r153",
      "r154",
      "r155",
      "r194",
      "r203",
      "r234",
      "r235",
      "r236",
      "r241",
      "r253",
      "r304",
      "r343",
      "r344",
      "r346",
      "r368",
      "r370",
      "r377",
      "r393",
      "r394",
      "r445",
      "r448",
      "r449",
      "r450",
      "r451",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r460",
      "r480",
      "r484",
      "r490",
      "r492",
      "r494",
      "r495",
      "r502",
      "r503",
      "r504",
      "r505",
      "r508",
      "r513",
      "r666",
      "r670",
      "r712",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r527",
      "r537",
      "r547",
      "r579"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r89",
      "r90",
      "r165",
      "r180",
      "r339",
      "r345",
      "r355",
      "r464",
      "r465",
      "r466",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r705",
      "r706",
      "r707",
      "r708"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r461",
      "r468",
      "r469",
      "r477",
      "r722"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r528",
      "r538",
      "r548",
      "r580"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r529",
      "r539",
      "r549",
      "r581"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r536",
      "r546",
      "r556",
      "r588"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r625",
      "r723",
      "r725"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails",
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested restricted stock awards",
        "verboseLabel": "Unvested Restricted Stock Awards",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r636",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails",
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested restricted stock units",
        "verboseLabel": "Restricted stock units outstanding",
        "netLabel": "Unvested Restricted Stock Units",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets",
      "http://www.mineralystx.com/role/NatureofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedTerseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r46",
      "r361",
      "r375",
      "r376",
      "r388",
      "r403",
      "r507"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated \u2028Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62",
      "r91",
      "r92",
      "r93",
      "r95",
      "r102",
      "r104",
      "r106",
      "r144",
      "r145",
      "r146",
      "r167",
      "r242",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r263",
      "r286",
      "r288",
      "r289",
      "r291",
      "r297",
      "r335",
      "r336",
      "r372",
      "r374",
      "r389",
      "r731"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "mlys_SaleOfStockConsiderationReceivableOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "SaleOfStockConsiderationReceivableOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum aggregate offering price",
        "label": "Sale Of Stock, Consideration Receivable On Transaction",
        "documentation": "Sale Of Stock, Consideration Receivable On Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds of sale of stock",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails",
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share (in USD per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "mlys_SaleOfStockPricePerShareWeightedAveragePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "SaleOfStockPricePerShareWeightedAveragePrice",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share (in USD per share)",
        "label": "Sale of Stock, Price Per Share, Weighted Average Price",
        "documentation": "Sale of Stock, Price Per Share, Weighted Average Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/AccruedLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Liabilities",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Potential Common Shares Excluded From Calculation of Net Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "presentation": [
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofFinancialInstrumentsMeasuredatFairValueHierarchyDetails",
      "http://www.mineralystx.com/role/FairValueofFinancialInstrumentsScheduleofHeldtoMaturityUSTreasuryBillsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]",
        "label": "Cash and Cash Equivalent [Table]",
        "documentation": "Disclosure of information about cash and cash equivalent by type. Excludes restricted cash and cash equivalent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "mlys_ScheduleOfCommonStockAuthorizedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "ScheduleOfCommonStockAuthorizedTableTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Authorized Shares of Common Stock",
        "label": "Schedule of Common Stock Authorized [Table Text Block]",
        "documentation": "Schedule of Common Stock Authorized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Reported in Statement of Operations",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails",
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r207",
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r241"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails",
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r44",
      "r45",
      "r46",
      "r72",
      "r73",
      "r74",
      "r119",
      "r178",
      "r179",
      "r180",
      "r182",
      "r185",
      "r190",
      "r192",
      "r285",
      "r384",
      "r385",
      "r386",
      "r387",
      "r484",
      "r609",
      "r628",
      "r629"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r135",
      "r136",
      "r475",
      "r476",
      "r479"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofStockBasedCompensationReportedinStatementofOperationsDetails",
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentialCommonSharesExcludedFromCalculationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r207",
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r241"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested Restricted Stock (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares Available for Grant (in shares)",
        "terseLabel": "Shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options Outstanding (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative shares issued (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockScheduleofAuthorizedSharesofCommonStockDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.mineralystx.com/role/StockBasedCompensationScheduleofOptionsbyPlanDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r212",
      "r231",
      "r232",
      "r233",
      "r234",
      "r237",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r28",
      "r31",
      "r32",
      "r60",
      "r61",
      "r62",
      "r78",
      "r79",
      "r80",
      "r91",
      "r92",
      "r93",
      "r95",
      "r102",
      "r104",
      "r106",
      "r118",
      "r144",
      "r145",
      "r146",
      "r167",
      "r193",
      "r242",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r263",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r338",
      "r365",
      "r372",
      "r373",
      "r374",
      "r389",
      "r440"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92",
      "r93",
      "r118",
      "r169",
      "r170",
      "r172",
      "r174",
      "r336",
      "r347",
      "r380",
      "r390",
      "r392",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r440",
      "r470",
      "r471",
      "r514",
      "r730"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92",
      "r93",
      "r118",
      "r137",
      "r169",
      "r170",
      "r172",
      "r174",
      "r336",
      "r347",
      "r380",
      "r390",
      "r392",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r423",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r440",
      "r470",
      "r471",
      "r514",
      "r730"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r531",
      "r541",
      "r551",
      "r583"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of offering costs (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r27",
      "r28",
      "r46",
      "r384",
      "r440",
      "r452"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock from stock option exercises (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r27",
      "r28",
      "r46",
      "r218"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of offering costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r27",
      "r28",
      "r46",
      "r389",
      "r440",
      "r452",
      "r520"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock from stock option exercises",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r28",
      "r31",
      "r32",
      "r46"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.mineralystx.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.mineralystx.com/role/CondensedBalanceSheets",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r31",
      "r32",
      "r41",
      "r404",
      "r421",
      "r441",
      "r442",
      "r507",
      "r521",
      "r628",
      "r630",
      "r631",
      "r663",
      "r713",
      "r731"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Stock",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r177",
      "r179",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r193",
      "r285",
      "r296",
      "r443",
      "r444",
      "r453"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.mineralystx.com/role/CapitalStockNarrativeDetails",
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquity",
      "http://www.mineralystx.com/role/CondensedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowElementsAbstract",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Disclosure of Non-Cash Financing Activities:",
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "mlys_TanabeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.mineralystx.com/20260331",
     "localname": "TanabeMember",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tanabe",
        "label": "Tanabe [Member]",
        "documentation": "Tanabe"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.mineralystx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.mineralystx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.mineralystx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59",
      "r120",
      "r121",
      "r122",
      "r123",
      "r351",
      "r353",
      "r473"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r113"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.mineralystx.com/role/CondensedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders - basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r113"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "181",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-181"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "SubTopic": "310",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480341/340-10-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r717": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r718": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r719": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r720": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r721": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r722": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r727": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>58
<FILENAME>0001933414-26-000084-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001933414-26-000084-xbrl.zip
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M+Y[AF:R/6ZL&R__E$__RET]\ZJ&MS_N_Z,:+Y'ISD_U:T0UW9FKS*\NV&"S
M>+O"@<SA'PU=9Q9]A-]_ "-QC!%__YOWP,:_5D95@)"E37$F9ES=6/"Z^36L
M#F!Y:^GL[3_9O"(9<"KCJMJI].N QKU&HZDT?_F4F'6+EP0L[:OACC3S?YCF
M?(5OW/ UW4H?MY_7"^YAN*TG7]&K]/]+V?T% YA=IS>8VG-%XNS@UPKPCZNQ
M\<;TZE@S$9?XVQKU2O\K?K'["Z]]QTE [,;2OX X2+Y;AV^J4YAE4M6U\-B
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M*%744\&G)5[[;OB$-<!:'5EI+Q=Y?G=\NEBG/X\0V2&#I;RZWT7YC=^QW!"
MMZ4:K C6Z,I*;EIO&2ERPNBV05/>']VP+%BS+;=[9:A(P7FXN7-68L8P"-%V
M<#$O].*RQ_.$REDPH>S!D0-+WYLE=>JY%6_(\22/9,24I%N2[OM$FN9"NDIN
M!2..3+JD:WRBKKR[M35.*!.-]H$"?VBR*W2.&J/UF$.=CY\F3-)&(WL*"\$>
M-9)E>ZA-4.-CR8!U/SMT"^)X>)GL39C+$*%$T^=QV)W;#;MSK^Y7'6]X/[-=
M\NA>.<S4\+8YZE[\[\D(*@'3>O2(-H1S];W5CQ2RR;22UF1^^P[FO;"#^22L
M;3+3GEEUZ##M]ZHVALU=:>:K-G<1;>-0 9#$CR S]%;#:CP^!*SX:0%/L1WJ
M;G\%7( Y. I6HA5A&=+$06[ZI\T'IF)![R=J  [T@[&]O(&0UD]#AV(U=S_]
MIO2/(5="Z-_-&#_)U>WI"\ GLC>CUS5/VZ(3?1&88%JWW8T+QWI-1$&A1" A
M#\LUM9G+KH(/GX/ ;L.B-]-#GY/3M9:-> (+_SGBB1C]B7Q1>!?$F]>WF&_W
M:FJCL:E;?2%#X+-N46G4FO7TGV);S/A]L]W>ZHFUBUK_\GRZ7>]_ KVE5Z98
M6H5J'/X$HHY)WV'<Q)5N@+'J!V@C?HF I<!,J:'(A83G84:=4KOX]%/#^-DL
MN3'9&\"?,:1:VZ#V^=ZX"KT3K&O&&VIE*B976!K>_9[G6 EA6ZSL8N.Q'IC+
M2"*AC:&S%V;:U%3B5#!U[X">D_9OGY^?6EGOIP[0=6#I7R)D%0T+MW52JR"M
MFG*CW2I(X/T[7!.5Y'#\;6U##JUW) =LD]&1NYWE*+TR#^5=$>2OC!RP))(U
M?6I8ANLY=%MR*E*YS&[((,O$,0/M#A*'O"/Y-M'VDGN=O:59F213+#3:( -R
M1B-L]2"WVN?8.J[1.2$AP&/]["4?PEF)@,SEE\Z/JC<(A]!Y),C8W9:.,8FG
M)3>:93_I$MDVB9"]D0TS?)IRL[EW#?"#(]O%>J._V:XKC1U[&LB4>#S$.<B2
M,TL.V2JW;TF8K,CM"PG]UAK94X8XL2VI=U?*E>RY?&5"TAG@W)),.1S.]5:*
MEP+A7.'K719UU,7>O=WBM3US/<D@RI EBYW,O=LV&O=I,<$<C;C@@#GG$\KU
M#]L*K?H?;-MD^FZ]TF_)O<*TA"CK,[R/B78(5%*P<9/:.)'[GF*QO2*-NMB+
MLCMOPAPA/:4/PD.:I53^\<^LO-W(Z ?%(X[SN00#3&%J*LC'@MQ=E#=@[VYK
M;HLM&/.POU%97G+M=\D58^-G:P2=BX\H1]Z^AE"W4V2;>&>=5K:_:+</Y577
ML>VHW'"NQ8VGG.L;E#=>^6$-6,22:;LG<\MUP%N&TXSJW6[?A>5>![G) ^3>
M^3ZEVP:MMR<W4CP_!;I/R<%Z*BFJI*C,MN->%(4!,* .*,LJ:($HZF+K)@::
M0*R(AN9YCC'T>8$)SP9X1,W11.4K61IJKC'BF7$&5A[23UZ56-8V%TMIG2GG
MVW+CI\GZ5O7*2R@5ZDH.&%3\#J;Y#=&_LM2OJKNN7UG^J_C"22]E'3ULUY<2
M%+)_E?&,:%+0)+^2NB^*NENY4G=O7:>\_%>QDKI["E)W2C)BH:G[8ITM_Z _
MF%[58$':,PN:%/I8CPT;:=G3F4^)+-:E*6,[1))N+G.Z-6,O%)_;LA6GLK85
M9X!Z XYY/WSL;WDW7FK+*1C>5KTY>^K[+%:PP7U;B?8:U*ZUVVC*G=9RU>Q\
M*_OOAZ0G<*%>$F,:?K>.1XSK6H7GN-B\B+%5Z;<:LM)NR*U6AI;B)T:,967L
MLC+V7D5AU5PJ8RMJ'I6QVXVR,O8^RR@K8Q>CMO1VE;$?4SH'W20[!YU8I>SU
MM;&+L/CLE;!1:*]BU>];&+O7JW6[W6WK8C>[-16?.LVZV$4=M0J."]^KS68N
M1;:[M5:GDU/A[W)-Y9I@3=WU,PD7ZH*.W.#] ,ZQ.G911V4$:SDLIV'IB*^T
MSA?SUR[_]$K[7_-K"]*J,UQ.;#H\QWY==%6>"B0&L$RT$#53^F7H?.K?:X9>
MO;6D:VV&GIAUP%FSZW,$5-1<G4-*M%@O(91,$2+89#!78PT'%OFH>KY\M*BC
M+J;I!;\J*!N$9&)Y4]O/U%]@_R8-Z<$510UW^DTS-6O$)(U\<U_8B.%U%+8*
MDM2ZVCRY<(?BCRH+@N5[-=Q>>]O*U6,2XGM?K6)UTYX,*H#<4_)*]R]368Z/
M<!>7RK)-)DM[?6IK6M?NQ4257B>_\A@EO1P??4IZ64,OG>WI9:NLKQ[60NTU
MY$YG[R+;)4D5!L,NCJ2VRJ;L9LRFW)^X>I5^HZ[*+66Y%46!<BI+NBKI*@=1
MU3NPJ((55?I*3Y'5UMXU^D\E3SDS(<1";\0451Q_=:B0U/5%@5W7)S>0/4[D
MP6 2S<P?FL8(?AG#W-8SU<K"<<$7\(#+([O^O%7-B?IZ[!OH__1=CZ+&GNSH
M:@<O=6XM<:5#&(IK9WJP@VM<S-9XJ@"> M>OIR5^)>(#2S?8X=Q@9;7>#'D^
MZQ-]8@3QQ4?BO(=5V2*I !9+/V4DCWI$'BJ01U/NU3MRLU[6@#YEK$ICQ!L*
MYJW J;]KIL]B*+7,5!N -26RG!FRJ+D@RY;BN0F8U.W*G=SZBI7X=$!\HB@)
M]7-Y,H4[F3SU\\-0>BN@]*)(CCQK*Z0522X(9JPT *EY&_]HSPAIV!MS1L8I
M-@4M_JBR3/M.1E%C=Z.(?KPCS'9O!&;K6QM(;320VF@AE5T BH]>NRDHY<D4
M3$%I[JZ@K*#Z97VD@X[!Y68-)>H4#G5*HB[JR>182#\7FNX6B:;+_F/EJ#,=
ME6?EYP*;SL1WJD,-*UU@"1]FN52HI#2/RSO#(JDZI8.U/)G+/9D\+<M,H2GH
M72*A<!V3"0_L#]]P#8\],N?%&#&NOCZPD?ULT2RDR6[M-<>H1;G=W#O&OD3$
MDD5<[LGD:*<6C4,H]6)QB NY53NU9G G-*KTK95>S_)DRI,I3^:,3F:[II7O
MT6-/493\FNR5N%,4W'D?U%&+@SKOG=WTSH>?K&+S77-&DZ"$3:M4OD_'#Y^Y
MK\0E%;A1WJW"C:(T*OUV4^YVVK*J+J= []5E?J]#/9*SZVCX6B3FNFM'Q/V@
M<GK4FZ:CYE ]1U&:0)0E+9:T6-+B7K1XZ,H\"EBD_7871&>G%)TEN9;DNJ=_
MY]VJ_B@@ION-9E/NJ,L%('9M]%O2;$FSYT"S6Y'LP2L*@1 '2E7D5BNOJ^QC
MD6L9^%V..M-1)6J7H\YT5(G:Y:@S'56B=CGJ3$>5J%V..M-1)6J7H\YT5(G:
MY:@S'56B=CGJ3$>5J%V..M-1)6J7H\YT5(G:Y:@S'56B=CGJ3$>5J%V..M-1
M)6J7H\YT5(G:Y:@S'56B=CGJ3$<1:G_RM*')@FZ@L1:N4\UY-JP@BKR7S&X8
M,<MCC@C=[_\R=#XMM!7=>B):1O"(B%&'/9C:S&57P8?/P18,B\+ZZ:'/R1>T
M9DLAZO0^_O/G5T/W)E>]7JW;[6(N@"!M\6+^JU*K_[L 8^+[9K>FXE,I/]5K
MRK\7^:P+/&H5'!>^5YO-39#/=(C=6JO3V6JF<DWEFM:NJ;M^)J%"!#\&N4@M
M:HN=3B9KJXX4C'ZW77YO:5A*^AR7"P?/&.LN)(QU4A/&>#T2B7*],M3>V71X
MCOW*/ZM9()&UY?HJZ?Q^8(JJPDJD$6!MV.JM)8GJL)O[CJ\!3#ZP+!16#48C
M?^J;FL=T#J\O;&R,#&\=AET6A)YL+\"E>)XE53OL?)9XOF4"7"M8K7J^K+:H
MHS*"-7,V:F&1E%>HRB 6-F_U[&$UF-J^M9;!K<*>G,IK%S5#/UGM[PL;L>F0
M.67!O\.-.EB-T0LMZ:?6WZ^D7[?2[RIRJ]&66ZV\VM,>OXK)&OP[(,X5B0MF
MKU.RW;Y/C\92*I&H6;K7;RR\UP/2*2FFI)B+H!CET+5[@";[BJS4&W*WU2S)
MJB2K4R6KK<K8J>J[E;%3L5=!JR,K[7W*V)6451A$NSC*VH:P-C1IS(&<5"R&
MWI;;O;R:A1^MFESN_1UB5REBBBJ.OU+#20Q+9Y9W5>V1-_F=\0A;Q).+R!X#
M..@^RD5\D&:^@[]XDF=+@Z?OTN#980S[],F2Q3P<;@2/CFS7<R4PNB5WPLPQ
M_#9FV')>_ !#_[R5'&CDT#(0]X![8WJPPVM<3!KR-L!V49?P=O.U4L$]444=
M5?;0W,D/UESK!XOA^Q<?:8]WP^0^,5@L_>1NZQ&#E_9;[:[<4.L%:8=9HE39
M,/<$3V8K\;>A8^X*4J=NMUM2>DP(MBI]M2XKW;W]WB4ZE81^N2>3IYY[&$)O
M%XS0\VQPK:HIAMFBC5445%EI>8T=>RH^VC/"(O;&G)'A9@H'*:K:7]1195/0
MG<R1]9WVUIHC].,=8;9[(S!;W]HTP?8&K;I<[^3E<BJ L_9\T:OL)%W4D]E*
M8\G2&&R%QK('U<>TEVZEWY3K^[<T*3&KI/G+/9FM.A4=F^1[Q2+Y,G&[''6F
MHW*Z&CT]4YP8576H 7M"4WS&+%=#%E.:V^7M7Y%TH]*#6Y[,Y9Y,GI9JIA@2
M]%:14+B.R80']H=ON(;''IGS8HP8UW<?V,A^MF@64GVWU7(;]4J_+;>:>;7#
M+A&Q9!$7>#(Y&K:%XQ!*L3C$Q=[;_6">9-IN>1=7WL452KZ4CM/R9,J3*4^F
M:">S70Y8-V,.&$CA6VMD3]DW$,5;ZU)JI=_HR8U&#ME?)>X4!7>6%/J#H$ZC
M.*CSWJE,[WSXR>(UWS5G- DJU[1+Y?MT//,BET_4T6T HNNVCU5Y*9_O4NO:
M]-ZMKDVCB0EN<K/5E'NMO!)Y\CC4([F_CH:O16*NV1.F\X3*Z5%OFH[:RZ%B
M3J.50\6<DA9+6KQL6FSL4+UJ2X6_3;5X&DVYW=R[%D])L"7!GA_!;F6E-[*:
MZ3F0;J?2;_;:<JN^+&FS&^LES98T>WXTNQ7)'ES&=BO]=J,K*R<O83/U/L+W
MKFM\E"\:T&17&*Y@C-8CADK%\2=,TD88!:M9<RSB8]D>O$ISX&M+,F"9SXYF
M2C/-H2) WH2Y6 $([^DQ?'9L6)HU,F"$ZVD>%0QR:RM[.(DWM^& /L]LEZ(C
MKAQF:I[QPD1/)8&OL:?$J=:C1[0AG*'OK7XD>]>I]Z%! G5CH<90[+^X="0.
MH]49*NUVI]EI*KVF6E>ZG5Y741MCUE7TQG#4^U]% 4M2/#4).Q3,M&=6'3I,
M^[VJC6%S5YKYJLU=1-$X5  D8D5=9-V9H;<:5N/Q(6#%3PL8B.U0B,T54#QS
M<!2L1"O",J2)@\SR3YL/3$5N]T1MR8!^KI'3 HW\\DE;+#FU2"SOBK%+A?8)
M8[_#-T#]<U<"-N%H,^8#&W1EZ=8:K2;R JS[.N1/CR%7(NAK[D3Z:MJO;C%6
MG\XG/A@6\%G;=S5+=S\6>J6^I?FZX3%]]3+3F,G[=ND#!E>K<R:W39N^=J^F
M-AJY-/=2&K5F/?VG[3N.-=OM_!:U_N4;;AS/K#_7$_!T)GV'<1-7N@$.HJ<U
M!;H08(3WK[G!(&;-GGP'FHQWTF6OGOY2WYD\ XE)3!4OD'A%^[_!X]^DK]_N
M_O$H?7VX^R[=W=\\#)YN?_Q5&EP_W?[]]NGVYO$J"U+M7D1W$[;M%(64[\KR
M3$HM*'IL%V>^=\;&27OE3L.[5L"XM5X.<6O%26$JB>#,B&"IZ.DAB*!9K_2;
MJJPJRO&)X +4GG2TB"7686UYAP$BC PP_RTA\/!;_#Q"YXR/3AO#DNP90Y^;
M]2SA@;T8GL'<O92C8ZM !U5T3BJA;NOJ&V7:ZIK+.(P6_6TQ)75K1EFP9-,R
MZ3DG[-E46SP?[,'T&KG=W+MD5P%%[4EQUL%HY##""7LLZ88[PC;)$OPY8:8.
MUG<5#M5W#&\NN6R$'XPU)8;+Y*)UU0("2 ^F-FSN7T0W=^,O N;NP-+O'38U
M_*E[:[TPH?]L35@-K(775I<)JTQ;.UG,VL"2WPFSFACE6F^VCX]9%ZL'?V$S
M,(8,.F#JIJ7%3KQ4AG?@RG&(PF>3TY&EQTDIC1A:H/T61'<I-=_WT7QW117,
M#C@1/??XB:>GOL#SM12N)YKU##,E/6VNRT1C1]/0AH99>MW6TFJC>4(GCGJE
M3[Y5CSF@-J(CEADO&%-5ZAK[7-/=6J"P:R[[POB_MY8 ]:V ]$,(Z!_,2Y,I
MG4I?[2[?TY4*R$GC3]8;KOWQIUOIMY8;VA92)\DJ4?=NM]QHS)9Y\?LC#)CJ
M,\W09<GV)LR11K[CP&*$I)5)U/)?^#<;FA!?MN-D@_&W3$<"^%_8F '8]9LW
M]' S4/+O$.0#@OC6CI,>.DYZ*3<EI4ON9#%K@ZWX/IC5PF %N=$[,Y?<J2G)
MY&259MJ<4A3(+2<TYYA-=#D:\T$BVU)5'@+\/8<[.F(XU+]%0$^C&05HIKZL
M^YQBB%N)0_NKS1EP:$NFK**X;^UU3U(LS?KT LA^9(D-V^<:^UQ*TATJ"AFS
M)N\=^\70F?[;_*>+INE=< :#\ BVIBU>6K/9V2<Z<ZLC/ $M^R)Q<8M@X$/A
M8A,4B9;<3&F37B!<%"(@6$$ \";/J<U1!<GP_ &2C=Y_91<@4[/EHMW^^/O-
M8YZY:&=]\5/0HU[A@O2=T0049"J ,-6<WYG(OM\O!/#\+9$-_D8P,X)N0:,_
M?,-A?V.F_F1_%R&6CR%XMY9%+="+FAVYV5QN=5\:MB>+3AN<C(=#)PQ943MR
MMU,:L<=#%7&.1MYL^"2=\WER8<<&".CN5\>>1C F_SRGIX&E7VNFZ=Z-<R.H
M#O#GNBJWZGL75R]O@HJ%;)MX]!&0K0O(UI+KA<&U4X_I*_P"S]<267+D&I3
MD(,C=Y/E?^;^LSU]N;?!,>SA/^M5^LVFW,O#9,E\BB=@SUPJ1N[IT<T!(]OU
M2K^GYF/U'!0C<W'J'KI.TUY^W:,L[@*D;#;7[M?;'X,?UWFX=G/RS^?^_/EI
M? <*B@WK8!\Y)I9;4=(8S"C)<%V?VO[98ZP&,K5Q*?;H=VGF._B+A^5A!D_?
MI<&SPZB2KTS58F X?AL^/K+=RXN?W:J-52.[<7LKH'HWCC6FVUH"*UC]45:5
MO:N*E&Z28J%20\T5E<;&&].K_V*.G89%:MCLN2!H='[BYO14GRR2A8L1>T;H
MS-Z8,S+<2[KL/)"7G0CXCJ#JW@BHZEO+!JIL4F\5)96ZO.9\?P_Z"D1:QA6L
M5:(N.Y8*F>!6>.Y?+K!<X+$7>&D&+[\=1)/5G3!S#!_&,)/U?)E&ZR&"L.[&
M)$T"8^,:X9HF2EH@2HZ?7U<:HN\<5)45/3!4:OFB_:3S+T_8@%OI&C0L:>8/
M36,4<M+0)[B"M9;&7MQ]DZ\G<+W[II.;^Z8T]8J%1LJ&7NSY.Y2[P)Z[/1GX
M=$%PZ=05\<(O\'P#@L-@J)F(?9"&\Z";;IG9>CA7YHJ(DZ\!Y/>(..E5^FI3
M5CM[UV(JDUI/'PTW6":'0\-.G4M)M;-W2;DRH;5,:#TA<6J(DB#2!UT4!?F(
MIB))62SD0Q_8'[[Q B1C[6@=GK]/)6LT,?(O_-]-!-$'YGJ.,?*8CC\,+#WY
M16SD/6S$UI>+N(Q,'^%Z\S:B"K4/FL=NP*0?>5NS06QI4Y>5YC[5@4I_WTD)
MU8)CI%KIM^IR3]G;>BW=C'M6OUXE$:2J-&3/AF7!]DK?81H%-@](@5L35 ,T
MW8XJ]]3E.YW2MWC2:-8K$IIA_(G2E.N]HJ!9>;V>E9LS2X^Q\KP6UJZU,JSL
M\\QV#<22*X>9&ICS[#.:<-4&/;T(:] U< +0U96/Z1$!!_2RG&9WY.WV?19\
M<</-W?OR10RF4%2Y<P*.IAPLL)+\2O)3"J678+1*&VM#+!<M+!K]%=31VX"M
MZ+:/=7B*YNG=N+0+</6F)[@^^K.929F FBEA7TS3=GV'HH1^V%:5U,'P'D6*
M+E(NJI[A"=[LGXMWZ3X9FD:F25K<+]Y7F+[.2Z%H.W8>R,A1."Q6,I4STTRV
MW_MY:"?IRLG4G+M7=P+U*/3UUJ)&1/H7'[\"IHF6\YUSK\&6-5/\_>1HELO?
MFJ9\="K]O=6.K<_I2#ZYDLA*(MMP!748(NOFV1GPL&1V&OK()RJZ&7C68G[-
MJ>8\&U8 '-0F$IY.I;OHZL1O<L34[B9$5>D>/_(- DJ,;=NS;(]Q=+&0_P=?
M/=AD9GG>[.K3I]?7U]K;T#%KMO/\2:W7&Y\<^/E3,/:==Y$$;+?6)D"N=N)J
M5#'UN^:,)ASO&XHLJ76U+;$WTI]$&3E*],"A?][=H=9:;A,]]*+BC=>\?5](
MJ>V(4GN5?JO1J*W*4@7XF?!73<)]RDN;Y)T X_O0IJ@.@N[GV;ENZ#9Z!Q6K
M="<IN^G6*_UVLUU;==\A=K/Z:&HA;XJA:0K5Q=C+B&&[RX/P?IKLR@!ST1AE
M(+*G"2-U? H+F:.VCHN'$W%0*:?^N<\.6)XS8.2X?6_"7"P_@WP!ZQJ*&%X8
MX7J:1W:J6TMZ]&,0$&]NM)'C+-T7O!JZ-PF$5.PIP:;JT2/:T+5-WUO]R#*#
M>Q_@KP5U<^&F(_9?7#JBH]'J#)5VN]/L-)5>4ZTKW4ZOJZB-,>LJ>F,XZOVO
MHH"8%$]-0A?33'MFU:'#M-^KVA@V=Z69K]K<14D0APJ 1*RHBUI99NBMAM5X
M? A8\=,"RK8=ZDU_!?*=.?S&Z!>M",N0)@YRH#]M/C"U 0?V1%8NT,\ULB^*
MQM/Z*\GD77%UR>U$N/H=O@&ZG[L2, A'FS$?%"'@W*#GK2;O JS[!W$O$"/7
M(8OZ&K*HQY!%%7D+'WQ+\W4#Q.''E<O,P-\2"AQR7+&3_B]#YU,_C17E X:!
M Z"&S8.J7UV"0"8^*2UO.R-O5)5*%F =!RTEI28)W>:'/X5Y1LL>C:3Z<N<\
M:Y;Q+^(]@,]T0T%_@#)S[X @MCSZ\VX<XGB$XI&O^ E>\9M)*6B!RJ-P1<JP
M?*8///$=+H"!>C1#!'!\X+4_L*(W\:W??!<VY;J!CB1VL(!'\)N8EM85O:Z:
M_D(UD]1>QN%W%-KK&*'T =0AX#2D.WV4#%";I*%ASR::,]5&-!*XCM"MP%H9
M42EH@(O.7IAISU#=FC+=&"%HD6EY   &EJKA,NIAHSN@%UF8*Z7/78<]^Z I
MP0R:J8/-S1RP]6JXK& )E'K:^>QBEI7NCS#ERM(199@L :! >CDVJFDR7RJ,
MFCD&@Y?.90E$G&G.)4T')<' R9DNQU\DN7/+P\XZH!-.C*'AV0XH@YHGQ4"
MT\:V-J8A3/) +_&"FA CS=$-&PP+@@PLCRKB2!H%F?*\L%5[E84/&>>>S&=@
MFP.#)\T<S G2(AG:QE/;&1HZF3"RY/JC"6KNHPG, !3WNZ%;;!Y F+<D'[J
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MZ](<Q^#^)!"$8##_B\K$NIXL:M2B#!1UIU"6L@"&Z+SB<M=W [4E5$ZGS)N
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M&1YY$WAL#^C<HY'OY'F#?Z,Y&$/LWC.'W'\KK_![*5?XO1.\PO\!/. ;AFO
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MESAJUWB+G3"Y2'>NMY%Y<\PHJ")SA(R0#!KX-L@9K*CH=O<FN4,U'TB>7RQ
MQGV?1Y1 8WV4P!<V]"+W2=*M$FHBJ(0,T'$]0/\(*K%?;>?:8;KA8;.D:]]Q
M6-;,^%@<0:O2;S4:LMI5"E_2\# \[OC"K.02)9?8DTN$$46[LH&V8 -*\=E
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MKM@ID YL-A6D</(^0-UVYJ&>A@7<@%&Y/I8WYB=5DQ[QKQBY .A!8?NG4$^
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M^T] =(V#/0.EXG@WV?0;6TT;GO1J^Z8NF<;O!!-[2 M?6D'2$@.&: <K1S9
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M5B^5*E. D"#,M#WU*OVF4FLNNX;?@PB3AYD/$7;J:%6JM57WJGM0X9I(U7V
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MOG*2>RCNFQ\*O8,E7TG=BQ>*1 D;$E>*UPF:1DC;"10$&P@4B^/!<3M,?I[
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MGL-D1 /L4*V6HWYS0>8E7A&1>H[%D)05K8?( 0R\8FEU]\SF^QHR]K4ULOE
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M\9.IN@-#1P%&Z#*.ZW F#!+H) K\R%95T'B]JJVVR^J>BQ&8W(C480-Z(PF
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MH3B"34>H_:8^2H]XE-K=@[?G<T'^LR\1*.;?Q843$T?[*-.6/\FTY7.5MOS
M1+)CMKW]1.2JJ)42CX-$7('D$&P"^8GU/UQP'RQ@0=&)W=S%<GWZM..?(/ "
M#H]B!@J%[CF+GOM<NC :KH5*T6$P3M ;['-$AYPXTI2WB^5V[-H7NE; "JD>
M1J7=8V)SNM"E+9@/*\:I"@C0!UHQ4MG0,@_==#GGO467#9<ZM[4\M[5=Y[;N
MM^RN-J#-1N+;UIE Q2U>1%4,%"1 @XFJXE)&2Y"Q1&8(U(H4:\N;U@\N1E-]
MVJ4U3(6X9G1*,13%C,P*6\68XD*=+#&GO%2-RURB*TQRF_KSO!(>H^=868SE
MA=,H\##PA=;?&![A([?PC-Q+\LUP6"4I%,*Q^8X\#N,>6.O-'97S. L5^PHJ
MC*=9.AX,-<'T00<X*G)@> %'UM68S,I'.;2F];[ =%G \0+H#SF72]4'VG)P
M5,=D.:JJ+U'U33QH] 6&%#2D(A09/< 5BOT\8\!P2*<8)\)R8,Q;IJ)A8N*<
M-9C(XO"E&"/N"0[GEU'$RW5!<$D6RVPO.&[8CQTN@;/@@YSU9+VSF8&Y3" ,
M52 W+E];?S:'H3$F0RYYKB+XEIQG%T$TQC'(?N9F*:3:=,]/XDR5945,#+"6
ML+\T&&QW3<&86,"=]&T>(V<GNO:]_@RIO(=T-7X!C"3P@ N+91P16294V"0N
M%$)O0[%8R 9I'V%672KQB<()G%N\C5WZ!%UG_?P58^6H;9TEL8/5U&<Q5@K^
M'U 4_IV!,#6/N(.^$!4_I#':=T[P\WRJR)YBU+" AJ!6C@G6Y^BQ1R4RLN8,
M0]HSZMD=3I @7%&\0&\?8Z[8AC<'OLU",9L'$<4YK3A/MLW=!S".,79/U\]!
M?RL-I&F=\2+(,V:,5^VM)[#"CUK:PXO9=41!5&2!H<"R.DR:(7X$U+U\6+G5
MN.=C6 <(P.:_S9HZ>4% T7D:4!F'Y .@^*.J2EOK&]:,J8R;L]^27/Z,/(5W
M2"<E<7?*@8;EA[F GGCI!!F)-\F^X-LHKXQ3<:,$^U'/$KLT75GC$DB$+%(9
MRW*1HKB0BJ1]J1S3OD#0!#U+K)%@EJU]>GAP@$%,G$M8%!PRC#5+5 "$O7XP
M.$%[CO,29<Q8;0(>Q2Q4S[EA2W(QM:0WYWM1W(.I"$D%QV*/.)^+C/?IP>N=
M&0M5?>AQK4'@+&QF$[:<ELW^YQA.HB.+1M5NF'4F45[6J!,X_'^S1%/I27JU
M\TU7U0UYD+GP!B/Y$TD"A=05<A<L8Z7Y7^'ZL:!<\SB2+F55$QBLPC)=6RY5
M@ $R8Y<5%81EK^3BG#VK8W^'%MI'!%>YI>WZ8)[E72?R> W9*V"[GZ\"W^3X
M,SF0648E7JCS:)@'A>Y")?:FTF0I3#()[&"$D9917I;R=ADMRD RE/@.!&\8
M8^@*3MR,,&84O(R$\Y'H.ERACP@YP+]#'$.QU>H.9<S8LYY?K\QW0L\E"39/
MQ&OURQO5Y],/:77IIC?%Q_7G*^"YM//\=6[U-EML^<K^"/+-F_NV]WO-3K?[
MS/O25W!0G6Y_XZ->5D/W5199T<[N^[>T)&HLD#(57=%=NL17?:U1CF^QS#=/
M]"6LU/UWO-]M/3;V,#!$^T/ZS&_5\9Z]JP_6[?V>NMUQVXA6R9H7$D)&J[K-
M4_9<(J60(?C8RW9(JJL?&KK?AH.];FWN?N)OU7GLI8SL/KN"=3I[1+)?-4Y:
M#G-YE^Z8SZ_9RWXT;<$67KWA[KV+]J '44U>3S^MPU[?[IT\?N/<FKQ>!'D-
M[%9[USZMU6K-O'^2_XP03C=+?O?9=J ][/7L4:^[/4.KVP(_PJ:,L/?<H-Z4
M*FU*;VB/NMW];]:\5\SY8Y[/=#?FO*V24RF2Z_3LSFU;4%9 XWR^&],^&<'.
MC.J=J=S.'+8'?;O5>GP+[3[UYVYOCUBTV:9K2W%8=U-^L%6I[L$<M.QVK[.S
M3EOUIN(;=.'Z&-3'8'DY^BU[M+.+ISX*]5%X?D?AL-UNVZW^R=Z(!%+QCBFO
M<%^2@?.PYNFJ_;P/:;$ZE4!F#Q@-K7*/ #7[?=4=+;?MWKF_:+&[ZJO>2B/P
M79_8MXWZ'2R[R;MW<TE;H4NQDZ:Q/\YT#K]Q-5:[Z&4H[UQ56)(;V@AQ:=*&
M#&")[,7YP\5>-;IAD[V",)GW,%87V58@+F3KQ97VRNM;<'&!B^K;>!7%A<HP
MLY<2IRJ_&C1;2SM5NG)8,>13[UF94HX=_@37V6%_O\)MJGTI#,;[(Z.[,+\Y
MC,(&-TO3ZU#2&G"E,R N4%X>M3PEZD6XU!IXSPH/\D#*<^$U?DEHB'E-K[?<
M1?PN;9Q?C3IW>ER_:6TW]KJ2OKR2OE-7TM>5]$]42;^SDJ+KFY:T!R_VL7IN
MO##; <FBY(PA^T$ZJ<)T$L@9/-R13:*YDFZYD2L6T3I86T<%/;?JZ)L2Q,H5
MP8N_Z@R&RSJ5;DJ/7>;S 5*;2''I1UD"DU-#]=:,D^J9X?'M47.P_O$W3[C(
MF'?@P/LEJ_.XVK[+:C/%>%(2+61YW>DUN_=K&[1/1LVN=6N[X+:]L66'*6^E
M-75),^J-+>=O:@J-S\?N/0E>Y.I>(%0XN+L1M''DN)0[#9T,*=FI0,$.Z1'K
M%MLTXN6>MK?8=G/LBIEXQ1ET5]0W'#\/-II+>PC+I9'U.,G]\1C?^^W@9O$X
M;!T\M>Q;J<>0);YA&LL>R5_-5A1 9>\()&;_VG#_U""3C)1O?>*:V[R:5^/N
M*Y#]0AL.!H&A$OL0]7?\/IM'$J29T;Z5Q2YA5A Y TUY*32Y"C['=7?B(@
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M+D*A'#)\+-X$ZF7(,2HI!Z6N/9L'"QPEJ28AS)W 32]]9$T&JT"D; _,$U)
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MP9PJ41[=3\T89L32T)BTI4@D\BKX(V\.8LI>)KEY7FAOHSW(LL6(\D'>$)Y
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M[-$"$)(HH+T(0X""MG#48HP?>P "&Q/<($R!T'%3*"&>N/1+QL<9@.CE<[L
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MQA%BL$O]LA_9+NTQ%;#%GNY>)D;?YMN*YIGNZ>YG9JO]OH/,.CK94@H@"!0
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MMT^8+-,0OR.Z/DUBET>OLP'OX_ LF_+B/>ZS/QB@#R"BW_K<C]4*Q/R5939
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M4T]+B_$F0AG&+U<-#Y.;4]KXB9>?^5-"WBT(CWF[SUQQ']*7?ICX(Q#;3$8
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MJ]1-+%TH7 BSL3Z"=BL>1\JZ*'2MER\&KE?VA7KTEOX"+$:0P6I[IFJ;TVR
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MF?ZB:>6!HR[I)5V9TBB)P"R+D9T?-W[J??SQ[!L,I&OK**L?7:]B^MWQ9<V
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M"[1=55+UI?9M:M%-X:-(LB.&=IZ7-8IX#>D!\<( ]>1F'(0@C@C&)!->-O]
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M_[Q10["&V\<[8&Q?P*@'<Z:1D@@15QK3\9+8YYU'7AVU;YSD&*R$P+H/[O+
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MZG!Z4=/&7/\=MY$YT$\"Y ]!'-DCM+ DV%&.#3.UO^M7()]F)V%''ST*7 0
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MK[<0LZ1&?8Z21)CTP7I/Z+1L&]=83N SINQ?DAN+RW3W<;\P9DX&>"KU15=
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M%2:AV>%(Q/A_'?^(6/]W-]^-G?%1\ZG(3O-M:,@!H/8,]<>P]CO*I5LCX<C
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M(5WP)=TP%Z>^1<DJ9$5YFI[S_O1N[7\.#;S!)&"6\9@&2F_FO!E/4(2O3ZV
M[;_KGJP@3@>6G&>\SV52S1CO2GZ=,#8AS"(L:X"2M8%PH/3FV-_3?[;FA8D
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ME_O''L?C,U>>+3-E%_L[7O]5]<^^W_!/?1/%@!"<V<%Q1AA')HX??V\8)>3
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M4)B8].2.BDX6T2IB A/$M(E"LWDG_P*6&//TO1387<@LG@8GEW&L@>Z_ >R
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M'_F9S0$6M E..E@DT:'8IJ4&4K\1!A2\>'&NZ\(,1RR8;<81QU*EIYM2_2K
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M*"J^0-VCBOD,8^Y?L(!1##+95G#NA^>RNX$4*\@TE,VSO%0 Z0+6=<2H;^-
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MICMZD1X8HCE2'YGDF'I&_ZN>*,$W:3S[$/"]4*@--W-:?.^Z::G- 2@#HSF
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M!50NS]]P$\=6D1'?K41_'(7-<U#H=IMYHX_=789LMO\J7_H_,<?C/^T"C.O
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M]BO0UTT.H.T)^QR7U<K_X  ^_+B3;)5&SP ?-'$ ^V@N&7T$;D)8?R!6)CF
MR*/_O$T@50ZY%\@![(*YM/@*--%Q\#<',(AETP3H"0AV)1?8I7\0JCZ(; G:
M6.8 5I$<P/(?B$K$'I=9<R"L+2#U) ? <C[*]OIQXZD01$\N8IR;B UQ.^KE
M-N;, 6QPFU'K8$R!R%SG/Z@78!*X)'O^,[=93:[8:1Q +I=64W[YH;RQH^S;
MB._5B)YK',#>?> ^MS>FV0BW76\.P)$+4O-')Q*'6+X<0*D LX4#V/F+JWON
MF+#Q$;3+[9&>4<P^3V17@=C</[ UCQYP4=\$[H=R  N=W&*52\[CKQ"KW.ZH
M\J8_M?E3FS^U^5.;/[7Y4YL_M?E3FS^U^5.;_X':[%OW8@IUL'FY,O!O<P!\
M"+;J4:92&MT>2.'6N#\T'+/&B&0+(>F6'1MFE# :A 9AGEW<$V1 :6G,EN@T
MEC*% Q"/DN!V:,JNY*(S95<C*H"SP%UY=O\!F@:F05B6E]2AW,;K.]8)M330
MU]T9^,[40#!D&P1E$[8,XVNY.FLGYLU$@@_"P#DYT_L++%7LNB=<.O+?M\!#
M@CW1\;4 2#\?SWH.G*WC .RK"B"WLSF ?ID>)$TD"['Q)UA=D .0N='!;B,C
MOLV"@LH_@6_^Q]2<G/'_E"+V*) ,DJ*'=35&1*?6A)[7D<@X_.A.+.H8JH%'
MSO-=JF$W].%.X_WS$3 II.2+T4H7_F/Z(4;RBJ7S*+B3ZEPEUGCMX_Z'M<3:
MJ'BAF*Y[(CXF#1>QGA)V!<9BS4&1YI5:_2=\U;!V^WZ8_DUM;@!^B?)#N=W/
MX;K3L:<N7CE"+JK-#9[S 7*/&H;.URI"SW:9-5X\V?]8>;2+<"[.-@&55,(U
MOZ.!XUL=VP)M3$MP6K.8Z?Q:4GH;JOCC_M9 FO@$.>JTC K7Y8[QW\RO=$@.
M8'=^;1G B3M7;%H9L ?,-:Q7T3LF"SNI,,3RSCN6[;+Q9,RW>66[)_B@VQ8H
M/%F/ZWIDBU",PD7#>D'5;^E=H]?APW4I1K+A3^>L$1'P#,FN*,=K<>XIE0G=
M8^^N9OH.'N)!U!.+J(K#;KT7TQ._SQG65_*'YK3 HS/I*%*V>D_$M#:?>N_(
M\,8=I;^\O>P59U6QJ=8T&Y1Y>L] B:S. P,? U6CB!RW+9M25E@7#Y7OQD24
M,6+9!<\-&;A6NF]8>%&VUI\+]I7N?_>?%SS_%]3A^J#T<$34%T]62D+74NF*
M'38E(UE6[&I@AI^Q<\F;3"]YY:_3'6^A[:05_-3Q/ET\55L^1P$M;A>S85]L
MDVGGFELH(>Q:9H,64]CMM4XY4'[SD"U*+7Q"IG]!_MF4#JFY+M.4>M]97.AA
M5.-,T/&@!]$Q4LQD<;MDQXP7GDX?:HA.I29*9?ZG8L;(^WY#9U2(*>/CE65C
M!\E)3X.JSJ6>7<'YF)$\Q29BG:TRR2BX&:HL($>E^?;.&\S]T- U:?J_\1G2
M&A]UAPV.9//J< !>VXPK',#ZH"GV&P?PF<O0<J/QK&1'-B;HVJ[*(MM$#'G
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M2YM?]!ZF)]O+*H,>BF:/R/#%89*PQPV%"\SSY\K 69'/,A?:#*<ZWK/.=7
MCZ79\Z?#&AT:#B!=0PY\X84*.&6!A( ^ST@)*=6ABHC"K#<;BL>+5U.@#U35
M?GV^.ML[;4TO *),8T44;?,WU^CA5DHV18YR&1@S',7R8X_#ZY4SR-IR&^"@
M=MIMRL+=/+.;WJ'V(7 ?JM4"!B2SQ ',!-,<Z(T,&=BB"3V2FDJX6D.5>TMR
M@8A-77OEFSVSAQE1U_+S,'YL5N7W_+3DD^@BR!/_P:8_:\P*:H_#Z][E([K;
MSZW \I?CRNYL+%6_V%_!H9*ZP#R@2MMN$E4C^:SVW"O,G5+&ID4CL#;\Q0?^
MJ,/71WL4, .\KV^FIZ^L9D;X5=S:C8VNZ8V^3 '13.AXQA6F/GV6>HTTCHQ?
MHW2\ QY/$X&MXZ(?GE%B6^IZYW[!G=<7*7GV7HOOO2;VA,]DK:E!PP7A1[_'
MD5V:28V(&#)6L,GW27"AZ/O@LA?O/9K>2NX=+]^8,KNCT-O8V$7R4+&_/F#4
MFU\C]L'P/$FBULK*)L:[U_9VTX,C,B(6@LZ):7*GI?;T2EYO>UO,WX:HG#]0
M56U[OBL2/=W#'4$W(<>-9&'0+C=IZO>$=FG8VA\4^:1\/ DLL>EV:O(;E@=6
M:&Q6<I]I2+Z\;<0/= Y-70A3?+/@6GU=[HYVSTI4OEKD\^5@J7O6CX>#*MS\
M<M0>="MWK>KJ[Z<>T4F&)G?:5*I8B;@%.%::\WY-9%R?L/.]FJ\TD'5]M/ 9
M1BDHY<<Q[7X*@UYUGR-EV.\7Q3Q8.44L+#\ZG@,@@0GD!LIC<ZTI!.F\Z""F
M_W4TKOX2M[!XZCUQ+EI78Q[W_871Z(/#<6J;JSD)K=KTKVY292\(>ZEZ$1]<
MX1CU4H;Z7S5N_7>:.]+V[I6[3#/4(,$S#,A\ ?!F3[29Q[9 >3,#E+38H2.[
M[T?95;N]L^('?E'^9?CW?V0H7]BB,(DU,J*'$ _A5]E9&JUBGZ5O=AD=J1]7
M<X],\M->P[>PD:^N( *A0N?K.KW47C6>ZI8L[I=ZD##0(_AI;;I"0RI)CZ T
MDGVNT#)S5:_RAJ&>@E6KQM:9!ZZE74%6%[*NCP0DY_JHOAE_7LEKA?/1M+4.
M]2&6Y$WK]5^Y_-#1$$IK8N5I(::5EY%/VX_Z%LH3H]PQ,"\P99XY0\MP#WXS
M-:^>\(T?Y!:G6ZDNFPN;F5'>:WQ6'W.Y=_B5(B!J)]X5&D<5B+U@8!_SSG'P
MOH>OQ_T^GH1R*YPS]'!2>4Q&J&+O!1__C'P;9[F,J47@D^Q#0@::;\IT%8SN
MHX7W7Z/JMB.!FI-S4N[_R+1H\5L0ACC]">T#%=@#/0%#],[H/):EAR[I,</"
M@BO6PUI*(K+J16FTH^#&U('(AX\?>O<\]N8S$;D^F^^X:B1'?_F$0CB<OASX
MTDU>,S4X[YHB^KA6A%/X38R^;5FYY7C,V*M,U4%)PS13M<&5%U859VTT62GR
M]LW&;TM&:W$541 (6CK@7];.7NR^CAIT LAWC=Z:*Y!2CSB"Z'I-D:1_86X<
MV']!LVI\XBAGC(A;82>C<Q'?M'OJH&EK0/4C'1>I,CT?@/&"I+ZD :H>\@"?
MI_(F;;Q\M&C/)\66M0?VYMGM_IXTGU(87YRS\K6/$2KQ'+VE&.DX='H_NT59
MRR\M6?G;\K"Z=ZXG&X?Q/C#*\#8J*O.9G,B]E^?N$V>1-\M87\;5U3>FA*='
MYCWUB#LO59]:IC]AOSG2];'R_R#NNZ*:VMIH<XH%4!'I17*."$A7Z1#(+R@(
M")'>B8"4@/06)"2_TKM2E2I"B)30>Q5".8* ]%X2I+<$(012N#E/=]QQ[[@/
M]^6^[)$\9.?;ZYO?_.9<>^V]XGK-DH0TA3/T3W:&CWHR!)X'29KE;/-IR9J$
MWQ)R^CGI5+E@K.>],":Z6W,BM^],Y45XTA/;M?% =H13 W$7G'3,.X, EU%,
MS9NG VT+:G*>GN3=/CBH7Y(TGT: _<)A/F5?,\=M+K<T-E=W=-6T-+5EK2)
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MCUI9OFX2DH(#-LQQ7ANYM4'O<QEB,3 'UC9 >>CLOTTS$[L+G,O"6;Y&%A#
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M)W?+7BV8[IP.'\KM>_%9>GI!O5WI(^SM/2]+B>W_Q0F?]=#"F.6SS"2=I O
M'!7Y W7N/[9+!Y\K7 "^U1=> )RYF;;5[AUM2)EI5*/%&9V3%X").I5LQAO0
MUT_L$RD+!F1#"H0()$/IT9TRE)OP='@3.8+B"8SO_ OU:O?!CH#CE& W^,;)
M&CWN9:/2<,E">%?O?,&!35C13WJ^Q@6@=?$"$$EQ) !ODGR$X>6XEJ9)5%VS
MNGHF-(UN>VUKYKQU."!7X'S*TL*CGI[\>TQ[(61Y,_@TU6'$^4UA5+=+QG;
M+\*77U,;&5/T//ZPLJ$,!Y_U%R3=O1QBT5/F=3D@E.F5,E?B4'@O.(8P=?KV
M1%NV3I#B1A58Z46"QM>HF@ED[E3!JEI*@-'WC;/NM%&4-(M6T5=X5"]?BK!\
MU8VR<%VZ_5??$^F1&%G^BI!IMS>#GIT(2,-Z!AB6B'4/N[O_3TO'DAU1021U
M;$ 6Y:-VD'/:,6*N]GY<:?F'/<26&<-CN/HCHF8+Z9"\2*)__K9:-6>+1[:%
M%\;%QE A!/:X^B2=Y>D!P^PG[C^[F*/Q^KKIXZ=:9W%?*%V/@OYJE:(=CLL_
M[-MH-N(@-HF7#F7[D<,CT?'K=LLX\:^$>X-HFS%#E;'SGUM.=E5NVK)] R_W
M.[6-N-#QWSVJEE;=]0;0.R,RUJ%'$CI+.X]S&"RC5&F$+#.J"$H=N8FTLB]*
M8.>RWFTUW<I7]>':4J-G1EV*;B"Q7@ (PJ6$\! +QD1M5UW^^,B:?E-GO#HF
M>GJ>#V.]5.A<BW!?VZ-V?V_#M6/>^L)9F<39YP)^WK>ZXX2V9$LS_E9-$9(%
MSIJC3;@EM3G4#+N- I@B4/AEI0N?I"KV6= SNY+B%H^ ?GT)_?*R3?' J32]
MN:T4;WHZMLNQG)TBH;P74H+L4U[A4 R3>0A.(0,Y%%>$4>ZQ)[L?--DHO7"H
MY1BG2<,$^NE!H=KA_)1"TNU@=)S:JQMZJ$S2[TC)*:)N;S9#?/Q;]8E4Y\WR
M-,>'!<X((='>.9\9XBQ&*^CSNA'4C!S2ZV2_9%:NYS7QQMIC^.@D2PVKNZM?
M4;:R[,ENFFK<:EOI4R><OP,J(K<SA^P%@XE63K"'7,K*S79VHJQ70/>R J5J
M#7*+XF8%B2U@J> U'5,,]][Y9=3!HX9)D0Z2@M3;&@@5N';5-;1%%LC"[[RW
MOO(#[K?6%*7*^YMOM&$VR<[W8Z8E[LSURNWH4.6;4V2^"B6>/,G)CDJ@1+D6
MYBYA1D,@#2/EP)G^ZON#,UD76\'X<H/KPT;HUVF1'8W"R@D9$_5E)?5;XTC=
M<0=)>@%#EC%<0'P\FH*ZP5"D/&GG7N-'RE&@O<9;PY5P'ZASD0>4$WG3UFI9
M\)#-4V#C0R=B/GR>+;C=]DOOH_4WMYY^9(C($1BWUWS0P*N;(+D/%1/2*3?6
MB)!;U<V+ N?#UR)B-RT*:@?PU0WT?Z9*SJ;D7,^P_,K\HC,@403PAM,7@@15
MK< J\BRT$!PTC2L^-#))T44?E@S\1.T)$E"WOE'=D$/!M? 8N]1I2#+PADQQ
M8[@-';N\1--SY/Q*;.A.*H3')7V6-'Z7+M44SX@G>?[V)B7:+LQ$1?I.+MQ2
M+=>U>M)L<IJU(GTR7;:XN+(X;V+* VYMMTDO?&MWU#0M(16@CC HW%\A6K)S
M4**'&*S<5*UYZ]WY*72Q"4W."NO58+ ELV9!D2&NS]Y]8/3^DZNK*^LG'B?(
MW9FA\-O5*I*=-WR]])M!,OJIR>'#JOAM(^]%2)YHJ/[UMKNI;6-W6V^K'F_4
MV9F8I$*;QY2RJ W",3OBM%OR:]"8"X ;E"+./@!)S)>N:9\$/5@=G?<@0&YJ
M8]Z39Q6\ G!= )#BEQV+&CXTU6Y>H[).MB(;SM%8_*JK;IPP56FQ(=?=^1XA
ME[@&%F@VC:X]K]]:J].\_+9[L(P^6:/RS(=W[<N/G/;P7#_%^V.XUODRX9GY
M9D/M5(=I[=AHSGN]!+&<*)#S1N/.PVB>ZU7$4H=YA^G610H;@U6;>AL&_@WL
M#HDI$-3DP+F%4]48/_)%_]V,KT-;^VCS!TB#(&-S,&H[B5!VUJCT$AE3]#1X
M0T!="D4^N^7>I-QJ'@EAC]YH3CLYO 32Z_7SN;P)DNDU*35(I*C_D3A4)ZE2
MCN--[';<GNH9ZY]BZDHXR<KCW7FT&Q*FR\EJOM,@_>I%>\6*7#(OMP''(_'(
M/B/YDC7OIX8-XI>\5&U.M_=:;!,#W\R@NL/ /X]H'!< U_W5+KH5D%MJ]%R$
MV8CJAL%[==\O ">0=P)^8%JBQ 5@5A1,5[<[FV"P_'$!D."BYUT EBE5S%X%
M)MB'8\;5&<\&^%_[7@ 8#:K\W]ZA_EE@N0#X,<\@4',BON_#M'>[S'*.H3VA
M8Y @RN%7(!M-KQPNTM?%U>Y8!3<P::*T$!>>O3W%S2?7!/@5C][(^4)[7-U5
M';>7?SLS)%,IBV<HUJ4QZD=_UQ_XF43&]9?M+#W61C[YJ[YGE?;OUIN?]412
M0M2K)*T&^=RU.5@LBE*GBVST/V?LF):;<"*/W>X>A#C7YLY7RG-:9/"KF6)5
M33TY=)0CLMH.6K]AU12PLV>6Y%?T@DXA&\;L$?([JHD>DP22JO2(PU!T^@^?
MD<@);3W+&M-8!:Q/CX4-N0E3P 4+F;>,4]@WNOYPVN"ZWN>)AG!;0]YHE<YE
M,A353W/,@^"L2#,1)_[M2,X;NZZ*L)G!!TH#ZWPV&<26*#LQGMJOENC8K].X
MP?HUF[=!U;.OEX=5P[@M8UBB/M>QE[K&%]_=-U292CG8^:9C-HD6AC=_4\C(
M*Q*K0N^3P3TKE+LZ*:NH1&!]?A759F?Y#G%@KX[(J3<9Y,4V,&W)5KB(>#I1
MY;5@.:8H(TN;=<!);FD*FP+C*P*'0BO!>/G\ 9R:S_Q/ZG/(<,!AL:NX(G[D
M*@X>&MWM3*$F^''Y4MH_%PM+YAO8I#.P\84.\>7ZQO!VYXVOYEB5;I=WY4G8
M;\(ZU*V7#]"Q?4-"Z]=X>&2-RSI&7V5O)"34441(Z N G,RE< @'/17LUA71
M)<"XA.HV0(J[6W;Q(/[&,UMNY^_3[0;$+IP%4C-,L?T'@=C4Y\-)"=.AY-WX
MZ.CCN*98E]9S+C[O]3.>S>0"X&W5%,H(#X?$(IQ[V^7Z\J_\M&JUT_BPIA*C
MU+,:L!CT+%_QMK19S=GE/_CC_D';U.^L)Q?[4?+U=$SS.C+VOPT&K-[_@-#A
M5<'R.N2ZFZ1O]9DW$$IG<D5LODEF_DR:2EV<I7_H<I:;L\45U PB%Z&-#G4D
M$4LB)!9D'HI/^9,&IMBO]X7X2R.>H/ !FE7^?W+F4/?=M&<NM9OL(@7'F:-Z
M;SV;<7X!,*^I:]I8J^*$7P $":;$*AQ(22]Z^#Z<U6IO0GFT2M*7W"RIPGBF
M 4:R9DC+2K&-K$7USY3;E"?"3(IBRDW,(X:JGP]= .KK6"PR5(=[\B0%MY79
MAH8'']9N))J93+7<_4@:92J__[[2%* )TBL85VAZI(,BHK(9I: 0[KFFW)WG
M8TW<1=B/MS_0+/?SJ31<I1I\.UZ@ACL_2^XQD*O>D=]M5![;4;+93XE->];P
M8;&3:VV4=V<388 _Y/H9:B@LB?MIU>YSW4^6]WJBG2KT]C4-5?S?'R8QK)-N
MT94[9?G3B;X-,#7%^PWWO>O7_JE1D<::X-:JI\I \E@^I_M'Z>'MCL.P,,4B
M(Z6&@H>P4HDYS_/;U!<[!=6I3)^HB'+=;DBY3O-*PWOU599TU67D?PQ #ZRI
M WD&\!!>W1<K'*)MTR,9]"2_+Z%UGKJ0K.?->LAA^OMKP4YP]C4'P1\D1\I*
M_QC.&6ZC2A/7I0>6.G O6YO*9CIFJ0V))H'DFLZ_WSL:8"W721<*9=1(F*U_
MW'5>MJ:G1&Y$B\QZGCP1#'MBFHKNP*X/#87]LJ&KFM>#I1N <Q/=F4QOKK=T
MA9QHB"+\1DHZ[&\YED H,63;?&*D!';G^Q/H&-X(4$'U #9/<Y#/UNS6V4\?
MH%\C^\H]4HD;N%A6[FT^NSAC&(WCZ-,5JIWW5.N:K)ZM<I0>S9EOEVLLEY 4
M:L\);B& 1!7?:_,.6\Z#(%(Q]<@A0KK/'GFCUN8@/(MD0+[+I$AWQG<H&]CM
M,+&@_DHL0_FIIB1-XX>BH%QT_LW)BI/;!GW+=PL>$9=;".&N@EFU$T C(N-M
M]GI>_72$];B-\E3%6ZC#=Y*MW,9']GA-%=(TJE](OILBRP/=8?@E%%J"OKN;
M%6K+?L7Q)O6\\!U_6^J@6/.A*:I49?*\\F_%F')J]G.3CUL60[6(V]?$1+BE
M=0]+'Y4IS'L7G_TM,4BVB Q-;5((L>E(20.O?EJI07U-B0*R=O[.F(#6EG01
ML,ZKFP-Z@@81VB2S<>B.FE&=7\FWLJTU2+Z!H/VC2]]Y!)8+RF!JY?;+L//&
M5.1P>*A/H%,MG;U[A;.Y"3Q*:7O3_I^>%_<7]7K\K.((1(XD247B#ZR0ILB"
MEJ+;DR/]2IY&($>,V?8TCJ!Q;K9NJ)9K76D?5:C-EOAUT!]'"%^VWED3JQ)4
M%ZM,3TNLG$@^. _G)C [5QV#99O*B5"GN)0@%Y9%*1V$T62FJFQ7O]%1"G?#
M1PW7/X<+LWPW7AKR=&9;^,]\< S26P&RG^1L.?F3),,H*+7?8@#CEY<]#>02
MAA 04EJ?T"ZH"N]Z)>;A ><_-;4]Q@-N[W+S8?=*MOO1UA+#%GTFS_O";=EB
M/E6;>?S Q/6U&,F73YG*#M;.FSE_&.EX9N@>H&)<2_8TF'/'\L)_Z4/R,$.W
M%4@7 ,J]E#TP59$Q? &H*]BCDV)6V6/;?0B[D$2;S857[8:$#AWQ!$NB3AO^
M(\T>[_FA_N68@N5$E<['H)(^_PE;FU&1)R(0C-7HW<P?=/$(30E2EP )P^<[
MP[M:6]&*N>ZHD6%W ZJE;_5J@B4EVCX9(VW0Y^1LD]44Y7:)?T1"Y8M%.1=&
M6OY5TY7('D=/O(N)1WLE1IEDFJZZ>A;J[.8)?<+@KCE;H#)Q^FV*\;V+[(NZ
M##YQIGAWN9$X&887 "&FI[W=NW*.[L\W^H-.O70!<(3[T#7^..=C(CN2 F&P
M)'QB3&4GEU.MX0EK-VI(N@3O*+QZ0H?R5WEVRI-.?KC_@$X=,3^N;'=ESD^[
M3.;DE"RZ44U.$(\-^NWE]*D<_LLK[\"Y$\B:SQ5Y]MM^2. 8CA+Z%M^NI/W>
MZ==5TZH<'+T+U#_5:_;]@15"O,G_T[;)^;#TP]*A"/1^Z*>:VG*C>J9&L<S&
MB26KM@?6W,+:W&^'(;A>?"[M-UFOZVI=]PF=7UYO\3D+H#HR"4LM$/4&58_I
MEHM9!E"R,.!NN7F]^MV5&!1G>\@76/ Y*JI^6_&Z)CM' <>NQ7[)=C8V);J^
M ZI#XE+K:U<S>UV256$U?_=WLH1;SFG5]7:W7I+E'R0=O]R705E<OEI8 ]5_
MCK*Y-VV!UL98:=[)ZEKR%/'$KX$XF\M5/9$1HM4I@-65<[G7(RP+OI<LR!N-
MUJ\];WPXDN11*?'( 40[LC#4>IAXEIJT=A<;%+ 31<]'K28[\%*:\ 5SMN:D
MS0%@+)"#IHW"%UPS)!7U=/[UXT!3>![>UKOKVNJ:=Z.\N&)> 18:4FIEJS"=
M+TBR>%\XY-OX>B96I'GB)!3;^0?=_US?F1)R>X""P$3Y(]*NZ-Y.3KGF3(1_
M<>-^N/?'EUV+3"#'4)QWGAJW:Y&IX'][G8JNF%Z/\"N/3J0B2W'$JFO7R@@>
M%FF1FC4L W,2PU*R+@?%"[9:?LGC^:F:MTFC-$Y<OXWR_GE!S94HT!-ZV7QC
M"WK1':DV&3C&^HAX 3 A3B+E.TFRZ!)<8)S&2K3"I<G]*JS7 ?;.U E6P-;S
M<KWM[HN",A<'>9?F@JO ^-!HMIT+@$7/#"9^T'UZ8V/DGK.#M>XEK?I/BQ)K
M-=Z1VT:^I=*:@IS\YJ:!&)12B:G*1L%<=<;AO:,IIE3-,A(>&^X#UPABRMJ+
MT)4I;3Y=KG(4IAR.8LC;(@<8?Y%.]W\+)X6V/W)<-;0D-&2B2Q[A[>4(M[\E
M&&D*I/H50XJMC<Y_CFVG25$@UA.!7H^ZZDZ@MQY/AYQR, P-DAGO*0S^@C@^
MZ:)("5]"]_2PNR]=GQN34I6FG=TTXWPE-OE.A4AD!%;8#G<=RODDS(9/(DS_
M.3*G^^7-7ND_RPAY2!>]&2-)CK+CGUURDJ<5!2WW^K9^5HS:,6LK@#$BL+*7
M1W5'+D#_:,!:@&^FL-)^HQHE$%2\!/K!-^$!#NT_@CHX391\[JZXM%*YCZQW
M@DLU>I5:&]#T>E[E^T]N]Q: F3X(C] B#O0<2/;@E]EW:8Y[)"L)0W,XR/M6
MIAQ;_*<R4>'7R/&T4BWO^^G$$PDCW\B<R)!!W]2O&_S) I"<-#;XX/1&9*XH
MKW?RR'!@JCME8/5TCX7HB>?=ZZA@3(.;#HK6V-FVA>_6-J:L=G6/LGHTY@N3
M-A-DJ_[V');T[ YW#%.PB8G]G&B @;GRW?G1KM:$O$OB^B;8Y^5\#KT%[^A=
M?#+PP8<=\7=AYAJ)3Z .8=#[@:;QS-4TJR<W0_HQC"I9_WEKM?C,TW(SK<]9
M(Y_M"L]$'@3,GH'_\B)?72'H;_XJ,@)TM] $/;465G*H'E8SIB-\W":K2^:A
MQVFRTF 4%*F.7$DO9G(M, 98Q]NC870*:1P_EJ)LS"CF&:EX*:K6MYQ,3\C*
MB3>-O3JINKZM1(*]%GJ-20A:\E^>[_&2M57%5M*!W#030C+?B H4=W#UZ^JO
M2C6" %?92*=D0C+O]2>#Z*LST9P+/>GB<:71_01124JIX]&>+$\ 5H!4RC\Q
M*C/D2XFW2@R6]2]Z^VG>.*&]>!R2E3U,+7L>7R^GJB?J:4457XW9,V6ZJJ_T
M2I 4*8? _E7#8&TY&\E),7B>8TM!$88M5IZ%JYMV3C1X&?0(BS1VA,EXV';(
M&3.UMR>T/G. <8MM^]M_%=<;$X<\Z45G&"Y*X5I7C!6#_QNE->;JS 7 2I[U
M0<_&&5(X:,J#J]QQRU5%,KW(DDT '@^V[S%+@I:91&$\ GHK4<Y;CK5[6;>O
M/;&3ZI-SO#*L7]SR:CX-H[ OU7>D9_NQ0]%X(J</[ R919$5*%%4=DH"&4O'
M@$Q)?W1/"U^AO,%N+]^=;I?'W@V&?-INTA2H&5<("^=':&#MATH]6SO;O(JT
MIN-/31<=%G!>9)BUM\AY%2?SUW)B),@E_.GOJP\1@XV>:7C/%[ZS>U)!S@G8
M:T'/=.[ "RH=8?W1G-<C\\7TT85737(QH]Q[*TK0S/43_[DUO[1R0Y-R40DM
M&__*)WQ?CH:L]?4EYW>PSO$4"2HG@^E]&^7VQ4D0&XH4P4< H4"/U[Q.4<<A
MI4@S<323Y_!:P3B%TN+)8P/!87^#K>.^+C5@7$.+XI+.;9N9)Q,*WYYE!T;O
M]$R%RXJ3=),1BJN),6Q]?$)U())V7("T-S1]]3X;@S-/92;2W:ELO$<GK7*+
M[OE'5/*MQ.J3!^:[?9+?3,N5\X&RW1M\K>,X([10&[L19ZDJ+61]6F)P&YKI
MOQ%B'+]@%B:.JYK39; X4E]Z,(6-%%4.3EVSQ'4EV>@DE"Y3I*"4R/(0?$'L
M%=TEF>4BGK3 I*!PU\QR<@)6\S)315S.'?=H/'^RJ.9=Y-VEF$N)6#N,;D:P
M<_EM&./X1]D(#\PD7#^ "DZM]@J=O 0"'>[D/"\R'EW$6!@H] S66H42)%HG
M70/'O_[\&)$/O&3)8<#!UV1DCF1M;^NT++=8EIH;E@M]<E2/F*,"&3A-%DH*
M'DRYI]$TH,[.">OB +\<_7-E]#/L7+CE>E1>5I*"O3@!/X4]":)RSWOR<.PP
M+DU8 ._8PC<:.>M-']H5818H[PF-L%17X1NC49*KGB^7_]X(+(S'QO?H8_4_
MNHISX!+80?+D>@;6'/_+@[8XEI-XQIFT.D'XZE*_,S%L(29O[JM0()E8D?&T
MO^.L_C1+4=03YF,Z_.^N,EVUISCV^15R\E0G+\)&^&]-WEJ*/<&'5PLD7RZ6
M\ 7EN:UV&'F\:SCC;[TBT4#5K O=T/[Y]G!=Z60N^A0$7_M^BJMDQ6TNJI^
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M/FMQU1VXD):3U] _<"$U!I:?A6)5=-0%^0G;Z<D@,'$E<X[H@ESP4A65')8
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M)<,F*<@F@Z)'XWC/H%GI;!$3.3I &:ERLV-=[&O'8@:#-M(Q'Q/VC&II\W3
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M&;WTGAD#6Q=C31;+9!7(1$,Q'XZ2(8; OK,V>]6]%OS+$@MW?Y#J$8?4:P]
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MB?]!R>ED13H 40^BGF.X]"T0\0_&JQUTP*XMPU!I8(H'S 5"D]&LG4\\/$T
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M7W-^_QN/^?-?(]8V+"2R4=S;PC@_I1N3A&/1QR L/VCT9G=FD;OECURO@M5
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MER92/OY\'.T459_DU0YZ\]25W"I-U%TLB&PZEP[C1]I=[UQZ[U#Z2!)%,$[
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MXY)9N>3@S15W!J]_-:] <:<[25LG[8>*/ XD/?&-[^$_><%M'H*H!3K0XMQ
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M-_^[/X#\JRZK&X)<A_J=#_=2Y==4:/].B9M"OK&16$P:>5 L^V#:J?+J=:G
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MM10>+![4N_3YJ$#&K-91;#JO_5I"G7Q=P.NV-N!_:9J%91$<01W@Y%V5J-V
M\2FAI&+!>.WV+LQA;\_5 W^YL$NWQE\/R3K?R&F_^>5Z=T'+1>25XUM_ACK
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MR;XG [>KW._#7EE.K1^&__L(!;#8LJNOF:07%$TSHN9;JGC"OWALW=EP,7K
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MF,6(F]"J>"-I=_#SQW6\,!5+R'WT7. \OKIUTU1W;?'I&8'[[?Y*4W6OW#B
MW!R6GC4?Y)6W'AP&@5>9SQM"Z=.L1(0@3&'5]"_0$^BBT+#'==H\!W +[PL(
M.4_!7:Z@"7WGYK[+]S:_^NQA[(L9F5.L]?_I<7FF==<(?() U<F]1=G/[6C!
M?)N.D?R&CF2WZ=0(I #<9*31&2RQ9N^;,D"^P_9;C7!3N6Y>8UV^!4FIIK95
M4?P<RUP7O4+K2W/X59\8ED#R;X^&'E!G6OC/FLT.V,.;TW8GS%WJ=F7TT-<M
M/>ZT-]LZ?N7,UU) <_0 :C$+#VW.J*&.P1^H]=UF7C_EBI\? E#_#N2I'F:U
MT85XW)"$JHLC$SO:18];8DX2-0K[K/=!T?NQ0'Y& N%R5#KMU\280X OWNV/
MYIZ.+9AO$M*1WAD/0GQQ*9K#JDFA>SK%![]OF00]+WF9>'9R@\42\K?+<UL^
M+&E/&5V.%63LG<@S;S*B.96^S4*#_%>$A"Z><@V,,;HI!G5\@Q4GSAD;^!7/
M%/57&<6+>0^:DG<J)A(U/_X[G_4"./F#??#$38XL?L$7J!&V]ZLWL(R5@'_[
MZ+9S=#->'S81J/AH]"<#%2CGJ#T,:;8OH6O]C(+5"O#J6?%)"B*#/+ J>\I#
M<S6M0=A^6>PWT*["R05.]:KBO WVN!A)% 2.MN20-$SD/X-?X>M1K%G8(A;L
M;S9K%MV@)395FH:4NKM\>QX5)&0YO7/*U1;Y5FI]U#KNM_F%%>,RA$$_4)'Q
MD^RCLG)VX!U0!#]Z<W!T^RT=)  1NG^A-CO4^:E4&C8%:P@Y 2JUN11#",9V
M5<8.QZ7VF.3#VS'!%N@N.\+HQ5FG>O-+Q& :8\OLI,YT.<UV/6,BQ\(#^@JY
M6@)J[,"'O.A8:4E"(7W& @D>MQG.)[:;MRQ75:^[OQ//J^MKBN%.V(O4K=VK
M5]',?UG!P%K2GN:H%?O6&K-JL%"7K="5SS&/SZ^RP/T3HOM]"IBA3E-9S]"8
M8.1[W613;8+GU1WJ/MXV5S]7<::,]]TKI07>Q2C8;%4B>G;;MI#')F&FH.?S
MO$I9(LS\G:(YAO\)I#FM+<#RWM!8Y::6[J+%LJ7!T;.[-!WZ70XK>K,'8Z.?
M \41<WTZC%%*2 ;B%G4MHYO\S(B4G2J;M9H:MUU5![%_R4%Q@R#18-6&( Z*
M Y5HYZK$WH;5" @.\2TIWZ;& #@H#ON?*&[P?Z(X(VTJLFH(,<!!\8WDKX5*
M.>Z '::LK ,IZ7C6V;;*>K?NKP_-:^:)^A77*N3++U5\8VK6[T9)*YN:Y!Q]
MG7'K=)C2!*VV'@,X=H7*S>89(S7\$KA'QIV!Q9%PJ0>@<[!2DX2O-(7X@^*S
M3/Y&ZG?<]25\2/!>K1^='INJ*4:]/Q;ZT)J0;Q-V?(O<PA\MSIA,'VM,51\+
M>SOGGO*Q4=C6XLP;+PV@4DW:@)R>E;]GDTB5L:*5K;G4AUY3PJT$0S4;7ML-
M+*]&@MXIE^%U,'^)JDKOM_(#TWT2=&%XI'AZ>&>8ILXQ?R\>(?#(%E JT\';
M5SP-%XC* $K2(&FYQX8>WTZYN/?&2OKF=IN]_4L_(63Q_P0XSDUQJ485RUAQ
M]<<,4]$RC][@9 P=* 7=OSB6-T\(OH, T&M%(] N0I@,P*_*TS>P<E2\P-!=
M<EQG ^]C[5[Z+%>P]<Z3#FY;_[B'"'F1PI\9,L0?'C;EI5/L .S:/%.T@8Z$
M/@>U0S+J#U*-7_872Y!3R:=<"1Z_09MY#.W"P@U=??@(9[M8^4..>6L?Q?[>
M%>NR*BE/?Z'G%<W:_K8WN)=JJ#E2Y:6D]QBNI1BZ?-<,YS_Z5P)H9ZO9]N<*
MT-6.S\I!#@$WOFS2D99):_FL,!O!FZ$T0P/@$MI_[NV*^P2D6*J]#@-9(9\
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MZV*'$I^3!)39O!P*Y_X#_N<D0F,SEZW'L#SA8]Y"VU-!?S'O==A2>\21@CM
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M*NX54XL,XO,'*DQB3\"%A5^=?>D.*J=<5ZL<5A6TP,*)]4?8Q"QTBTO[U\Z
M\('0@NI 72M1.<LRN+S&A:8[[RG>0D]R-F<24THM\@-=2=V6-XGC:HH5,/7=
M9YR(&G*&5\@ L7E/N6@&]%]8:6P W)#Q(:0*+DM]=,HET*-(N2LU;/8)(<U
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M[((L<T6_/2P9QQ2C< CLQ2A3@I70!HC'=:S7G-Q%3 /.<G!OXOWC"<K\^S&
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M],PKG1=2HZ+I-ZZ6DE)C"\\F;[BTYE>ICT,95]!,T7TZB@- SQDXRL_^AB7
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M&<]ZGE8G.)?R*U+<RM4(--Y=X%:]"J>8F6 JBENL&_+:H<:1#V2#3JPVXTE
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M3BE<S%<](;=;U7+-))Z8Y\@=*6SVO;>8!M>V*I52J;RO=<VF1$=QI"$ZF^&
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MI<7T'[_E=36))?+.1Y5HAD)R;U8*1"2.^T\)(?,IM>E3G"HCA3S'/KM^>+U
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M;V\]1M<FH5:Q3^&":IZ^H5"!:6F1?L02U0EY/NB$"@A?"$,6^B_<T;<C*M6
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M?UH3\6V!C-CR5F6!\.+&;#,,8NL*8ETHZ4_%SW\0.!"B1]!*%] 2^8ESEG%
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MF*0 ?S_A_KO]Z>'VR- W@"@V ) !!#3O)$>#"5AQ;%KS,4>BE#CD/.S<PAZ
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M09XAF5MURPB**U/TF..M]C&'EI3B,<<:>9Z%+4)\@; ?X!"[.=^!64C,V+;
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MCI032U!Y;0C9:=+Y2SH%^\-HI4_?VD,@.:NYET54!JE.C["GDFSK[!_T+/_
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M]B]?GHMW!OWR1[KA9"<776*<*0>#BNT7Q^%/[>-33&0G9RVI(GWW#=^AA!N
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M,N-24!IP%-&G[HS-7C#185L*PLCP!8+CO]^&0Z4K40XZ\(F=$G1#QJLF_&G
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MI[73[BP&-9IGPKAPK:FF QL5KO,1TTK&/ZI]L<;-2I@G4:]/Z'/V)'8NK&_
M4P0?US0"]1YREKB4^XJERYIB R0--(#$\6BR?^9S#VH=^>#%.R.!@!H8PB^
MN" V[A\&K*5K$(ND1F,;XD/E-:-.W6VUJ$CG]S&2'@O8;&G9 ;53:IFREEEN
MBN1K<RI@/\:AG$NEZP+<7 ,K)#%6,+\JI_#5R?:>V>XCJCW4L2*IRR[UKK%Q
MWR^U8/6#9RV/MWZ]KY#.<GRP-H9L5R0L%J DD&[5:22J#3B1#1 VL*?6=4(X
M-N,9MTQI7N1L#+'5MZNIJJ:8[@\297K0>*>880$4\!\PJ[Z[$P.YG9;":K5T
MY#V:X8LF_+@  ]P;-^([1X^_WK$R=3<C3JKHLD!?8 #OPXE8W6[;?=A]E^18
M2)IUJYBO[NBSH(/GYA]U]=_X-'X=:/]@;*\;K*>=JV6ZY:)N-N/K6SF8SN*^
M<A+)/AJ(*8A:3"<:2I!=.UNOD$$] 2]( GY&\G!9&CBQ,D#50$[K$"\,*4NM
M'D!#CZIJT,8:-TI_ZB-J,- ((F1=7PB/'TP/]XN4GGA-%-LS2!=RN9_$W^FF
M'FH8=[G0R-Y:>DOLAEGW-?PR!X?\0ZMULR[9G7,"W;:O,%I<.,P0IP5YQ^HK
MOA9:NH]O#@E@_,Z:!-9CF )LP%+ QDE2GG:AUU =NT'\S# */0P4QP8((CW]
MY!SBK:A&^>0!M0Y([DO\L>E=&N^K-G'3]_1\*]I*/N5!(=(<-U(9.N_5 <$.
M7YIX"ME+R_75[0MN6>)^0]V7$#"/573&4^EK)GO.R];V,1Y<^,-':_H^_,'^
M6E?Z%S>WP.-*E$"\O'NY;=:R4D>HPU]FIMG3'>([(0\?W&]^&$H_U<X&U/ R
M)8.HI,6HH0TOLMK,P;[B.()KFJ[M&E?$1R=1O!&7@"D+(G3HA9@FH:+DTCDB
MM7O;PL^?1*Q-U;!J&G],,RKYN^MTN3=+K[ZHH^=>^C0VCVH)A_2O>WPJ#7*9
MG!WK($X=0]"1.Y]Z0?>M@U;'WS<%%;7L%L[ :XB>5/2>]R218>1R9PP^1XO-
M6W9M'K74]M</[K- _<T&G",L9N:0ZC!,_BM+:DR!Y$5"JB;J3Q@;0$%U\*9$
M2*%IUWNN/H1Y$1>DZ<TT+V)#A'U/PEZ%*^\:2W8,!^1:VSQ.+YZZX>5.L7Q,
M)(I+%=45^MJ:E7VB5=!$)G4SN0LI4'/!0'J*9LG-;(RNV\>=IACGN2N*Z0OY
MS3'.WS?[)!Y4B?*ZO\!&8Z17=>VL@@\>KUM"?O5:&GOG_/KJ'W5"@'_@C[-8
MEQ"=H(^.&X<,%:;#!%R,P@MDRHW ?=TI*N[D7\65ZVT\+?F=*($6OR4+V>$
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M2)CJ67)LYWT%$F!Q/(0'TIXE+Y(XZ;E=2#Z9,3_-^-%,QZ;FT>=TS]X=JZ:
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MTT&+EK8G=AAMI =S)?.^)'B#9I(_Y_7^(/"PQ.@K#\4M5'3,D;QKN3-6E="
M2F#-_2&*BM5.YU]X1E3._I':V?K8TO69!Z2%_L.HR[!,+2(-]4=@&2AAQX5G
MT6"2>^_#JD%OCJR6TN31<H1NBJ&9&S+20511\*.-G2,.;;:B).3*^] :([BM
M;"@7TT5QB\<D=8_DJHAKA?N);LL)?\)9^0VXFARCE)W]^WEG,$N3'5L)J+K5
M%!QP9FO_WX!UIINI?_MJ-Z$Z# ,Z"&?QU=S>"U>3NE?O%O0@*WR 'D4[-UIP
MXD6IV"D?<5(B#FV"F\2%7QESCUL@5;_0-37ZVDA4[J*'44!'-'*5VGE]2>/8
M?MUD[O3.Y<$/ZG^V*FM)P4:Z;-[_>.QM7Q+[>3( Q9V0\OZ3N6UJY[>*6*PD
MXM0ZC&YF8(#]EG7E^@-3.=^NBBZ,0@_49 "ZOX]B1,#2 N@RB&:&*>HE$G"%
M@*-C>5].DI^X<+>!HT<A.BF:[L?%(63@9HEF0X=OYGNL^+O;6@E^>RKY)=OY
MVS,+_(ODI5\"KP@3;6JAY4_X!Z00._K@Q"O6'F]0<T3UHP9E:+"M'>C%\A[4
M*G7C5ZM,'IC!#QNJ</.OB 2Y;Y ^-AB$!:Z0'FPUW66RZ.%D$B<]F76VFN'(
MM!@SD"#STJUX-X7*M%")EZ@+67F#K_W>TW?V$>&[ Q+VD5 M0QUSNW$M;N\/
M*EO"?^";&Z//90X0]L\MB;UYU):Y /P>&J+<PU (]/"P/:7L]SRVTRK-NFM=
MB*8;IDO^^5@MOD3/OE#52S\P)XVO(=?\3Q3/4H5^Z#%F8KRT6,I[H4KD3K.+
MTH+/UXT9H_=XVE8[:CJ$Q>G*D$=\:T)M3%-1E,G.@5OV4N>I:%(*7*.D#^I!
M,40@$\4+VF1HRA6/ _!C-=^8,I$>4(&[:N[-G^H8,OLH\8&K=/&WI@)!6^EM
M%ZE^/#H4J0M?WI/9 %P=5[C_=0'Q[*OW_P=S[QG5U-*&@<;/HRA%1'J1'*5W
MZ44@1SF @(#T3@2D2R<2,)*CTNN1JE010NB1WHD0BH" ="E"BH T253BEA1N
MSEWWKG5_W/_W_LJ:O;)FS7[G>=_G>6:OF;GS($^ [:R@@\V07E??:+YKC@W5
MJD3^L;E#<8;5B!/WL_$;.K7WOSHU;!WLTNZ83$3"RO5_]C6*A"C7KDZ).]!L
M]L&<K!H#!J0YL1U\6#;]L^1>DLP02Y*)A"4<UY^"S@3>"W0\0?6/I6A +WD&
M;GL][/RU*K55F/[3P',#Y]"SH*R1:3OJV[* 2 V=.]K$*RK'$K*S*.0-?8OB
MG77-LB^:K9R:8JM]^],)A.<C/H$.7W:B [UK[2>;G6,7<?.5G,;LS=2\V$K+
M^3%1>=TDB^-34/U<94JERVVKO-BP(Q.ND!@!M+"4]&_7V:-X]+"X(F#$RO*W
MC'^1?NDSW @.((0"I?[+J-27']"CJ*0R)0."ZT90SNX!J]*M]<[37Y!!QNA
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M?&@\F"GN"D-#,OJ@F289/V&HQGB-#.9FJ7@V^DWR+R+WL*7,2+P.L$7*OC2
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M"\MZ03X9#4/!6#P+QL[[W(#D6(:A+OTOX#=-ECD+9C\&IY:WELZ,>/A91HU
M+Y7A<(9:%,.RZP-%.HW1+]%]@ =%<%!O*9'0];!/%;/GCQM0:IW]>=5JQVX^
M^+EV$G>*3B"%7U%*3-KG.49$9S$Y6U'!,[IV8C_6Q;'2\4KISH4?\Y%YMGZ
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M7&/J, ,8):QW ]0Z#U_@+S<TV%$CR-Y=MA=-(#Q,)1W'L]]*L[+.#*Y.?+Z
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M]811:ZHVO1UH95OZ+-<>(\$*:&1884X'@Q,QE\2+V#5P23H8;P/O:;0Q 8M
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MPFF*'(96Z,W@8&<"/)-)PTR 95T9=;@9^_/\)2"^@ DH_5Y+2WJ)6(" :3;
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M4&*ZG$[S8U?@YXHN\^-B;&1?A;L(VS)C>%>MK&Q0VOG%[D\$.7TO^0N6JA9
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M?9/=&QR$ZD#1W2NYYQ(0L9@PDWG%;F&L>ZBB*2:'IDY/90(@+.,_.J8O2[M
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MDLI<P-;S]/!JR^R=1F13FAO.C]Y2<CO>+%QH8UP@8SXN.Z^"3)"A$?LG$HY
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M-P.U5.L AT$"_ODN7R(YP*+[ O,&<$(JX9$*T]Q7P&$:]V%Q2/<;H3BA-#1
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MBLB[5';^ZZ5:N9?8S=8247/>$Z^2B(X?&A-<C:3_.19+<V!S&52B>N[A'TT
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M%FI:XQ9\/>@8= V8(25'-V!<IO1M,2EY-"8S67LG&G^Z[<H;0)0TDAQU%JE
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M"._+,=&RR&O#7W_R2?)^D*3PY_F,?8WWX$)J7UQS@';VC=7<N[MO[S4G3*9
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M?(D4I,#2K,9*K@.U'B0]OF"!:NN7-S@&Q"?C5EXC^'V9Y'<P*@64"0=1D,]
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MBWCXM3?,(GSO'P66\;83\*NHT7?PV].Z<B+X<&A I6[BTG1;LLZ(P^SC8T"
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M?NVU VV?+ME. CZO4!BU*B^3JAHK?E0U:EU:XO069>?>W'8U)V?$I,-R!O_
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M*QD.;KH?V8[FH6$6]?,K^#9FOGX\ ?G-=(^':\KN?(@]FBH><W?Q,]V=,7R
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MY/D?D_DSV4WIL]7+\GO.S',FM  R)AE%RIM@WIUMERM98EH!YG1[\I?FI\B
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M\A@3M,A835&TXUTJW?;K>K1H)#8G)4SP]+/)2\[246FYT^\Z:#%K&Z4S#KZ
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M]0T2BPRL)4YE2'\,*C<&GL K"&6<)FH,U_Z@N3RWMK';;W&YWG*ZG"P- ;[
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MR+XC^X[L.[+OR+XC^X[L.[+OR+XC^X[L.[+OW]D^NT-Y-N G%-V9JDQJ9J@
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MB7H*O\MQ#@M^8O9%+S/SIJPV&YWDD5AZEF2!"6\NY5M8.JDRH$)U5QL#^KT
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MH4T$B-G(.@Z_24/1@>7>6LUXH)@#/'OBUT[JR=@P4B?,J$."C'S8?3 XYRE
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M[#_6<6E.4CYJV:5,DEGC47MIY6U>%OQ;28R#/PE[B9B%/WEZT&;EPURS\90
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M.=J"90#.E/-I4N=/C1*%-CV-1T077\;UNZM_?O5?>@+X)Q9=+$0\'8Z<H/Y
MA]V\EWF]5(%BX+E_+:3?<\.6)/S66UQ%_V[ :9N"I>>!PO//KW9-D*R&E:1@
MBH/306N[77\PA <@@/(!2]2-\02 ,N4X,ZZ\/80Y. -%PVP;+P;%D,\U0O@1
MID1(HW#/&E@;$4(M3Q#L+V@[E;^XAK3EJ.'I_3G5-W03OO5GL/$P[ W%*E?%
MB;M)>S.G+%)PN<L9O8\0;6_Y\6LC9>9O#78$#,X?9"[;D!B!F26^P\.?EZ8&
M,*E]MK$R9[%4Y?Y&+T4QZ8^,1+C%I8JOI4WXVEQK#A\W#T]*L0O!2JA^3%W_
M:WH(8XZ-83DP;1&KE.F7H<*B@$4?FFO<(5@;2*.FMC]M<R#$[0OSNB/*(>(>
M -EIXJ?:'C/JS#ID3F\VIE>\SM4LY,H%\!]?@C.U[XXX/ZZ2L/[-'.]"PEKP
M>GAYW13('=$5@_A@392;-0+O].F%_GT_V+XBELBU;["Q6'2BDCA[K?-\,$%/
M>\QU^C'[+>[M]1- .?LE1Q0PY?#_^S:\D_7L+@B,,)MTLQEHH*4Q#.D\0#@-
M3L$D!=R?9)V$GR2D(A\M[D1_VP2#6G_M15G<:?R&_&T)+>,/EFQM:AO'!\D!
MB0'A-LS[L7ZX8Q[;$2TQ?7A,??*I_T =>U<N,UKR]G#2N /[#6]WI=(2)8-&
MK$EY>LRE2S=GG[(6SI_[JBUK^7QHUN[=(:S'["G2-D5GJ<',Q'9YYLL\ SV5
MTT^>T6,$L-]SQ#8P)U%76.) ^%):[&QY1G!)15R8IL"Z37G<&<8OM[Y(BNJ<
M!3SJ5O?10OZJT='5=DI^H:;3&.X_GK#F[.ESU:]_56L\2.WVOI#80ZVRK2TM
M7:FT(#=838H$ZOZUU5JL>^F+'^GZQMOGNEY;&[;1Q7"W+!AIOJD.7I*2MX:^
M0J8%YB0A84P=SG<RS9;+FDQ:J9:^?5!A#@^"6Y-=AL"-X!H=L^#R=90$D$H6
M0IIA^QZ_RW?N^M-O=I4($;4NGS58=WU6%5"YX'8S,&QN+H&SDP*S'7B4JW3V
MYKD*-PGS++6;:;-A?I'/@[O(+9FJ=M;48-CU/]+I3Q/,4Y4D7CY]&J-L?H]@
M9;:KMSQ2(-=D"6L'"_T+?JA)4,,Q#^L<D3'(KD?Q<<O7LDL2P'R"RAB%T0TL
MX3T8_,5VVNH]>F,S^!QGFB[.G&PA5>_CI&XMCL:'.[U!#%C135_L[9QU022N
MF&UWW/TV]&Y]6QB'6=0JL,A^]+8ZMD.% KN'O_N[JHHJ)EL\)3\% C?-&@_=
MU'\:E99 SC_AF0V-QUG+6-W#*C/Q/ZYUSD=ZNM>/FW5;Y.-ZTN;SA;]G</A^
M_0]!QA-\T8 R>LN!>0]Y_1LKA*;J.J:[$_]<;VN?]W5M6I]8PY1""QR:)&T9
M6UR"R.F>78U'7D/7(E2AA.G&D].Z!(&-[*;P,<N "A<N$BK\<E^].$AOE8?G
M3!6JN2OQB_0;9!,79 E;N\&%!G45NOP?DY6&^-^TD:TMO3Z^[3"6]9'NN*!B
MI6%36K(SPVXL>"1Q:4$SUZ.O1HW+IKH'R8U%!-HH0X9VS+-%H)&V)<A2A$!<
MPH(\($51Y[W[S"/H'BVFJ:QTH\N \_7>)RO=_+FT4TC]KJ;[/9&0^/0/_"9[
M7:<^]70%&$5%F@IF?BM2*2T+-+;IOU<V'-7J73EE7?(^IF#J"=$D&I*0D%>>
M3L[260YR&A)XEGLXRE1@B31SP_DGUQ!XU^^H8=I&??,GT!R)X00$T];W<W]J
M0HW;V.]8%]XYK^7D57:._7HTC32EHWND,Z>N\@L6I3QBWIQSGKT!\SUSUB4R
M(E65[4]Y[*.7P\9=^JHZ9=-HGRWT-,2&Y'>+S]%H-&*(-\H3ER%LP=33*C,Y
MYFGK'8O6K.FL-(-.3B35SZK45&>E;7$I.SC^_YPLY@(#ZY@G\P>ZFP ]R,*P
M'V).?>/]N?R_1VS/#5;3[[QI35C0L_^;Y^[CP9LMO*_N45X8R7H7N%I>K<VP
MK%T//8RC'(%RH2?!@BPG=A9'%44B@"!PT)RV"1WTR5K>'69)43]!=4H0(2[P
M >AC'I%<Q>:)?1FN//(7+Q*C1?4D4,>V]@A"0T+YE;H,YE1DH:&Y,?M!0DM.
M7$O5'Q0-$$7C=)%'KY1K#;LX=8A&PR9]%2'V"*7H+V(['*\*V61%3/4MU,A;
MN<*S:QPYD9I#].]J@0\2!U;0+CW>LE$Q_.DYBII173Z58'-+U1LW,6T[..*)
MPV0VE\0^&@54G9(ABS4& P/"/-9TBW[0::[O?>8&T'S@JX!F7X,[2Y@$\9G[
M4A-V7>"N!ZJ'C50M@[FBB:_:Y)O+W!4$J1[F@B:,^3#<]F?=Z];[*+D1@#^.
MA[*;;/]$1YL?(8Q]L)ML?%)VJAR1468+=<I$-1AD#* 86;?SBGFMU,<95F>)
M<ML?]^%+_L,DHHUMKX7HLK_.QT;JJO(U]0N2-M:YBN'P6I]1$@:XM+/53B,L
M"6]5T%<_<7FNI?!O2 ,:>=N!#N\#2TRA=.>XE:<.ED<0&2]HIY+"(K# 07<>
M;T+8[;&MP( P]2@=J*P_2@0_V3@$E1 6]@PD[4=9_6,:_,M(U2[^J=J2RM>6
M(\0,;0$:5V.ACDW$R0:"%/JG[=?OT_4K1<L<:_2DK<J%)+$D[+Z3YSE&9O$#
MZFZ:J#YODK9TJ[#@JD[EJIBBWADC6DLUB)%BI.-K0/\TA3/)XA_12FMB:&&E
M)BND["NLGD3_B,0!>CC&%78-VB?M!>AL*'J61'2-BV:I4ZW/K[=-$X5?<W0-
M4,65P$W&Y,_5*9;UQ?1FZ60#T:*_]*3OQX[[X"?5R\=]TU=&)I=-<C[1T0F[
MLDNZW?:4'[8U"<4WRV11CUYG4JS/F;M79LO,F;Z93-%P6?@QD?<A/;.F8FWF
MF72U\K#W'ZVR)2JA*QG+Z0O/PFTBU3.^L378<01?S.S<8E BQ$_]%B.+70*A
M(("@@2*-<;QU]*S6!.M69?.KT,C;DZ?>EX4Q5>]T&&E.[=QM@ H!*(MA6<$+
M3(?R5.:]EA@CZ[, YI5^'"]1I\4BAC"YY>CVJL;4 +=UN5$<W,B.JS_F"</J
M)3*L"F%LN(BD$_N8I\Z,5"9^N.M^"O8*FQH1"]G,W'2(_OAQ!0MY)#8\S+J=
M!7ZXV%EH2)Q?F<<4AQU&[/R_FS+[C27QXYCGRW<N])@?\VQ? #6&<S;$V.N+
M9-8;21#=YIAG,M =_3?92OC0< ;*?B,IS(8AJK=4]V\!BY=.[ \PWG.!X3&J
MG\P I1WSW.VZ@EM=.'G,DS%*A;!?$=AF0VD_-;G"</F\T7^XSU!RS#.AQCJ,
MY/ M'_,H9=!N<8CR"MQ[,GUB!_*:7#M:J&@F+S=U-Z9Y4(9[+MP_.J1,LY.U
MH6S?D->3J,NH";04P5=X%L<H2:)HQE>'BM+1O:VETS&K<7N6(=N6Q>!W;;#D
M37&]V+DOTIT,2M!R G+R5WA$\#8-$?*R)2BY1>!E6:^DRMOFG(=USM:^27U>
M47E]*IZSQSR.51:8_(V]FE&4)_39=#A3PX">UBO,QX+1LV6%\[\-+A718R)\
M_)N<LGW \\OXX"3>(79Q3"\3Y%,'Y#/EK5!AH\-?A*!M>,TYB24\@2723B2#
MBNGBF1A1'.I/2TI^323G7*=8S3))I,]@/N^8IS>K1L;$XN4#6(#O2I_WZ\&D
M865&<_HR0;V8,LT_U"_KR\=E>?_8U\<OP2C@]@3;%-\7/1/H;97WO2V1KAG8
M(17<0HXZ.R]98B]5>P!W?CU*["E&!+8"Z-.+E!(W'D[^@FXEXTE%0M>Z'IFA
M>R*)'6VZCB!A4^'1,VKH<"$4-$C9$<W'$F&7<2ZCQLCX@ZV^<+IO[[.VO2(1
M>FOSMVS2S3$=_2V2\^T,&[6\ZRDYL_*4QLT_7!>'EFO:XF]'_D,^PH@\<1*B
M!<45!%G'T>QZ3$'9RM3.<E61Q#!YJ9:QAMY)[.=W5?;CLLTK!UR%N+(CC'1?
M&A5CA=*>-<OZ[#68_5-@)NWB7Y*]W!KZA#Y@\+3/\]HSB3.5@U4]E/VJT<]8
M12&WT?SM'4 9MT5_QW*A3;72?U$BFB98 ;3GRQW*=+0%Z4%0DW6Q\XS+1E)$
M%$_*PP"W'D?IFA36>&90(V!APS1K@WN<'[S((G9K7.Y[PM$3Z(F@%IYIB']7
MQS+T;/ <T:_$J]QCA):%B\5]5?F&-==J8R".C H2$7DI:..HRT9J@P!9^6N'
MU>* J52OT4F7?Y!1KWIN,".6OS^^"I*2M;J8H_"02T(D9&)['3Y0V4W&B0Z%
M:*_L;Z\/VQF^W,KP07V',JZ"V+HL"*YQ"7IXO4ONF.<[X9@G9&7U']2Y8Y[!
M/P N/7HP"#U*(_+^$X6^ 2*NDLAUT]T8?A::_:Y#BH;KS\G;CHLSN@6CYNX$
M(O7"'SRJZC]2B@DK#/SFYKYA$%@#D^Y<P/S'2N%C9F?[G3=O"ZH3:)R_Z!<A
MT2VF5T;K9Q&N+5_E[OZN?$O&JN:NH7,!2D; KD@4[K5Q%3N9$:?N/&NN/J_A
MQ!1^T07ZITL)*":RQ'HEDX<$LGP:0_+>)LX8<Q\5Q)OSL(75'U=7E=3SX(.Q
M>9=X@?\OBK]G1L&#+TI2 U\X6@C3NS3>OM%$U(FQ1YT84YIU;Y ,8&J&L<F6
MPO,UC@H"^79CU8J$O(6%\06W&?7'[R.Q]_%-L69#C8ZT8N=I,N5'3U, \5 <
MGI"B[ZUME*_V5;4_^9&T5DUR][U>AY1+(V%*TOYA"MA^NX),6ZNGSPD)2QUI
M?$39X'YWW9S1<TZ_$7\X];K(\Y=KA&YX5WI=*2!+O2!:B]AFJ8A6Q&?)&BFZ
MAGZPJ5!)M1+%]GW0O(9[>'CKX-:2:>\.\(R+?9@8T"D._UK;25R_)@@1"!)'
MWJ$SL"4WHE *">G*2KL:]@-1"D>];4VYQ;,;%W\.W!C;:_W;>3CR0Q0>D@W
M+WAJ!\NC>Y$6"7T3E*\5,FH$Q4$_;T7S'%4KFS0=M?5+E*6XFH1",:M:U7.>
MFK,FA2"?8YXQ\EG]'NCM!9[%(AX:4W-P+9A+?!Z)_AK1I")]H!8B2;;1F;)+
M5O6A]/-%8&>6N(>IU'[R59><Q4IC+W_O8+1+-*:AN9\/LE@"_@TH9!JQ4..L
M:VBZS U:&3D9+(N\63<6T,C<-G!HP8\_G"A:F+SPJG_';"I,\+? '#-QQR-.
M4E18Q8*K*<,N.,3(BUC5_77N I5S'I=<DD&MV]O=6KU4E5#HZE#RQ>BVG[)E
MZV1%/-&VCZD7S\CH\8;=K+G6A;H#C4&&0<K"S]#C8E!*]W>KG<0?Y<HACWFB
M$57".38]U"=98J[Z4M0*"V%)6^)4MX]D=8U3ZDDOK$_NL[^ZSG=*&LC/-G-A
M__<-VA[G'+L [;>3#!%DB54@YABIM*X:-(4LN-:<C0Z<U&%?';TQ'J3N3=H6
M]_N9,!$4Q+JAQI .S3[H^C.#2/.C?U%+^OU!>[_:PQ"A*XL+<B,-*C.^IQY\
MW M^^\/2H&@PQG52"Y$8DN6:>J4\BS_T8W",ZV H#2ZA=BO9868I2G2W+5<I
M1EXM>.<TC2$2W^'RI:XEN4II:)/":4CN6?RP_%9ESU'\%99_F+I)#7&9Z*$H
M6HCD#:E4O(BNM)ZY$4S@MKS%$GG]":. &I8NNW$D@RH<W761I#LLT9?]O)GX
M65U74]!#/?/7S*QU,1!BVMS9B6]OC[VN$NDV?W6#,P*O"C#35.\B:INM!RN]
MSO60;1 H1/C525K]T>W$]:+8Y<..2IM^$N--C/G?O4M:Y\O,0]>_3$>O3\6H
MO*DPT"A@E]K2C"!'CG1YS?@&H7-'-X9.Y-$T@E]_?;KU2SB5XJ^C%6'L1]EP
M((X703,7+U&#1>'>RL23MBE(Q<>.\F7^^I^=2O9AK2A?!.Z_M)^=]"!/VD#W
M&+H&@+K3V8P$VHCJVT#O";S<!8?IHJ&>9^-]S[$1C-;MGVH!H[-+J<O+AA6)
MUZ3>H!]_\J:_M0+U+"'29KSJOKN79RL99BKRWDR](!SCH/4KJ>PY:D0[Q@7G
M\T,T-"G8#/,Y8LHM:\4H*'=9]G2=2ZKUV^"K2IJ4TPX5CI)?/4](Y0X)OQDO
M--C0Y=0YIMS55=HNX:_/[[QST[(/;=QU'?"@;?:2?^MP8_Z&\+\3!/Z+=040
MI$#D_!;,3<0/^J[.IA:'R/VXKMA(F.RP?!  ;KH+3]$>8'!L6XJ<<X!-Y5'M
M9 FQ98[:DCWVGT.RV(/=#E/M\(H7A=(Z\]>B<L>)BY4CDA[HE,Q!QG)RVCY7
M:^C%:*//_!HM$;)60:2J+9(%KUA=_!2I/Y C4CC61X4S_<,;U[R##SOY=;5/
M+:9WTRTU;A^NGC[FT0I,D=$)K$Y-MAF;J+J@/#LX^%^501/^OT]?^-V)L0LK
M)5GJY,'M23/EC?@FR," A/B2PM*E9@GQ:NI4BLZ^Y77IM:MO7_W_M5_OQ,$M
MSFFN^-13.N8)#3GF>5Z(5F<K0E:2CGG:N80.H71T@PDFK&P?\\S''/,0BIG%
MT"'?H__^?SQU;QM^S*,\QI6Z=] SY]CMD'W7]<G]F2!6NI'9,8^7BQ.G]/8N
M';2K,W3,L[G M<BRX4"EZ_;^_W7E,@&87JP2!E2A+-FH2M17C RW^!+1C]*^
MFU*&5[I04OC>CVL&K%GQE$4!@FB*MZI+B3.I#RH)_@,!-Z$;#8Z&UP*:/=).
M<3Z1SC.N0_MGU)V(!2*RSR2RB[SR'6T<M@I*1E4J,>K3K/:>L0(L+E;,W_Q9
M%.I9*8J0WZ:KJ2+IW/R%-&^S0@ JS93#@LU@I*.O=+TM(E,?,4 ))?_>84$#
M4<1K:+$>?WGP@64L:0<]=<"5(?/L"9>H'/-OZHTMH6S0YR;G\<&HBS*J^:=B
M^1[[-.<M2*3]JHR(-<C^TQN[I*75BU6.1 ?8S5Y30C^WLAQDV]<6#>M$UL9(
MW9HQL)\W=+F5;E1EX5?SJ +N5GS()>F_O^4ZU0'IS+UZ(Z'LVJW0G61/2;KO
M5BZ]J@].Q;S&"*AC^D2 "LID?RX.+E!L5C-:/2>H8GD7$+'[2!M("/.X<A3!
M,@VFU)S:I=]T<1L(VC,R[I5\?""8W1R+M=;J(3$0>3LSE6&9Q?)A0D[#0]O>
MJZ<'5=]8P0)WB"\^373;UW:6/HK[L&,E?Z#S>!X7!988W"+K9JPA$\*/>4Y^
M8'=!'H^F@B3!_[Y7#P3Q3HO#R'>)(GFG98@H#> 7G=AO T3V<-0FDG/H+O,(
MVT%K>99&_4?2_A>=E!L=6H^19M0 M.U8*0EI6NO7)8)OCY2,4NR9 3M%$QVI
M[N--PN>2TJX;73R/T5DWM:A,N==K;J5BL^I?J&\2SE65>#*$D:IZSK'T"DM'
MQ:YT6R7+([--PV'84G5FQJ,)[V^H6<T%<"XGISF1I3@D3".H=_2['>,K&P-B
MV+!;P**PD,WF+E[\%+JI0VII6'R$;$F8"$2J!QL=-,"."K.SJM>?[Q?E!N$0
M1',Z*'HE2-Q/_E)'7>SNU-#(J'Y@]@G>6U<'Z9A9*<>_S%6JTM1=KX3;,+)M
MK#1L,F6>E*F$J5N%DB;6NI>67:MI+8E@HLA)E!NSWGQT?J.P<++@_=*.LMNM
MU6.>.1F.0 9]^E]F^2H#>8/]"B7#^6R+&C>H9^G3PD:[ TY0V(PZ.%V@'RIF
MY$M).X.H7!CMTWMZG9/VC@7^%AJY(^+O^K/N 87)'++PD!ZW:-5A&WA8N) ,
MKRR(="_5JTAU(H<VE*>J]K%3]T*5O=;ML=8'P8V/5$B9L _&$V:MAA</O>F]
M/F%^2THQL:"YR#<,?[W5+#.3*P=%V!L7=_SV7,N>=:'IIBR):<8V.X:C!2CU
M@&B.T.\G;@/7:+^HN%@C,ZHPSR;FMPX;+^J.R-#%!'C@%Z\@*>#-4M IH,2V
M>?+G7B%O[W.%(B6:50-EDBZ>@?-P[7SM,N?/S@1N71K^..G_Y&>PD?'CZW=N
M5@?_';H^ZX%^:5*CO[MP#]. Y6LQYZL(/^,)2^J92 [^[MRCG13,L+P&PQ,B
M]#L?YW6XMJ&LT*F@_UFWI4K>FJ?(J3)J *X6_;V,-DK4_(ZSI8-?5GPM^@-(
MW67YC^D$G9N?NU$"$HM*Z]7$(O1L)J,),PPG3W5 \?WZD\V#J]*ZE-B?C)[K
M_^UYTBSXH-)"LR?XI/EA*6S0*49LW\5<8($!ZYFT#P^N2,IL%4D? SO9:7V]
M5.99>^HR\9IB-0&1,<LY:#ORM$_OS+%'Y?Q["BQZ$7N$VXK@6K0#V#'#D3PT
MWUBP$HP@B2>\%D'<,@=>A=5H6^=T@R21YZH1JV93&E[?< %!E(EIBT;2"[R>
MYUW+,(,O*Y+38/%;1-K7AFHKN^0JV]<]1)%MQ5MO"/#8&OXKB2'))4//]IMO
M/UL*Q@E'5R242([.&B KPRVR@Y]:?:F(5"S; Y^=YE9$+83F+)R(YJV%P DS
MVAR^< H7P&>$[XX%=KC!<$@/^@2:UH)20(B8-#"MZI;0O"SM;QTA%,+9];SK
M/6[S9+\ZYS7(68S#^&V)-E'.7]&-^$UBG#Y<.-[EV0.,O4MF*7;7"XMNL*E2
M\AO'NMK[W_CB5Q;QK6'<7%H6!WIKA6DN?I4V.=ZY87&0GKA@S@\KZZPN*Y\&
MCWY#+[X#"4$6RR T8]SL 2,=B"I>  Q^6L] &;4TT]Z@N-DLUG/\#O&8)YXC
M!X"H%IUP(F;NGNOW[EH8"9;7GT"5XW5)[>^QO$4\^IFCR\DM]<<$C3]&MC[<
MKP=?&KJL6UJIN7VFK89_S+T2ST==_S":OI-N;I.I*--N+C1BTX@Q[[LEE>.M
M>D.?0^UX),'PP1I6K8?YY,%+W S+OJ"[6UR+"M^CNR4)OM?ASIUXDD[AA7OL
M][K7[6PZ<]6W&MF&UES,,]E@,'Y2;]9UPV$!HAFC.LE849N&.O[227KC([!2
M?X_RH*WSI7YECU:CBW(*.8X+"2*9.O4;ZFLY^* O*@W@9S0"2VR:PQ_ #$:T
M4],2"8M9F(^XGK2$8Y[Z@9YC'JD-\$D21QOU3=Z@E1:VVC?O9I*JFO2E0ZP,
MBABEO/<C!S:V-K8UUK6F]<:9UG6,_S1RB'KOGU=,8\>% D%_#F*]UNE" ?'$
M%<E$\P;B_765)&$^ORQ3:?U4N)G./P6B!0^Q_>9&.V)I_53W!5X!JU O#2C,
MT;UC&ZVR4A&@7M$9H#&Y%27#5$9WNX$-.#.8!O*V$P43 ZV?PE"L >6X+<R'
M]04)>MQ6&EVD_YF!7FQ8S?.EWJ4;K9.-!/'-YSG1EDTQO[OZ)DS;-$S@!<QT
MY+R)=TEDU\FM_6$1NTE$@Y!L]S+B1U?Y!9!*KOC],H.(%'XKAS]/6A=I/8GV
MKU#VQ*B5B)=)*'T1,E/$GXER-Y:F5]Q0"Q PIBPKO"?KJ9,"I=4#\QUAJNWE
MQSP\Z,44B#1ZL1(LQJZ&+):&0QH&MD)H_T[2+1%FB;>[V!]UR")()QHAMH;#
M"]2C$R#2_TSN04_^(+/,QDKH466%*Q5+3 1.)\'(132!4F-PN[5%.OK4P18B
M7X!(&MHU3OU:I_\\](F(RT/LO8(%E;SB:','6^+H3+O)Z\8LS517V,_#:U%W
M0^%4=JI\H:G*T":_72+CZ2JV-,A6;R$RY'$7^AMF>_5_%A>-T>:X:4Y@B9 Y
M?)M, Q@(#]U.BZ+$T*=[(R'BB%=!9UA7 76*89*ZML-X&3UFL9/&"M?+RTZH
M_ [7"_% -!.E Q,>5 /F"P*8L_ BU8:Q +"V$F5+'=D5,1*2D@W-5F:JR ^J
MA-&U;9_D-#@69OI*_)ZEDIZ18NIW$Z/3^=C1H%2U^N+Y1%Q\L\YA8;'55<L0
MN'R*WHZQ K5S5553!^#CVAG,KNF2Y'S'\$&\K0&5BBW,XN@,L?^8I]%G2/@%
M1++K'.(3D$/13&;9DF0$K/GGC4.HPA)F 1$U\)!UE%3]U2[EEJE0W'DX2KI^
MVD@+7HK('N@59R[I!ZGCLKU#K.2_^B_![H?U4>IT#K5$U\N^;JC>S/X[,7-^
M_=+(N?SH']@6_;(TW)G;E[]OG"M1:;,MU$/HU:?UJ<^7E#9F.*443M>ANQW^
MQ3B#@RU#NL!BSE8-\RI+L(5=C@Z S*KH!W6!6%?@<T/"PD DL;FM<R=N#WT6
M^!LVF)?]D?/'M$[ATP'SL:V@/555#PBQZ")=.)YE\PYV9)GI2M84?O*/MJM^
M-5$NT5D6=[+,?UWIVK"QU;T8]O=+-^\]S4_&%_QYVK+Y2[FA/*V^XF:*9D!\
M%8WHIC#_?M9MOCS=TB\_0!5Z^._\[*M9SAR&9K.Y\]W:D5WPK\@D?QR-Y?SN
M#Y5 0A?EPBG0?LBK+L-QHP#:X Z4!DE01]ZJ1?#V7W7LTJ$O ;Z>:"'%94:6
M%CU@N+_F:FX(N[#88UWUPZ:!WG=:D\.; =U4/87A2N\I^2QG[\O?*ZVRPO@_
M+J>X6HZ7C)XT-+&8F=6;\G>OR\EY2PU..[.V=+DRQ^@=Q>"I;0QU/[GFVLQ<
M4&3YU"3Z(:$NCI6[NE5\S.,S25,]YG$(CZGZ933-,8E(8\<M0?;_*MZ3A!X\
MAK 1)<<\Y=0H5?=3E/]'B7 \]7];[9VX RA"MC!,'<X$EYTYC@(:5S%,4Z0@
MX$NO'^@F-![S] J,\KLB[]#*<ZCY:.'Y34@C9$!?URU%1=V*;WPDX*:<0;\J
M]B_^\;)JE8'3)U$EO5*QAIJ4+K%L7C$H_\9]/Y74Z'D]75EQF2R+G-#:K;2"
M3]]*H*!<E0F*C4GCH7W6]O-)S: 6=CN[BK"82:99IO&CAM"-%8E&NDQASK"!
M1#Q+E\:[)$]X!W\.[<$(S&RX@IM+D(9T\9(R_[RP'U=5U6L8F*B D_-EO7?K
M;QAI?8Z^\AJJFA,L%&%W^9,=-F_)UPKQ54V)SRD_N5B%EOQ^<M_24/?[7K#D
M&=DG^\NRN@I+)B66-SQT3Y$\X_HQM,>XURP]N@#G]'XE<*+?U:&IG2(LBW0#
MN+EQS"/F%Y[H.NI"(R>$;HL83^M4E=F6U>#EKC V1L)^%Q']^IO81O"\RS>J
M>1C6K*=,]JI0S37U)8.0@F+%52F%Z>)8"\FAWRZ9>5[!.E[QD'7WSCNL$>ZI
MD6#TT]-8YPF,J]Q\;$-W7V"Y5&^D(SUI.WUVBYHSGF9>F1N<2T $\[812HH^
M55=VZ[0([*->CW,C)@$E:R'IN8C(H!KA9&YHS$AL*F;;COX"RU(-@M,FR^(8
M+?M1RE/=G-UHS^P ;_</$YTYBJ)-1OCX;%[AU$]F!+^*(5-+BI,9?L8 9A8Q
MVLI$,QTY7[AVU/&R9#3IFHRP[$$9:S' ;5'II>YH0HITK^<J%9?"T4!(](/.
MLH8^U >])R&MJ\EK!@X3U:/LF%*8X^8R,4A4BU7KP95,_O3Y,][A%48."*^#
M>N)XSU2%R1>6T;?$@IQ?YJ854.']QWFAJ E8]RCK*9;/(G!X)D(!E8SN/HL,
M681(HKN5CWD>J&). AG$HV%,=)>0WX(0W6M<4[T0:;AD+7 XQ='XAO]><NG(
M!U]!SFDEO&+H^^3)M$>Y(#?5;T[]7.JCMCG Z$(^E3>#P[3DQS%74&SE?O#(
M/8X?_GU30H6<K*M'[N-B-2%05GF)I8DC\TI:+\:'L+@U!N1R^:&W!$::&_3W
M9)KG,4\"IF$%!P=Q^8XLD-\WJ_D"&5 N%B3D#[Y*Q_1J)DT7\=,]<Y_&GJ[=
M#BPC[>-$W(9.'S[6=8M83M=L^J_/49$2G"^=E@J2X=W^T)^\:9O3C[4ICDOQ
M?^HZ4]4O&)[V9GEYNBIQ6-%X]DK(O?2YO!#L%\WN+[ Z>CCKK"KC!A<R8>B9
M<.JS0IHPA[^*'L0PFNB21@9.-X[&0QIPKU#2:T6*.283NFAA('0=?597;\(H
MDC)OHDA_ONZ:^EI@J'2 =ZY#L/)[GU']^J_H/8!PY=.BUIZ\=MS'PTRXU_VU
M)?^I3!&;@L,/)A,JI@?(L:+TV<IG3I<':?M5]S#U ];"7VQ^V2:+UH36Z.WT
M_Y@*GML"?4#3K*$S:$K%IU% W;H?P?+X]SP( ,OT1LT]E]A:19<C8;2=>+3O
M)DY@';L8N6D=+?C>'4BB%A4N!9T'(K>[Y!J.>6+"?4^]9-QN^[7ZL2$/$5B]
M,-\ANPIRD^CY'N2;[K7[HQ;QO4.-DFR7@[<^-_PE+A3V19GP^! ']R@EM<Y$
ME_!'9%E0-[RUSI7Y8\?JE_&&GLA=SYV6FD>U.6NFQSRG?OYVS".(YAI&>GP&
M,V?[7>1E@3"7ON'E3T6=LN*]D;%IR@WQY_88R):+)ELK)^W2,0_BZS'/UI_H
M];!!,BU$<$):KU<84 A*P%\[6?3Z'6K&>]-Y4G%P%D8SKD$J$2(T%-9>N,":
M#TZT)H[[@)Z0%F\OF\:O#[A8JYMK;<S%7E0A7\WYZC*5\0F<V-Z^AB_C0%]N
MD&EA.7$=3C7H;HW'NIK"1D,E@"DC#["@@N2J;=I+ ,=5;IJ=,U+V:3Y#4+LG
M+ /D=X_(WVC\H=CQ0&B]*$C8UTIJK\0PQ/Z3]Y\6+/]0%<,(IDH8V$EG5 2A
M&%#BF9\#1/@0]BI Q,_4#D%N(N^R<2A%U%<4""!SNT,WFF-@P00#)8L38".#
M>J0X[37@2*04=)T/L+9//7)&J97A:U+CBLN64^O@?WTZ>N"\X.)!#+A>_6V@
MTWU3G;@BTF/Q^B/&HR*1H1SEXU]:Q;1RUB<+/%M5-1?>]M -'3O7XZUTP]ZE
MQMI[_9>'G>.]Y6F.)^Q1R>Q44[91.\,2B*3Q4II9,H7<J B.H7W2TCRUV25@
M,2A"E=$\I;,#0LPM<FIH5KMDA_S%@[AJ78P0#"4ZI5OSG,HT)>%TEIZUL0Q>
M-K5/ZJH[63M[YUM@#%=TZ\):IA6S#?DL3L8G[P)M.G5:?4IB\1^6KMDG*^]^
MP;IE9&]H)766QA-[,J\DNY8X.MR?#!]6"<S"-"0&VW349N%"#P)"(?<(BPO?
M>%GGR R-3P,L.[+8420+!=1:KT3@,$N:A\HA$#J%L"\L%/X(LJM)/+(_YB'A
MA8>Y4O=/<'LIX@*#VR!>)[),L=4,CCP-O1T94DONJW#^01X-*O6#2* #W#;[
M2'OMI\O;.@K5'N<&5#]^E[VR/*X:B2@R21%N[OL[ZS'NU7K_2-C3Y=/S'VIA
ME-V6JB\SBN%5SRS"B[]DZYXQ><Q(#A9<'S-!I!;%TX-F-CE\A>5(_V^L *8?
M-["$?\^_P"6"&N)>LGSI M"F"<YIQ.8MNCV:WVG @/=-6/ [N$'4[G#DJ90R
MXTJ7X7<SB&,>2E!O^^=0.4]0@W^&BX$IQ$?O>K9X:'V7UN>U!_ZD8@E9!RF[
M,'8F>U)_6S[B*?Z:#>Y&B"G%^K'?8I:QD8E#<J%D*WZKM+1X6"X">F +S\DK
MV"K:8N(XI[N9<.0C=@E2DQOGLVP, 8:+0_.%:LXZ,6[1^\L6T4EH4; 0X':#
M-I)$#W>9U$"I(U"_[.G2"#O+.MK/$FJ41"]9B'5/QI.48UU//Y53->,QN^8H
MX3B+'S[(Z#WTD3CII-!_7]7;]^576'\Y2#@!:Y!.O ERS'Q@/?ME(N7:S49(
MN&K;TR0K2_T/^X^^)V8]2"IS/9OB?WZY8+U?BY'"--YY6NNDL+CO:*G[J!U]
M&MW-UW&-FL;M.AT$VCT"'^*OV8U?_:A+G>RF#D.*C.'O,,U:EF4-9[#K!$E'
MQNW2MZK.Y7YL"%RP$ONE<*G_N5-57T:%=?*N:Y9KB@I<I=!DSR8ZA'_$\O!2
M.?G-<+:26H64Y$].?59[A]'YNH,!EO3R$B$.I<!M^4X(2(^\"(&D0,\AIB4>
M\XB'$A*?.W1^-;5OF&894X?(HO^S8?EC\]DY?]3I2:/K\ K/*YTUE''-@.V?
M\E$&C(7ISTL;NMC57U@;BQDGHM>"O..!^Y^6=@7>C [__D"+L%'QR3*9_8?I
MK[LO]?_XAM75G=I>T)@724E?+]G:WC7M*83> 9J/>7CO(^_3-;O;JZ)"_@O8
M,*]M/.?M9X?<+-34(6S_NZ5;BX8ALIVL)C0HJCQ=M&.>Y/VT4P#$MD'8:"KO
M($Y3K>PVQKK5#6IQ3LJKPXAHUUO!1]4*SA87<<Q1H^NJ]O4]*Y2<P$J44708
M_BP:BG3]P_H&=MR_Q"VR<8GWF.?%<+]Z:/"NX0YPX0F(=H0#-!(^?09*_'\;
M^ .4"#I[Y;<MH<G/.R_75#4N'O.D.\5 -GO1^^*Y$>&LY!#($9?-MU[\]R0F
MTQ01CI  UZW:5O%8HSR3XM_3/PA<(((260]M+P;'^I&V1;9O/DLS<!<NK']R
MP'K3<;?-8YT$B!*^1'UV)A_*/.(D'?-8O&$[3J_&M:&-H#2NA@$NK&ZI4R$S
M;@PRNQ@IS%1TAA/P)IV+Z 2RN Y:'&%G Q1C 9(KT%[Y8QY1%!!N25MY0TW8
MPLLYV4[_U-!\-+8=JMS().I,I96;^5Z8 S52%A2'B]\^<I9N38J%\C=>WJVP
MU4>04N6U[MT+4[0T,]$R4[XV[P(/^3RP#$"]$FKX)6J7KF&5KOZ8:_<WFEHX
M<ETPU@04"*QS.PRI;X2'QSS?DQC1P$NFPHP?&F\=QU*F_:*.5%$)XAL0T5",
M]!I!?$_='R*Z/LLHH72Z]8DS7)]5E&UF/].;.C*>BA$J]&]B,*K*U1,5.\%_
M4=UG76+AKTK>_GKT"^LF*!U*B<U2]EH5]KUD$EP^9Z5>^P@<V#$]<5D*)76/
MZ)@EX&23?)C_H;2\D+2\4M^4Y[K@"'E?"91,0[B.!!16TUC7N4UHEAN1<2Y(
MF:*]T]*.)G'$*$-& ?TK2@N0P2'**&-(7>KA8R/X$E2"I4*JQKM]<;)^?8^.
M>0%6V?A[O3T0-1!!Q0B[ ]<"']*5&,]R(1NRQB81JP+_M)8+"75\U.DL4A%E
MK]M:9:D@LI?HNN9-\GKC&P6=9:V:BK_>\JG)/T@B.N!U79U*%]YDE2G;651T
M\K6C(YZJ/T[; E&=>D?CR*=8?-1_AW;$C!Y0CGEXD&":XYOP6J"B;T%YHF:O
M4,1XO+KDBG5(>,33S[E_G*[9?G_>P].]PS'[B768SCW"2N/E_3H'+(6V5^&*
M=[ED5V&E89L1=1Z:-*98!;NPYJMOEU3P3_'IJD'KV^D<PFWT7URLO@%/D^",
M09NA++$J+JM[!T!Z73'$-&E_Z-D.$5K0W0EUJ/6D4<@Q#Q\H90DHK "N]F^9
M1OPN38Y%2BT&Q1I8M9\W#LW.6= :-\HL]$[_\P@BH>)L5!&'0(4I]W<JQF'C
MT\-CQ*RX.L"A!J2P,5ESZ;H&UN+!I\'#2FK=][6^%HLB'=*"^S@C47D;T7_9
M,G0EX:B8R8N:)=>EL20R%G-ZX9K)Z 80\4\<2YU>0XX+P[P$26H@Y>A!O4<F
M+\-+UL*?._5V"L')9_R>=[VLV)@M6ZFB? ZSU+3\V,$EP6?F^W6U%++?(1D!
M62L%%Q+?TUJV3!MP9E;Z'5>PL17*6$L#$?/2)3W)?NWE#%@_?+[>]YF$2-RP
M\K!]L0 IJS/ST%\GSS&OPWLI'#&O+AL.^0^7CI<?\]0[;1UP,RKSW[-UT-W7
M4$K<M#(,PYQE70=*Z'941J%P*MIG1PCXY4S_78DHL(2)>ZZ(+ZSI*D%7(@AF
MM+1^/Z0I%7?*WU.&+H3]L/9\D?3S BVE)ME5 QL@_/V?:ZEZ\?5&&[$AD@[$
M;T2\A8R!5LSJ5I59TWB*DAT_Q:K:]W3_O0[W \M#YUG1CY)?%6@I_4\QG297
M K^8\ZD?9OI77&J<+RQL*VEC-TLPN$WY53&Z.RP,(X#JD=[I&1)TXO!%43S$
MK040%4NB.?6LRV-=2H@'?<\=1E-TS;9J6,I+#]OH':#S'3<D8AN9?(W6#<.@
M'M VU$!B7*Q\0(4S_%G?7$S;SRE3>_V+?46LQ=Q@C*NM_7M,8^FD9A5I-0AC
M&K_<W.&I-+<4HB>K^@IQJ=;%>M$N.4>[62WG2OZR10['@UR\@J$Y06=4.0*U
M7$\BE9GW.=\Q$I!'$/DUKO932@P=34"=F>CZW=5S'7V>)8-%9/1Q3HTKT$]E
M)] BN]]L2/ODUL*Z1*9UXWVG;CJ[^J'G_K-@4]$U#X1H42 U]D-/OU[U,G$I
MNW8/*VNW4NRHL^Z0<Z'K(DZM0.Y._]AT?O91B1$*I,T([O56L<DCFIF#A\R,
M!VV<'"L$2B>":K-;V<6H 6AC>!P:3IB!+^IMJU+0#<;EK < C(*3]( QTG4^
MKH$OM-6[0241SI_[DD8I$/%9.$JZ+6!$<"KCZHR"NR$*FKOHF[TBV2%H01;T
M#"7!E Q@"UD6ZI (LY[WN^G@-&$7IV+S^N:=/XKRE0.XQ'^NWA*95J8:_?W_
M&!]A76 3(,MZ(%K0-'O9]YC'1:F[\3=FZ_\>2#DA-ZX0H7#_37_RSX$7'UZ'
M:.WQO\O84BZ=,U-W,].\GB[894J)VV;2VAE<]?%J&JE,;]X*H]DQ"IMHZ#[K
MF4UJ3BQ* 4Z@FV_.UL;H3A66(W ]IP9L23]+:5N>?WU+1*3^"FRE=%K8<'JF
MO,=1)!$BUE1P>JOCVJV$C@NXG&"?*&*84F:P_'^Z>/GL-B7])ANR921*7N/4
M="-M7A]U713U\/<D92UDMB*5DH=^Y3IV>VG!IKN'K:JO7<SJW AWLK&+(??Q
M*DH,18T=*C&Y(JC;'7P2-2H!/LTUUQ36=0YXN104*__;5(<;[2J)\6%*EQD%
M<J'KI09V!% MAH910Q19:<_J65XB<U36?]K5.F:OE1445>L":(4F%=XWQ2HN
M1Z,C"Y]<A*?V3M#EPVAO'T?Y44)@--8EIKG]QS<]7N/%:GT3%=O!;WKL[&KL
M-MY4J#DU)FL*N1!XP=UC([MG!F([R\SO]5/@E#^3DUL?29-6_LGYR[(2/#5H
M8TEX%!;P&'6$/,E.0BDB1*@K250N</L;"#:]I'B8N#%AH7.'&CMAV2F*%G<H
MS>+TI#L/0V0\V#5CT?(/;?I_?L(-!CLE1%ST);9T$#3+$K')7_U,HI=<$RLL
M!*3,SU<I#P__&E%1M[4O45B&F=O8-'!@M+FUPS[6]0$7QX@B[Z>#4HZWDHNN
M%MZ5UPBC7XLQOX<]HVY@[W")*6V766)DT6MU/D5G_::8[%P:M7E;F.F#[KZ/
MTN9>('[H[R#&7]SL%F)IT<C$8=!-NG#L-EB9!:9U_LR%E:?%%4G2Y7$G-L>0
MU^FIA/#P8#1VWBQ0HQ@QH9\TG*IC WT-'Y]%IT/P$_>Q6+/K0<W[,R T2QC@
M$A[>D]_7T" J^QTZ@# #O3<1AGZQH-# +@SLDF89?M,,T^3G?&,47:1EUU'D
MK/N?&7!E+IO2>7'SD^MHW!Y. F':>Z6KANK6>458U'73("CNXL3>D%,=>JK7
MLR@[";\_7?'F<(EYF9LI1/!E6M"6'M-IB/EPHTL"T@S9(E$%X=UMPM$XRIB1
M:A2W/^BA_F@??^<A043)CR^1[D-__WF9;'35AV2;9*;=,7* -N 0*(FAD].:
M1/(1DR#Z'!*'?LQE"RI0(@CX8[I_%+@4-["3XAHUNLV[=*=+&EA:%,J'=._$
M@N4;@7!:"13(7R3SP]J:RHK7B\Z2U#IN?&!9?-MGF_8ZXFKF_!V;/"5::"DK
M60SX9J'ELFYSX:MOW"X'B[P>#@ZDZ6T+<[UUT1]:9_+OUF()6O. ]4P(=;3G
M-]J2 S")II7O?)*7KJ,W<GAH[S?RXA)&L.6S@$#WU"]\=L:[C9QPUZ!8SA\W
M:N=G+[TF[EI76\)Y/ ]RR@A<^?=)92+CGP;7,O3F$3/U%Z.36TPTSIBG,O?3
M'O49W32Z-::10+.@IO6.SI[@U@H]G[CSSJ_+\-M6&.[TVO.)O$E<G'52X]!*
MG,E4$=F$?C5S)-T_SR,;*Y\0CO77=G&'+ABN82K6HK&U*%-\VH8;PX4^&L]1
M0@U#>% 7$#T_U6_UH0P!0]IJWX)B5^S40K_,<'@O6&0<;VF[HFIXAXK'IT;.
M84LM(A$EK\2\9.]\J"S.O3[#6F)%<4U,1G>;00*Y2$A>TMQ2_[?%TGF)FC&>
M9]BY.QJLZ_021CJ00)F3\YD5EH9)Y!6]J5VON\KE+8Q9N5.0<VNNA%BC:^"<
MQ<CVFB![DJYJ:]#V7H1.^X!G(:3*[9:Q9+^*[113<6[Y()0EM,00_W>.'47&
MG( $L24X?''<2#B3D")4@BS+;EQ7SFU18EMB44800FR#)/W4&5:UF7Q?WT92
MTX$(.F]*\\83ZO!L8?-I;ZX,B=VWU.N;-?!SD@97^6)3["S$&&C59[RG6W[=
M9#BV<0@X$A<=@, T0-UZ^]]!JCOL>H(W^CN3D0&HT@Y, :DE=')SD5034$$C
M]X!FFKI^IX%Z6U@R%3"^&M@QCR#2K7I#NOKR1IM]\.B'3ZXKJI'Y24,K;=<*
MILNZ*+O=-]4KFBV-"+7SP@WHQ5PRS7YG+HDCKT0'<?C^?6^XPC>4')P@;61(
MV8:ZTC3[1F/:3!FZ3761Q0C7@8$46,VLJX"<@!UM.H'U6XA>/$N/RGUFC@2W
M^#9%WL.?&V\=M8%?0-T,(]R..'^7G=[%WF1LSQU]8ZVQ8R$!$$!SE26:T8^6
MTQF=(3,^L@M9,N7(/^@^V#*/.=8]P(NB?OV?!NF.IB:M]5T_"!_2_N"BY%WE
M"PM&Y^5:U58OIB"[N'++OR @E+'S#]J:3+,BQY%IMH2XA;/ FW^W:U\"UFF&
M2YCD?=#Y=0G(F3#K5])_K>4%OJ8@&EL?3(6RGRL 9K2WENB0*LE =>B6],A<
M:#!C[<H?FD=;OAH>U^P\*V:@YY WJ'.Z8TAMVJ&.)G"WPP;-@$?=ZJT*"RY!
M^-YL2C3;'_U?M+UW4%/KV^^=O2T("(AT4+ A'50Z1O)3! 0$)'00(B(E(!TD
M0"![*TU:MDA1!+*1$D,+O1F($,I61#H(2$F0WA*0L"#M9#]GYKQESIQYYYEY
M_UF3F<QDW5GW=7VO[V?=ZUZ7V.R:@XB+^\8N_%KEM;4YN6;BB*/3A$;#ALJ
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M=W/0P"U:OP)IS]RN?)*$0SXHU99TK7O8IO;KHT5C \04Y3$/7.W;Y!;$XX>
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M3UBFPX'M<- J<0'S@[B9S;C&#&3E<$#>'! ?\^PXRF]'-&XX[N80P922#G,
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M(N@^BO+C6L1+VV*^< _E[RF-RGI0+%](:,-%R5*Q=#>%WXZ$J"KTPW$N%=U
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MVI%>+0G/=:Z3!D\MK$RV7;D;  MHTRVIR EI?-25M7=*/YQ;P_&577_UQ!4
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MER) &!1E"6*?L;@I"02!$U$U_/KT(SV+XJ-P^W?,CDD/9^?MS<JP?E;O5M:
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M)9$E"WU^OK5NK' 291HIXWU_ZKRO;]/6"B7U8:W62M*ZWP 7$RT9$GCYL>^
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MA4[E@*66@<G8ER_!7UI?!CJYSA^0:>;,"H0X8@;)O[N=!#T6LGWFQK*2#"F
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M;]D]:^T??C_%G%$E<O#"0U&5?--QRY-A>*0,YA0HPZ;GH2_NBATDI!OE!CM
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MXRKQ4E^=HPX8;^\<TVI8ICDX"&GZ0.F 5T'?EW*C1[%_PJ=UN<F"4J,TJBZ
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MOPC=0''@";@-[,J.ZD:\^R=2T*=\S=[]4K$4L1(UBHEE=%_[[:K64$T?=1A
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MK$S9D^T(V?J,E^4+=T4>?0)@.@FLHN\KV!)'VW'#6_+U+03G@<:\SU4#A!-
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M*Y(6=>/O9THXC&J=1>Q^^=>4%OS^Z>UC_DS2DS%R2>)BW_)92)]XCAD9@6?
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M UIQP;8:&4D/^VJD5I \-.!K-S'NQTT-4%/'N?4)1?VW%FOY\ALMHI1%R">
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M>Z2'#-4<'&HX4R94RP:0K:A:1G)YARID!<L>A.">S ,4FFBYC#X(KK/</-!
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M/URS5K42'F)^X.4<\&0(8 /F >3SAWP%H&'*5;=D/H%L97PH[,P\CDB^1?/
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M8D (8@&$O+"<($-Q"%#TT3 ,) E'+0.+.0W0.,G58O%^J<WW_V4:J*>2 >F
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MEW<"6](^$V_*Q6;=O,I3/LW " LL59*+S+<6".W;=) R"#C!6[N?$CAC9)X
M=/YNRLLK1_?95[>U7MX]S7QN&_=WK>O"8 $D4A1@HK(\1R:3*'3GNZ,(' 2S
MX)WBYX39?/I)%WQW2^G@'3(O"L"014 Q2B"S6%,=^D;M2!*'78\$[U0? 8%!
ME/32+OI;$K%#7?AWY7C/=?%_B)7P*;K#\\01E(!9* "&$N?04&>W0I<-#B)L
M>O7)W21??(.+1J2C,#XL"P&![C?6EZ[/U^%]2T$RJ;>!L- L1ADM[P2VPP?J
M=Q+QK])5RVU=^?>R<9!E&70VG&F ,Z@II%"38K8UTD90(E@:H>DNT$P6>P(8
MVN/A374MRF5#/$P!R7@&",Y89A2'6H4.,K42D@AFIBNZM8I_BM03@,Z3],U?
MC7?RFF=9"(03!L#(%H)R1P,.W8.F040*Y?R3%-N=)#M"R@G I*/6O)T9+ O
M6>Y$DQ-$"7+,:1D8,KT$I5#B'Q(^X:2? )3VR\W;N3!$^/<2&<@5)5(8QF >
M.FS93DD*=?TAP1- W@F@YO-&KDI=BOKVLUB8N[-$ZQ9NU:YSH&&82G=PR',1
MNG:HDYA$*M$"N,=!Q)T";A[)_RBNW9?;1^#=D=/II'UQ$8& 1,X'%()3RQ K
M, D=8#Q,562G.8SZ]T$55A<1T>7#>_^\V,A%J<ZMF]G9U2=F51J# <V53]PL
M*."Y1:"P"@FEB('%7HU+,U38.7ID4 167Q52EK'!<+;^<F5^%?7O9MV^P7)"
M@4!2 9MKDBG)->-V$!(:0T?>96:$P30IIK#=W&_!'YS+]=Y]V<Q%R7U:KJ%
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MYD.^H3,'GU,P_7D4)ZFK:N&6X&HW\L=J;0; EG +A'&L^D>FK,D892A\'L%
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MF (I%/RJ/#P7+^6V<R24HR@[X7W\0%WL^ U\V, G*N^=<<L^IIB3^)"=.W(
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M51WXQ+_G;0C$0ODD%T=:93^:M;\[ON]"<,+S9A Z8QU+PPOYY%9627<T,52
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M''1_N[S?#^72O%^;ZX:S(#4!(G/+QVK+.((*P>(TCR@<0W5<ZY;&\>/$ND\
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M/VY<C\7L*=J('%9_ M[2^Z6S<>;!/'WP?^#Y?5['M65%,O_L()7 2DNMTIK
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M+64;G1^K]1VI8>+]PV=))/P_4<\]\IO?HM_]PO\CQ<K\Q[_]_U!+ P04
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MM5>"W :NZUL4)OJ52G<PD.9.RG!&U.0$AC2;2DV#N"WO/1F34"MIB5$>49J
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M77F]QU( B6&D*3 ?@A2DQJ=@,14EE(>4JI-.VBL1I.7>>DIZNTK0V\] SKT
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M[T=A)-)!'L<*\@-5* . T;.FB72:5((V@__K 1DYR5N]<HJ4!T'C,V.K?3E
M,'A3-63#U'KD#$,-VB15:">*TR1MIEZ+ZH[/ ;&8,&1LP,A)4.HDAH])4=VK
MR I%.7Q5\_ QWG@-G$VO^?I5>[=U-/MS)>J["+YS%BK42NM75@6M!$U>X)_=
MN09E*05=E3XT6.0\:$ZD,@!XWF[R:5D1&SVUWN(1F,QK)R;R/C/(),@K9VAQ
MK;QI8QHB>!W/RV2Z/LF9PC1;S,,PT#C/K7NPC,>C"]0?)]2HD/8<0,D)9,%F
M<90IFU9D$T.!$\[R,<=!RS]*U"8,)".S^=1,R,N.&%VYMR84:,R<M /?K]]Q
MKO50;1<Y&'O()7R%:UOZ6/#ZN,BWS\=%NJ7!JCUD;[%[I.,XX/"<X;L#1.1_
M9H^PP&O3+W=FUZQC6/V2BY*AAYV2JRNV0C][]8=\J<UT,E_L/,M<AT5."CT6
MH>99K;U9<L;@9^)4>R.$/N[7NZW6HYPL>/):9Y/MUCOP8K5/_[NYP+50W8D'
M_#$]W45DT'PP_Q=91@*9MKR!N'M3?Z"^-N*W\N%JB2WU&.9+GAA6V]UDH/8P
MI+/_?") EFG/_HQ97CTF1T!I/7FGP,3F)"1@G0='TP*>!]98S_D<K,1,WD2[
ML$,NJ"A-"X9V=8M?X2+%5I<*396G.=?-ZBI)7^W"E062A_;H+JPS10H9:U&Z
M0>H;!8M$U-":VLP7!YUZP$,U!2V<#;4][VJE#AFOA.E&E/1:E<!3R'_AJR#]
MVOTFZ^[N,!@I35AMO)F]Y-)DP<>)K=1).O0$R;N.@FJ=+1.%"VA/3JRJ4KLF
MP2#K[8$L.%M(/"9SKD]6LN!G[!Y>B1W @>:WUH"]YOXRF<WLMA)NS36VFYW9
MHV-8/[=)S_=WUC_2UE?G9>OK.\/WGL]RXCJKAMFLC/TZ/<%>O4FQLB7'=W<!
MC]\\0-U=P<[U"K1K;L[Q6'W[ U8Z$"%77-HK%&-LO,>#TH4%GLMY;X%@"JC9
M=0SW4GLJH?+P3"W=YAF4[OJXUP%-OF\OJ4#,C*T_CS3"9;J;M')-H%_0NC"W
M6,YB_<-)Q -)@RO8E;9[JK->#VB&G C)P%FYVS0*RW<@/$IO1G9Q3HG(K14F
M4;R8M7.*ECD6S^&ENQ3@!V,E<;*06RZGH]F5*=],5^^D#TN^6KLS6<05B]DS
M23%-IIBJ?VNFS56].0RKU+TRY]Q(H$:^LDN!&M]T$ M-SX20".HD=R]4:>Z:
MU0:;,UH7@BMDD>>E6EL@'9$82$G4SZD4$9FCR!<(-5E/AC_[*-IYSE'T7:2'
M4IE4?\>[=1Y%+(36%85TQC[:2E'NC.ULS2@AOYXO)Q'60>2JJ2<^Q\WM6H>V
MU<=Y_! /2V$MTD5G,UE9IR':B:3+LLB!XF59V,,#X2>[<RL#+%69XX**VZ0"
MK() "@4FZB,:C)0$-^7BK)X]9YPIC "Q7L@C28NW+)#82;DM_B6F4]SLHNX+
MQ=]2X,=-?TOD0QU?%^F_<O0/QN#E>6*_%)(;NO[M%$.?\FD''RC(\\;>-.8<
MI'7/TD$4.3L9X=UB2-@)J)^._$*A;_96M\UZUA-8+%TCF)I)@96[8B-J C)0
MV O1, 37"9^P!#N+O,NV,ZR$YFXI?S/FBK1\1][DC2%7/C@A;':5)KD@Y SI
MPKK&)-5R-O+5,3$'V+!A$6,48?8H?CL:E^D7]TTL].5QTR )%^?Q=XB1W><<
M(R^E"@:I3NPE@:M;<%[G\&S9Y8Z.,IO_+]A$H8?1K]E;4H6[;AYO; 0?TXB&
MC1BT5X(=:7XK?9O)$@)O@#?:8UB4]WA 22)BA;P<U=<7;'\X]Q9+C:"P#+>-
M 1(:L6>1&B63\JV9"+;R0 P6Z4T[M%76EL=66<*FW*#U5AQ!._;O\(B>%"GN
MJ?(D=QFFK<EC:$4JT+&NB3XNJE3_2!7F[K>O,&_9OU-AB_XNA_\#4$L#!!0
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MI_RE'[B4G^ZW3@?V-U;_!U!+ P04    " #QB:9<5$PHM2P(   K)0  %@
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M4$L! A0#%     @ \8FF7.#9- U?O@  MF<( !$              ( !
M &UL>7,M,C R-C S,S$N:'1M4$L! A0#%     @ \8FF7.V1+4];"@  .68
M !$              ( !CKX  &UL>7,M,C R-C S,S$N>'-D4$L! A0#%
M  @ \8FF7  G0FQ_#   QWD  !4              ( !&,D  &UL>7,M,C R
M-C S,S%?8V%L+GAM;%!+ 0(4 Q0    ( /&)IEQ.^P<+ZB$  -"S 0 5
M          "  <K5  !M;'ES+3(P,C8P,S,Q7V1E9BYX;6Q02P$"% ,4
M" #QB:9<0%&P'QY!!0#D3 < %               @ 'G]P  ;6QY<RTR,#(V
M,#,S,5]G,2YJ<&=02P$"% ,4    " #QB:9<HZ3$-[B   !&@ 4 %0
M        @ $W.08 ;6QY<RTR,#(V,#,S,5]L86(N>&UL4$L! A0#%     @
M\8FF7!3GP\A_1   S,0# !4              ( !(KH& &UL>7,M,C R-C S
M,S%?<')E+GAM;%!+ 0(4 Q0    ( /&)IEPOJ#>K90X  -)A   6
M      "  =3^!@!M;'ES,C R-G$Q,3!Q97@Q,#$N:'1M4$L! A0#%     @
M\8FF7+3SJUHE"   :B4  !8              ( !;0T' &UL>7,R,#(V<3$Q
M,'%E>#,Q,2YH=&U02P$"% ,4    " #QB:9<5$PHM2P(   K)0  %@
M        @ '&%0< ;6QY<S(P,C9Q,3$P<65X,S$R+FAT;5!+ 0(4 Q0    (
M /&)IEQ@TX/ZC00   $3   6              "  28>!P!M;'ES,C R-G$Q
M,3!Q97@S,C$N:'1M4$L! A0#%     @ \8FF7#\,XUF)!   H1(  !8
M         ( !YR(' &UL>7,R,#(V<3$Q,'%E>#,R,BYH=&U02P4&      P
,#  @ P  I"<'

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>mlys-20260331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mlys="http://www.mineralystx.com/20260331"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mlys-20260331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
        </entity>
        <period>
            <instant>2026-04-27</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
        </entity>
        <period>
            <startDate>2023-02-14</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mlys:TanabeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mlys:TanabeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mlys:TanabeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mlys:TanabeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mlys:TanabeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:EquityIncentivePlan2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mlys:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:EquityIncentivePlan2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-10</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:AtTheMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PriorATMAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-21</startDate>
            <endDate>2025-11-09</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mlys:PriorATMAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-09</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2023IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2023IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2023IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2025IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2025IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2025IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2020EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2020EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2020EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2023EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mlys:A2023EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">mlys:CatalysPacificFundLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001933414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">mlys:CatalysPacificFundLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>mlys:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-27">0001933414</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-29">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-31">--12-31</dei:CurrentFiscalYearEndDate>
    <ecd:TrdArrDuration contextRef="c-78" id="f-312">P446D</ecd:TrdArrDuration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-41614</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">MINERALYS THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">84-1966887</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">150 N. Radnor Chester Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-10">Suite F200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Radnor</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">19087</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">888</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">378-6240</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">MLYS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-19">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-20">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-21">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-22">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-24">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="c-1" id="f-25">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="0" id="f-26" unitRef="shares">82498101</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-32" unitRef="usd">112779000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">172921000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DebtSecuritiesCurrent contextRef="c-3" decimals="-3" id="f-34" unitRef="usd">533281000</us-gaap:DebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">483714000</us-gaap:DebtSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-36" unitRef="usd">6410000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">4751000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-38" unitRef="usd">652470000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">661386000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-40" unitRef="usd">32000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">38000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-42" unitRef="usd">360000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">382000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-44" unitRef="usd">652862000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">661806000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-46" unitRef="usd">1116000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">2017000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-48" unitRef="usd">13602000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">13096000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-50" unitRef="usd">14718000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">15113000</us-gaap:LiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-52" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-53" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="4"
      id="f-54"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="4"
      id="f-55"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="0" id="f-56" unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="0" id="f-57" unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="0" id="f-58" unitRef="shares">82454950</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="0" id="f-59" unitRef="shares">82454950</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="0" id="f-60" unitRef="shares">81536557</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="0" id="f-61" unitRef="shares">81536557</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-62" unitRef="usd">8000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">8000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-3" id="f-64" unitRef="usd">1134644000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">1103854000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-66" unitRef="usd">-496508000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">-457169000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-68" unitRef="usd">638144000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">646693000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-70" unitRef="usd">652862000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">661806000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-72" unitRef="usd">24365000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-3" id="f-73" unitRef="usd">37879000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-74" unitRef="usd">20975000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-75" unitRef="usd">6568000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-76" unitRef="usd">45340000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-5" decimals="-3" id="f-77" unitRef="usd">44447000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-78" unitRef="usd">-45340000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-79" unitRef="usd">-44447000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-1" decimals="-3" id="f-80" unitRef="usd">5996000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-5" decimals="-3" id="f-81" unitRef="usd">2239000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-82" unitRef="usd">5000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-83" unitRef="usd">-3000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-84" unitRef="usd">6001000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-85" unitRef="usd">2236000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-86" unitRef="usd">-39339000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-87" unitRef="usd">-42211000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-88"
      unitRef="usdPerShare">-0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-89"
      unitRef="usdPerShare">-0.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-90"
      unitRef="usdPerShare">-0.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-91"
      unitRef="usdPerShare">-0.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-92" unitRef="shares">82834752</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-93" unitRef="shares">82834752</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-94" unitRef="shares">53163551</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-95" unitRef="shares">53163551</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="0" id="f-96" unitRef="shares">49821915</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-97" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-98" unitRef="usd">493770000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-99" unitRef="usd">-302518000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-100" unitRef="usd">191257000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-10" decimals="-3" id="f-101" unitRef="usd">12509000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-11" decimals="0" id="f-102" unitRef="shares">14907406</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-11" decimals="-3" id="f-103" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-12" decimals="-3" id="f-104" unitRef="usd">188740000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-10" decimals="-3" id="f-105" unitRef="usd">188741000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-13" decimals="0" id="f-106" unitRef="shares">146907</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-14" decimals="-3" id="f-107" unitRef="usd">123000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-5" decimals="-3" id="f-108" unitRef="usd">123000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-3" id="f-109" unitRef="usd">3645000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-110" unitRef="usd">3645000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-111" unitRef="usd">-42211000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-112" unitRef="usd">-42211000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-16" decimals="0" id="f-113" unitRef="shares">64876228</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-3" id="f-114" unitRef="usd">6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-115" unitRef="usd">686278000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-116" unitRef="usd">-344729000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-117" unitRef="usd">341555000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-20" decimals="0" id="f-118" unitRef="shares">81536557</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-119" unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-120" unitRef="usd">1103854000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-121" unitRef="usd">-457169000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-122" unitRef="usd">646693000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-23" decimals="-3" id="f-123" unitRef="usd">82000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-24" decimals="0" id="f-124" unitRef="shares">568320</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-25" decimals="-3" id="f-125" unitRef="usd">20187000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-23" decimals="-3" id="f-126" unitRef="usd">20187000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-26" decimals="0" id="f-127" unitRef="shares">350073</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-27" decimals="-3" id="f-128" unitRef="usd">4055000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-129" unitRef="usd">4055000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-27" decimals="-3" id="f-130" unitRef="usd">6548000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-131" unitRef="usd">6548000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-28" decimals="-3" id="f-132" unitRef="usd">-39339000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-133" unitRef="usd">-39339000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-29" decimals="0" id="f-134" unitRef="shares">82454950</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-135" unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-136" unitRef="usd">1134644000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-137" unitRef="usd">-496508000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-138" unitRef="usd">638144000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-139" unitRef="usd">-39339000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-140" unitRef="usd">-42211000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-141" unitRef="usd">6548000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-3" id="f-142" unitRef="usd">3645000</us-gaap:ShareBasedCompensation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-1" decimals="-3" id="f-143" unitRef="usd">4625000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-5" decimals="-3" id="f-144" unitRef="usd">1046000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-145" unitRef="usd">6000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-5" decimals="-3" id="f-146" unitRef="usd">15000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">-289000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c-5" decimals="-3" id="f-148" unitRef="usd">-52000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-149" unitRef="usd">1948000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-5" decimals="-3" id="f-150" unitRef="usd">4396000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-3" id="f-151" unitRef="usd">-402000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-5" decimals="-3" id="f-152" unitRef="usd">-1546000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-153" unitRef="usd">-39471000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="-3" id="f-154" unitRef="usd">-45487000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities contextRef="c-1" decimals="-3" id="f-155" unitRef="usd">347443000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities contextRef="c-5" decimals="-3" id="f-156" unitRef="usd">127876000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities contextRef="c-1" decimals="-3" id="f-157" unitRef="usd">302500000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities contextRef="c-5" decimals="-3" id="f-158" unitRef="usd">35000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-159" unitRef="usd">-44943000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-5" decimals="-3" id="f-160" unitRef="usd">-92876000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-23" decimals="-3" id="f-161" unitRef="usd">20218000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-32" decimals="-3" id="f-162" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-163" unitRef="usd">4055000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-5" decimals="-3" id="f-164" unitRef="usd">123000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-165" unitRef="usd">1000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-5" decimals="-3" id="f-166" unitRef="usd">10000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-33" decimals="-3" id="f-167" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-10" decimals="-3" id="f-168" unitRef="usd">189166000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-169" unitRef="usd">24272000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="-3" id="f-170" unitRef="usd">189279000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-171" unitRef="usd">-60142000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="-3" id="f-172" unitRef="usd">50916000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-173" unitRef="usd">172921000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-9" decimals="-3" id="f-174" unitRef="usd">114091000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-175" unitRef="usd">112779000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-19" decimals="-3" id="f-176" unitRef="usd">165007000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <mlys:OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="c-1" decimals="-3" id="f-177" unitRef="usd">7000</mlys:OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <mlys:OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="c-5" decimals="-3" id="f-178" unitRef="usd">289000</mlys:OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:DebtSecuritiesCurrent contextRef="c-3" decimals="-5" id="f-179" unitRef="usd">533300000</us-gaap:DebtSecuritiesCurrent>
    <us-gaap:InvestmentsAndCash contextRef="c-3" decimals="-5" id="f-180" unitRef="usd">646100000</us-gaap:InvestmentsAndCash>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-181">Nature of Business&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mineralys Therapeutics, Inc. (the Company) is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company&#x2019;s product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. The Company has completed two pivotal clinical trials of lorundrostat for hypertension, one Phase 2 clinical trial in hypertensive participants with chronic kidney disease, and one Phase 2 clinical trial in hypertensive participants with obstructive sleep apnea. The Company submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in December&#160;2025 for lorundrostat for the treatment of hypertension in combination with other antihypertensive drugs. The FDA accepted the NDA submission and provided the Company with a Prescription Drug User Fee Act target date of December&#160;22, 2026 for lorundrostat. The Company was incorporated as a Delaware corporation in May 2019, and it is headquartered in Radnor, Pennsylvania. The Company&#x2019;s operations to date have been limited to business planning, raising capital, in-licensing, conducting preclinical and clinical trials, and performing research and development and other activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since its inception, the Company has not generated any revenue from product sales or other sources and has incurred significant operating losses and negative cash flows from operations. The Company&#x2019;s primary uses of cash to date have been to fund research and development activities, business planning, establishing and maintaining the Company&#x2019;s intellectual property portfolio, hiring personnel, raising capital, and providing general and administrative support for these operations. As of March&#160;31, 2026, the Company had an accumulated deficit of $496.5&#160;million and cash, cash equivalents, and investments of $646.1 million. For the three months ended March&#160;31, 2026, the Company had a net loss of $39.3&#160;million and net cash used in operating activities of $39.5&#160;million.&lt;/span&gt;&lt;/div&gt;Since inception, the Company has funded its operations by raising aggregate gross proceeds of approximately $1.1 billion from the sale of the Company&#x2019;s common stock, convertible preferred stock, pre-funded warrants, and convertible notes. The Company has a limited operating history, and the sales and income potential of its business is unproven. The Company expects to continue to incur substantial losses for the foreseeable future as a result of the Company&#x2019;s research and development and other activities. Additional funding will be required to continue with the Company&#x2019;s planned research and development and commercial launch activities. The Company expects to finance its operations through equity offerings, debt financings, and other capital sources, including potential strategic collaborations, licensing, and other similar arrangements. The Company believes that its cash, cash equivalents, and investments as of March&#160;31, 2026 will be sufficient to allow the Company to fund operations for at least twelve months from the issuance date of these condensed financial statements.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-182" unitRef="usd">-496500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:InvestmentsAndCash contextRef="c-3" decimals="-5" id="f-183" unitRef="usd">646100000</us-gaap:InvestmentsAndCash>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-184" unitRef="usd">-39300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-185" unitRef="usd">-39500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c-34" decimals="-8" id="f-186" unitRef="usd">1100000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-187">Summary of Significant Accounting Policies&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and applicable rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules and regulations, certain footnotes or other financial information normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the Company&#x2019;s financial information. These unaudited condensed financial statements should be read in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;conjunction with the audited financial statements and related notes in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any reference in these notes to applicable guidance is meant to refer to authoritative U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) of the Financial Accounting Standards Board (FASB).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in one operating segment for the purposes of assessing performance, making operating decisions, and allocating Company resources. The Company&#x2019;s chief operating decision maker (CODM) is its chief executive officer, who considers net loss to evaluate overall expenses associated with conducting research and development activities, which includes evaluating the progress of ongoing clinical trials and the planning and execution of current and future research and development and other activities. Further, the CODM reviews and utilizes functional expenses (research and development and general and administrative) as reported in the statements of operations to manage the Company&#x2019;s operations. Other segment items included in net loss are interest income, net and other income (expense). These measures of performance, significant expenses, and other items are each reflected in the condensed statements of operations. The accounting policies of the segment are the same as those described below. The measure of segment assets is reported on the condensed balance sheets as total assets. All assets are held in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Estimates have been used in the following areas, among others: research and development accruals and income taxes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All highly liquid investments that have maturities of 90 days or less at the date of purchase are classified as cash equivalents. The Company&#x2019;s cash and cash equivalents balances as of March&#160;31, 2026 and December&#160;31, 2025 include cash balances and amounts held primarily in interest-bearing money market accounts and U.S. Treasury bills. As of March&#160;31, 2026 and December&#160;31, 2025, the Company did not have any restricted cash balances. The following table provides a reconciliation of cash and cash equivalents as reported in the condensed statements of cash flows to the condensed balance sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.183%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.467%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Credit Risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has no significant off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts, or other hedging arrangements. Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash balances in several accounts with three financial institutions that, from time to time, are in excess of federally insured limits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to disclose information on all assets and liabilities reported at fair value that enables an assessment of the inputs used in determining the reported fair values. ASC Topic 820, Fair Value Measurement, establishes a hierarchy of inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the observable inputs be used when available. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy applies only to the valuation inputs used in determining the reported fair value and is not a measure of the investment credit quality. The three levels of the fair value hierarchy are described below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; quoted prices in active markets for identical assets and liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; other significant observable inputs (including quoted prices for similar assets and liabilities, interest rates, credit risk, etc.)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; significant unobservable inputs (including the Company&#x2019;s own assumptions in determining the fair value of assets and liabilities)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For certain financial instruments, including cash and cash equivalents, prepaid expenses, accounts payable, and certain accrued liabilities, the recorded amount approximates estimated fair value due to their relatively short maturity period. Refer to Note 3. &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional details of the Company&#x2019;s financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally invests its excess cash in money market funds and investment-grade short- and long-term fixed-income debt securities, such as U.S. Treasury bills. Such investments are included in cash and cash equivalents and investments in the condensed balance sheets. The Company determines the appropriate classification of securities at the time of purchase and re-evaluates such designation as of each balance sheet date. Securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are carried at amortized cost, adjusted for the accretion of discounts using the interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company invested in marketable securities during the three months ended March&#160;31, 2026 and 2025, and no impairment charges were recorded. For held-to-maturity investments, the Company periodically reviews each individual security position that has an unrealized loss, or impairment, to determine if that impairment is other-than-temporary. If the Company believes an impairment of a security position is other than temporary, based on available quantitative and qualitative information as of the report date, the loss will be recognized within total other income, net in the Company&#x2019;s condensed statements of operations, and a new cost basis in the investment will be established.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Offering Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain legal, professional, accounting, and other third-party fees that are directly associated with in-process equity issuances as deferred offering costs until such equity issuances are consummated. After consummation of the equity issuance, these costs are recorded as a reduction in the capitalized amount associated with the equity issuance. Should the equity issuance be abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the condensed statements of operations. Deferred offering costs as of each of March&#160;31, 2026 and December&#160;31, 2025 were $0.2&#160;million. Such costs are classified in other assets on the condensed balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its stock-based compensation awards in accordance with ASC Topic 718, Compensation &#x2013; Stock Compensation (ASC 718). ASC 718 requires share-based payment arrangements to be recognized in the condensed statements of operations based on their grant date fair values. The Company&#x2019;s stock-based awards are subject only to service-based vesting conditions. The Company measures restricted common stock awards using the difference, if any, between the purchase price per share of the award and the fair value of the Company&#x2019;s common stock at the date of the grant or modification. Restricted stock unit awards are measured at the grant date fair value based on the closing price of the Company&#x2019;s common stock on the date of the grant. The Company estimates the fair value of its stock option awards using the Black-Scholes option pricing model, which requires the input of assumptions, including (i)&#160;the expected stock price volatility, (ii)&#160;the calculation of the expected term of the award, (iii)&#160;the risk-free interest rate, and (iv)&#160;expected dividends. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Due to the Company&#x2019;s limited operating history and a lack of company-specific historical and implied volatility data, the Company has based its estimate of expected volatility on the historical volatility of a group of similar publicly-traded companies. The Company believes that the companies in the group were most representative of the Company and had characteristics similar to its own, including stage of product development, a focus on the life sciences industry, and other economic and industry characteristics. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; The Company uses the simplified method to calculate the expected term, as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term for options granted, and utilizes the contractual term for options granted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Dividends &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; To date, the Company has not issued any dividends and does not expect to issue dividends over the life of the options and therefore has estimated the dividend yield to be zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the closing of the Company&#x2019;s initial public offering of its common stock in February 2023, the Company determines the fair market value of its common stock using the closing price of its common stock as reported on the Nasdaq Global Select Market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense related to time-based awards, including restricted stock units, is recognized on a straight-line basis by recognizing the grant date fair value over the requisite service period, which is generally the vesting term. Management evaluates its award grants and modifications and will adjust the fair value if any are determined to be spring-loaded. The Company accounts for forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Loss Per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s basic net loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share attributable to common stockholders is computed by giving effect to all potential common stock equivalents outstanding for the period, determined using the treasury stock method. For purposes of this calculation, unvested restricted stock awards, restricted stock units, and stock options to purchase common stock are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive. The weighted-average number of common shares used in the basic and diluted net loss per share attributable to common stockholders calculations includes the weighted-average pre-funded warrants outstanding during the period, as they are exercisable at any time for nominal cash consideration. The following table sets forth the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;potential common shares excluded from the calculation of net loss per share attributable to common stockholders because their inclusion would be anti-dilutive: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,420,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,778,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,188,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,087,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard-setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#160;(ASU 2024-03), and in January 2025, the FASB issued ASU 2025-01, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require the Company to disclose additional information about specific expense categories in the notes to the financial statements on an annual and interim basis.&#160;ASU 2024-03 is effective for the Company's fiscal year 2027 and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of ASU 2024-03 on its disclosures. While the Company expects that additional disaggregated disclosures will be required upon adoption, the guidance will not affect the recognition or measurement of expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-188">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) and applicable rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules and regulations, certain footnotes or other financial information normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the Company&#x2019;s financial information. These unaudited condensed financial statements should be read in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;conjunction with the audited financial statements and related notes in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any reference in these notes to applicable guidance is meant to refer to authoritative U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) of the Financial Accounting Standards Board (FASB).&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-189">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in one operating segment for the purposes of assessing performance, making operating decisions, and allocating Company resources. The Company&#x2019;s chief operating decision maker (CODM) is its chief executive officer, who considers net loss to evaluate overall expenses associated with conducting research and development activities, which includes evaluating the progress of ongoing clinical trials and the planning and execution of current and future research and development and other activities. Further, the CODM reviews and utilizes functional expenses (research and development and general and administrative) as reported in the statements of operations to manage the Company&#x2019;s operations. Other segment items included in net loss are interest income, net and other income (expense). These measures of performance, significant expenses, and other items are each reflected in the condensed statements of operations. The accounting policies of the segment are the same as those described below. The measure of segment assets is reported on the condensed balance sheets as total assets. All assets are held in the United States.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-190"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-191">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Estimates have been used in the following areas, among others: research and development accruals and income taxes.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-192">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;All highly liquid investments that have maturities of 90 days or less at the date of purchase are classified as cash equivalents.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:RestrictedCash contextRef="c-3" decimals="INF" id="f-193" unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-4" decimals="INF" id="f-194" unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-195">The following table provides a reconciliation of cash and cash equivalents as reported in the condensed statements of cash flows to the condensed balance sheets (in thousands):&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.833%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.183%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.467%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:Cash contextRef="c-3" decimals="-3" id="f-196" unitRef="usd">1150000</us-gaap:Cash>
    <us-gaap:Cash contextRef="c-4" decimals="-3" id="f-197" unitRef="usd">1030000</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-198" unitRef="usd">111629000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-199" unitRef="usd">171891000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-200" unitRef="usd">112779000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-201" unitRef="usd">172921000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-202">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Credit Risk &lt;/span&gt;&lt;/div&gt;The Company has no significant off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts, or other hedging arrangements. Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash balances in several accounts with three financial institutions that, from time to time, are in excess of federally insured limits.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-203">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to disclose information on all assets and liabilities reported at fair value that enables an assessment of the inputs used in determining the reported fair values. ASC Topic 820, Fair Value Measurement, establishes a hierarchy of inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the observable inputs be used when available. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy applies only to the valuation inputs used in determining the reported fair value and is not a measure of the investment credit quality. The three levels of the fair value hierarchy are described below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; quoted prices in active markets for identical assets and liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; other significant observable inputs (including quoted prices for similar assets and liabilities, interest rates, credit risk, etc.)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; significant unobservable inputs (including the Company&#x2019;s own assumptions in determining the fair value of assets and liabilities)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For certain financial instruments, including cash and cash equivalents, prepaid expenses, accounts payable, and certain accrued liabilities, the recorded amount approximates estimated fair value due to their relatively short maturity period. Refer to Note 3. &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional details of the Company&#x2019;s financial instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c-1" id="f-204">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally invests its excess cash in money market funds and investment-grade short- and long-term fixed-income debt securities, such as U.S. Treasury bills. Such investments are included in cash and cash equivalents and investments in the condensed balance sheets. The Company determines the appropriate classification of securities at the time of purchase and re-evaluates such designation as of each balance sheet date. Securities are classified as held-to-maturity when the Company has the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are carried at amortized cost, adjusted for the accretion of discounts using the interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company invested in marketable securities during the three months ended March&#160;31, 2026 and 2025, and no impairment charges were recorded. For held-to-maturity investments, the Company periodically reviews each individual security position that has an unrealized loss, or impairment, to determine if that impairment is other-than-temporary. If the Company believes an impairment of a security position is other than temporary, based on available quantitative and qualitative information as of the report date, the loss will be recognized within total other income, net in the Company&#x2019;s condensed statements of operations, and a new cost basis in the investment will be established.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="c-1" id="f-205">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Offering Costs&lt;/span&gt;&lt;/div&gt;The Company capitalizes certain legal, professional, accounting, and other third-party fees that are directly associated with in-process equity issuances as deferred offering costs until such equity issuances are consummated. After consummation of the equity issuance, these costs are recorded as a reduction in the capitalized amount associated with the equity issuance. Should the equity issuance be abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the condensed statements of operations.</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts contextRef="c-3" decimals="-5" id="f-206" unitRef="usd">200000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts contextRef="c-4" decimals="-5" id="f-207" unitRef="usd">200000</us-gaap:DeferredOfferingCosts>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-208">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its stock-based compensation awards in accordance with ASC Topic 718, Compensation &#x2013; Stock Compensation (ASC 718). ASC 718 requires share-based payment arrangements to be recognized in the condensed statements of operations based on their grant date fair values. The Company&#x2019;s stock-based awards are subject only to service-based vesting conditions. The Company measures restricted common stock awards using the difference, if any, between the purchase price per share of the award and the fair value of the Company&#x2019;s common stock at the date of the grant or modification. Restricted stock unit awards are measured at the grant date fair value based on the closing price of the Company&#x2019;s common stock on the date of the grant. The Company estimates the fair value of its stock option awards using the Black-Scholes option pricing model, which requires the input of assumptions, including (i)&#160;the expected stock price volatility, (ii)&#160;the calculation of the expected term of the award, (iii)&#160;the risk-free interest rate, and (iv)&#160;expected dividends. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Due to the Company&#x2019;s limited operating history and a lack of company-specific historical and implied volatility data, the Company has based its estimate of expected volatility on the historical volatility of a group of similar publicly-traded companies. The Company believes that the companies in the group were most representative of the Company and had characteristics similar to its own, including stage of product development, a focus on the life sciences industry, and other economic and industry characteristics. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; The Company uses the simplified method to calculate the expected term, as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term for options granted, and utilizes the contractual term for options granted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Dividends &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014; To date, the Company has not issued any dividends and does not expect to issue dividends over the life of the options and therefore has estimated the dividend yield to be zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the closing of the Company&#x2019;s initial public offering of its common stock in February 2023, the Company determines the fair market value of its common stock using the closing price of its common stock as reported on the Nasdaq Global Select Market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense related to time-based awards, including restricted stock units, is recognized on a straight-line basis by recognizing the grant date fair value over the requisite service period, which is generally the vesting term. Management evaluates its award grants and modifications and will adjust the fair value if any are determined to be spring-loaded. The Company accounts for forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-209">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Loss Per Share &lt;/span&gt;&lt;/div&gt;The Company&#x2019;s basic net loss per share attributable to common stockholders is calculated by dividing the net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. The diluted net loss per share attributable to common stockholders is computed by giving effect to all potential common stock equivalents outstanding for the period, determined using the treasury stock method. For purposes of this calculation, unvested restricted stock awards, restricted stock units, and stock options to purchase common stock are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive. The weighted-average number of common shares used in the basic and diluted net loss per share attributable to common stockholders calculations includes the weighted-average pre-funded warrants outstanding during the period, as they are exercisable at any time for nominal cash consideration.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-210">The following table sets forth the &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;potential common shares excluded from the calculation of net loss per share attributable to common stockholders because their inclusion would be anti-dilutive: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,420,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,778,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,188,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,087,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-35" decimals="0" id="f-211" unitRef="shares">7420692</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-36" decimals="0" id="f-212" unitRef="shares">6778317</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-37" decimals="0" id="f-213" unitRef="shares">702948</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-38" decimals="0" id="f-214" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-39" decimals="0" id="f-215" unitRef="shares">64714</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-40" decimals="0" id="f-216" unitRef="shares">309028</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-217" unitRef="shares">8188354</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-5" decimals="0" id="f-218" unitRef="shares">7087345</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-219">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard-setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#160;(ASU 2024-03), and in January 2025, the FASB issued ASU 2025-01, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require the Company to disclose additional information about specific expense categories in the notes to the financial statements on an annual and interim basis.&#160;ASU 2024-03 is effective for the Company's fiscal year 2027 and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is evaluating the impact of ASU 2024-03 on its disclosures. While the Company expects that additional disaggregated disclosures will be required upon adoption, the guidance will not affect the recognition or measurement of expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-220">Fair Value of Financial Instruments&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents financial instruments measured at fair value on a recurring basis based on the fair value hierarchy as of March&#160;31, 2026 and December&#160;31, 2025 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers within the fair value hierarchy during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following methods and assumptions were used by the Company in estimating the fair values of each class of financial instrument disclosed herein:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money Market Funds &#x2014; The carrying amounts of money market funds reported as cash and cash equivalents in the condensed balance sheets approximate their fair values due to their short-term nature. The fair values of money market funds are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasury Bills &#x2014; As of March&#160;31, 2026 and December&#160;31, 2025, the Company had short-term U.S. Treasury bills. Fair values of these securities are determined by Level 2 inputs utilizing quoted prices &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(unadjusted) in active markets for similar assets. The following table presents information about the Company&#x2019;s investments in held-to-maturity U.S. Treasury bills as of each reported date (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Original Maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;between 3 and 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Original Maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;less than 3 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;between 3 and 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-221">&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents financial instruments measured at fair value on a recurring basis based on the fair value hierarchy as of March&#160;31, 2026 and December&#160;31, 2025 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-41" decimals="-3" id="f-222" unitRef="usd">111629000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-42" decimals="-3" id="f-223" unitRef="usd">161943000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:HeldToMaturitySecuritiesTextBlock contextRef="c-1" id="f-224">The following table presents information about the Company&#x2019;s investments in held-to-maturity U.S. Treasury bills as of each reported date (in thousands):&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Original Maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;between 3 and 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Original Maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;less than 3 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;between 3 and 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:HeldToMaturitySecuritiesTextBlock>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent contextRef="c-43" decimals="-3" id="f-225" unitRef="usd">533281000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent>
    <us-gaap:DebtSecuritiesHeldToMaturityFairValueCurrent contextRef="c-43" decimals="-3" id="f-226" unitRef="usd">533211000</us-gaap:DebtSecuritiesHeldToMaturityFairValueCurrent>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent contextRef="c-44" decimals="-3" id="f-227" unitRef="usd">9948000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent>
    <us-gaap:DebtSecuritiesHeldToMaturityFairValueCurrent contextRef="c-44" decimals="-3" id="f-228" unitRef="usd">9948000</us-gaap:DebtSecuritiesHeldToMaturityFairValueCurrent>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent contextRef="c-45" decimals="-3" id="f-229" unitRef="usd">483714000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent>
    <us-gaap:DebtSecuritiesHeldToMaturityFairValueCurrent contextRef="c-45" decimals="-3" id="f-230" unitRef="usd">483891000</us-gaap:DebtSecuritiesHeldToMaturityFairValueCurrent>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss contextRef="c-4" decimals="-3" id="f-231" unitRef="usd">493662000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue contextRef="c-4" decimals="-3" id="f-232" unitRef="usd">493839000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-233">Commitments and Contingencies&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tanabe License Agreement &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company entered into an exclusive license agreement (the Tanabe License) with Tanabe Pharma Corporation (Tanabe) (formerly Mitsubishi Tanabe Pharma Corporation), pursuant to which Tanabe granted the Company an exclusive, worldwide, royalty-bearing, sublicensable license under Tanabe&#x2019;s patent and other intellectual property rights to exploit products incorporating lorundrostat (formerly MT-4129) (Lorundrostat Product) for the prevention, treatment, diagnosis, detection, monitoring, or predisposition testing with respect to indications, diseases, and conditions in humans. Pursuant to the Tanabe License, the Company paid Tanabe a $1.0&#160;million upfront fee and development milestone payments of $9.0&#160;million in the aggregate. The Company has remaining obligations to pay Tanabe commercial milestone payments of up to $155.0&#160;million in the aggregate upon first commercial sale and upon meeting certain annual sales targets, as well as additional commercial milestone payments of up to $10.0&#160;million for a second indication. Additionally, the Company is obligated to pay Tanabe tiered royalties at percentages ranging from the mid-single digits to ten percent (10%) of aggregate net sales of each Lorundrostat Product on a Lorundrostat Product-by-Lorundrostat Product and country-by-country basis, until the later of (i) the expiration of the last-to-expire valid Tanabe patent claim covering a Lorundrostat Product, (ii) ten years from the first commercial sale of a Lorundrostat Product, or (iii) the expiration of regulatory exclusivity in such country. Such royalties are subject to reduction under specified conditions, including lack of patent coverage and generic competition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has no remaining development milestone obligations under the Tanabe License and did not incur any development or commercial expenses pursuant to the Tanabe License during the three months ended March&#160;31, 2026 and 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is obligated to use commercially reasonable efforts to conduct and complete the development activities and to file for regulatory approval for at least one Lorundrostat Product in a major market country and consider in good faith developing at least one Lorundrostat Product in a non-major market country. If the Company elects to sublicense its rights under the Tanabe License to a third party with respect to exploitation of lorundrostat or any Lorundrostat Product in certain countries in Asia, the Company has agreed to negotiate such a sublicense first, for a specified period of time, with Tanabe, if Tanabe notifies the Company that it would like to obtain such a sublicense. The Company also agreed not to commercialize any competing product prior to three years following the first commercial sale of the first Lorundrostat Product in any country without Tanabe&#x2019;s prior consent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless terminated earlier, the Tanabe License will continue until the expiration of all of the Company&#x2019;s royalty obligations to Tanabe. The Company may terminate the Tanabe License for any or no reason upon 90 or 180 days&#x2019; prior written notice to Tanabe, depending on whether the Lorundrostat Product has received &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;regulatory approval. Tanabe may terminate the Tanabe License if the Company or its affiliates or sublicensees initiate a challenge to the patent rights licensed to the Company by Tanabe. In addition, either party may terminate the Tanabe License in the event of an uncured material breach by or bankruptcy of the other party, subject to certain notice and cure periods, or upon the other party&#x2019;s bankruptcy or insolvency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company was not subject to any material legal proceedings during the three months ended March&#160;31, 2026 and 2025, and no material legal proceedings are currently pending or threatened.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Indemnification Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners, and other parties with respect to certain matters including, but not limited to, losses arising from breach of such agreements or intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with officers of the Company and members of its board of directors that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as officers or directors. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not aware of any claims under indemnification arrangements, and it has not accrued any material liabilities related to such obligations in its condensed financial statements as of March&#160;31, 2026 and December&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <mlys:CollaborativeArrangementRightsAndObligationsUpfrontFee contextRef="c-46" decimals="-5" id="f-234" unitRef="usd">1000000.0</mlys:CollaborativeArrangementRightsAndObligationsUpfrontFee>
    <mlys:CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments contextRef="c-46" decimals="-5" id="f-235" unitRef="usd">9000000.0</mlys:CollaborativeArrangementRightsAndObligationsDevelopmentalMaximumAggregateMilestonePayments>
    <mlys:CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments contextRef="c-46" decimals="-5" id="f-236" unitRef="usd">155000000.0</mlys:CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments>
    <mlys:CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments contextRef="c-46" decimals="-5" id="f-237" unitRef="usd">10000000.0</mlys:CollaborativeArrangementRightsAndObligationsSecondCommercialSaleMaximumAggregateMilestonePayments>
    <mlys:CollaborativeArrangementRightsAndObligationsRoyaltyPercentage contextRef="c-47" decimals="2" id="f-238" unitRef="number">0.10</mlys:CollaborativeArrangementRightsAndObligationsRoyaltyPercentage>
    <mlys:CollaborativeArrangementRightsAndObligationsExpirationPeriod contextRef="c-46" id="f-239">P10Y</mlys:CollaborativeArrangementRightsAndObligationsExpirationPeriod>
    <mlys:CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments contextRef="c-48" decimals="INF" id="f-240" unitRef="usd">0</mlys:CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments>
    <mlys:CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments contextRef="c-49" decimals="INF" id="f-241" unitRef="usd">0</mlys:CollaborativeArrangementRightsAndObligationsFirstCommercialSaleMaximumAggregateMilestonePayments>
    <mlys:CollaborativeArrangementRightsAndObligationsNonCompetePeriod contextRef="c-46" id="f-242">P3Y</mlys:CollaborativeArrangementRightsAndObligationsNonCompetePeriod>
    <mlys:CollaborativeArrangementRightsAndObligationsTerminationPeriod contextRef="c-50" id="f-243">P90D</mlys:CollaborativeArrangementRightsAndObligationsTerminationPeriod>
    <mlys:CollaborativeArrangementRightsAndObligationsTerminationPeriod contextRef="c-47" id="f-244">P180D</mlys:CollaborativeArrangementRightsAndObligationsTerminationPeriod>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-245">Accrued Liabilities&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-246">&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <mlys:AccruedResearchAndDevelopmentCostsCurrent contextRef="c-3" decimals="-3" id="f-247" unitRef="usd">4587000</mlys:AccruedResearchAndDevelopmentCostsCurrent>
    <mlys:AccruedResearchAndDevelopmentCostsCurrent contextRef="c-4" decimals="-3" id="f-248" unitRef="usd">3460000</mlys:AccruedResearchAndDevelopmentCostsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-3" decimals="-3" id="f-249" unitRef="usd">2312000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-4" decimals="-3" id="f-250" unitRef="usd">5540000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-3" decimals="-3" id="f-251" unitRef="usd">6703000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-252" unitRef="usd">4096000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-253" unitRef="usd">13602000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-254" unitRef="usd">13096000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-255">Capital Stock&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2026, the Company had reserved authorized shares of common stock for future issuance as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,420,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under the 2023 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,866,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under the ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-funded warrants issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under the 2025 Inducement Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,147,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;At-the-Market Equity Offering Sales Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November&#160;10, 2025, the Company entered into an ATM Equity Offering Sales Agreement (the ATM Agreement) with BofA Securities, Inc., Evercore Group L.L.C., and Goldman Sachs &amp;amp; Co. LLC, pursuant to which the Company may sell shares of its common stock having an aggregate offering price of up to $300.0&#160;million from time to time. During the three months ended March&#160;31, 2026, the Company sold pursuant to the ATM Agreement an aggregate of 568,320 shares of common stock at a weighted-average price of $35.66 per share for aggregate net proceeds of approximately $20.2&#160;million after deducting commissions and offering expenses. There were no sales of common stock pursuant to the ATM Agreement during the three months ended March&#160;31, 2025. From inception of the ATM Agreement and through March&#160;31, 2026, the Company sold an aggregate of 2,720,508 shares of common stock at a weighted-average price of $41.45 per share for aggregate net proceeds of approximately $112.4&#160;million after deducting commissions and offering expenses. As of March&#160;31, 2026, approximately $187.2&#160;million of shares remained available for sale pursuant to the ATM Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;21, 2024, the Company entered into an ATM Equity Offering Sales Agreement (the Prior ATM Agreement) with BofA Securities, Inc. and Evercore Group L.L.C. Effective November&#160;9, 2025, the Prior ATM Agreement was terminated in connection with the execution of the ATM Agreement. There were no sales of common stock pursuant to the Prior ATM Agreement during each of the three months ended March&#160;31, 2026 and March&#160;31, 2025. From inception of the Prior ATM Agreement and through its termination effective November&#160;9, 2025, the Company sold an aggregate of 1,914,040 shares of common stock at a weighted-average price of $14.32 per share for aggregate net proceeds of approximately $27.3&#160;million after deducting commissions and offering expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mlys:ScheduleOfCommonStockAuthorizedTableTextBlock contextRef="c-1" id="f-256">&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2026, the Company had reserved authorized shares of common stock for future issuance as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,420,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under the 2023 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,866,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under the ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-funded warrants issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under the 2025 Inducement Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,147,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mlys:ScheduleOfCommonStockAuthorizedTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-51" decimals="0" id="f-257" unitRef="shares">7420692</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-52" decimals="0" id="f-258" unitRef="shares">2866922</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-53" decimals="0" id="f-259" unitRef="shares">2067084</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-54" decimals="0" id="f-260" unitRef="shares">702948</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-55" decimals="0" id="f-261" unitRef="shares">549755</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-56" decimals="0" id="f-262" unitRef="shares">539748</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-3" decimals="0" id="f-263" unitRef="shares">14147149</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <mlys:SaleOfStockConsiderationReceivableOnTransaction contextRef="c-57" decimals="-5" id="f-264" unitRef="usd">300000000.0</mlys:SaleOfStockConsiderationReceivableOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-23" decimals="0" id="f-265" unitRef="shares">568320</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <mlys:SaleOfStockPricePerShareWeightedAveragePrice
      contextRef="c-23"
      decimals="2"
      id="f-266"
      unitRef="usdPerShare">35.66</mlys:SaleOfStockPricePerShareWeightedAveragePrice>
    <mlys:ProceedsFromIssuanceOfCommonStockNet contextRef="c-23" decimals="-5" id="f-267" unitRef="usd">20200000</mlys:ProceedsFromIssuanceOfCommonStockNet>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-58" decimals="0" id="f-268" unitRef="shares">2720508</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-59"
      decimals="2"
      id="f-269"
      unitRef="usdPerShare">41.45</us-gaap:SaleOfStockPricePerShare>
    <mlys:ProceedsFromIssuanceOfCommonStockNet contextRef="c-58" decimals="-5" id="f-270" unitRef="usd">112400000</mlys:ProceedsFromIssuanceOfCommonStockNet>
    <mlys:MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale contextRef="c-59" decimals="-5" id="f-271" unitRef="usd">187200000</mlys:MaximumAggregateOfferingPriceOfRemainingCommonSharesAvailableForSale>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-60" decimals="0" id="f-272" unitRef="shares">1914040</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-61"
      decimals="2"
      id="f-273"
      unitRef="usdPerShare">14.32</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-60" decimals="-5" id="f-274" unitRef="usd">27300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-275">Stock-Based Compensation&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Incentive Award Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants equity awards under the 2023 Incentive Award Plan (the 2023 Plan). During the three months ended March 31, 2026, the Company began granting restricted stock units under the 2023 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2025 Employment Inducement Incentive Award Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains the 2025 Employment Inducement Incentive Award Plan (the 2025 Inducement Plan), under which non&#x2011;qualified stock options and restricted stock units may be granted in connection with the commencement of employment. During the three months ended March 31, 2026, the Company began granting restricted stock units under the 2025 Inducement Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Equity Incentive Plan (the 2020 Plan) continues to govern the terms of outstanding awards, although no new awards are granted under the plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2026, the Company had the following balances by plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unvested&lt;br/&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unvested&lt;br/&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares Available&lt;br/&gt;for Grant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,841,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,866,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Inducement Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,420,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,406,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains the 2023 Employee Stock Purchase Plan (the ESPP) under which eligible employees may purchase shares of common stock through payroll deductions. As of March&#160;31, 2026, the Company had 2,067,084 shares available for issuance, and 57,839 cumulative shares had been issued under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized was allocated as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-276">&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2026, the Company had the following balances by plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unvested&lt;br/&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unvested&lt;br/&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares Available&lt;br/&gt;for Grant&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,841,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,866,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Inducement Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,420,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,406,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-62" decimals="0" id="f-277" unitRef="shares">6841701</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="c-63" decimals="0" id="f-278" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="c-64" decimals="0" id="f-279" unitRef="shares">568040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-62" decimals="0" id="f-280" unitRef="shares">2866922</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-65" decimals="0" id="f-281" unitRef="shares">325344</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="c-66" decimals="0" id="f-282" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="c-67" decimals="0" id="f-283" unitRef="shares">134908</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-65" decimals="0" id="f-284" unitRef="shares">539748</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-68" decimals="0" id="f-285" unitRef="shares">253647</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="c-69" decimals="0" id="f-286" unitRef="shares">64714</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="c-70" decimals="0" id="f-287" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-68" decimals="0" id="f-288" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-3" decimals="0" id="f-289" unitRef="shares">7420692</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="c-71" decimals="0" id="f-290" unitRef="shares">64714</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="c-54" decimals="0" id="f-291" unitRef="shares">702948</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-3" decimals="0" id="f-292" unitRef="shares">3406670</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-72" decimals="0" id="f-293" unitRef="shares">2067084</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="c-73" decimals="0" id="f-294" unitRef="shares">57839</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-295">&lt;div style="margin-bottom:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized was allocated as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-74" decimals="-3" id="f-296" unitRef="usd">2476000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-75" decimals="-3" id="f-297" unitRef="usd">1628000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-76" decimals="-3" id="f-298" unitRef="usd">4072000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-77" decimals="-3" id="f-299" unitRef="usd">2017000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-300" unitRef="usd">6548000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-301" unitRef="usd">3645000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-78" id="f-302">The material terms of this Rule 10b5-1 trading arrangement are described below:&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.066%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.738%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Name and Title&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Action Taken&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Type of Trading Arrangement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nature of Trading Arrangement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Duration of Trading Arrangement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Catalys Pacific Fund, LP&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption January&#160;9, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading plan intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of the Company&#x2019;s common stock pursuant to the terms of the plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 9, 2026 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March&#160;31, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrIndName contextRef="c-78" id="f-303">Catalys Pacific Fund, LP</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-78" id="f-304">Catalys Pacific Fund, LP</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-78" id="f-305">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrAdoptionDate contextRef="c-78" id="f-306">January&#160;9, 2026</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrExpirationDate contextRef="c-78" id="f-307">March&#160;31, 2027</ecd:TrdArrExpirationDate>
    <ecd:TrdArrSecuritiesAggAvailAmt contextRef="c-79" decimals="0" id="f-308" unitRef="shares">2000000</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-309">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-310">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-311">false</ecd:Rule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#f-176"
          xlink:label="f-176"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-175"
          xlink:label="f-175"
          xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Cash and cash equivalents as of March&#160;31, 2026 exclude investments of $533.3&#160;million. Cash, cash equivalents, and investments amounted to $646.1&#160;million as of March&#160;31, 2026.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-176"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-175"
          xlink:to="fn-1"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
